0001413329-18-000023.txt : 20180426 0001413329-18-000023.hdr.sgml : 20180426 20180426075837 ACCESSION NUMBER: 0001413329-18-000023 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 101 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180426 DATE AS OF CHANGE: 20180426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Philip Morris International Inc. CENTRAL INDEX KEY: 0001413329 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] IRS NUMBER: 133435103 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33708 FILM NUMBER: 18776207 BUSINESS ADDRESS: STREET 1: 120 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (917) 663-2000 MAIL ADDRESS: STREET 1: 120 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 10-Q 1 pm-033118x10qxdoc.htm 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One) 
(X)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2018
OR
 
( )
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number 001-33708
Philip Morris International Inc.
 
 
 
 
 
(Exact name of registrant as specified in its charter)
 
Virginia
13-3435103
(State or other jurisdiction of
    incorporation or organization)
(I.R.S. Employer
    Identification No.)
 
120 Park Avenue
New York, New York
10017
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code
(917) 663-2000
 
 
 
 
 
 
Former name, former address and former fiscal year, if changed since last report
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ        No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  þ        No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer    þ                        Accelerated filer            ¨  
Non-accelerated filer    ¨  (Do not check if a smaller reporting company)    Smaller reporting company    ¨
Emerging growth company    ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  þ
At April 23, 2018, there were 1,554,473,725 shares outstanding of the registrant’s common stock, no par value per share.

-1-

PHILIP MORRIS INTERNATIONAL INC.
TABLE OF CONTENTS
 
 
 
Page No.
 
 
 
PART I -
 
 
 
 
Item 1.
 
 
 
 
 
Condensed Consolidated Balance Sheets at
 
 
March 31, 2018 and December 31, 2017
3 –  4
 
 
 
 
Condensed Consolidated Statements of Earnings for the
 
 
Three Months Ended March 31, 2018 and 2017
 
 
 
 
Condensed Consolidated Statements of Comprehensive Earnings for the
 
 
Three Months Ended March 31, 2018 and 2017

 
 
 
 
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity for the
 
 
Three Months Ended March 31, 2018 and 2017
 
 
 
 
Condensed Consolidated Statements of Cash Flows for the
 
 
Three Months Ended March 31, 2018 and 2017
8 –  9
 
 
 
 
10 – 37
 
 
 
Item 2.
38 – 68
 
 
 
Item 4.
 
 
 
PART II -
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 6.
 
 
 
 
In this report, “PMI,” “we,” “us” and “our” refer to Philip Morris International Inc. and its subsidiaries.

- 2-

PART I – FINANCIAL INFORMATION
Item 1. Financial Statements.
Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions of dollars)
(Unaudited)
 
 
March 31,
2018
 
December 31,
2017
ASSETS
 
 
 
Cash and cash equivalents
$
7,200

 
$
8,447

Trade receivables (less allowances of $25 in 2018 and $25 in 2017)
3,373

 
3,194

Other receivables
521

 
544


Inventories:
 
 
 
Leaf tobacco
2,737

 
2,606

Other raw materials
1,481

 
1,563

Finished product
4,374

 
4,637

 
8,592

 
8,806

Other current assets
907

 
603


Total current assets
20,593

 
21,594


Property, plant and equipment, at cost
15,056

 
14,566

Less: accumulated depreciation
7,597

 
7,295

 
7,459

 
7,271

Goodwill (Note 4)
7,667

 
7,666

Other intangible assets, net (Note 4)
2,455

 
2,432

Investments in unconsolidated subsidiaries and equity securities (Notes 11&14)
1,395

 
1,074

Deferred income taxes
1,150

 
1,007

Other assets
2,351

 
1,924

TOTAL ASSETS
$
43,070

 
$
42,968








See notes to condensed consolidated financial statements.
Continued

- 3-

Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (Continued)
(in millions of dollars, except share data)
(Unaudited)
 
 
March 31,
2018
 
December 31,
2017
LIABILITIES
 
 
 
Short-term borrowings (Note 10)
$
608

 
$
499

Current portion of long-term debt (Note 10)
4,662

 
2,506

Accounts payable
2,156

 
2,242

Accrued liabilities:
 
 
 
Marketing and selling
668

 
708

Taxes, except income taxes
5,085

 
5,324

Employment costs
770

 
856

Dividends payable
1,675

 
1,669

Other
1,556

 
1,346

Income taxes (Note 9)
508

 
812

Total current liabilities
17,688

 
15,962


Long-term debt (Note 10)
29,578

 
31,334

Deferred income taxes
822

 
799

Employment costs
2,272

 
2,271

Income taxes and other liabilities (Note 9)
3,192

 
2,832

Total liabilities
53,552

 
53,198


Contingencies (Note 8)

 


STOCKHOLDERS’ (DEFICIT) EQUITY
 
 
 

Common stock, no par value
(2,109,316,331 shares issued in 2018 and 2017)
—

 
—

Additional paid-in capital
1,856

 
1,972

Earnings reinvested in the business
29,985

 
29,859

Accumulated other comprehensive losses
(8,883
)
 
(8,535
)
 
22,958

 
23,296

Less: cost of repurchased stock
   (554,850,007 and 556,098,569 shares in 2018 and 2017, respectively)
35,308

 
35,382

Total PMI stockholders’ deficit
(12,350
)
 
(12,086
)
Noncontrolling interests
1,868

 
1,856

Total stockholders’ deficit
(10,482
)
 
(10,230
)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
$
43,070

 
$
42,968



See notes to condensed consolidated financial statements.

- 4-

Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings
(in millions of dollars, except per share data)
(Unaudited)
 
 
For the Three Months Ended March 31,
 
2018
 
2017
Revenues including excise taxes
$
18,426

 
$
16,556

Excise taxes on products
11,530

 
10,492

Net revenues (Note 18)
6,896

 
6,064

Cost of sales
2,615

 
2,177

Gross profit
4,281

 
3,887

Marketing, administration and research costs
1,833

 
1,449

Amortization of intangibles
22

 
22

Operating income
2,426

 
2,416

Interest expense, net
227

 
219

Pension and other employee benefit costs (Note 3)
6

 
20

Earnings before income taxes
2,193

 
2,177

Provision for income taxes
559

 
541

Equity investments and securities (income)/loss, net
(13
)
 
(22
)
Net earnings
1,647

 
1,658

Net earnings attributable to noncontrolling interests
91

 
68

Net earnings attributable to PMI
$
1,556

 
$
1,590


Per share data (Note 6):
 
 
 
Basic earnings per share
$
1.00

 
$
1.02

Diluted earnings per share
$
1.00

 
$
1.02

Dividends declared
$
1.07

 
$
1.04








See notes to condensed consolidated financial statements.


- 5-

Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Earnings
(in millions of dollars)
(Unaudited)

 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Net earnings
 
$
1,647

 
$
1,658

Other comprehensive earnings (losses), net of income taxes:
 
 
 
 
Change in currency translation adjustments:
 
 
 
 
Unrealized gains (losses), net of income taxes of $192 in 2018 and $156 in 2017
 
(371
)
 
303


Change in net loss and prior service cost:
 
 
 
 
Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($11) in 2018 and ($9) in 2017
 
50

 
56


Change in fair value of derivatives accounted for as hedges:
 
 
 
 
Gains (losses) recognized, net of income taxes of $10 in 2018 and $11 in 2017
 
(64
)
 
(75
)
(Gains) losses transferred to earnings, net of income taxes of ($1) in 2018 and $2 in 2017
 
2

 
5

Total other comprehensive earnings (losses)
 
(383
)
 
289

Total comprehensive earnings
 
1,264

 
1,947

Less comprehensive earnings attributable to:
 
 
 
 
Noncontrolling interests
 
56

 
63

Comprehensive earnings attributable to PMI
 
$
1,208

 
$
1,884













See notes to condensed consolidated financial statements

- 6-

Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ (Deficit) Equity
For the Three Months Ended March 31, 2018 and 2017
(in millions of dollars, except per share amounts)
(Unaudited)
 
PMI Stockholders’ (Deficit) Equity
 
 
 
 
 
Common
Stock
 
Additional
Paid-in
Capital
 
Earnings
Reinvested in
the
Business
 
Accumulated
Other
Comprehensive Losses
 
Cost of
Repurchased
Stock
 
Noncontrolling
Interests
 
Total
Balances, January 1, 2017
$
—

 
$
1,964

 
$
30,397

 
$
(9,559
)
 
$
(35,490
)
 
$
1,788

 
$
(10,900
)
Net earnings
 
 
 
 
1,590

 
 
 
 
 
68

 
1,658

Other comprehensive earnings (losses), net of income taxes
 
 
 
 
 
 
294

 
 
 
(5
)
 
289

Issuance of stock awards
 
 
(71
)
 
 
 
 
 
104

 
 
 
33

Dividends declared ($1.04 per share)
 
 
 
 
(1,620
)
 
 
 
 
 
 
 
(1,620
)
Payments to noncontrolling interests
 
 
 
 
 
 
 
 
 
 
(17
)
 
(17
)
Other
 
 
(1
)
 
 
 
 
 
 
 
1

 
—

Balances, March 31, 2017
$
—

 
$
1,892

 
$
30,367

 
$
(9,265
)
 
$
(35,386
)
 
$
1,835

 
$
(10,557
)
Balances, January 1, 2018
$
—

 
$
1,972

 
$
29,859

 
$
(8,535
)
 
$
(35,382
)
 
$
1,856

 
$
(10,230
)
Net earnings
 
 
 
 
1,556

 
 
 
 
 
91

 
1,647

Other comprehensive earnings (losses), net of income taxes
 
 
 
 
 
 
(344
)
 
 
 
(39
)
 
(383
)
Issuance of stock awards
 
 
(29
)
 
 
 
 
 
74

 
 
 
45

Dividends declared ($1.07 per share)
 
 
 
 
(1,668
)
 
 
 
 
 
 
 
(1,668
)
Payments to noncontrolling interests
 
 
 
 
 
 
 
 
 
 
(36
)
 
(36
)
Adoption of new accounting standards (Note18)
 
 
 
 
238

 
 
 
 
 
 
 
238

Other (Note 17)
 
 
(87
)
 
 
 
(4
)
 
 
 
(4
)
 
(95
)
Balances, March 31, 2018
$
—

 
$
1,856

 
$
29,985

 
$
(8,883
)
 
$
(35,308
)
 
$
1,868

 
$
(10,482
)

 
See notes to condensed consolidated financial statements.

- 7-

Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions of dollars)
(Unaudited)
 
 
For the Three Months Ended March 31,
 
2018
 
2017
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
 
 
 
 
 
 
 
Net earnings
$
1,647

 
$
1,658

 
 
 
 
Adjustments to reconcile net earnings to operating cash flows:
 
 
 
Depreciation and amortization
242

 
197

Deferred income tax provision
26

 
27

Cash effects of changes in:
 
 
 
Receivables, net
(113
)
 
504

Inventories
338

 
1,243

Accounts payable
(62
)
 
84

Accrued liabilities and other current assets
(509
)
 
(2,207
)
Income taxes
(315
)
 
(510
)
Pension plan contributions
(25
)
 
(18
)
Other
151

 
(135
)
Net cash provided by operating activities
1,380

 
843

 
 
 
 
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
 
 
 
 
 
 
 
Capital expenditures
(365
)
 
(292
)
Investments in unconsolidated subsidiaries and equity securities
(18
)
 
(5
)
Net investment hedges
(665
)
 
(254
)
Other
30

 
8

Net cash used in investing activities
(1,018
)
 
(543
)
 

















See notes to condensed consolidated financial statements.

Continued

- 8-

Philip Morris International Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Continued)
(in millions of dollars)
(Unaudited)
 
 
For the Three Months Ended March 31,
 
2018
 
2017
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
 
 
 
 
 
 
 
Short-term borrowing activity by original maturity:
 
 
 
    Net issuances - maturities of 90 days or less
$
103

 
$
374

Long-term debt proceeds
—

 
2,482

Long-term debt repaid
—

 
(814
)
Dividends paid
(1,659
)
 
(1,618
)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 17)
(91
)
 
—

Other
(91
)
 
(83
)
Net cash provided by (used in) financing activities
(1,738
)
 
341

Effect of exchange rate changes on cash, cash equivalents and restricted cash
131

 
234

 
 
 
 
Cash, cash equivalents and restricted cash(1):
 
 
 
Increase (Decrease)
(1,245
)
 
875

Balance at beginning of period
8,476

 
4,331

Balance at end of period
$
7,231

 
$
5,206

 
 
 
 
(1) Following the adoption of Financial Accounting Standards Update ASU 2016-18, "Statement of Cash Flows: Restricted Cash," the amounts for cash and cash equivalents shown above include restricted cash of $31 million and $130 million as of March 31, 2018 and 2017, respectively, and $29 million and $92 million as of December 31, 2017, and 2016, respectively, which were included in other current assets in the condensed consolidated balance sheets.







See notes to condensed consolidated financial statements.

- 9-

Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
 
Note 1. Background and Basis of Presentation:

Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates and their licensees are engaged in the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products, in markets outside of the United States of America. Throughout these financial statements, the term "PMI" refers to Philip Morris International Inc. and its subsidiaries.

Reduced-risk products ("RRPs") is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.

To provide a greater focus on both parts of PMI's business -- combustible and reduced-risk products -- and to support PMI's transformation towards a smoke-free future, effective January 1, 2018, PMI began managing its business in six reportable segments as follows: European Union; Eastern Europe; Middle East & Africa; South & Southeast Asia; East Asia & Australia; and Latin America & Canada. For further details, see Note 7. Segment Reporting.

Certain prior years' amounts have been reclassified to conform with the current year's presentation, due primarily to new accounting guidance related to revenue recognition, pension costs and restricted cash and PMI’s decision to reorganize its reportable segments. For further details, see the condensed consolidated statements of cash flows, Note 3. Benefit Plans, Note 7. Segment Reporting and Note 18. New Accounting Standards. The changes did not have a material impact on PMI's consolidated financial position, results of operations or cash flows in any of the periods presented.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2017.

Note 2. Stock Plans:

In May 2017, PMI’s shareholders approved the Philip Morris International Inc. 2017 Performance Incentive Plan (the “2017 Plan”). The 2017 Plan replaced the 2012 Performance Incentive Plan, and there will be no additional grants under the replaced plan. Under the 2017 Plan, PMI may grant to eligible employees restricted shares and restricted share units, performance-based cash incentive awards and performance-based equity awards. Up to 25 million shares of PMI’s common stock may be issued under the 2017 Plan. At March 31, 2018, shares available for grant under the 2017 Plan were 22,939,200.

In May 2017, PMI’s shareholders also approved the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors (the “2017 Non-Employee Directors Plan”). The 2017 Non-Employee Directors Plan replaced the 2008 Stock Compensation Plan for Non-Employee Directors, and there will be no additional grants under the replaced plan. A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the 2017 Non-Employee Directors Plan. At March 31, 2018, shares available for grant under the plan were 1,000,000.


- 10-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Restricted share unit (RSU) awards

During the three months ended March 31, 2018 and 2017, shares granted to eligible employees, the weighted-average grant date
fair value per share and the recorded compensation expense related to RSU awards were as follows:
 
Number of Shares Granted
Weighted-Average Grant Date Fair Value Per RSU Award Granted
Compensation Expense Related to RSU Awards (in millions)
2018
1,249,650

$
100.70

$
38

2017
1,202,060

$
98.47

$
35

 
 
 
As of March 31, 2018, PMI had $196 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

During the three months ended March 31, 2018, 1,378,550 RSU awards vested. The grant date fair value of all the vested awards was approximately $114 million. The total fair value of RSU awards that vested during the three months ended March 31, 2018 was approximately $143 million.

Performance share unit (PSU) awards

During the three months ended March 31, 2018 and 2017, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a three-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group and on an absolute basis (50% weight), PMI’s currency-neutral compound annual adjusted operating income growth rate, excluding acquisitions (30% weight), and PMI’s performance against specific measures of PMI’s transformation (20% weight). The aggregate of the weighted performance factors for the three metrics determines the percentage of PSUs that will vest at the end of the three-year performance cycle. The minimum percentage of PSUs that can vest is zero, with a target percentage of 100 and a maximum percentage of 200. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned.

During the three months ended March 31, 2018 and 2017, shares granted to eligible employees, the grant date fair value per share
and the recorded compensation expense related to PSU awards were as follows:
 
Number of Shares Granted
PSU Grant Date Fair Value Subject to TSR Performance Factor Per Share (a)
PSU Grant Date Fair Value Subject to Other Performance Factors Per Share (b)
Compensation Expense Related to PSU Awards (in millions)
2018
401,500

$
118.98

$
100.69

$
21

2017
393,460

$
128.72

$
98.29

$
17


(a) The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.
(b) The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.
 
 
 
As of March 31, 2018, PMI had $57 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.

During the three months ended March 31, 2018, there were no PSU awards that vested.


- 11-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 3. Benefit Plans:

Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to substantially all U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans. PMI adopted ASU 2017-07 "Compensation - Retirement Benefits" on January 1, 2018, retrospectively for all periods. Following adoption, the service cost component of net periodic benefit cost continues to be included within operating income, while all other cost components are included below operating income, within pension and other employee benefit costs, including $19 million and $22 million related to net postemployment costs for the three months ended March 31, 2018 and 2017, respectively, and $3 million and $4 million related to net postretirement costs for the three months ended March 31, 2018 and 2017, respectively.

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:
 
 
Pension (1)
 
 
For the Three Months Ended March 31,
(in millions)
 
2018
 
2017
Service cost
 
$
53

 
$
51

Interest cost
 
28

 
26

Expected return on plan assets
 
(87
)
 
(79
)
Amortization:
 

 

Net loss
 
43

 
44

Prior service cost
 
—

 
3

Net periodic pension cost
 
$
37

 
$
45


(1) Primarily non-U.S. based defined benefit retirement plans.

Employer Contributions
PMI makes, and plans to make, contributions, to the extent that they are tax deductible and to meet specific funding requirements of its funded pension plans. Employer contributions of $25 million were made to the pension plans during the three months ended March 31, 2018. Currently, PMI anticipates making additional contributions during the remainder of 2018 of approximately $46 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.


- 12-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 4. Goodwill and Other Intangible Assets, net:
Goodwill and other intangible assets, net, by segment were as follows:

 
Goodwill
 
Other Intangible Assets, net
(in millions)
March 31,
2018
December 31,
2017
 
March 31,
2018
December 31,
2017
European Union
$
1,474

$
1,419

 
$
439

$
458

Eastern Europe
334

321

 
22

16

Middle East & Africa
107

102

 
185

178

South & Southeast Asia
2,938

3,010

 
987

1,004

East Asia & Australia
561

567

 
59

44

Latin America & Canada
2,253

2,247

 
763

732

Total
$
7,667

$
7,666

 
$
2,455

$
2,432

Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from December 31, 2017, were as follows:
(in millions)
European Union
Eastern Europe
Middle East & Africa
South & Southeast Asia
East Asia & Australia
Latin America & Canada
Total
Balances, December 31, 2017
$
1,419

$
321

$
102

$
3,010

$
567

$
2,247

$
7,666

Changes due to:
 
 
 
 
 
 
 
Currency
55

13

5

(72
)
(6
)
6

1

Balances, March 31, 2018
$
1,474

$
334

$
107

$
2,938

$
561

$
2,253

$
7,667

Additional details of other intangible assets were as follows:
 
 
March 31, 2018
 
December 31, 2017
(in millions)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Non-amortizable intangible assets
 
$
1,341

 
 
 
$
1,323

 
 
Amortizable intangible assets
 
1,818

 
$
704

 
1,798

 
$
689

Total other intangible assets
 
$
3,159

 
$
704

 
$
3,121

 
$
689


Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2018, were as follows:


(dollars in millions)
Gross Carrying Amount
Initial Estimated
Useful Lives
    
Weighted-Average
Remaining Useful Life
Trademarks
$
1,555

2 - 40 years
    
19 years
Distribution networks
151

5 - 30 years
    
9 years
Other (including farmer contracts
  and intellectual property rights)
112

4 - 17 years
    
11 years
 
$
1,818

 
 
 


- 13-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Pre-tax amortization expense for intangible assets during the three months ended March 31, 2018 and 2017 was $22 million and $22 million, respectively. Amortization expense for each of the next five years is estimated to be $84 million or less, assuming no additional transactions occur that require the amortization of intangible assets.
The increase in the gross carrying amount of other intangible assets from December 31, 2017, was due primarily to the purchase of additional intellectual property rights related to PMI's reduced-risk products, as well as currency movements.

Note 5. Financial Instruments:

Overview

PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings.

PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Canadian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble, Swiss franc and Turkish lira. At March 31, 2018, PMI had contracts with aggregate notional amounts of $33.4 billion of which $7.1 billion related to cash flow hedges, $11.3 billion related to hedges of net investments in foreign operations and $15.0 billion related to other derivatives that primarily offset currency exposures on intercompany financing.

Effective January 1, 2018, PMI elected to early adopt Accounting Standard Update 2017-12 “Derivatives and Hedging (Topic 815) Targeted Improvements to Accounting for Hedging Activities,” which did not have a material impact on PMI’s consolidated financial position or results of operations.


- 14-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2018 and December 31, 2017, were as follows:

 
 
Derivative Assets
 
Derivative Liabilities
 
 

 
Fair Value
 

 
Fair Value
(in millions)
 
Balance Sheet Classification
 
At March 31, 2018
 
At December 31, 2017
 
Balance Sheet Classification
 
At March 31, 2018
 
At December 31, 2017
Foreign exchange contracts designated as hedging instruments
 
Other current assets
 
$
48

 
$
84

 
Other accrued liabilities
 
$
433

 
$
197

 
 
Other assets
 
6

 
34

 
Other liabilities
 
1,237

 
880

Foreign exchange contracts not designated as hedging instruments 
 
Other current assets 
 
60

 
22

 
Other accrued liabilities
 
20

 
37

 
 
Other assets
 
—

 
—

 
Other liabilities
 
67

 
14

Total derivatives
 
 
 
$
114

 
$
140

 
 
 
$
1,757

 
$
1,128


For the three months ended March 31, 2018 and 2017, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
 
 
 
 
 
 
 
 
 
 
(pre-tax, in millions)
For the Three Months Ended March 31,
 
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives
 
Statement of Earnings
Classification of Gain/(Loss)
Reclassified from Other
Comprehensive
Earnings/(Losses) into
Earnings
 
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
 
2018
 
2017
 
 
 
2018
 
2017
Derivatives in Cash Flow Hedging Relationship
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
(74
)
 
$
(86
)
 
 
 
 
 
 
 
 
 
 
 
Net revenues
 
$
(9
)
 
$
9

 
 
 
 
 
Cost of sales
 
—

 
—

 
 
 
 
 
Marketing, administration and research costs
 
8

 
(9
)
 
 
 
 
 
Interest expense, net
 
(2
)
 
(3
)
Derivatives in Net Investment Hedging Relationship
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
(608
)
 
(249
)
 
 
 
 
 
 
Total
$
(682
)
 
$
(335
)
 
 
 
$
(3
)
 
$
(3
)

Cash Flow Hedges

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to certain forecasted transactions. Gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. As of March 31, 2018, PMI has hedged forecasted transactions for periods not exceeding the next fifteen months with the exception of one foreign exchange contract that expires in May 2024. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.

- 15-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)


Hedges of Net Investments in Foreign Operations

PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges, primarily of its Euro net assets. For the three months ended March 31, 2018 and 2017, these hedges of net investments resulted in losses, net of income taxes, of $757 million and $294 million, respectively, principally related to changes in the exchange rates between the Euro and U.S. dollar. These losses were reported as a component of accumulated other comprehensive losses within currency translation adjustments, and were substantially offset by the gains generated on the underlying assets. For the three months ended March 31, 2018, the gains for amounts excluded from the effectiveness testing recognized in earnings based on the changes in fair value were $67 million and were accounted for in interest expense, net, on the condensed consolidated statement of earnings. The premiums paid for, and settlements of, net investment hedges are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.

Other Derivatives

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in marketing, administration and research costs in PMI’s condensed consolidated statements of earnings. For the three months ended March 31, 2018 and 2017, the gains (losses) from contracts for which PMI did not apply hedge accounting were $95 million and $(39) million, respectively. The gains (losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.

For the three months ended March 31, 2018 and 2017, the net impact of these contracts on the condensed consolidated statements of earnings was not material.
 
 
 
 
 
 
 
Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses

Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Gain as of January 1,
$
42

$
97

Derivative (gains)/losses transferred to earnings
2

5

Change in fair value
(64
)
(75
)
Gain/(loss) as of March 31,
$
(20
)
$
27

At March 31, 2018, PMI expects $30 million of derivative losses that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These losses are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.
Contingent Features
PMI’s derivative instruments do not contain contingent features.
Credit Exposure and Credit Risk
PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limit and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.

- 16-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Fair Value
See Note 11. Fair Value Measurements and Note 13. Balance Sheet Offsetting for additional discussion of derivative financial instruments.

Note 6. Earnings Per Share:
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net earnings attributable to PMI
$
1,556

$
1,590

Less distributed and undistributed earnings attributable to share-based payment awards
3

3

Net earnings for basic and diluted EPS
$
1,553

$
1,587

Weighted-average shares for basic EPS
1,553

1,552

Plus contingently issuable performance stock units (PSUs)
1

1

Weighted-average shares for diluted EPS
1,554

1,553

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.
For the 2018 and 2017 computations, there were no antidilutive stock awards.

Note 7. Segment Reporting:

PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes and other nicotine-containing products, including RRPs, in markets outside of the United States of America. Reportable segments for PMI are organized by geographic region and managed by segment managers who are responsible for the operating and financial results of the regions inclusive of all product categories sold in the region. Effective January 1, 2018, PMI began managing its business in six reportable segments. PMI’s reportable segments are the European Union; Eastern Europe; Middle East & Africa; South & Southeast Asia; East Asia & Australia; and Latin America & Canada. PMI records net revenues and operating income to its segments based upon the geographic area in which the customer resides.

PMI’s chief operating decision maker evaluates segment performance and allocates resources based on regional operating income, which includes results from all product categories sold in each region. Effective January 1, 2018, PMI began using operating income to evaluate business segment performance and allocate resources, replacing operating companies income used previously.

On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, "Revenue from Contracts with Customers." PMI adopted this standard retrospectively to each prior period presented. For further details on this standard and its impact on PMI, see Note 18. New Accounting Standards. The amounts presented for the reportable segments reflect this adoption.
 
PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's six reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors.


- 17-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Segment data were as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net revenues:
 
 
European Union
$
1,988

$
1,740

Eastern Europe
567

516

Middle East & Africa
961

961

South & Southeast Asia
1,081

1,031

East Asia & Australia
1,591

1,210

Latin America & Canada
708

606

Net revenues
$
6,896

$
6,064

Operating income:
 
 
European Union
$
740

$
748

Eastern Europe
151

159

Middle East & Africa
374

491

South & Southeast Asia
429

370

East Asia & Australia
515

472

Latin America & Canada
217

176

Operating income
$
2,426

$
2,416


PMI's net revenues by product category were as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net revenues:
 
 
Combustible products:
 
 
European Union
$
1,836

$
1,709

Eastern Europe
527

513

Middle East & Africa
884

957

South & Southeast Asia
1,081

1,031

East Asia & Australia
737

813

Latin America & Canada
704

605

Total combustible products
$
5,769

$
5,629

Reduced-risk products:
 
 
European Union
$
152

$
31

Eastern Europe
40

3

Middle East & Africa
77

4

South & Southeast Asia
—

—

East Asia & Australia
854

396

Latin America & Canada
4

—

Total reduced-risk products
$
1,127

$
435

 
 
 
Total PMI net revenues
$
6,896

$
6,064

Note: Sum of product categories or Regions might not foot to total PMI due to roundings.


- 18-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's cigarettes and other tobacco products combined. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include reduced-risk products.

Net revenues related to reduced-risk products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's heated tobacco units, IQOS devices and related accessories, and other nicotine-containing products, which primarily include our e-vapor products.

PMI recognizes revenue, when control is transferred to the customer, typically either upon shipment or delivery of goods.


Note 8. Contingencies:
Tobacco-Related Litigation
Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.
It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.
Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.
We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.
It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    
To date, no tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.
The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 24, 2018, April 25, 2017 and April 22, 2016:
 

- 19-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Type of Case
 
Number of Cases Pending as of April 24, 2018
 
Number of Cases Pending as of April 25, 2017
 
Number of Cases Pending as of April 22, 2016
Individual Smoking and Health Cases
 
62
 
63
 
66
Smoking and Health Class Actions
 
11
 
11
 
11
Health Care Cost Recovery Actions
 
16
 
16
 
16
Label-Related Class Actions
 
1
 
—
 
—
Individual Label-Related Cases
 
1
 
1
 
3
Public Civil Actions
 
2
 
2
 
3
Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 476 Smoking and Health, Label-Related, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Thirteen cases have had decisions in favor of plaintiffs. Nine of these cases have subsequently reached final resolution in our favor and four remain on appeal.

The table below lists the verdict and significant post-trial developments in the four pending cases where a verdict was returned in favor of the plaintiff:

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
February 2004
  
Brazil/The Smoker Health Defense Association
  
Class Action
  
The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.
  
Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.


- 20-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
May 27, 2015
  
Canada/Cecilia Létourneau
  
Class Action
  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
  
In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)


- 21-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
May 27, 2015
  
Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais

  
Class Action
  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion, into a trust within 60 days.
  
In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

- 22-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
August 5, 2016
 
Argentina/Hugo Lespada
 
Individual Action
 
On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages.
The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
 
On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires.

Pending claims related to tobacco products generally fall within the following categories:
Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.
As of April 24, 2018, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:

•
62 cases brought by individual plaintiffs in Argentina (34), Brazil (10), Canada (4), Chile (6), Costa Rica (1), Italy (3), the Philippines (1), Russia (1), Turkey (1) and Scotland (1), compared with 63 such cases on April 25, 2017, and 66 cases on April 22, 2016; and
•
11 cases brought on behalf of classes of individual plaintiffs in Brazil (2) and Canada (9), compared with 11 such cases on April 25, 2017 and 11 such cases on April 22, 2016.

In the first class action pending in Brazil, The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In February 2017, the Chief Justice of the Supreme Court of Justice denied plaintiff's appeal. In March 2017, plaintiff filed an en banc appeal to the Supreme Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. Both appeals are still pending.

In the second class action pending in Brazil, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil, filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities,

- 23-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the ADESF case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the ADESF case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.

In the first class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005.  Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million), in the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.4 million) beginning in December 2015 through March 2017. See the Blais description for further detail concerning the security order. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than three years after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the second class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion, including pre-judgment interest (approximately $12.1 billion). The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion, including pre-judgment

- 24-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

interest (approximately $2.4 billion)). In addition, the trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at 99,957 members. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award into a trust within 60 days, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD 5 billion (approximately $3.91 billion) into trust, to secure the judgments in both the Létourneau and Blais cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. Such security may take the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.4 million) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $593 million) in seven equal consecutive quarterly installments of approximately CAD 108 million (approximately $84.6 million) beginning in December 2015 through June 2017. In March 2017, our subsidiary made its sixth and final quarterly installment of security for approximately CAD 37.6 million (approximately $29.4 million) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.
In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of Adams, below).
In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.
In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and

- 25-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).
In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).
In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.
As of April 24, 2018, there were 16 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (10), Korea (1) and Nigeria (5), compared with 16 such cases on April 25, 2017 and 16 such cases on April 22, 2016.
In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related

- 26-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.
In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing. In June 2017, the trial court set a trial date for November 4, 2019.
In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Pre-trial discovery is ongoing.
In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. While discovery initially was scheduled to begin in 2017 by agreement of the parties, to date, the discovery process has not started.
In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed

- 27-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. While discovery initially was scheduled to begin in 2017 by agreement of the parties, to date, the discovery process has not started.

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Pre-trial discovery is ongoing.
In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.
In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.
In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.
In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately $53.7 million allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.

Label-Related Cases: These cases, brought by individual plaintiffs, or on behalf of a class or purported class of individual plaintiffs, allege that the use of the descriptor “Lights” or other alleged misrepresentations or omissions of labeling information constitute

- 28-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of April 24, 2018, there was 1 case brought by an individual plaintiff in Italy (1) pending against our subsidiaries, compared with 1 such cases on April 25, 2017, and 3 such cases on April 22, 2016, and one purported class action in Israel (1).

An individual plaintiff filed the purported class action, Aharon Ringer v. Philip Morris Ltd. and Globrands Ltd., on July 18, 2017, in the Central District Court of Israel. Our Israeli affiliate and an Israeli importer and distributor for other multinational tobacco companies are defendants. Plaintiff seeks to represent a class of smokers in Israel who have purchased cigarettes imported by defendants since July 18, 2010. Plaintiff estimates the class size to be 7,000,000 smokers. Plaintiff alleges that defendants misled consumers by not disclosing sufficient information about carbon monoxide, tar, and nicotine yields of, and tobacco contained in, the imported cigarettes. Plaintiff seeks various forms of relief, including an order for defendants to label cigarette packs in accordance with plaintiff’s demands, and damages for misleading consumers, breach of autonomy and unjust enrichment.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of April 24, 2018, there were 2 public civil actions pending against our subsidiaries in Argentina (1) and Venezuela (1), compared with 2 such cases on April 25, 2017, and 3 such cases on April 22, 2016.

In the public civil action in Argentina, Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina, filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.

In the public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB 80.8 billion (approximately $2.57 billion). In May 2017, the King of Thailand signed a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with

- 29-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. Trial in the case began in November 2017. In March 2018, acting on a request from the Public Prosecutor, the court suspended the trial proceedings indefinitely and struck the case from the court list. The case may be reactivated by the court or upon application of a party.

The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $629 million). The case is in pre-trial proceedings. The trial is scheduled to begin in the last quarter of 2018. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court. In May 2017, the King of Thailand signed a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. On November 29, 2017, PM Thailand received notices of assessment in the aggregate amount of approximately THB 25.6 billion (approximately $813 million) from the Thai Customs Department alleging that PM Thailand under-declared customs values for the imports from Indonesia covering the period 2001-2003. The notices include the Indonesian import entries subject to the proceedings discussed above and are in addition to the fine sought by the government in the criminal proceedings. PM Thailand filed its appeal against the notices in December 2017. We believe that all of the notices of assessment are barred by the applicable statutes of limitations and are otherwise without merit. In March 2018, the Thai Customs Post Clearance Audit Bureau informed PM Thailand that the Thai Customs Department will cancel or otherwise not pursue the notices. PM Thailand is considering whether further procedural steps are required to confirm the finality of this development.   

The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean affiliate, were in compliance with South Korean tax laws.  In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.  In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $254 million), of which KRW 100 billion (approximately $93 million) was paid in 2016 and KRW 172 billion (approximately $160 million) was paid in the first quarter of 2017.  These amounts are included in other assets in the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows.  PM Korea is appealing the assessments. The tax authorities have also referred the matter to the Public Prosecutor, who will further investigate and decide whether to file criminal charges against PM Korea and/or other alleged co-offenders. If the Public Prosecutor decides to prosecute, it may seek up to three times the underpaid tax for company criminal penalties and up to five times the underpaid tax for individual criminal penalties. PM Korea believes that it has paid cigarette-related taxes in compliance with the South Korean tax laws. In addition, the South Korean Ministry of Strategy and Finance (“MOSF”) filed a criminal complaint with the Public Prosecutor against PM Korea and its managing director. In its criminal complaint, the MOSF alleged that PM Korea exceeded the monthly product withdrawal limits that the MOSF had set in its notice. The Public Prosecutor will investigate the MOSF’s criminal complaint and decide whether to prosecute.  PM Korea disagrees with the MOSF’s allegations.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.

Note 9. Income Taxes:
Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

In December 2017, the Tax Cuts and Jobs Act was signed into law. Accordingly, PMI recorded a provisional charge of $1.6 billion in its 2017 income tax provision, including a charge for the transition tax on accumulated foreign earnings of $1.4 billion and $0.2 billion due to the re-measurement of U.S. deferred tax assets and liabilities using a rate of 21%. PMI is evaluating the assumptions used in the analysis, as well as guidance issued by the U.S. Treasury Department and the Internal Revenue Service and has not

- 30-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

made any measurement period adjustments related to these items during the quarter. PMI will complete its analysis during 2018, and any adjustments to the provisional charges will be included in income tax expense or benefit in the appropriate period, in accordance with Staff Accounting Bulletin No. 118 (SAB 118).

PMI’s effective tax rates for the three months ended March 31, 2018 and 2017 were 25.5% and 24.9%, respectively. The effective tax rate for the three months ended March 31, 2017 was favorably impacted by the tax benefit of a legal entity restructuring ($61 million). In 2018, PMI's effective tax rate is expected to exceed the new U.S. federal statutory rate of 21%. PMI’s higher effective tax rate for the three months ended March 31, 2018 was primarily due to earnings mix by taxing jurisdiction, as well as the expected impact of Global Intangible Low Taxed Income ("GILTI") provisions of the Tax Cuts and Jobs Act, partially offset by the favorable tax treatment of Foreign Derived Intangible Income ("FDII").

Based upon PMI's current interpretation of the Tax Cuts and Jobs Act, PMI estimates that its full-year 2018 effective tax rate will be approximately 26%, subject to future regulatory developments. PMI is continuing to assess the impacts of the Tax Cuts and Jobs Act on the effective tax rate and income tax accounting, in particular the foreign tax credit limitations related to the new GILTI provisions. PMI will complete this assessment during 2018 and will make an accounting policy election on whether to treat GILTI taxes as a current period expense or include these amounts in the measurement of deferred taxes. Based on PMI’s assessment to date, no impact is expected from the Base Erosion and Anti-Abuse Tax ("BEAT") rules. Changes in currency exchange rates or earnings mix by taxing jurisdiction also have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2013 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.

It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Note 10. Indebtedness:
Short-term Borrowings:
PMI's short-term borrowings, consisting of bank loans to certain PMI subsidiaries at March 31, 2018 and December 31, 2017, had a carrying value of $608 million and $499 million, respectively. The fair value of PMI’s short-term borrowings, based on current market interest rates, approximates carrying value.

Long-term Debt:
At March 31, 2018 and December 31, 2017, PMI’s long-term debt consisted of the following:

(in millions)
 
March 31, 2018
 
December 31, 2017
U.S. dollar notes, 1.375% to 6.375% (average interest rate 3.566%), due through 2044
 
$
23,294

 
$
23,291

Foreign currency obligations:
 
 
 
 
Euro notes, 0.625% to 3.125% (average interest rate 2.250%), due through 2037
 
9,348

 
8,997

Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024
 
1,418

 
1,376

Other (average interest rate 3.378%), due through 2024
 
180

 
176

 
 
34,240

 
33,840

Less current portion of long-term debt
 
4,662

 
2,506

 
 
$
29,578

 
$
31,334



- 31-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Other foreign currency debt above includes mortgage debt in Switzerland and capital lease obligations at March 31, 2018 and December 31, 2017.
 
 
 
 
 
 
 
 
 
Credit Facilities:

On January 29, 2018, PMI entered into an agreement to extend the term of its $2.0 billion 364-day revolving credit facility from February 6, 2018, to February 5, 2019.

At March 31, 2018, PMI's total committed credit facilities were as follows:

(in billions)


Type
 
Committed
Credit
Facilities
364-day revolving credit, expiring February 5, 2019
 
$
2.0

Multi-year revolving credit, expiring February 28, 2021
 
2.5

Multi-year revolving credit, expiring October 1, 2022
 
3.5

Total facilities
 
$
8.0


At March 31, 2018, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.

Note 11. Fair Value Measurements:
The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:
Level 1 -
Quoted prices in active markets for identical assets or liabilities;
Level 2 -
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 -
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period.

Equity Securities

The fair value of PMI’s equity securities, which are determined by using quoted prices in active markets, have been classified within Level 1.

Derivative Financial Instruments

PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates

- 32-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 5. Financial Instruments for additional discussion of derivative financial instruments.

Debt

The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and $27 million of capital lease obligations, was $34,213 million at March 31, 2018. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, was classified within Level 1 and Level 2 in the table shown below.
 
The aggregate fair values of PMI’s equity securities, derivative financial instruments and debt as of March 31, 2018, were as follows:
 
(in millions)
 
Fair Value at March 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets/Liabilities
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Equity securities
 
$
272

 
$
272

 
$
—

 
$
—

Foreign exchange contracts
 
114

 
—

 
114

 
—

Total assets
 
$
386

 
$
272

 
$
114

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
Debt
 
$
35,464

 
$
35,293

 
$
171

 
$
—

Foreign exchange contracts
 
1,757

 
—

 
1,757

 
—

Total liabilities
 
$
37,221

 
$
35,293

 
$
1,928

 
$
—


Note 12. Accumulated Other Comprehensive Losses:
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:
 
(in millions)
 
At March 31, 2018
 
At December 31, 2017
 
At March 31, 2017
Currency translation adjustments
 
$
(6,097
)
 
$
(5,761
)
 
$
(5,783
)
Pension and other benefits
 
(2,766
)
 
(2,816
)
 
(3,509
)
Derivatives accounted for as hedges
 
(20
)
 
42

 
27

Total accumulated other comprehensive losses
 
$
(8,883
)
 
$
(8,535
)
 
$
(9,265
)

Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the three months ended March 31, 2018 and 2017. For additional information, see Note 3. Benefit Plans and Note 5. Financial Instruments for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.


- 33-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 13. Balance Sheet Offsetting:

Derivative Financial Instruments

PMI uses foreign exchange contracts and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the condensed consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. See Note 5. Financial Instruments for disclosures related to PMI's derivative financial instruments.

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:
 
(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet
 
 
Financial Instruments
Cash Collateral Received/Pledged
Net Amount
 
 
 
 
 
 
 
 
 
 
At March 31, 2018
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
114

$
—

$
114

$
(25
)
$
(68
)
$
21

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,757

$
—

$
1,757

$
(25
)
$
(1,719
)
$
13

 
At December 31, 2017
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
140

$
—

$
140

$
(50
)
$
(78
)
$
12

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,128

$
—

$
1,128

$
(50
)
$
(1,004
)
$
74



Note 14. Investments in Unconsolidated Subsidiaries:

At March 31, 2018 and December 31, 2017, PMI had total investments in unconsolidated subsidiaries of $1,098 million and $1,074 million, respectively, which were accounted for under the equity method of accounting. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses, dividends, capital contributions and movements in currency translation adjustments. The carrying value of our equity method investments at March 31, 2018 and December 31, 2017 exceeded our share of the unconsolidated subsidiaries' book value by $932 million and $927 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets, excluding $879 million and $873 million attributable to goodwill as of March 31, 2018 and December 31, 2017, respectively, is being amortized on a straight-line basis over the underlying assets' estimated useful lives of 10 to 20 years. At March 31, 2018 and December 31, 2017, PMI received year-to-date dividends from unconsolidated subsidiaries of $10 million and $120 million, respectively.

PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Management et Développement des Actifs et des Ressources Holding (MADAR Holding), formerly known as Société Nationale des Tabacs et Allumettes SpA. STAEM manufactures and distributes under license some of PMI’s brands.


- 34-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

PMI holds a 23% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia.

The initial investments in EITA and Megapolis Distribution BV were recorded at cost and are included in investments in unconsolidated subsidiaries and equity securities on the condensed consolidated balance sheets.

PMI’s earnings activity from unconsolidated subsidiaries was as follows:
 
For the Three Months Ended March 31,
(in millions)
2018
2017
Net revenues
$
923

$
840


PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:
(in millions)
 
At March 31, 2018
At December 31, 2017
 
 
 
 
Receivables
 
$
471

$
293

   
The activity primarily related to agreements with PMI’s unconsolidated subsidiaries within the Eastern Europe segment and the Middle East & Africa segment. These agreements, which are in the ordinary course of business, are primarily for distribution, contract manufacturing and licenses. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.

Note 15. Sale of Accounts Receivable:
To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2018 and March 31, 2017. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold, including excise taxes, for the three months ended March 31, 2018 and 2017, were $2,509 million and $2,092 million, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2018 and March 31, 2017, were $878 million, and $561 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the three months ended March 31, 2018 and 2017, the loss on sale of trade receivables was immaterial.


- 35-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)

Note 16. Product Warranty:

PMI's IQOS devices are subject to standard product warranties generally for a period of 12 months from the date of purchase or such other periods as required by law. PMI generally provides in cost of sales for the estimated cost of warranty in the period the related revenue is recognized. PMI assesses the adequacy of its accrued product warranties and adjusts the amounts as necessary based on actual experience and changes in future estimates. Factors that affect product warranties may vary across markets but typically include product failure rates, logistics and service delivery costs, and warranty policies. PMI accounts for its product warranties within other accrued liabilities. At March 31, 2018 and December 31, 2017, these amounts were as follows:
 
For the Three Months Ended
For the Year Ended
(in millions)
March 31, 2018
December 31, 2017
Balance at beginning of period
$
71

$
51

Changes due to:
 
 
   Warranties issued
76

168

    Settlements
(54
)
(148
)
    Currency
1

—

Balance at end of period
$
94

$
71


Note 17. Acquisitions:

On March 21, 2018, PMI acquired the remaining 49% interest in Tabacalera Costarricense, S.A. and Mendiola y Compañía, S.A. for a net purchase price of $95 million, which includes $2 million of contingent consideration. As a result, PMI now owns 100% of these Costa Rican affiliates. The purchase of the remaining 49% interest resulted in a decrease to PMI’s additional paid-in capital of $86 million.

Note 18. New Accounting Standards:

Recently adopted

On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for these goods or services. PMI adopted ASU 2014-09 retrospectively to each prior period presented. PMI elected this transition method solely to reflect the change in excise tax presentation in all prior periods presented resulting from PMI’s accounting policy election to exclude excise taxes collected from customers from the measurement of the transaction price, thereby presenting revenues, net of excise taxes. Based on PMI’s assessment, the underlying principles of the new standard, relating to the measurement of revenue and the timing of recognition, are closely aligned with PMI’s current business model and practices. As a result, the adoption of ASU 2014-09 did not have a material impact on the consolidated financial position or results of operations.

The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the three months ended March 31, 2017:

(in millions)
For the Three Months Ended March 31, 2017

Net Revenues:
 
 
 
 
 
As reported
 
Retrospective Adoption
 
   Net revenues
      Excises taxes
 
Net revenues
 
$
16,556

$
10,492

 
$
6,064


- 36-
Philip Morris International Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)


The change in presentation of net revenues also impacts segment disclosure requirements, primarily information for significant customers and geographic areas. While there is no change in the underlying business or customers, the amounts used to calculate what is disclosed are different following the change in presentation of revenues net of excise taxes and the associated segment revenues. Prior to this change, revenues including excise taxes were the basis for determining if sales to a customer or in a foreign country met the thresholds for disclosure. On the basis of revenues including excise taxes and due to the fact that PMI is not responsible for collecting excise taxes in certain markets, no customers met the requirements for disclosure. On this basis, net revenues attributable to customers located in PMI’s largest markets in terms of net revenues, namely Indonesia ($8.0 billion and $7.7 billion in 2017 and 2016, respectively) and Germany ($7.2 billion and $7.1 billion in 2017 and 2016, respectively) were included as part of segment disclosures.

Following the change in presentation and using net revenues excluding excise taxes as the basis for determining the disclosures, PMI had one customer in the East Asia & Australia segment (16% and 11% of PMI’s consolidated net revenues in 2017 and 2016, respectively) and one customer in the European Union segment (10% and 11% of PMI’s consolidated net revenues in 2017 and 2016, respectively) that meet the requirements for disclosure. Additionally, on this basis, the only foreign countries meeting the disclosure requirements are PMI’s markets in Japan ($4.7 billion and $2.8 billion in 2017 and 2016, respectively) and Indonesia ($3.2 billion and $3.2 billion in 2017 and 2016, respectively).

PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's six reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. For further details, see Note 7. Segment Reporting.

PMI recognizes revenue primarily through the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products. The majority of PMI revenues are generated by sales through direct and indirect distribution networks with short-term payment conditions and where control is typically transferred to the customer either upon shipment or delivery of goods. PMI evaluates the transfer of control through evidence of the customer’s receipt and acceptance, transfer of title, PMI’s right to payment for those products and the customer’s ability to direct the use of those products upon receipt. Typically, PMI’s performance obligations are satisfied and revenue is recognized either upon shipment or delivery of goods. In certain instances, PMI facilitates shipping and handling activities after control has transferred to the customer.  PMI has elected to record all shipping and handling activities as costs to fulfill a contract and such costs, which have not been incurred at the time revenue is recognized, are accrued.  For the three months ended March 31, 2018 and 2017, PMI did not have any material contract assets or contract liabilities. For further details on PMI’s performance obligations see Note 16. Product Warranty.

On January 1, 2018, PMI adopted Financial Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”), on a prospective basis. ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changed certain disclosure requirements and other aspects of current U.S. GAAP. PMI identified certain cost investments, which are applicable to ASU 2016-01 requiring them to be measured at fair value with the changes in fair value recognized in net income. At January 1, 2018, the cumulative effect of this change resulted in an increase to investments in unconsolidated subsidiaries and equity securities, deferred income tax liability and earnings reinvested in the business of $301 million, $63 million and $238 million, respectively.

Recently issued

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI has identified its lease management system to be used upon adoption and is in the process of identifying and evaluating the applicable leases. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.

- 37-

Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Description of Our Company

We are a leading international tobacco company engaged in the manufacture and sale of cigarettes and other nicotine-containing products in markets outside the United States of America. We are building our future on smoke-free products that are a much better consumer choice than continuing to smoke cigarettes.  Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, we aim to ensure that our smoke-free products meet adult consumer preferences and rigorous regulatory requirements. Our vision is that these products ultimately replace cigarettes to the benefit of adult smokers, society, our company and our shareholders.

Our cigarettes are sold in more than 180 markets, and in many of these markets they hold the number one or number two market share position. We have a wide range of premium, mid-price and low-price brands. Our portfolio comprises both international and local brands. In addition to the manufacture and sale of cigarettes, we are engaged in the development and commercialization of reduced-risk products ("RRPs"). RRPs is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking.  We have a range of RRPs in various stages of development, scientific assessment and commercialization.  Because our RRPs do not burn tobacco, they produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.

To provide a greater focus on both parts of our business -- combustible and reduced-risk products -- and to support our transformation toward a smoke-free future, effective January 1, 2018, we began managing our business in six reportable segments as follows:
 
•
European Union ("EU");
•
Eastern Europe ("EE");
•
Middle East & Africa ("ME&A"), which includes our international duty free business;
•
South & Southeast Asia ("S&SA");
•
East Asia & Australia ("EA&A"); and
•
Latin America & Canada ("LA&C").

We use the term net revenues to refer to our operating revenues from the sale of our products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. As discussed in Note 18. New Accounting Standards, on January 1, 2018, we adopted Financial Accounting Standards Update ASU 2014-09, "Revenue from Contracts with Customers." We adopted this standard retrospectively to each prior period presented. We made an accounting policy election to exclude excise taxes collected from customers from the measurement of the transaction price, thereby presenting revenues, net of excise taxes in all prior periods. Our net revenues and operating income are affected by various factors, including the volume of products we sell, the price of our products, changes in currency exchange rates and the mix of products we sell. Mix is a term used to refer to the proportionate value of premium-price brands to mid-price or low-price brands in any given market (product mix). Mix can also refer to the proportion of shipment volume in more profitable markets versus shipment volume in less profitable markets (geographic mix).

Our cost of sales consists principally of: tobacco leaf, non-tobacco raw materials, labor and manufacturing costs; shipping and handling costs; and the cost of the IQOS devices produced by third-party electronics manufacturing service providers. Estimated costs associated with IQOS warranty programs are generally provided for in cost of sales in the period the related revenues are recognized.

Our marketing, administration and research costs include the costs of marketing and selling our products, other costs generally not related to the manufacture of our products (including general corporate expenses), and costs incurred to develop new products. The most significant components of our marketing, administration and research costs are marketing and sales expenses and general and administrative expenses.
Philip Morris International Inc. is a legal entity separate and distinct from its direct and indirect subsidiaries. Accordingly, our right, and thus the right of our creditors and stockholders, to participate in any distribution of the assets or earnings of any subsidiary is subject to the prior rights of creditors of such subsidiary, except to the extent that claims of our company itself as a creditor may

- 38-

be recognized. As a holding company, our principal sources of funds, including funds to make payment on our debt securities, are from the receipt of dividends and repayment of debt from our subsidiaries. Our principal wholly-owned and majority-owned subsidiaries currently are not limited by long-term debt or other agreements in their ability to pay cash dividends or to make other distributions with respect to their common stock.

Executive Summary
The following executive summary provides significant highlights from the "Discussion and Analysis" that follows.

Consolidated Operating Results for the Three Months Ended March 31, 2018

•
Net Revenues - The change in our net revenues for the three months ended March 31, 2018, from the comparable 2017 amounts, were as follows:
 
For the Three Months Ended March 31,
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
(in millions)
2018
2017
 
Total
Excluding
Currency
 
Total
Currency
Price
Volume/Mix
Net revenues
$
6,896

$
6,064

 
13.7
%
8.3
%
 
$
832

$
327

$
342

$
163


During the quarter, net revenues, excluding favorable currency, increased by 8.3%, driven by a favorable pricing variance from all Regions, notably S&SA and LA&C, including higher IQOS device sales, mainly in EA&A, as well as favorable volume/mix, driven primarily by EA&A, despite the impact of the tax-driven cigarette industry volume decline and related down-trading in the Gulf Cooperation Council ("GCC"), principally Saudi Arabia.

Net revenues include $1,127 million in 2018 and $435 million in 2017 related to the sale of RRPs.


•
Diluted Earnings Per Share - The changes in our reported diluted earnings per share ("diluted EPS") for the three months ended March 31, 2018, from the comparable 2017 amounts, were as follows:
 
 
Diluted EPS
 
% Growth (Decline) 
For the three months ended March 31, 2017
 
$
1.02

 
 
2017 Asset impairment and exit costs
 
—

 
 
2017 Tax items
 
(0.04
)
 
 
       Subtotal of 2017 items
 
(0.04
)
 
 
2018 Asset impairment and exit costs
 
—

 
 
2018 Tax items
 
—

 
 
       Subtotal of 2018 items
 
—

 
 
Currency
 
0.03

 
 
Interest
 
—

 
 
Change in tax rate
 
0.03

 
 
Operations
 
(0.04
)
 
 
For the three months ended March 31, 2018
 
$
1.00

 
(2.0
)%

Income Taxes – Our effective income tax rate for the three months ended March 31, 2018 increased by 0.6 percentage points to 25.5%. The 2017 tax item that increased our diluted EPS in 2017 by $0.04 per share in the table above was due to a legal entity restructuring ($61 million). The change in the effective tax rate that increased our diluted EPS by $0.03 per share in the table above was primarily due to the Tax Cuts and Jobs Act. For further details, see Note 9. Income Taxes.


- 39-

Currency – The favorable currency impact during the reporting period results from the fluctuations of the U.S. dollar, especially against the Japanese yen, Russian ruble and South Korean won, partially offset by the Argentine peso and Swiss franc. This favorable currency movement has impacted our profitability across our primary revenue markets and local currency cost bases.

Operations – The decrease in diluted EPS of $0.04 from our operations in the table above was due primarily to the following segments:

•
European Union: Higher marketing, administration and research costs and unfavorable volume/mix, partially offset by favorable pricing;
•
Middle East & Africa: Higher marketing, administration and research costs and unfavorable volume/mix, partially offset by favorable pricing; and
•
Eastern Europe: Unfavorable volume/mix and higher marketing, administration and research costs, partially offset by favorable pricing;
partially offset by
•
South & Southeast Asia: Favorable pricing and lower manufacturing costs, partially offset by unfavorable volume/mix;
•
Latin America & Canada: Favorable pricing, partially offset by higher marketing, administration and research costs and higher manufacturing costs; and
•
East Asia & Australia: Favorable volume/mix, lower manufacturing costs and favorable pricing, partially offset by higher marketing, administration and research costs.

For further details, see the “Consolidated Operating Results” and “Operating Results by Business Segment” sections of the following “Discussion and Analysis.”

2018 Forecasted Results - On April 19, 2018, we increased, to reflect a lower effective tax rate, our 2018 full-year reported diluted EPS forecast to be in a range of $5.25 to $5.40, at prevailing exchange rates at that time, representing a projected increase of approximately 35% to 39% versus diluted EPS per share of $3.88 in 2017. Excluding a favorable currency impact, at then-prevailing exchange rates, of approximately $0.16, the forecast range represents a projected increase of approximately 8% to 11% versus adjusted diluted earnings per share of $4.72 in 2017.

This forecast assumes:

•
Currency-neutral net revenue growth of approximately 8.0%;
•
Operating cash flow of over $9.0 billion;
•
Capital expenditures of approximately $1.7 billion;
•
A full-year effective tax rate of approximately 26%; and
•
No share repurchases.

Our 2018 full-year diluted earnings per share forecast assumes a full-year effective tax rate of approximately 26%. The reduction in this rate compared to the full-year effective tax rate of 28% communicated in February 2018 mainly reflects two factors:

•
further analysis and interpretation of the scope and impact of the Tax Cuts and Jobs Act, primarily related to foreign tax credit limitations due to the Global Intangible Low Taxed Income provisions of the Tax Cuts and Jobs Act; and
•
revised foreign income tax estimates due to a change in the mix of our foreign earnings.

The Tax Cuts and Jobs Act has significant complexity, and our final full-year effective tax rate may differ from this assumption, due to, among other things, additional guidance that may be issued by the U.S. Treasury Department and the Internal Revenue Service, related interpretations and clarifications of tax law, and earnings mix by taxing jurisdiction.

We calculated our 2017 adjusted diluted EPS of $4.72 as reported diluted EPS of $3.88 plus the $0.84 per share charge related to tax items (primarily due to the impact of the Tax Cuts and Jobs Act). During 2017, we did not have an EPS impact related to asset impairment and exit costs.


- 40-

Adjusted diluted EPS is not a measure under generally accepted accounting principles in the United States of America ("U.S. GAAP"). We define adjusted diluted EPS as reported diluted EPS adjusted for asset impairment and exit costs, tax items and unusual items. We believe it is appropriate to disclose this measure as it represents core earnings, improves comparability and helps investors analyze business performance and trends. Adjusted diluted EPS should be considered neither in isolation nor as a substitute for reported diluted EPS prepared in accordance with U.S. GAAP.
This 2018 forecast excludes the impact of any future acquisitions, unanticipated asset impairment and exit cost charges, future changes in currency exchange rates, further developments related to the Tax Cuts and Jobs Act, and any unusual events. The factors described in the "Cautionary Factors That May Affect Future Results" section of the following "Discussion and Analysis" represent continuing risks to these projections.


Discussion and Analysis
Consolidated Operating Results
See pages 63-68 for a discussion of our "Cautionary Factors That May Affect Future Results." Our net revenues and operating income by segment are shown in the table below:
 
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Change
Net revenues:
 
 
 
European Union
$
1,988

$
1,740

14.3
 %
Eastern Europe
567

516

9.9
 %
Middle East & Africa
961

961

—
 %
South & Southeast Asia
1,081

1,031

4.8
 %
East Asia & Australia
1,591

1,210

31.5
 %
Latin America & Canada
708

606

16.8
 %
Net revenues
$
6,896

$
6,064

13.7
 %
Operating income:
 
 
 
European Union
$
740

$
748

(1.1
)%
Eastern Europe
151

159

(5.0
)%
Middle East & Africa
374

491

(23.8
)%
South & Southeast Asia
429

370

15.9
 %
East Asia & Australia
515

472

9.1
 %
Latin America & Canada
217

176

23.3
 %
Operating income
$
2,426

$
2,416

0.4
 %

As discussed in Note 7. Segment Reporting, effective January 1, 2018, we began using operating income to evaluate segment performance and allocate resources, replacing operating companies income used previously.


- 41-

Our net revenues by product category are shown in the table below:
PMI Net Revenues by Product Category

(in millions)
For the Three Months Ended March 31,
 
2018
2017
Change
Combustible Products
 
 
 
European Union
$
1,836

$
1,709

7.4
 %
Eastern Europe
527

513

2.8
 %
Middle East & Africa
884

957

(7.7
)%
South & Southeast Asia
1,081

1,031

4.8
 %
East Asia & Australia
737

813

(9.4
)%
Latin America & Canada
704

605

16.3
 %
Total Combustible Products
$
5,769

$
5,629

2.5
 %
Reduced-Risk Products
 
 
 
European Union
$
152

$
31

+100%

Eastern Europe
40

3

+100%

Middle East & Africa
77

4

+100%

South & Southeast Asia
—

—

—
 %
East Asia & Australia
854

396

+100%

Latin America & Canada
4

—

—
 %
Total Reduced-Risk Products
$
1,127

$
435

+100%

 
 
 
 
Total PMI Net Revenues
$
6,896

$
6,064

13.7
 %
Note: Sum of product categories or Regions might not foot to total PMI due to roundings.

Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of our cigarettes and other tobacco products combined. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include reduced-risk products.

Net revenues related to reduced-risk products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of our heated tobacco units, IQOS devices and related accessories, and other nicotine-containing products, which primarily include our e-vapor products.

We recognize revenue when control is transferred to the customer, typically either upon shipment or delivery of goods.


- 42-

Our shipment volume by segment for cigarettes and heated tobacco units is shown in the table below:
PMI Shipment Volume (Million Units)
 
For the Three Months Ended March 31,
 
2018
2017
Change
Cigarettes
 
 
 
European Union
39,671

42,540

(6.7
)%
Eastern Europe
22,039

24,596

(10.4
)%
Middle East & Africa
29,248

31,978

(8.5
)%
South & Southeast Asia
40,218

37,899

6.1
 %
East Asia & Australia
14,091

17,243

(18.3
)%
Latin America & Canada
19,013

19,296

(1.5
)%
Total Cigarettes
164,280

173,552

(5.3
)%
Heated Tobacco Units
 
 
 
European Union
928

184

+100%

Eastern Europe
564

54

+100%

Middle East & Africa
709

51

+100%

South & Southeast Asia
—

—

—
 %
East Asia & Australia
7,342

4,145

77.1
 %
Latin America & Canada
23

1

+100%

Total Heated Tobacco Units
9,566

4,435

+100%

Cigarettes and Heated Tobacco Units
 
 
 
European Union
40,599

42,724

(5.0
)%
Eastern Europe
22,603

24,650

(8.3
)%
Middle East & Africa
29,957

32,029

(6.5
)%
South & Southeast Asia
40,218

37,899

6.1
 %
East Asia & Australia
21,433

21,388

0.2
 %
Latin America & Canada
19,036

19,297

(1.4
)%
Total Cigarettes and Heated Tobacco Units
173,846

177,987

(2.3
)%

Heated tobacco units ("HTU") is the term we use to refer to our heated tobacco consumables, which include HEETS, HEETS Marlboro and HEETS FROM MARLBORO, defined collectively as HEETS, as well as Marlboro HeatSticks and Parliament HeatSticks.

References to total international market, defined as worldwide cigarette and heated tobacco unit volume excluding the United States, total industry, total market and market shares throughout this "Discussion and Analysis" are our estimates for tax-paid products based on the latest available data from a number of internal and external sources and may, in defined instances, exclude the People's Republic of China and/or our duty free business.

Unless otherwise stated, references to total industry, total market, our shipment volume and our market share performance reflect cigarettes and heated tobacco units.






- 43-

Key market data regarding total market size, our shipments and market share are shown in the table below:
 
 
For the Three Months Ended March 31,
 
 
 
 
PMI Shipments (billion units)
 
PMI Market Share (%)
Market
 
Total Market
(billion units)
 
Total
 
Cigarette
 
Heated Tobacco Unit
 
Total
 
Heated Tobacco Unit
 
 
2018
2017
 
2018
2017
 
2018
2017
 
2018
2017
 
2018
2017
 
2018
2017
European Union
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
France
 
9.8
10.8
 
4.3
4.7
 
4.3
4.7
 
—
—
 
44.4
42.8
 
0.1
—
Germany
 
16.1
17.5
 
5.8
6.7
 
5.8
6.7
 
0.1
—
 
36.3
38.2
 
0.4
—
Italy
 
16.1
16.2
 
8.0
7.8
 
7.7
7.7
 
0.3
0.1
 
52.1
51.7
 
1.5
0.5
Poland
 
9.8
10.2
 
3.9
4.3
 
3.9
4.3
 
—
—
 
39.7
42.1
 
0.5
—
Spain
 
9.9
9.9
 
3.2
3.2
 
3.2
3.2
 
—
—
 
32.3
32.1
 
0.3
0.1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eastern Europe
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Russia (1)
 
51.2
55.8
 
12.8
14.8
 
12.5
14.8
 
0.3
—
 
26.3
27.4
 
—
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Middle East & Africa
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Saudi Arabia
 
4.9
8.2
 
1.1
4.2
 
1.1
4.2
 
—
—
 
41.6
54.1
 
—
—
Turkey (1)
 
24.7
22.0
 
11.5
9.8
 
11.5
9.8
 
—
—
 
43.1
42.9
 
—
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
South & Southeast Asia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Indonesia
 
69.3
71.0
 
23.0
23.4
 
23.0
23.4
 
—
—
 
33.2
33.0
 
—
—
Philippines
 
15.3
16.6
 
10.8
11.0
 
10.8
11.0
 
—
—
 
70.5
65.9
 
—
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
East Asia & Australia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Australia
 
2.9
3.2
 
0.8
0.9
 
0.8
0.9
 
—
—
 
28.7
27.8
 
—
—
Japan
 
39.7
40.6
 
14.1
14.8
 
7.9
10.7
 
6.2
4.1
 
34.7
30.0
 
15.8
7.1
Korea
 
15.8
16.1
 
4.0
3.0
 
2.9
3.0
 
1.2
—
 
25.5
19.1
 
7.3
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Latin America & Canada
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Argentina
 
9.2
9.3
 
6.8
6.9
 
6.8
6.9
 
—
—
 
74.2
74.8
 
—
—
Canada
 
4.7
4.8
 
1.8
1.8
 
1.8
1.8
 
—
—
 
39.0
35.2
 
0.1
—
Mexico
 
7.6
7.9
 
4.9
5.1
 
4.9
5.1
 
—
—
 
63.5
64.4
 
—
—
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) PMI Cigarette Market Share February quarter-to-date as measured by Nielsen
Note: % change for Total Market and PMI shipments in the discussion below is computed based on millions of units



Consolidated Operating Results for the Three Months Ended March 31, 2018
The following discussion compares our consolidated operating results for the three months ended March 31, 2018, with the three months ended March 31, 2017.

Our total shipment volume decreased by 2.3%, principally due to:
•
the EU, reflecting lower cigarette shipment volume mainly in France, Germany and Poland;
•
Eastern Europe, reflecting lower cigarette shipment volume mainly in Russia and Ukraine; and
•
Middle East & Africa, reflecting lower cigarette shipment volume mainly in the GCC, notably Saudi Arabia, and North Africa, notably Algeria, partly offset by higher cigarette shipment volume mainly in Turkey and PMI Duty Free;

partly offset by
•
South & Southeast Asia, reflecting higher cigarette shipment volume, driven mainly by Pakistan and Thailand, partly offset by Indonesia; and
•
East Asia & Australia, reflecting higher heated tobacco unit shipment volume, driven by Japan and Korea.

- 44-


Excluding the net unfavorable impact of total estimated distributor inventory movements of approximately 2.1 billion units, driven mainly by Japan and Saudi Arabia, our total shipment volume decreased by 1.1%.     

Our shipment volume by brand is shown in the table below:
PMI Shipment Volume by Brand (Million Units)
 
First-Quarter
 
2018
2017
Change
Cigarettes

 
 
 
Marlboro
57,973

62,399

(7.1
)%
L&M
19,225

21,913

(12.3
)%
Chesterfield
13,875

11,544

20.2
 %
Philip Morris
10,659

10,608

0.5
 %
Sampoerna A
8,624

9,913

(13.0
)%
Parliament
8,460

9,199

(8.0
)%
Bond Street
6,975

8,485

(17.8
)%
Dji Sam Soe
6,696

4,459

50.2
 %
Lark
5,517

6,526

(15.5
)%
Fortune
3,583

2,882

24.3
 %
Others
22,693

25,624

(11.4
)%
Total Cigarettes
164,280

173,552

(5.3
)%
Heated Tobacco Units
9,566

4,435

+100.0%

Total Cigarettes and Heated Tobacco Units
173,846

177,987

(2.3
)%
Note: Sampoerna A includes Sampoerna.

Our cigarette shipment volume of the following brands decreased:
•
Marlboro, mainly due to Germany, Japan and Saudi Arabia, partly offset by Indonesia and Turkey;
•
L&M, mainly due to Germany, North Africa, Russia and Saudi Arabia, partly offset by Thailand;
•
Sampoerna A in Indonesia, partly reflecting the impact of its retail price increasing past its round pack price point in the fourth quarter of 2017;
•
Parliament, mainly due to Japan, Russia and Saudi Arabia, partly offset by Turkey;
•
Bond Street, mainly due to Russia and Ukraine;
•
Lark, mainly due to Japan, partly offset by Turkey; and
•
"Others," mainly due to: mid-price brands, notably Sampoerna U in Indonesia, partly reflecting the impact of above-inflation retail price increases; and the successful portfolio consolidation of local, low-price brands into international trademarks, notably in Russia; partly offset by low-price brands in Pakistan.

Our cigarette shipment volume of the following brands increased:
•
Chesterfield, mainly driven by Brazil, Colombia, Italy, Saudi Arabia and Turkey;
•
Philip Morris, mainly driven by Russia, partly offset by Argentina and Italy;
•
Dji Sam Soe in Indonesia, notably reflecting the continued strong performance of its Magnum Mild 16s variant launched in the second quarter of 2017; and
•
Fortune in the Philippines, reflecting the favorable impact of its narrowed retail price gap to competitors' products.

The increase in our heated tobacco unit shipment volume was driven by East Asia & Australia, primarily Japan and Korea.


- 45-

Financial Summary
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$
6,896

$
6,064

 
13.7
 %
8.3
 %
 
$
832

$
327

$
342

$
163

$
—

Cost of Sales
 
(2,615
)
(2,177
)
 
(20.1
)%
(13.9
)%
 
(438
)
(136
)
—

(335
)
33

Marketing, Administration and Research Costs
 
(1,833
)
(1,449
)
 
(26.5
)%
(18.6
)%
 
(384
)
(115
)
—

—

(269
)
Amortization of Intangibles
 
(22
)
(22
)
 
—
 %
—
 %
 
—

—

—

—

—

Operating Income
 
$
2,426

$
2,416

 
0.4
 %
(2.7
)%
 
$
10

$
76

$
342

$
(172
)
$
(236
)
“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding favorable currency, increased by 8.3%, driven by a favorable pricing variance from across all Regions, notably S&SA and LA&C, including higher IQOS device sales, mainly in EA&A, as well as favorable volume/mix, driven primarily by EA&A, despite the impact of the tax-driven cigarette industry volume decline and related down-trading in the GCC, principally Saudi Arabia.    

The favorable currency in net revenues was due primarily to the Euro, Japanese yen and Polish zloty, partially offset by the Argentine peso.

Net revenues include $1,127 million in 2018 and $435 million in 2017 related to the sale of RRPs, mainly driven by Japan and Korea.

Operating income, excluding favorable currency, decreased by 2.7%, mainly due to: unfavorable volume/mix, largely due to the GCC, principally Saudi Arabia; higher marketing, administration and research costs, primarily reflecting increased investment behind RRPs, predominantly in the EU; and the full-year contribution of $80 million to the Foundation for a Smoke-Free World; partly offset by a favorable pricing variance across all Regions and favorable manufacturing costs, notably in S&SA and EA&A.

Our effective tax rate increased by 0.6 percentage points to 25.5%. The effective tax rate for the three months ended March 31, 2017 was favorably impacted by a legal entity restructuring ($61 million). We are continuing to evaluate the impact that the Tax Cuts and Jobs Act will have on our tax liability. Based upon our current interpretation of the Tax Cuts and Jobs Act, we estimate that our 2018 effective tax rate will be approximately 26%, subject to future regulatory developments and earnings mix by taxing jurisdiction. For further details, see Note 9. Income Taxes.

We are regularly examined by tax authorities around the world, and we are currently under examination in a number of jurisdictions. It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Net earnings attributable to PMI of $1.6 billion decreased by $34 million (2.1%). This decrease was primarily due to a higher effective tax rate, partially offset by higher operating income as discussed above. Diluted and basic EPS of $1.00 decreased by 2.0%. Excluding a favorable currency impact of $0.03, diluted EPS decreased by 4.9%.

Operating Results by Business Segment

-Business Environment
Taxes, Legislation, Regulation and Other Matters Regarding the Manufacture, Marketing, Sale and Use of Tobacco Products

- 46-

The tobacco industry and our business face a number of challenges that may adversely affect our business, volume, results of operations, cash flows and financial position. These challenges, which are discussed below and in “Cautionary Factors That May Affect Future Results,” include:

•
regulatory restrictions on our products, including restrictions on the packaging, marketing, and sale of tobacco or other nicotine-containing products that could reduce our competitiveness, eliminate our ability to communicate with adult consumers, or even ban certain of our products;
•
fiscal challenges, such as excessive excise tax increases and discriminatory tax structures;
•
illicit trade in cigarettes and other tobacco products, including counterfeit, contraband and so-called “illicit     whites”;
•
intense competition, including from non-tax paid volume by certain local manufacturers;
•
pending and threatened litigation as discussed in Note 8. Contingencies; and
•
governmental investigations.

Regulatory Restrictions: The tobacco industry operates in a highly regulated environment. The well-known risks of smoking have led regulators to impose significant restrictions and high excise taxes on cigarettes.

We support a comprehensive regulatory framework for tobacco products based on the principle of harm reduction, including mandated health warnings, minimum age laws, restrictions on advertising, and public place smoking restrictions. We also support regulatory measures that help reduce illicit trade.

Much of the regulation that shapes the business environment in which we operate is driven by the World Health Organization's (“WHO”) Framework Convention on Tobacco Control (“FCTC”), which entered into force in 2005. The FCTC is the first international public health treaty and has as its main objective to establish a global agenda for tobacco regulation, with the purpose of reducing tobacco use. To date, 180 countries and the European Union are Parties to the FCTC. The treaty requires Parties to have in place various tobacco control measures and recommends others. The FCTC governing body, the Conference of the Parties (“CoP”), has also adopted non-binding guidelines and policy recommendations related to certain articles of the FCTC that go beyond the text of the treaty. It is not possible to predict whether or to what extent measures recommended in the FCTC guidelines will be implemented.

We continue to engage in a dialogue with regulators with respect to those measures that we do not believe would protect public health and, if implemented, could disrupt competition, severely limit our ability to market and sell our products to adult smokers, or increase illicit trade.

Certain measures are discussed in more detail below.

Fiscal Challenges: Excessive and disruptive excise, sales and other tax increases and discriminatory tax structures are expected to continue to have an adverse impact on our profitability, due to lower consumption and consumer down-trading to non-premium, discount, other low-price or low-taxed combustible tobacco products such as fine cut tobacco and illicit cigarettes. In addition, in certain jurisdictions, some of our combustible products are subject to tax structures that discriminate against premium-price products and manufactured cigarettes. We believe that such tax policies undermine public health by encouraging consumers to turn to illicit trade, and ultimately undercut government revenue objectives, disrupt the competitive environment, and encourage criminal activity. Other jurisdictions have imposed, or are seeking to impose, levies or other taxes specifically on tobacco companies, such as taxes on revenues and/or profits.

EU Tobacco Products Directive: In April 2014, the EU adopted a significantly revised EU Tobacco Products Directive (TPD), which entered into force in May 2016. All 28 Member States and Norway have adopted laws transposing the TPD.  The TPD sets forth a comprehensive set of regulatory requirements for tobacco products, including:

•
health warnings covering 65% of the front and back panels of cigarette packs, with an option for Member States to further standardize tobacco packaging, including the introduction of plain packaging;
•
a ban on characterizing flavors in some tobacco products, with a transition period for menthol expiring in May 2020;
•
security features and tracking and tracing measures that will become effective on May 20, 2019, and will increase operational expenses; and
•
a framework for the regulation of novel tobacco products and e-cigarettes, including requirements for health warnings and information leaflets, a prohibition on product packaging text related to reduced risk, and the introduction of notification requirements or authorization procedures in advance of commercialization.

- 47-


Plain Packaging and Other Packaging Restrictions: Plain packaging legislation bans the use of branding, logos and colors on packaging other than the brand name and variant that may be printed only in specified locations and in a uniform font. To date, Australia, France, Georgia, Hungary, Ireland, New Zealand, Norway, Slovenia and the U.K. have adopted plain packaging laws, which are in various degrees of implementation.

Several countries have initiated World Trade Organization (“WTO”) dispute settlement proceedings against Australia related to Australia's plain packaging legislation. The matter is still pending before the WTO panel.

Other countries are also considering adopting plain packaging legislation, including, but not limited to, Canada, Singapore, South Africa and Turkey.

Some countries have adopted, or are considering adopting, packaging restrictions that could have an impact similar to plain packaging. Examples of such restrictions include standardizing the shape and size of packages, prohibiting certain colors or the use of certain descriptive phrases on packaging, and requiring very large graphic health warnings that leave little space for branding.

Restrictions and Bans on the Use of Ingredients: The WHO and others in the public health community have recommended restrictions or total bans on the use of some or all ingredients in tobacco products, including menthol. Broad restrictions and ingredient bans would require us to reformulate our American blend tobacco products and could reduce our ability to differentiate these products in the market in the long term. Menthol bans would eliminate the entire category of mentholated tobacco products. The European Union has banned flavored tobacco products, subject to an exemption until May 2020 for menthol. Other countries may follow the EU’s approach. For instance, Turkey has banned menthol as of May 2020. Broader ingredient bans have been adopted by Canada and Brazil. Canada banned menthol in cigarettes as of October 2017. In addition, the Canadian parliament is considering a ban of menthol in all tobacco products. The majority of Canadian provinces have also adopted or are in the process of adopting menthol bans. The Brazil ingredients ban, which would prohibit the use of virtually all ingredients with flavoring or aromatic properties, is not in force due to legal challenges by tobacco industry unions, of which our Brazilian subsidiary is a member. It is not possible to predict the outcome of these legal proceedings.

Bans on Display of Tobacco Products at Retail: In a number of our markets, including, but not limited to, Australia, Canada, Norway, Russia, and Singapore, governments have banned the display of tobacco products at the point of sale. Other countries are also considering similar bans.

Bans and Restrictions on Advertising, Marketing, Promotions and Sponsorships: For many years, the FCTC has called for, and countries have imposed, partial or total bans on tobacco advertising, marketing, promotions and sponsorships, including bans and restrictions on advertising on radio and television, in print and on the Internet. The FCTC's non-binding guidelines recommend that governments prohibit all forms of communication with adult smokers.

Restrictions on Product Design: Some members of the public health community are calling for the further standardization of tobacco products by requiring, for example, that cigarettes have a certain minimum diameter, which would amount to a ban on slim cigarettes, or requiring the use of standardized filter and cigarette paper designs. In addition, at its meeting in November 2016, the CoP adopted non-binding guidelines recommending that countries regulate product design features that increase the attractiveness of tobacco products, such as the diameter of cigarettes and the use of flavor capsules.

Restrictions on Public Smoking: The pace and scope of public smoking restrictions have increased significantly in most of our markets. Many countries around the world have adopted, or are likely to adopt, regulations that restrict or ban smoking in public and/or work places, restaurants, bars and nightclubs. Some public health groups have called for, and some countries, regional governments and municipalities have adopted or proposed, bans on smoking in outdoor places, as well as bans on smoking in cars (typically, when minors are present) and private homes.

Other Regulatory Issues: Some regulators are considering, or in some cases have adopted, regulatory measures designed to reduce the supply of tobacco products. These include regulations intended to reduce the number of retailers selling tobacco products by, for example, reducing the overall number of tobacco retail licenses available or banning the sale of tobacco products within arbitrary distances of certain public facilities.

In a limited number of markets, most notably Japan, we are dependent on governmental approvals that may limit our pricing flexibility.

Illicit Trade: The illicit tobacco trade creates a cheap and unregulated supply of tobacco products, undermines efforts to reduce smoking prevalence, especially among youth, damages legitimate businesses, stimulates organized crime, increases corruption

- 48-

and reduces government tax revenue. Illicit trade may account for as much as 10% of global cigarette consumption; this includes counterfeit, contraband and the growing problem of “illicit whites,” which are cigarettes legally produced in one jurisdiction for the sole purpose of being exported and illegally sold in another jurisdiction where they have no legitimate market. We estimate that illicit trade in the European Union accounted for slightly less than 10% of total cigarette consumption in 2017.

A number of jurisdictions are considering actions to prevent illicit trade. In November 2012, the FCTC adopted the Protocol to Eliminate Illicit Trade in Tobacco Products (the “Protocol”), which includes supply chain control measures, such as licensing of manufacturers and distributors, enforcement in free trade zones, controls on duty free and Internet sales and the implementation of tracking and tracing technologies. To date, 54 Parties have signed the Protocol, and 35 Parties, including the European Union, have ratified it. The Protocol will come into force once the fortieth Party ratifies it, after which countries must implement its measures via national legislation. We expect, and welcome, that other Parties will ratify the Protocol.

As discussed in the EU Tobacco Products Directive section above, the EU regulations that mandate tracking and tracing of cigarettes and roll-your-own products manufactured or destined for the EU will become effective on May 20, 2019. The effective date for other tobacco-containing products, including some of our RRPs such as the heated tobacco units used with IQOS, is May 20, 2024.

In 2009, our Colombian subsidiaries entered into an Investment and Cooperation Agreement with the national and regional governments of Colombia to promote investment in, and cooperation on, anti-contraband and anti-counterfeit efforts. The agreement provides $200 million in funding over a 20-year period to address issues such as combating the illegal cigarette trade and increasing the quality and quantity of locally-grown tobacco.

In May 2016, PMI launched PMI IMPACT, a global initiative that supports third-party projects dedicated to fighting illegal trade and related crimes such as corruption, organized criminal networks and money laundering. The centerpiece of PMI IMPACT is a council of external independent experts with impeccable credentials in the fields of law, anti-corruption and law enforcement. The experts are responsible for evaluating and approving funding proposals for PMI IMPACT grants. PMI has pledged $100 million to fund projects within PMI IMPACT over three funding rounds. Substantially all grants under the first funding round were awarded in 2017. The second funding round began in September 2017 and is ongoing.

Reduced-Risk Products (RRPs)    

Our Approach to RRPs: We recognize that smoking cigarettes causes serious diseases and that the best way to avoid the harms of smoking is never to start or to quit. Nevertheless, it is predicted that over the next decade the number of smokers will remain largely unchanged from the current estimate of 1.1 billion, despite the considerable efforts to discourage smoking.

Cigarettes burn tobacco, which produces smoke. As a result of the combustion process, the smoker inhales various toxic substances. In contrast, RRPs do not burn tobacco and produce an aerosol that contains significantly lower levels of harmful and potentially harmful constituents ("HPHCs") than found in cigarette smoke.

For smokers who would otherwise continue to smoke, we believe that RRPs offer a much better consumer choice. Accordingly, our key strategic priorities are: to develop and commercialize products that present less risk of harm to adult smokers who switch to those products versus continued smoking; and to convince current adult smokers who would otherwise continue to smoke to switch to those products.

We recognize that this transformation from cigarettes to RRPs will take time and that the speed of transformation will depend in part upon factors beyond our control, such as the willingness of governments, regulators and other policy groups to embrace RRPs as a desired alternative to continued cigarette smoking. We also recognize that our part in this transformation must be funded from our existing cigarette business. For as long as a significant number of adult smokers continues to smoke, it is critical that the industry be led by responsible and ethical manufacturers. Therefore, during the transformation, we intend to remain a leading international cigarette manufacturer.

We have a range of RRPs in various stages of development, scientific assessment and commercialization. We conduct rigorous scientific assessments of our RRP platforms to substantiate that they reduce exposure to HPHCs and, ultimately, that these products present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to them versus continued smoking. We draw upon a team of expert scientists and engineers from a broad spectrum of scientific disciplines and our extensive learnings of adult consumer preferences to develop and assess our RRPs. Our efforts are guided by the following key objectives:

- 49-


•
to develop RRPs that adult smokers who would otherwise continue to smoke find to be satisfying alternatives to smoking;
•
for those adult smokers, our goal is to offer RRPs with a scientifically substantiated risk-reduction profile that approaches as closely as possible that associated with smoking cessation;
•
to substantiate the reduction of risk for the individual adult smoker and the reduction of harm to the population as a whole, based on scientific evidence of the highest standard that is made available for scrutiny and review by external independent scientists and relevant regulatory bodies; and
•
to advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including the communication of scientifically substantiated information to enable adult smokers to make better consumer choices.

Our RRP Platforms: Our product development is based on the elimination of combustion via tobacco heating and other innovative systems for aerosol generation, which we believe is the most promising path to providing a better consumer choice for those who would otherwise continue to smoke. We recognize that no single product will appeal to all adult smokers. Therefore, we are developing a portfolio of products intended to appeal to a variety of distinct adult consumer preferences.

Four RRP platforms are in various stages of development and commercialization readiness:

        Platform 1 uses a precisely controlled heating device that we are commercializing under the IQOS brand name, into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol. We have conducted a series of clinical studies for this platform, the results of which were included in our submission to the U.S. Food and Drug Administration (“FDA”) described below. As anticipated, the results of the first six-month term of the 6+6 month exposure response study were received at the end of 2017, and the related report is under preparation. We expect to submit the final report for these results to the FDA in the second quarter of 2018. We expect to receive the results of the second six-month term of the 6+6 month exposure response study for analysis in the second quarter of 2018.

    Platform 2 uses a pressed carbon heat source which, when ignited, generates a nicotine-containing aerosol by heating tobacco. The results of our pharmacokinetic study (that measured the nicotine pharmacokinetic profile as well as subjective effects) and of our five-day reduced exposure study indicate that this platform could be an acceptable substitute for adult smokers who seek an alternative to cigarettes. The reduced exposure study results showed a substantial reduction in relevant biomarkers of exposure to the measured HPHCs in those who switched to Platform 2 compared to those who continued to smoke cigarettes over a five-day period. The sustainability of this reduction as well as changes in clinical risk markers were assessed in a 3-month reduced exposure study. As anticipated, the results of this study were received at the end of 2017, and the related report is under preparation. We expect the report to be finalized in the second quarter of 2018. Subsequently, in accordance with standard scientific practices, we intend to share the conclusions in scientific forums and to submit them for inclusion in peer-reviewed publications.

    Platform 3 provides an aerosol of nicotine salt formed by the chemical reaction of nicotine with a weak organic acid. We have explored two routes for this platform, one with electronics and one without, and conducted nicotine pharmacokinetic studies with both versions. We expect to receive the results related to the version without electronics for analysis in the second quarter of 2018.

    Platform 4 covers e-vapor products, which are battery-powered devices that produce an aerosol by vaporizing a nicotine-containing liquid solution. Our e-vapor products comprise devices using current generation technology, and we are well advanced in the development and commercialization of our new e-vapor mesh technology that addresses certain challenges presented by some e-vapor products currently on the market. Our MESH products are designed to ensure the consistency and quality of the generated aerosol. We have conducted a nicotine pharmacokinetic study for which we expect to receive the results for analysis in the second quarter of 2018; the results of this study are expected to contribute to further developments of Platform 4 products.

Commercialization of RRPs: We are building a new product category and tailor our commercialization strategy to the characteristics of each specific market. We focus our commercialization efforts on retail experience, guided consumer trials and customer care, as well as digital communication programs.  In order to accelerate switching to IQOS, our initial market introductions typically entail one-on-one consumer engagement and introductory device discounts.  These initial commercialization efforts require substantial investment.

In 2014, we introduced the IQOS system in pilot city launches in Nagoya, Japan, and in Milan, Italy. Since then, we have continuously expanded our commercialization activities, and IQOS is currently available for sale in 40 markets in key cities or nationwide.


- 50-

In Japan, we have recently observed a slower-than-initially-projected RRP category growth in the first quarter, as we are now reaching different socio-economic strata with more conservative consumers who may show a slower pace of adoption than early adopters. We are adjusting our commercial plans in terms of the timing, intensity and content of communication to specifically address the needs of these adult smokers. In addition, we estimate that while some IQOS users are experimenting with competitive products, only a very small percentage of converted IQOS users in Japan switch to those products.

We estimate that only a very small percentage of adult smokers who convert to IQOS switch back to cigarettes.

In the first quarter of 2016, we started the large scale commercial production of heated tobacco units. During 2017, we experienced supply shortages resulting from stronger-than-anticipated demand, primarily in Japan. Currently, we are no longer experiencing capacity limitations. We are integrating the production of our heated tobacco units into a number of our existing manufacturing facilities and progressing with our plans to build manufacturing capacity for our other RRP platforms.

In 2017, we secured a second supplier of IQOS devices. We are no longer experiencing supply constraints on the IQOS devices and, based on demand forecasts, we expect to be able to fully supply our current and planned launch markets.

The adequate supply chain for our RRP portfolio, including the supply of electronic devices, is important to our business. We work with two electronics manufacturing service providers for the supply of our IQOS devices and a small number of other providers for other products in our RRP portfolio and related accessories. Although we work closely with these service providers on monitoring their production capability and financial health, the commercialization of our RRPs could be adversely affected if they are unable to meet their commitments. The production of our RRP portfolio requires various metals, and we believe that there is an adequate supply of such metals in the world markets to satisfy our current and anticipated production requirements. However, some components and materials necessary for the production of our RRPs, including those for the electronic devices, are obtained from single or limited sources, and can be subject to industry-wide shortages and price fluctuations. Our inability to secure an adequate supply of such components and materials could negatively impact the commercialization of our RRPs.

Our IQOS devices are subject to standard product warranties generally for a period of 12 months from the date of purchase or such other periods as required by law. We discuss product warranties in more detail in Note 16. Product Warranty. The significance of warranty claims is dependent on a number of factors including warranty policies and product failure rates and may increase with the number of devices sold.

To further improve the consumer experience, we introduced a new version of the IQOS device in the first quarter of 2017 and continue to develop product improvements.

We are also progressing with our commercialization efforts for the other RRP platforms:

•
We currently market our e-vapor products in several markets, including Ireland, Israel, Spain and the U.K. A city test of MESH, one of our Platform 4 products, is ongoing in Birmingham, U.K., and we expect to initiate a pilot launch of a next-generation version of this product in 2018.

•
In December 2017, we initiated a small-scale city test of TEEPS, our Platform 2 product, in Santo Domingo, the Dominican Republic.

•
In 2018, we plan to conduct a consumer test of our Platform 3 product.

RRP Regulation and Taxation: RRPs contain nicotine and are not risk-free. We therefore support science-based regulation and taxation of RRPs. Regulation and taxation should differentiate between cigarettes and products that present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to these products versus continued smoking. Regulation should provide minimum standards for RRPs and specific rules for product assessment methodologies, ingredients, labelling and consumer communication, and should ensure that the public is informed about the health risks of all combustible and non-combustible tobacco and nicotine-containing products. Regulation, as well as tobacco industry activities, should reflect the fact that youth should not consume nicotine in any form.

Some governments have banned or are seeking to ban or severely restrict emerging tobacco and nicotine-containing products such as our RRPs. These regulations might foreclose or unreasonably restrict adult consumer access even to products that might be shown to be a better consumer choice than continuing to smoke. We oppose such blanket bans and unreasonable restrictions of products that have the potential to present less risk of harm compared to continued smoking. By contrast, we support regulation that sets clear standards and propels innovation to benefit adult smokers who would otherwise continue to smoke.


- 51-

In the United States, an established regulatory framework for assessing “Modified Risk Tobacco Products” and “New Tobacco Products” exists under the jurisdiction of the FDA. We submitted to the FDA a Modified Risk Tobacco Product Application (“MRTPA”) for IQOS in December 2016, and a Premarket Tobacco Product Application (“PMTA”) for IQOS in March 2017. In May 2017, the FDA formally accepted and filed our MRTPA for substantive scientific review and, in June 2017, the FDA opened the period for the public to provide comments on our application. In August 2017, the FDA completed a preliminary review of our PMTA and accepted our application for substantive review. The FDA referred our MRTPA to the Tobacco Product Scientific Advisory Committee (“TPSAC”). TPSAC held a meeting on January 24 and January 25, 2018 to discuss our MRTPA. The recommendations and votes of TPSAC are not binding on the FDA. By regulation, the FDA’s decision on our MRTPA will take into account, in addition to the views of TPSAC, scientific evidence as well as comments, data and information submitted by interested persons.

Separately, on July 28, 2017, the FDA issued a policy announcement aiming to explore the potential of nicotine reduction in cigarettes in conjunction with the availability of less harmful products that deliver nicotine for adults who choose to use such products.

Future FDA actions may influence the regulatory approach of other governments.

In the EU, all EU Member States and Norway have transposed the EU Tobacco Products Directive, including the provisions on novel tobacco products, such as heated tobacco units, and e-cigarettes. Most of the EU Member States require a notification submitted six months before the intended placing on the market of a novel tobacco product, while some require pre-market authorizations for the introduction of such products. To date, we have filed a comprehensive dossier summarizing our scientific assessment of IQOS in 22 Member States. In addition, in Italy, in April 2018, we submitted under recent legislation an application for HEETS, used with the IQOS device, requesting regulatory recognition of the reduction of toxic substances and potential risk reduction resulting from switching to this product compared to continued cigarette smoking.

On December 12, 2017, at the request of the U.K. Department of Health and Public Health England, the U.K. Committee on Toxicity published its assessment of the risk of heated tobacco products relative to cigarette smoking. This assessment included analysis of scientific data for two heated tobacco products, one of which was IQOS. The assessment concluded that, while still harmful to health, compared with the known risks from cigarettes, heated tobacco products are probably less harmful. Subsequently, on February 6, 2018, Public Health England published a report stating that the available evidence suggests that heated tobacco products may be considerably less harmful than cigarettes and more harmful than e-cigarettes.

We make our scientific findings publicly available for scrutiny and peer review through several channels, including our websites. From time to time, adult consumers, competitors, members of the scientific community, and others inquire into our scientific methodologies, challenge our scientific conclusions or request further study of certain aspects of our RRPs and their health effects. We are committed to a robust and open scientific debate but believe that such debate should be based on accurate and reliable scientific information. We seek to provide accurate and reliable scientific information about our RRPs; nonetheless, we may not be able to prevent third-party dissemination of false, misleading or unsubstantiated information about these products.

To date, we have been largely successful in demonstrating to regulators that our RRPs are not cigarettes, and as such they are generally taxed either as a separate category or as other tobacco products, which typically yields more favorable tax rates than cigarettes. Although we believe that this is sensible from the public health perspective, we cannot guarantee that regulators will continue this approach.

There can be no assurance that we will succeed in our efforts to replace cigarettes with RRPs or that regulation will allow us to commercialize RRPs in all markets, to communicate scientifically substantiated risk-reduction claims, or to treat RRPs differently from cigarettes.

Our RRP Business Development Initiatives: In December 2013, we established a strategic framework with Altria Group, Inc. (“Altria”) under which Altria will make available its e-vapor products exclusively to us for commercialization outside the United States, and we will make available two of our RRPs exclusively to Altria for commercialization in the United States. In March 2015, we launched Solaris, a Platform 4 e-vapor product licensed from Altria, in Spain. In December 2015, we introduced Solaris in Israel.

In July 2015, we extended the strategic framework with Altria to include a Joint Research, Development and Technology Sharing Agreement. The additional agreement provides the framework under which PMI and Altria will collaborate to develop the next generation of e-vapor products for commercialization in the United States by Altria and in markets outside the United States by PMI. The collaboration between PMI and Altria in this endeavor is enabled by exclusive technology cross licenses and technical

- 52-

information sharing. The agreements also provide for cooperation on the scientific assessment of, and for the sharing of improvements to, the existing generation of licensed products.

Other Developments: On September 12, 2017, we announced our support of the Foundation for a Smoke-Free World. We agreed to contribute $80 million per year over the next 12 years, as specified in the agreement. We made an initial contribution of $4.5 million in 2017 and the first annual contribution of $80 million in the first quarter of 2018. The Foundation is an independent body and is governed by its independent Board of Directors. The Foundation’s role, as set out in its corporate charter, includes funding research in the field of tobacco harm reduction, encouraging measures that reduce the harm caused by smoking, and assessing the effect of reduced cigarette consumption on the industry value chain.

Governmental Investigations

From time to time, we are subject to governmental investigations on a range of matters. We describe certain matters pending in Thailand and South Korea in Note 8. Contingencies.

In November 2010, a WTO panel issued its decision in a dispute relating to facts that arose from August 2006 between the Philippines and Thailand concerning a series of Thai customs and tax measures affecting cigarettes imported by PM Thailand into Thailand (see Note 8. Contingencies for additional information). The WTO panel decision, which was upheld by the WTO Appellate Body, concluded that Thailand had no basis to find that PM Thailand's declared customs values and taxes paid were too low, as alleged by the DSI in 2009. The decision also created obligations for Thailand to revise its laws, regulations, or practices affecting the customs valuation and tax treatment of future cigarette imports. Thailand agreed in September 2011 to fully comply with the decision by October 2012. The Philippines asserts that to date Thailand has not fully complied with the WTO panel decision. The Philippines has repeatedly expressed concerns with ongoing investigations by Thailand of PM Thailand, including those that led to the criminal charges described in Note 8. Contingencies, and has commenced two formal proceedings at the WTO to challenge criminal charges against PM Thailand arguing that the criminal charges appear to be based on grounds not supported by WTO customs valuation rules and inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. The Philippines has also asserted that the demand notices received by PM Thailand from the Thai Customs Department in November 2017, described in Note 8. Contingencies, are inconsistent with Thailand's WTO obligations.

Acquisitions

We discuss our acquisitions in Note 17. Acquisitions to our condensed consolidated financial statements.

Investments in Unconsolidated Subsidiaries and Equity Securities

We discuss our investments in unconsolidated subsidiaries and equity securities in Note 11. Fair Value Measurements and Note 14. Investments in Unconsolidated Subsidiaries to our condensed consolidated financial statements.

Trade Policy

We are subject to various trade restrictions imposed by the United States of America and countries in which we do business (“Trade Sanctions”), including the trade and economic sanctions administered by the U.S. Department of the Treasury's Office of Foreign Assets Control and the U.S. Department of State. It is our policy to comply fully with these Trade Sanctions.

Tobacco products are agricultural products under U.S. law and are not technological or strategic in nature. From time to time we make sales in countries subject to Trade Sanctions, either where such sanctions do not apply to our business or pursuant to exemptions or licenses.

To our knowledge, none of our commercial arrangements results in the governments of any country identified by the U.S. government as a state sponsor of terrorism, nor entities controlled by those governments, receiving cash or acting as intermediaries in violation of U.S. laws.

We do not sell products in Iran, Sudan, North Korea and Syria. From time to time, we explore opportunities to sell our products in one or more of these countries, as permitted by law.

In January 2018, we commenced sales of cigarettes in Cuba, as permitted by U.S. law.

Certain states within the U.S. have enacted legislation permitting state pension funds to divest or abstain from future investment

- 53-

in stocks of companies that do business with certain countries that are sanctioned by the U.S. We do not believe such legislation has had a material effect on the price of our shares.

Operating Results – For the Three Months Ended March 31, 2018

The following discussion compares operating results within each of our reportable segments for the three months ended March 31, 2018, with the three months ended March 31, 2017.

Unless otherwise stated, references to total industry, total market, our shipment volume and our market share performance reflect cigarettes and heated tobacco units.

European Union:
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$
1,988

$
1,740

 
14.3
 %
0.2
 %
 
$
248

$
245

$
46

$
(43
)
$
—

Operating Income
 
$
740

$
748

 
(1.1
)%
(15.8
)%
 
$
(8
)
$
110

$
46

$
(67
)
$
(97
)
“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding favorable currency, increased by 0.2%, mainly reflecting: a favorable pricing variance, driven principally by Germany, Poland and the United Kingdom, partly offset by France; and unfavorable volume/mix, notably in France and Germany, partly offset by Italy.

The net revenues of the European Union segment include $152 million in 2018 and $31 million in 2017 related to the sale of RRPs.

Operating income, excluding favorable currency, decreased by 15.8%, mainly due to: unfavorable volume/mix, notably in France and Germany, and higher marketing, administration and research costs, primarily reflecting increased investment behind RRPs across the Region, partly offset by a favorable pricing variance.


- 54-

European Union - Total Market, PMI Shipment Volume and Market Share Commentaries

Total market, PMI shipment volume and market share performance are shown in the tables below:
European Union Key Data
 
First-Quarter
 
 
 
 
Change

 
 
2018

2017

% / pp

Total Market (billion units)
 
107.7

112.3

(4.1
)%
 
 
 
 
 
PMI Shipment Volume (million units)
 
 
 
 
Cigarettes
 
39,671

42,540

(6.7
)%
Heated Tobacco Units
 
928

184

+100.0%

Total European Union
 
40,599

42,724

(5.0
)%
 
 
 
 
 
PMI Market Share
 
 
 
 
Marlboro
 
18.3
%
18.8
%
(0.5
)
L&M
 
6.7
%
7.0
%
(0.3
)
Chesterfield
 
5.9
%
6.1
%
(0.2
)
Philip Morris
 
3.1
%
3.2
%
(0.1
)
HEETS
 
0.8
%
0.1
%
0.7

Others
 
3.4
%
3.2
%
0.2

Total European Union
 
38.2
%
38.4
%
(0.2
)

In the quarter, the estimated total market in the EU decreased by 4.1% to 107.7 billion units, or by 3.4% excluding the net impact of unfavorable estimated trade inventory movements, notably due to:
•
France, down by 9.4%, primarily reflecting the impact of significant excise-tax driven price increases in November 2017 and March 2018;
•
Germany, down by 7.9%, or by 3.0% excluding the net impact of estimated trade inventory movements largely related to the fourth quarter of 2017, primarily reflecting the impact of pricing in 2017 and in March 2018; and
•
Poland, down by 3.7%, or by 1.8% excluding the net impact of estimated trade inventory movements largely related to the fourth quarter of 2017.

Our total shipment volume decreased by 5.0% to 40.6 billion units, notably due to:
•
France, down by 8.9%, primarily due to a lower total market, partly offset by higher market share primarily driven by: Marlboro, partly resulting from the narrowing of its retail price gap with low price brands to €0.30/pack as of March 2018; and Philip Morris, reflecting its momentum during the first two months of 2018 driven by its price repositioning to €7.00/pack in November 2017;
•
Germany, down by 12.4%, primarily due to a lower total market and market share, reflecting the unfavorable impact of the estimated trade inventory movements; and
•
Poland, down by 9.2%, primarily due to: a lower total market, as well as lower market share, mainly due to: Marlboro, reflecting the impact of a widened retail price gap with the low price end of the market, as well as switching to RRPs; and L&M, reflecting an unfavorable comparison with the first quarter of 2017 related to brand support;
partly offset by
•
Italy, up by 2.1%, driven by favorable comparisons to the first quarter of 2017 related to distributor inventory movements, as well as higher heated tobacco unit shipment volume; and
•
Spain, up by 1.9%, driven by favorable comparisons to the first quarter of 2017 related to distributor inventory movements.


- 55-

Our total market share decreased by 0.2 points to 38.2%, with declines in Germany, mainly reflecting the unfavorable impact of the estimated trade inventory movements, and Poland, partly offset by gains in France, Italy, Romania and Spain.


Eastern Europe:
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$
567

$
516

 
9.9
 %
4.3
 %
 
$
51

$
29

$
60

$
(38
)
$
—

Operating Income
 
$
151

$
159

 
(5.0
)%
(10.1
)%
 
$
(8
)
$
8

$
60

$
(47
)
$
(29
)
“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding favorable currency, increased by 4.3%, principally driven by a favorable pricing variance, notably in Russia and Ukraine, partly offset by unfavorable volume/mix, primarily due to Russia.

The net revenues of the Eastern Europe segment include $40 million in 2018 and $3 million in 2017 related to the sale of RRPs.

Operating income, excluding favorable currency, decreased by 10.1%, principally due to: unfavorable volume/mix; higher manufacturing costs; and higher marketing, administration and research costs primarily reflecting increased investments behind IQOS in Russia; partly offset by a favorable pricing variance.

Eastern Europe - Total Market, PMI Shipment Volume and Market Share Commentaries

In the quarter, the estimated total market in Eastern Europe decreased, notably due to:
•
Russia, down by 8.3%, or by 7.3% excluding the unfavorable impact of estimated trade inventory movements, primarily reflecting the timing and impact of retail price increases in 2017 and the quarter, as well as an increase in the prevalence of illicit trade; and
•
Ukraine, down by 11.4%, or by 9.4% excluding the net impact of estimated trade inventory movements related to the fourth quarter of 2017, primarily reflecting the impact of excise tax-driven retail price increases in 2017 and the quarter.
PMI Shipment Volume (million units)
 
First-Quarter
 
 
2018

2017

Change

Cigarettes
 
22,039

24,596

(10.4
)%
Heated Tobacco Units
 
564

54

+100.0%

Total Eastern Europe
 
22,603

24,650

(8.3
)%

Our total shipment volume decreased by 8.3% to 22.6 billion units, notably in:
•
Russia, down by 13.9%, or by 12.7% excluding the unfavorable impact of estimated inventory movements, mainly due to the lower total market; lower market share, largely due to Bond Street, partly reflecting the impact of down-trading to competitive products in the low price segment, partly offset by higher share of premium-priced brands; and
•
Ukraine, down by 9.5%, mainly due to the lower total market;
partly offset by
•
higher heated tobacco unit shipment volume, notably in Russia and Ukraine.




- 56-

Middle East & Africa:
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$
961

$
961

 
—
 %
(1.5
)%
 
$
—

$
14

$
19

$
(33
)
$
—

Operating Income
 
$
374

$
491

 
(23.8
)%
(17.3
)%
 
$
(117
)
$
(32
)
$
19

$
(50
)
$
(54
)
“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding favorable currency decreased by 1.5%, predominantly due to unfavorable volume/mix, primarily related to Saudi Arabia, partly offset by Turkey.

The net revenues of the Middle East & Africa segment include $77 million in 2018 and $4 million in 2017 related to the sale of RRPs.

Operating income, excluding unfavorable currency, decreased by 17.3%, predominantly due to unfavorable volume/mix, primarily related to Saudi Arabia.

Middle East & Africa - Total Market, PMI Shipment Volume and Market Share Commentaries

In the quarter, the estimated total market in the Middle East & Africa decreased, notably due to:
•
Algeria, down by 26.7%, or by 4.4% excluding the net unfavorable impact of estimated trade inventory movements, primarily reflecting an increase in the prevalence of illicit trade;
•
Saudi Arabia, down by 40.8%, primarily reflecting the impact of retail price increases in 2017 and the quarter following the introduction of the new excise tax in June 2017 and VAT in January 2018;
partly offset by
•
Turkey, up by 12.4%, primarily reflecting a lower prevalence of illicit trade.
PMI Shipment Volume (million units)
 
First-Quarter
 
 
2018

2017

Change

Cigarettes
 
29,248

31,978

(8.5
)%
Heated Tobacco Units
 
709

51

+100.0%

Total Middle East & Africa
 
29,957

32,029

(6.5
)%

Our total shipment volume decreased by 6.5% to 30.0 billion units, notably in:
•
Algeria, down by 29.1%, mainly reflecting the lower total market; and
•
Saudi Arabia, down by 74.5%, or by 57.9% excluding the unfavorable impact of adjustments to distributor inventory levels in the quarter, reflecting the lower total market and market share due to the impact of the aforementioned excise tax and VAT increases on retail prices;
partly offset by
•
Turkey, up by 16.8%, reflecting a higher total market and market share; and
•
higher heated tobacco shipment volume, notably in PMI Duty Free.    

    

- 57-

South & Southeast Asia:
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$ 1,081
$ 1,031
 
4.8
%
5.6
%
 
$
50

$
(8
)
$
102

$
(44
)
$
—

Operating Income
 
$ 429
$ 370
 
15.9
%
19.2
%
 
$
59

$
(12
)
$
102

$
(54
)
$
23

“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding unfavorable currency, increased by 5.6%, reflecting: a favorable pricing variance, driven principally by Indonesia and the Philippines, partly offset by Thailand. The favorable pricing variance was partly offset by unfavorable volume/mix, largely due to Indonesia, partly offset by Pakistan and Thailand.

Operating income, excluding unfavorable currency, increased by 19.2%, mainly driven by a favorable pricing variance, as well as a favorable manufacturing and marketing, administration and research cost comparison, notably in Indonesia and the Philippines. The favorable pricing variance and cost comparison were partly offset by unfavorable volume/mix, mainly in Indonesia, partly offset by Pakistan and Thailand.

South & Southeast Asia - Total Market, PMI Shipment Volume and Market Share Commentaries

In the quarter, the estimated total market in South & Southeast Asia increased, notably driven by:
•
Pakistan, up over 100% or approximately 8.4 billion units, or by 31.4% excluding the favorable impact of estimated trade inventory movements, notably reflecting an increase in the duty-paid market driven by a reduction in the prevalence of illicit trade resulting from excise tax reform in May 2017;
partly offset by
•
Indonesia, down by 2.3%, reflecting soft consumer spending and above inflation excise tax-driven retail price increases in the quarter;
•
the Philippines, down by 7.8%, reflecting the impact of excise tax-driven retail price increases in 2017 and an approximately 25% excise-tax driven increase to the industry weighted average retail pack price in the quarter; and
•
Thailand, down by 8.9%, primarily reflecting the impact of excise tax-driven price increases in the quarter.
PMI Shipment Volume (million units)
 
First-Quarter
 
 
2018

2017

Change

Cigarettes
 
40,218

37,899

6.1
%
Heated Tobacco Units
 
—

—

—
%
Total South & Southeast Asia
 
40,218

37,899

6.1
%

Our total shipment volume increased by 6.1% to 40.2 billion units, mainly driven by:
•
Pakistan, up over 100%, reflecting the higher total market, primarily driven by the reduction in the prevalence of illicit trade and the favorable impact of estimated trade inventory movements; and
•
Thailand, up by 45.9%, mainly reflecting higher market share driven by the price repositioning of L&M;
partly offset by
•
Indonesia, down by 1.8%, mainly due to the lower total market, partially offset by higher market share, driven by Marlboro Filter Black 20s and Dji Sam Soe Magnum Mild 16s; and
•
the Philippines, down by 1.4%, mainly due to the lower total market, largely offset by higher market share.

- 58-




East Asia & Australia:
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$ 1,591
$ 1,210
 
31.5
%
27.5
%
 
$
381

$
48

$
15

$
318

$
—

Operating Income
 
$ 515
$ 472
 
9.1
%
5.7
%
 
$
43

$
16

$
15

$
46

$
(34
)
“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding favorable currency, increased by 27.5%, reflecting a favorable pricing variance, driven principally by Australia and Japan, as well as a favorable volume/mix, driven by heated tobacco unit volume in Japan and Korea.

The net revenues of the East Asia & Australia segment include $854 million in 2018 and $396 million in 2017 related to the sale of RRPs.
Operating income, excluding favorable currency, increased by 5.7%, mainly driven by a favorable pricing variance, favorable volume/mix, mainly in Korea, and a favorable manufacturing cost comparison driven by Japan, partly offset by higher marketing, administration and research costs, principally related to increased investment behind RRPs in Japan and Korea, and affiliate reorganization costs in Australia.

East Asia & Australia - Total Market, PMI Shipment Volume and Market Share Commentaries
In the quarter, the estimated total market in East Asia & Australia decreased, notably due to:
•
Australia, down by 8.4%, primarily reflecting the impact of excise tax-driven retail price increases in 2017 and in the quarter;
•
Japan, down by 2.3%, primarily reflecting the decline of the total estimated cigarette market; and
•
Taiwan, down by 20.2%, primarily reflecting the impact of excise tax-driven retail price increases in June 2017.

PMI Shipment Volume (million units)
 
First-Quarter
 
 
2018

2017

Change

Cigarettes
 
14,091

17,243

(18.3
)%
Heated Tobacco Units
 
7,342

4,145

77.1
 %
Total East Asia & Australia
 
21,433

21,388

0.2
 %

Our total shipment volume increased by 0.2% to 21.4 billion units, or by 11.2% excluding the unfavorable impact of an estimated 1.0 billion cigarette units and 1.4 billion heated tobacco units of distributor inventory movements in Japan compared to the first quarter of 2017, driven by:
•
higher heated tobacco unit shipment volume in Japan and Korea, reflecting higher market share;
largely offset by
•
lower cigarette shipment in Japan and Korea, down by 25.8% and 6.1%, respectively, primarily reflecting the lower total cigarette market and lower cigarette market share.




- 59-

Latin America & Canada:
Financial Summary -
Quarters Ended March 31,
 
 
 
 
Change
Fav./(Unfav.)
 
Variance
Fav./(Unfav.)
 
2018
2017
 
Total
Excl.
Curr.
 
Total
Cur-
rency
Price
Vol/
Mix
Cost/
Other
(in millions)
 
 
 
Net Revenues
 
$ 708
$ 606
 
16.8
%
17.0
%
 
$
102

$
(1
)
$
100

$
3

$
—

Operating Income
 
$ 217
$ 176
 
23.3
%
31.3
%
 
$
41

$
(14
)
$
100

$
—

$
(45
)
“Cost/Other” in the above table reflects the currency-neutral variances of: cost of sales (excluding the volume/mix cost component); marketing, administration and research costs; asset impairment and exit costs; and amortization of intangibles.

During the quarter, net revenues, excluding unfavorable currency, increased by 17.0%, reflecting a favorable pricing variance across the Region, notably Argentina, Canada and Mexico.

Operating income, excluding unfavorable currency, increased by 31.3%, largely reflecting a favorable pricing variance, partly offset by higher manufacturing costs, mainly in Argentina, and higher marketing, administration and research costs, partly related to increased investment behind RRPs in the Region.

Latin America & Canada - Total Market, PMI Shipment Volume and Market Share Commentaries

In the quarter, the estimated total market in Latin America & Canada decreased, notably due to:
•
Brazil, down by 8.0%, primarily reflecting the impact of retail price increases in 2017;
•
Colombia, down by 15.7%, primarily reflecting the impact of excise tax-driven retail price increases of approximately 25%; and
•
Mexico, down by 2.7%, primarily reflecting the impact of the retail price increases in January 2018.
PMI Shipment Volume (million units)
 
First-Quarter
 
 
2018

2017

Change

Cigarettes
 
19,013

19,296

(1.5
)%
Heated Tobacco Units
 
23

1

+100.0%

Total Latin America & Canada
 
19,036

19,297

(1.4
)%

Our total shipment volume decreased by 1.4% to 19.0 billion units, notably in:
•
Argentina, down by 1.7%, reflecting the lower total market and lower market share; and
•
Mexico, down by 4.0%, reflecting the lower total market and lower market share.

Financial Review
Net Cash Provided by Operating Activities

During the first quarter of 2018, net cash provided by operating activities of $1.4 billion increased by $0.5 billion compared with the first quarter of 2017. Excluding favorable currency movements of $0.1 billion, the change was primarily due to lower working capital requirements of $0.2 billion and the 2017 payment in the South Korean tax matter (see Note 8. Contingencies for additional information).

Net Cash Used in Investing Activities

During the first quarter of 2018, net cash used in investing activities was $1.0 billion, compared with net cash used in investing activities of $0.5 billion during the first quarter of 2017. This increase in net cash used of $0.5 billion was due principally to cash collateral posted to secure derivatives designated as net investment hedges of Euro assets following the strengthening of the Euro

- 60-

versus the U.S. dollar, and higher capital expenditures. For further details on our derivatives designated as net investment hedges, see Note 5. Financial Instruments.

Our capital expenditures were $0.4 billion and $0.3 billion during the three months ended March 31, 2018 and 2017, respectively. The 2018 expenditures were primarily related to our ongoing investments in RRPs to support capacity expansion (notably for heated tobacco units). We expect total capital expenditures in 2018 to be approximately $1.7 billion.

Net Cash Provided by (Used in) Financing Activities

During the first quarter of 2018, net cash used in financing activities was $1.7 billion, compared with net cash provided by financing activities of $0.3 billion during the first quarter of 2017. The change was due primarily to no debt issuance in the first quarter of 2018 compared with long-term debt proceeds, net of repayments, of $1.7 billion in the first quarter of 2017, and the purchase of the remaining 49% interest in our Costa Rican affiliates. For further details on the purchase of the remaining 49% interest in our Costa Rican affiliates, see Note 17. Acquisitions.

Dividends paid in the first quarter of 2018 and 2017 were $1.7 billion and $1.6 billion, respectively.

Debt and Liquidity

We define cash and cash equivalents as short-term, highly liquid investments, readily convertible to known amounts of cash that mature within a maximum of three months and have an insignificant risk of change in value due to interest rate or credit risk changes. As a policy, we do not hold any investments in structured or equity-linked products. Our cash and cash equivalents are predominantly held in demand deposits with institutions that have investment-grade long-term credit rating. As part of our cash management strategy and in order to manage counterparty exposure, we also enter into reverse repurchase agreements. Such agreements are collateralized with government or corporate securities held by a custodial bank and, at maturity, cash is paid back to PMI and the collateral is returned to the bank. While we entered into these agreements during the periods and had an average balance during three months ended March 31, 2018 of $0.8 billion and an average balance during the full-year 2017 of $0.9 billion, we had a zero balance both at March 31, 2018 and December 31, 2017.
We utilize long-term and short-term debt financing, including a commercial paper program that is regularly used to finance ongoing liquidity requirements, as part of our overall cash management strategy. Our ability to access the capital and credit markets as well as overall dynamics of these markets may impact borrowing costs. We expect that the combination of our long-term and short-term debt financing, the commercial paper program and the committed credit facilities, coupled with our operating cash flows, will enable us to meet our liquidity requirements.
Credit Ratings – The cost and terms of our financing arrangements as well as our access to commercial paper markets may be affected by applicable credit ratings. On March 1, 2018, Standard & Poor's affirmed our long-term credit rating at "A" and short-term at "A-1", and revised our outlook to "Stable" from "Negative." At March 31, 2018, our credit ratings and outlook by major credit rating agencies were as follows:

 
  
Short-term
  
Long-term
  
Outlook
Moody’s
  
P-1
  
A2
  
Stable
Standard & Poor’s
  
A-1
  
A
  
Stable
Fitch
  
F1
  
A
  
Negative


- 61-

Credit Facilities – On January 29, 2018, we entered into an agreement to extend the term of our $2.0 billion 364-day revolving credit facility from February 6, 2018, to February 5, 2019.
At March 31, 2018, our committed credit facilities and commercial paper outstanding were as follows:

(in billions)
 
  
 
  
Type
 
Committed
Credit
Facilities
 
Commercial
Paper
364-day revolving credit, expiring February 5, 2019
 
$
2.0

 
 
Multi-year revolving credit, expiring February 28, 2021
 
2.5

 
 
Multi-year revolving credit, expiring October 1, 2022
 
3.5

 
 

 
Total facilities 
 
$
8.0

 
 

 
Commercial paper outstanding 
 
 

 
$
—


At March 31, 2018, there were no borrowings under the committed credit facilities, and the entire committed amounts were available for borrowing.

All banks participating in our committed credit facilities have an investment-grade long-term credit rating from the credit rating agencies. We continuously monitor the credit quality of our banking group, and at this time we are not aware of any potential non-performing credit provider.

Each of these facilities requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“consolidated EBITDA”) to consolidated interest expense of not less than 3.5 to 1.0 on a rolling four-quarter basis. At March 31, 2018, our ratio calculated in accordance with the agreements was 10.3 to 1.0. These facilities do not include any credit rating triggers, material adverse change clauses or any provisions that could require us to post collateral. We expect to continue to meet our covenants. The terms “consolidated EBITDA” and “consolidated interest expense,” both of which include certain adjustments, are defined in the facility agreements previously filed with the U.S. Securities and Exchange Commission.
In addition to the committed credit facilities discussed above, certain of our subsidiaries maintain short-term credit arrangements to meet their respective working capital needs. These credit arrangements, which amounted to approximately $2.9 billion at March 31, 2018 and $2.8 billion at December 31, 2017, are for the sole use of our subsidiaries. Borrowings under these arrangements amounted to $608 million at March 31, 2018, and $499 million at December 31, 2017.
Commercial Paper Program – We continue to have access to liquidity in the commercial paper market through programs in place in the U.S. and in Europe having an aggregate issuance capacity of $8.0 billion. At March 31, 2018 and December 31, 2017, we had no commercial paper outstanding. The average commercial paper balance outstanding during the first quarter of 2018 was $3.6 billion. The average commercial paper balance outstanding during 2017 was $5.2 billion.

Sale of Accounts Receivable – To mitigate credit risk and enhance cash and liquidity management we sell trade receivables to unaffiliated financial institutions. These arrangements allow us to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. We sell trade receivables under two types of arrangements, servicing and nonservicing.

Our operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2018, and March 31, 2017 were $878 million and $561 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows.

For further details, see Note 15. Sale of Accounts Receivable to our condensed consolidated financial statements.

Debt – Our total debt was $34.8 billion at March 31, 2018 and $34.3 billion at December 31, 2017.


- 62-

On February 14, 2017, we filed a shelf registration statement with the U.S. Securities and Exchange Commission, under which we may from time to time sell debt securities and/or warrants to purchase debt securities over a three-year period.
 
 
 
 
 
 
 
 
 
Guarantees – At March 31, 2018, we were contingently liable for $0.8 billion of guarantees of our own performance, which were primarily related to excise taxes on the shipment of our products. There is no liability in the condensed consolidated financial statements associated with these guarantees. At March 31, 2018, our third-party guarantees were insignificant.

Equity and Dividends

We discuss our stock awards as of March 31, 2018 in Note 2. Stock Plans to our condensed consolidated financial statements.

During 2017, we did not repurchase any shares under a share repurchase program and we do not presently intend to repurchase shares of our common stock in 2018.
Dividends paid in the first quarter of 2018 were $1.7 billion. During the third quarter of 2017, our Board of Directors approved a 2.9% increase in the quarterly dividend to $1.07 per common share. As a result, the present annualized dividend rate is $4.28 per common share.

Market Risk
Counterparty Risk - We predominantly work with financial institutions with strong short- and long-term credit ratings as assigned by Standard & Poor’s and Moody’s. These banks are also part of a defined group of relationship banks. Non-investment grade institutions are only used in certain emerging markets to the extent required by local business needs. We have a conservative approach when it comes to choosing financial counterparties and financial instruments. As such, we do not invest or hold investments in any structured or equity-linked products. The majority of our cash and cash equivalents is currently invested in demand deposits maturing within less than 30 days.
We continuously monitor and assess the credit worthiness of all our counterparties.
Derivative Financial Instruments - We operate in markets outside of the United States of America, with manufacturing and sales facilities in various locations throughout the world. Consequently, we use certain financial instruments to manage our foreign currency and interest rate exposure. We use derivative financial instruments principally to reduce our exposure to market risks resulting from fluctuations in foreign exchange rates by creating offsetting exposures. We are not a party to leveraged derivatives and, by policy, do not use derivative financial instruments for speculative purposes.
See Note 5. Financial Instruments, Note 11. Fair Value Measurements, and Note 13. Balance Sheet Offsetting to our condensed consolidated financial statements for further details on our derivative financial instruments and the related collateral arrangements.

Contingencies
See Note 8. Contingencies to our condensed consolidated financial statements for a discussion of contingencies.

Cautionary Factors That May Affect Future Results

Forward-Looking and Cautionary Statements
We may from time to time make written or oral forward-looking statements, including statements contained in filings with the SEC, in reports to stockholders and in press releases and investor webcasts. You can identify these forward-looking statements by use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements and whether to invest in or remain invested in our securities. In connection with the “safe harbor” provisions of the Private Securities

- 63-

Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements. We elaborate on these and other risks we face throughout this document, particularly in the “Business Environment” section. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider the following to be a complete discussion of all potential risks or uncertainties. We do not undertake to update any forward-looking statement that we may make from time to time, except in the normal course of our public disclosure obligations.
Risks Related to Our Business and Industry
Consumption of tax-paid cigarettes continues to decline in many of our markets.
This decline is due to multiple factors, including increased taxes and pricing, governmental actions, the diminishing social acceptance of smoking, continuing economic and geopolitical uncertainty, and the continuing prevalence of illicit products. These factors and their potential consequences are discussed more fully below and in the "Business Environment" section.
Cigarettes are subject to substantial taxes. Significant increases in cigarette-related taxes have been proposed or enacted and are likely to continue to be proposed or enacted in numerous jurisdictions. These tax increases may disproportionately affect our profitability and make us less competitive versus certain of our competitors.
Tax regimes, including excise taxes, sales taxes and import duties, can disproportionately affect the retail price of cigarettes versus other combustible tobacco products, or disproportionately affect the relative retail price of our cigarette brands versus cigarette brands manufactured by certain of our competitors. Because our portfolio is weighted toward the premium-price cigarette category, tax regimes based on sales price can place us at a competitive disadvantage in certain markets. As a result, our volume and profitability may be adversely affected in these markets.
Increases in cigarette taxes are expected to continue to have an adverse impact on our sales of cigarettes, due to resulting lower consumption levels, a shift in sales from manufactured cigarettes to other combustible tobacco products and from the premium-price to the mid-price or low-price cigarette categories, where we may be under-represented, from local sales to legal cross-border purchases of lower price products, or to illicit products such as contraband, counterfeit and "illicit whites."
Our business faces significant governmental action aimed at increasing regulatory requirements with the goal of reducing or preventing the use of tobacco products.
Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volume in many of our markets, and we expect that such factors will continue to reduce consumption levels and will increase down-trading and the risk of counterfeiting, contraband, "illicit whites" and legal cross-border purchases. Significant regulatory developments will take place over the next few years in most of our markets, driven principally by the World Health Organization's Framework Convention on Tobacco Control ("FCTC"). The FCTC is the first international public health treaty on tobacco, and its objective is to establish a global agenda for tobacco regulation. The FCTC has led to increased efforts by tobacco control advocates and public health organizations to promote increasingly restrictive regulatory measures on the marketing and sale of tobacco products to adult smokers. Regulatory initiatives that have been proposed, introduced or enacted include:
 
•
restrictions on or licensing of outlets permitted to sell cigarettes;
•
the levying of substantial and increasing tax and duty charges;
•
restrictions or bans on advertising, marketing and sponsorship;
•
the display of larger health warnings, graphic health warnings and other labeling requirements;
•
restrictions on packaging design, including the use of colors, and plain packaging;
•
restrictions on packaging and cigarette formats and dimensions;
•
restrictions or bans on the display of tobacco product packaging at the point of sale and restrictions or bans on cigarette vending machines;
•
requirements regarding testing, disclosure and performance standards for tar, nicotine, carbon monoxide and other smoke constituents;
•
disclosure, restrictions, or bans of tobacco product ingredients;

- 64-

•
increased restrictions on smoking in public and work places and, in some instances, in private places and outdoors;
•
restrictions on the sale of novel tobacco or nicotine-containing products;
•
elimination of duty free sales and duty free allowances for travelers; and
•
encouraging litigation against tobacco companies.
Our operating income could be significantly affected by regulatory initiatives resulting in a significant decrease in demand for our brands, in particular requirements that lead to a commoditization of tobacco products, as well as any significant increase in the cost of complying with new regulatory requirements.
Litigation related to tobacco use and exposure to environmental tobacco smoke could substantially reduce our profitability and could severely impair our liquidity.
There is litigation related to tobacco products pending in certain jurisdictions. Damages claimed in some tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. We anticipate that new cases will continue to be filed. The FCTC encourages litigation against tobacco product manufacturers. It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Please see Note 8. Contingencies to our condensed consolidated financial statements for a discussion of pending litigation.

We face intense competition, and our failure to compete effectively could have a material adverse effect on our profitability and results of operations.
We compete primarily on the basis of product quality, brand recognition, brand loyalty, taste, R&D, innovation, packaging, customer service, marketing, advertising and retail price and, increasingly, adult smoker willingness to convert to our RRPs. We are subject to highly competitive conditions in all aspects of our business. The competitive environment and our competitive position can be significantly influenced by weak economic conditions, erosion of consumer confidence, competitors' introduction of lower-price products or innovative products, higher tobacco product taxes, higher absolute prices and larger gaps between retail price categories, and product regulation that diminishes the ability to differentiate tobacco products. Competitors include three large international tobacco companies and several regional and local tobacco companies and, in some instances, state-owned tobacco enterprises, principally in Algeria, Egypt, the PRC, Taiwan, Thailand and Vietnam. Industry consolidation and privatizations of state-owned enterprises have led to an overall increase in competitive pressures. Some competitors have different profit and volume objectives, and some international competitors are susceptible to changes in different currency exchange rates.
Because we have operations in numerous countries, our results may be influenced by economic, regulatory and political developments, natural disasters or conflicts.
Some of the countries in which we operate face the threat of civil unrest and can be subject to regime changes. In others, nationalization, terrorism, conflict and the threat of war may have a significant impact on the business environment. Economic, political, regulatory or other developments or natural disasters could disrupt our supply chain, manufacturing capabilities or distribution capabilities. In addition, such developments could lead to loss of property or equipment that are critical to our business in certain markets and difficulty in staffing and managing our operations, which could reduce our volumes, revenues and net earnings.
In certain markets, we are dependent on governmental approvals of various actions such as price changes, and failure to obtain such approvals could impair growth of our profitability.
In addition, despite our high ethical standards and rigorous control and compliance procedures aimed at preventing and detecting unlawful conduct, given the breadth and scope of our international operations, we may not be able to detect all potential improper or unlawful conduct by our employees and partners.
We may be unable to anticipate changes in consumer preferences or to respond to consumer behavior influenced by economic downturns.
Our business is subject to changes in adult consumer preferences, which may be influenced by local economic conditions. To be successful, we must: 
•
promote brand equity successfully;
•
anticipate and respond to new adult consumer trends;
•
develop new products and markets and broaden brand portfolios;

- 65-

•
improve productivity;
•
convince adult smokers to convert to our RRPs;
•
ensure adequate production capacity to meet demand for our products; and
•
be able to protect or enhance margins through price increases.
In periods of economic uncertainty, adult consumers may tend to purchase lower-price brands, and the volume of our premium-price and mid-price brands and our profitability could suffer accordingly. Such down-trading trends may be reinforced by regulation that limits branding, communication and product differentiation.
We lose revenues as a result of counterfeiting, contraband, cross-border purchases, "illicit whites" and non-tax-paid volume produced by local manufacturers.
Large quantities of counterfeit cigarettes are sold in the international market. We believe that Marlboro is the most heavily counterfeited international cigarette brand, although we cannot quantify the revenues we lose as a result of this activity. In addition, our revenues are reduced by contraband, legal cross-border purchases, "illicit whites" and non-tax-paid volume produced by local manufacturers.

From time to time, we are subject to governmental investigations on a range of matters.
Investigations include allegations of contraband shipments of cigarettes, allegations of unlawful pricing activities within certain markets, allegations of underpayment of customs duties and/or excise taxes, allegations of false and misleading usage of descriptors and allegations of unlawful advertising. We cannot predict the outcome of those investigations or whether additional investigations may be commenced, and it is possible that our business could be materially affected by an unfavorable outcome of pending or future investigations. See “Management's Discussion and Analysis of Financial Condition and Results of Operations-Operating Results by Business Segment-Business Environment-Governmental Investigations” for a description of certain governmental investigations to which we are subject.
We may be unsuccessful in our attempts to introduce reduced-risk products, and regulators may not permit the commercialization of these products or the communication of scientifically substantiated risk-reduction claims.

Our key strategic priorities are: to develop and commercialize products that present less risk of harm to adult smokers who switch to those products versus continued smoking; and to convince current adult smokers who would otherwise continue to smoke to switch to those RRPs. For our efforts to be successful, we must: develop RRPs that such adult smokers find acceptable alternatives to smoking; conduct rigorous scientific studies to substantiate that they reduce exposure to harmful and potentially harmful constituents in smoke and, ultimately, that these products present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to them versus continued smoking; and effectively advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including communication of scientifically substantiated information to enable adult smokers to make better consumer choices. We might not succeed in our efforts. If we do not succeed, but others do, we may be at a competitive disadvantage. Furthermore, we cannot predict whether regulators will permit the sale and/or marketing of RRPs with scientifically substantiated risk-reduction claims. Such restrictions could limit the success of our RRPs.
We may be unsuccessful in our efforts to differentiate reduced-risk products and cigarettes with respect to taxation.

To date, we have been largely successful in demonstrating to regulators that our RRPs are not cigarettes, and as such they are generally taxed either as a separate category or as other tobacco products, which typically yields more favorable tax rates than cigarettes. If we cease to be successful in these efforts, RRP unit margins may be adversely affected.
Our reported results could be adversely affected by unfavorable currency exchange rates, and currency devaluations could impair our competitiveness.
We conduct our business primarily in local currency and, for purposes of financial reporting, the local currency results are translated into U.S. dollars based on average exchange rates prevailing during a reporting period. During times of a strengthening U.S. dollar, our reported net revenues and operating income will be reduced because the local currency translates into fewer U.S. dollars. During periods of local economic crises, foreign currencies may be devalued significantly against the U.S. dollar, reducing our margins. Actions to recover margins may result in lower volume and a weaker competitive position.

- 66-

Changes in the earnings mix and changes in tax laws may result in significant variability in our effective tax rates. Our ability to receive payments from foreign subsidiaries or to repatriate royalties and dividends could be restricted by local country currency exchange controls.

The Tax Cuts and Jobs Act that was signed into law in December 2017 constitutes a major change to the U.S. tax system. Our estimated impact of the Tax Cuts and Jobs Act is based on management’s current interpretations, and our analysis is ongoing.  Our final tax liability may be materially different from current estimates due to developments such as implementing regulations and clarifications. In future periods, our effective tax rate and our ability to recover deferred tax assets could be subject to additional uncertainty as a result of such developments. Furthermore, changes in the earnings mix or applicable foreign tax laws may result in significant variability in our effective tax rates. Because we are a U.S. holding company, our most significant source of funds is distributions from our non-U.S. subsidiaries. Certain countries in which we operate have adopted or could institute currency exchange controls that limit or prohibit our local subsidiaries' ability to convert local currency into U.S. dollars or to make payments outside the country. This could subject us to the risks of local currency devaluation and business disruption.
Our ability to grow profitability may be limited by our inability to introduce new products, enter new markets or improve our margins through higher pricing and improvements in our brand and geographic mix.
Our profit growth may suffer if we are unable to introduce new products or enter new markets successfully, to raise prices or to improve the proportion of our sales of higher margin products and in higher margin geographies.

We may be unable to expand our brand portfolio through successful acquisitions or the development of strategic business relationships.
One element of our growth strategy is to strengthen our brand portfolio and market positions through selective acquisitions and the development of strategic business relationships. Acquisition and strategic business development opportunities are limited and present risks of failing to achieve efficient and effective integration, strategic objectives and anticipated revenue improvements and cost savings. There is no assurance that we will be able to acquire attractive businesses on favorable terms, or that future acquisitions or strategic business developments will be accretive to earnings.
Government mandated prices, production control programs, shifts in crops driven by economic conditions and the impact of climate change may increase the cost or reduce the quality of the tobacco and other agricultural products used to manufacture our products.
As with other agricultural commodities, the price of tobacco leaf and cloves can be influenced by imbalances in supply and demand, and crop quality can be influenced by variations in weather patterns, including those caused by climate change. Tobacco production in certain countries is subject to a variety of controls, including government mandated prices and production control programs. Changes in the patterns of demand for agricultural products could cause farmers to produce less tobacco or cloves. Any significant change in tobacco leaf and clove prices, quality and quantity could affect our profitability and our business.
Our ability to implement our strategy of attracting and retaining the best global talent may be impaired by the decreasing social acceptance of cigarette smoking.
The tobacco industry competes for talent with consumer products and other companies that enjoy greater societal acceptance. As a result, we may be unable to attract and retain the best global talent.
The failure of our information systems to function as intended or their penetration by outside parties with the intent to corrupt them or our failure to comply with privacy laws and regulations could result in business disruption, litigation and regulatory action, and loss of revenue, assets or personal or other confidential data.
We use information systems to help manage business processes, collect and interpret business data and communicate internally and externally with employees, suppliers, customers and others. Some of these information systems are managed by third-party service providers. We have backup systems and business continuity plans in place, and we take care to protect our systems and data from unauthorized access. Nevertheless, failure of our systems to function as intended, or penetration of our systems by outside parties intent on extracting or corrupting information or otherwise disrupting business processes, could place us at a competitive disadvantage, result in a loss of revenue, assets or personal or other sensitive data, litigation and regulatory action, cause damage to our reputation and that of our brands and result in significant remediation and other costs. Failure to protect personal data and respect the rights of data subjects could subject us to substantial fines under regulations such as the EU General Data Protection Regulation.

- 67-

We may be required to replace third-party contract manufacturers or service providers with our own resources.

In certain instances, we contract with third parties to manufacture some of our products or product parts or to provide other services. We may be unable to renew these agreements on satisfactory terms for numerous reasons, including government regulations. Accordingly, our costs may increase significantly if we must replace such third parties with our own resources.


- 68-

Item 4. Controls and Procedures.

PMI carried out an evaluation, with the participation of PMI’s management, including PMI’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of PMI’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, PMI’s Chief Executive Officer and Chief Financial Officer concluded that PMI’s disclosure controls and procedures are effective. There have been no changes in PMI’s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, PMI’s internal control over financial reporting.



- 69-


Part II - OTHER INFORMATION
 
Item 1.
Legal Proceedings.
See Note 8. Contingencies of the Notes to the Condensed Consolidated Financial Statements included in Part I – Item 1 of this report for a discussion of legal proceedings pending against Philip Morris International Inc. and its subsidiaries.

Item 1A.
Risk Factors.
Information regarding Risk Factors appears in “MD&A – Cautionary Factors That May Affect Future Results,” in Part I – Item 2 of this Form 10-Q and in Part I – Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2017.

- 70-


Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
Our share repurchase activity for each of the three months in the quarter ended March 31, 2018 was as follows:
 
Period
 
Total Number
of Shares
Repurchased
 
Average
Price Paid
Per Share
 
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
 
Approximate Dollar
Value of Shares that
May Yet be Purchased
Under the Plans or
Programs
January 1, 2018 –
January 31, 2018 (1)
 
—

 
$
—

 
—

 
$
—

February 1, 2018 –
February 28, 2018 (1)
 
—

 
$
—

 
—

 
$
—

March 1, 2018 –
March 31, 2018 (1)
 
—

 
$
—

 
—

 
$
—

Pursuant to Publicly
  Announced Plans
  or Programs
 
—

 
$
—

 
 
 
 
January 1, 2018 –
January 31, 2018 (2)
 
5,582

 
$
105.76

 
 
 
 
February 1, 2018 –
February 28, 2018 (2)
 
122,425

 
$
104.06

 
 
 
 
March 1, 2018 –
March 31, 2018 (2)
 
1,981

 
$
103.30

 
 
 
 
For the Quarter Ended March 31, 2018
 
129,988

 
$
104.12

 
 
 
 
 

(1)
During this reporting period, we did not have an authorized share repurchase program.

(2)
Shares repurchased represent shares tendered to us by employees who vested in restricted share unit awards and used shares to pay all, or a portion of, the related taxes.

- 71-


Item 6.
Exhibits.
 
 
 
 
 
 
3.1
 
 
 
 
10.1
 
 
 
 
10.2
 
 
 
 
10.3
 
 
 
 
10.4
 
 
 
 
10.5
 
 
 
 
10.6
 
 
 
 
12
 
 
 
31.1
 
 
 
31.2
 
 
 
32.1
 
 
 
32.2
 
 
 
101.INS
 
XBRL Instance Document.
 
 
101.SCH
 
XBRL Taxonomy Extension Schema.
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase.
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase.
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase.
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase.


- 72-

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

PHILIP MORRIS INTERNATIONAL INC.
 
/s/ MARTIN G. KING
 
Martin G. King
Chief Financial Officer
 
April 26, 2018

- 73-
 EX-12 2 pm-ex12_033118xq1.htm EXHIBIT 12 Exhibit
Exhibit 12
PHILIP MORRIS INTERNATIONAL INC. AND SUBSIDIARIES
Computation of Ratios of Earnings to Fixed Charges
(in millions of dollars)
 
 
Three Months Ended
 
March 31, 2018
Earnings before income taxes
$
2,193

Add (deduct):
 
Dividends from less than 50% owned affiliates
10

Fixed charges
292

Interest capitalized, net of amortization
—

Earnings available for fixed charges
$
2,495

Fixed charges:
 
Interest incurred (1)
$
266

Portion of rent expense deemed to represent interest factor
26

Fixed charges
$
292


Ratio of earnings to fixed charges
8.5

 
(1) Interest incurred includes an interest benefit of $15 million not related to third party debt.

- 1 -




Exhibit 12
PHILIP MORRIS INTERNATIONAL INC. AND SUBSIDIARIES
Computation of Ratios of Earnings to Fixed Charges
(in millions of dollars)
 
 
For the Years Ended December 31,
 
2017
 
2016
 
2015
 
2014
 
2013
Earnings before income taxes
$
10,589

 
$
9,924

 
$
9,615

 
$
10,650

 
$
12,542

Add (deduct):
 
 
 
 
 
 
 
 
 
Dividends from less than 50%
owned affiliates
120

 
117

 
127

 
107

 
1

Fixed charges
1,203

 
1,166

 
1,232

 
1,284

 
1,216

Interest capitalized, net of
amortization
1

 
—

 
(3
)
 
1

 
4

Earnings available for fixed charges
$
11,913

 
$
11,207

 
$
10,971

 
$
12,042

 
$
13,763



Fixed charges:
 
 
 
 
 
 
 
 
 
Interest incurred
$
1,098

 
$
1,071

 
$
1,137

 
$
1,172

 
$
1,105

Portion of rent expense deemed to
represent interest factor
105

 
95

 
95

 
112

 
111

Fixed charges
$
1,203

 
$
1,166


$
1,232


$
1,284


$
1,216


Ratio of earnings to fixed charges
9.9

 
9.6

 
8.9

 
9.4

 
11.3


- 2 -

 EX-31.1 3 pm-ex311_033118xq1.htm EXHIBIT 31.1 Exhibit
Exhibit 31.1
Certifications
I, André Calantzopoulos, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: April 26, 2018
/s/ ANDRÉ CALANTZOPOULOS
André Calantzopoulos
Chief Executive Officer

-1-
 EX-31.2 4 pm-ex312_033118xq1.htm EXHIBIT 31.2 Exhibit
Exhibit 31.2
Certifications
I, Martin G. King, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c.
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d.
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: April 26, 2018
/s/ MARTIN G. KING
Martin G. King
Chief Financial Officer

- 1 -

 EX-32.1 5 pm-ex321_033118xq1.htm EXHIBIT 32.1 Exhibit
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, André Calantzopoulos, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)        the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)        the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ ANDRÉ CALANTZOPOULOS
André Calantzopoulos
Chief Executive Officer
April 26, 2018
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Philip Morris International Inc. and will be retained by Philip Morris International Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 


-1-
 EX-32.2 6 pm-ex322_033118xq1.htm EXHIBIT 32.2 Exhibit
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin G. King, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1)        the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)        the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ MARTIN G. KING
Martin G. King
Chief Financial Officer
April 26, 2018
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Philip Morris International Inc. and will be retained by Philip Morris International Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 


-1-
 EX-101.INS 7 pm-20180331.xml XBRL INSTANCE DOCUMENT 0001413329 2018-01-01 2018-03-31 0001413329 2018-04-23 0001413329 2018-03-31 0001413329 2017-12-31 0001413329 2017-01-01 2017-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001413329 us-gaap:TreasuryStockMember 2016-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-03-31 0001413329 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0001413329 us-gaap:TreasuryStockMember 2017-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-03-31 0001413329 us-gaap:CommonStockMember 2016-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001413329 2016-12-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2017-03-31 0001413329 us-gaap:RetainedEarningsMember 2017-01-01 2017-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0001413329 us-gaap:CommonStockMember 2017-12-31 0001413329 us-gaap:TreasuryStockMember 2017-01-01 2017-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-03-31 0001413329 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001413329 us-gaap:CommonStockMember 2017-03-31 0001413329 us-gaap:RetainedEarningsMember 2018-03-31 0001413329 us-gaap:TreasuryStockMember 2017-12-31 0001413329 us-gaap:RetainedEarningsMember 2017-03-31 0001413329 us-gaap:RetainedEarningsMember 2017-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2016-12-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2017-12-31 0001413329 us-gaap:RetainedEarningsMember 2016-12-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001413329 us-gaap:TreasuryStockMember 2018-03-31 0001413329 2017-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2018-03-31 0001413329 us-gaap:CommonStockMember 2018-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0001413329 us-gaap:PerformanceSharesMember 2018-01-01 2018-03-31 0001413329 pm:A2017NonEmployeeDirectorsPlanMember 2017-05-31 0001413329 pm:PerformanceMetricPerformanceAgainstSpecificMeasuresOfTransformationMember us-gaap:PerformanceSharesMember 2018-01-01 2018-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2018-03-31 0001413329 us-gaap:PerformanceSharesMember 2018-03-31 0001413329 us-gaap:PerformanceSharesMember us-gaap:MinimumMember 2018-01-01 2018-03-31 0001413329 pm:FairValueMember us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001413329 pm:A2017PerformanceIncentivePlanMember 2018-03-31 0001413329 pm:GrantDateFairValueMember us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-03-31 0001413329 pm:PerformanceMetricCurrencyNeutralCompoundAnnualAdjustedOperatingIncomeGrowthRateExcludingAcquisitionsMember us-gaap:PerformanceSharesMember 2018-01-01 2018-03-31 0001413329 pm:PerformanceMetricTotalShareholderReturnMember us-gaap:PerformanceSharesMember 2018-01-01 2018-03-31 0001413329 pm:A2017NonEmployeeDirectorsPlanMember 2018-03-31 0001413329 us-gaap:PerformanceSharesMember us-gaap:MaximumMember 2018-01-01 2018-03-31 0001413329 pm:A2017PerformanceIncentivePlanMember 2017-05-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0001413329 pm:PerformanceShareUnitsOtherPerformanceFactorsMember 2018-01-01 2018-03-31 0001413329 pm:PerformanceShareUnitsTSRRelativeToCustomerPeerGroupMember 2017-01-01 2017-03-31 0001413329 us-gaap:PerformanceSharesMember 2017-01-01 2017-03-31 0001413329 pm:PerformanceShareUnitsOtherPerformanceFactorsMember 2017-01-01 2017-03-31 0001413329 pm:PerformanceShareUnitsTSRRelativeToCustomerPeerGroupMember 2018-01-01 2018-03-31 0001413329 us-gaap:PostretirementBenefitCostsMember 2017-01-01 2017-03-31 0001413329 us-gaap:PostretirementBenefitCostsMember 2018-01-01 2018-03-31 0001413329 pm:PostemploymentBenefitPlansMember 2017-01-01 2017-03-31 0001413329 pm:PostemploymentBenefitPlansMember 2018-01-01 2018-03-31 0001413329 us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-03-31 0001413329 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-03-31 0001413329 pm:MiddleEastAndAfricaMember 2017-12-31 0001413329 pm:SouthAndSoutheastAsiaMember 2018-03-31 0001413329 pm:EastAsiaAndAustraliaMember 2017-12-31 0001413329 pm:EastAsiaAndAustraliaMember 2018-01-01 2018-03-31 0001413329 pm:MiddleEastAndAfricaMember 2018-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2017-12-31 0001413329 pm:EasternEuropeMember 2018-03-31 0001413329 pm:SouthAndSoutheastAsiaMember 2018-01-01 2018-03-31 0001413329 us-gaap:EuropeanUnionMember 2017-12-31 0001413329 pm:MiddleEastAndAfricaMember 2018-01-01 2018-03-31 0001413329 us-gaap:EuropeanUnionMember 2018-03-31 0001413329 pm:SouthAndSoutheastAsiaMember 2017-12-31 0001413329 pm:LatinAmericaAndCanadaMember 2018-03-31 0001413329 pm:EasternEuropeMember 2018-01-01 2018-03-31 0001413329 pm:EastAsiaAndAustraliaMember 2018-03-31 0001413329 pm:EasternEuropeMember 2017-12-31 0001413329 us-gaap:EuropeanUnionMember 2018-01-01 2018-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2018-01-01 2018-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember 2018-03-31 0001413329 us-gaap:DistributionRightsMember 2018-03-31 0001413329 us-gaap:TrademarksMember 2018-03-31 0001413329 us-gaap:TrademarksMember us-gaap:MaximumMember 2018-01-01 2018-03-31 0001413329 us-gaap:TrademarksMember us-gaap:MinimumMember 2018-01-01 2018-03-31 0001413329 us-gaap:DistributionRightsMember 2018-01-01 2018-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember 2018-01-01 2018-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember us-gaap:MinimumMember 2018-01-01 2018-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember us-gaap:MaximumMember 2018-01-01 2018-03-31 0001413329 us-gaap:DistributionRightsMember us-gaap:MinimumMember 2018-01-01 2018-03-31 0001413329 us-gaap:TrademarksMember 2018-01-01 2018-03-31 0001413329 us-gaap:DistributionRightsMember us-gaap:MaximumMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2016-12-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2017-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-03-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2018-03-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-12-31 0001413329 us-gaap:ForeignExchangeContractMember 2017-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-03-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-03-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:MaximumMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember pm:MarketingAdministrationAndResearchCostsMember 2018-01-01 2018-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember pm:MarketingAdministrationAndResearchCostsMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:MiddleEastAndAfricaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EasternEuropeMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:EuropeanUnionMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EasternEuropeMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:SouthAndSoutheastAsiaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:LatinAmericaAndCanadaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:LatinAmericaAndCanadaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:EuropeanUnionMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:MiddleEastAndAfricaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EastAsiaAndAustraliaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EastAsiaAndAustraliaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:SouthAndSoutheastAsiaMember 2017-01-01 2017-03-31 0001413329 pm:ReducedRiskProductsMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:EastAsiaAndAustraliaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:EastAsiaAndAustraliaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:MiddleEastAndAfricaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:MiddleEastAndAfricaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:MiddleEastAndAfricaMember 2018-01-01 2018-03-31 0001413329 pm:ReducedRiskProductsMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:LatinAmericaAndCanadaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:EastAsiaAndAustraliaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:LatinAmericaAndCanadaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:EasternEuropeMember 2017-01-01 2017-03-31 0001413329 pm:CombustibleProductsMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember us-gaap:EuropeanUnionMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:SouthAndSoutheastAsiaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:MiddleEastAndAfricaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember us-gaap:EuropeanUnionMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:EasternEuropeMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:SouthAndSoutheastAsiaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:SouthAndSoutheastAsiaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:LatinAmericaAndCanadaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember us-gaap:EuropeanUnionMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:LatinAmericaAndCanadaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:EastAsiaAndAustraliaMember 2018-01-01 2018-03-31 0001413329 pm:CombustibleProductsMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:SouthAndSoutheastAsiaMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember us-gaap:EuropeanUnionMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:ReducedRiskProductsMember pm:EasternEuropeMember 2018-01-01 2018-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:CombustibleProductsMember pm:EasternEuropeMember 2018-01-01 2018-03-31 0001413329 pm:CeciliaLetourneauMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:CA 2018-01-01 2018-03-31 0001413329 pm:CaseDecidedInFavorOfPlaintiffMember 2018-03-31 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualSmokingAndHealthCasesMember country:RU us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:TheAttorneyGeneralOfOyoStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2007-05-25 2007-05-25 0001413329 pm:TheAttorneyGeneralOfKanoStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2007-05-09 2007-05-09 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:SmokingAndHealthClassActionsMember country:CA 2015-10-01 2015-10-30 0001413329 pm:IndividualSmokingAndHealthCasesMember country:AR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:PurportedLabelRelatedClassActionMember country:IL us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:HealthCareCostRecoveryActionsMember country:NG us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:PublicCivilActionsMember country:VE us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember us-gaap:PendingLitigationMember pm:OtherLitigationMember country:TH 2016-01-18 2016-01-18 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-07-01 2015-07-31 0001413329 pm:IndividualLabelRelatedCasesMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:IndividualSmokingAndHealthCasesMember pm:ScotlandMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:SuzanneJacklinMember us-gaap:PendingLitigationMember country:CA 2012-06-20 2012-06-20 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-10-01 2015-10-30 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember pm:OtherLitigationMember country:KR 2016-11-01 2017-03-31 0001413329 pm:SmokingAndHealthClassActionsMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:SmokingAndHealthClassActionsMember country:CA us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:PublicCivilActionsMember 2017-04-25 0001413329 pm:IndividualLabelRelatedCasesMember 2016-04-22 0001413329 pm:IndividualSmokingAndHealthCasesMember country:TR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember pm:OtherLitigationMember country:KR 2017-01-01 2017-03-31 0001413329 pm:TheAttorneyGeneralOfLagosStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-03-13 2008-03-13 0001413329 pm:TheAttorneyGeneralOfOgunStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-02-26 2008-02-26 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:UnderAdvisementMember pm:SmokingAndHealthClassActionsMember country:CA 2015-08-01 2015-08-31 0001413329 pm:HealthCareCostRecoveryActionsMember country:KR 2014-04-14 2014-04-14 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CA us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2017-03-01 2017-03-31 0001413329 pm:CeciliaLetourneauMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember pm:OtherLitigationMember country:TH 2017-11-29 2017-11-29 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember pm:OtherLitigationMember country:TH 2017-01-26 2017-01-26 0001413329 pm:ImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:SmokingAndHealthClassActionsMember country:CA 2015-10-01 2015-10-30 0001413329 pm:SmokingAndHealthClassActionsMember country:BR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:IndividualSmokingAndHealthCasesMember country:BR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:HealthCareCostRecoveryActionsMember 2017-04-25 0001413329 pm:IndividualSmokingAndHealthCasesMember 2017-04-25 0001413329 pm:IndividualLabelRelatedCasesMember 2017-04-25 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:SmokingAndHealthClassActionsMember country:BR 2004-04-30 0001413329 pm:HealthCareCostRecoveryActionsMember country:KR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:PublicCivilActionsMember 2016-04-22 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember pm:OtherLitigationMember country:KR 2016-01-01 2016-12-31 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-07-01 2015-07-31 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:PublicCivilActionsMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:SmokingAndHealthClassActionsMember 2017-04-25 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-06-01 2015-06-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:HealthCareCostRecoveryActionsMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:AdamsMember us-gaap:PendingLitigationMember country:CA 2009-07-10 2009-07-10 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:AwardpersmokerperyearMember pm:SmokingAndHealthClassActionsMember country:BR 2004-04-01 2004-04-30 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CL us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualSmokingAndHealthCasesMember country:PH us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:TheAttorneyGeneralOfGombeStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-10-17 2008-10-17 0001413329 pm:IndividualSmokingAndHealthCasesMember country:IT us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:AharonRingerV.PhilipMorrisLtd.AndGlobrandsLtd.Member pm:PurportedLabelRelatedClassActionMember 2017-07-18 2017-07-18 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-06-01 2015-06-30 0001413329 pm:ImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-10-01 2015-10-30 0001413329 pm:PublicCivilActionsMember country:AR us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:SmokingAndHealthClassActionsMember 2016-04-22 0001413329 pm:SubsidiaryAndOtherKoreanManufacturersMember pm:HealthCareCostRecoveryActionsMember country:KR 2014-04-14 2014-04-14 0001413329 pm:HealthCareCostRecoveryActionsMember 2016-04-22 0001413329 pm:CasesRemainingOnAppealMember 2018-03-31 0001413329 pm:IndividualSmokingAndHealthCasesMember 2016-04-22 0001413329 pm:IndividualLabelRelatedCasesMember country:IT us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:HugoLespadaMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthIndividualActionsMember country:AR 2018-01-01 2018-03-31 0001413329 pm:LabelRelatedClassActionMember 2017-04-25 0001413329 pm:LabelRelatedClassActionMember us-gaap:SubsequentEventMember 2018-04-24 0001413329 pm:LabelRelatedClassActionMember 2016-04-22 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:CA 2018-01-01 2018-03-31 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:BR 2018-01-01 2018-03-31 0001413329 pm:HugoLespadaMember us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember country:AR 2016-08-05 2016-08-05 0001413329 2017-12-01 2017-12-31 0001413329 country:US 2018-01-01 2018-03-31 0001413329 us-gaap:ScenarioForecastMember 2018-01-01 2018-12-31 0001413329 pm:ThreeHundredSixtyFourDayRevolvingCreditExpiringFebruaryFifthTwoThousandNineteenMember 2018-03-31 0001413329 pm:MultiYearRevolvingCreditExpiringFebruaryTwentyEighthTwoThousandTwentyOneMember 2018-03-31 0001413329 pm:MultiYearRevolvingCreditExpiringOctoberFirstTwoThousandTwentyTwoMember 2018-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2017-12-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2018-03-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2017-12-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2018-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2018-03-31 0001413329 pm:UsDollarNotesMember 2018-03-31 0001413329 pm:UsDollarNotesMember 2017-12-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2017-12-31 0001413329 pm:ThreeHundredSixtyFourDayRevolvingCreditExpiringFebruaryFifthTwoThousandNineteenMember 2018-01-29 0001413329 pm:UsDollarNotesMember 2018-01-01 2018-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember us-gaap:MaximumMember 2018-03-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2018-01-01 2018-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember us-gaap:MinimumMember 2018-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember us-gaap:MinimumMember 2018-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember us-gaap:MaximumMember 2018-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2018-01-01 2018-03-31 0001413329 pm:UsDollarNotesMember us-gaap:MaximumMember 2018-03-31 0001413329 pm:UsDollarNotesMember us-gaap:MinimumMember 2018-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2018-01-01 2018-03-31 0001413329 us-gaap:FairValueInputsLevel3Member 2018-03-31 0001413329 us-gaap:FairValueInputsLevel2Member 2018-03-31 0001413329 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-03-31 0001413329 us-gaap:FairValueInputsLevel1Member 2018-03-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-03-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2017-03-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-03-31 0001413329 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-03-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2018-03-31 0001413329 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-03-31 0001413329 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2017-12-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2018-03-31 0001413329 pm:ManagementEtDeveloppmentDesActifsEtDesRessourcesHoldingMADARHoldingMember pm:STAEMMember 2018-03-31 0001413329 pm:EITAMember 2018-03-31 0001413329 pm:EITAMember pm:STAEMMember 2018-03-31 0001413329 us-gaap:MinimumMember 2018-01-01 2018-03-31 0001413329 2017-01-01 2017-12-31 0001413329 pm:EquityMethodInvestmentGoodwillMember 2017-12-31 0001413329 pm:MegapolisMember 2018-03-31 0001413329 us-gaap:MaximumMember 2018-01-01 2018-03-31 0001413329 pm:STAEMMember 2018-03-31 0001413329 pm:EquityMethodInvestmentGoodwillMember 2018-03-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2017-01-01 2017-03-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2018-01-01 2018-03-31 0001413329 pm:TabacaleraCostarricenseS.A.AndMendiolaYCampaniaS.A.PurchaseOfNoncontrollingInterestMember 2018-03-21 2018-03-21 0001413329 pm:TabacaleraCostarricenseS.A.AndMendiolaYCampaniaS.A.PurchaseOfNoncontrollingInterestMember 2018-03-21 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:CustomerConcentrationRiskMember pm:CustomerOneMember us-gaap:EuropeanUnionMember 2017-01-01 2017-12-31 0001413329 us-gaap:AccountingStandardsUpdate201601Member 2018-01-01 0001413329 pm:RevenueIncludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:ID 2016-01-01 2016-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:CustomerConcentrationRiskMember pm:CustomerOneMember us-gaap:EuropeanUnionMember 2016-01-01 2016-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:ID 2017-01-01 2017-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:CustomerConcentrationRiskMember pm:CustomerOneMember pm:EastAsiaAndAustraliaMember 2017-01-01 2017-12-31 0001413329 pm:RevenueIncludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:DE 2017-01-01 2017-12-31 0001413329 pm:RevenueIncludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:ID 2017-01-01 2017-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:CustomerConcentrationRiskMember pm:CustomerOneMember pm:EastAsiaAndAustraliaMember 2016-01-01 2016-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:JP 2016-01-01 2016-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:JP 2017-01-01 2017-12-31 0001413329 pm:RevenueExcludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:ID 2016-01-01 2016-12-31 0001413329 pm:RevenueIncludingAssessedTaxMember us-gaap:GeographicConcentrationRiskMember country:DE 2016-01-01 2016-12-31 0001413329 us-gaap:AccountingStandardsUpdate201409Member us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2017-01-01 2017-03-31 iso4217:BRL xbrli:pure iso4217:CAD pm:cigarette iso4217:THB xbrli:shares pm:segment pm:manufacturer iso4217:USD xbrli:shares iso4217:KRW pm:performance_metric pm:litigation_case pm:plaintiff pm:defendant pm:patient iso4217:ARS pm:year pm:installment iso4217:USD false --12-31 Q1 2018 2018-03-31 10-Q 0001413329 1554473725 Large Accelerated Filer Philip Morris International Inc. 33400000000 7100000000 11300000000 15000000000 16 3 66 0 3 11 16 1 63 0 2 11 10 1 5 16 1 1 34 10 4 6 1 3 1 1 1 1 62 1 1 1 2 1 2 9 11 May 27, 2015 May 27, 2015 August 5, 2016 February 2004 P20Y P10Y 1074000000 1395000000 301000000 272000000 0 0 272000000 22000000 13000000 2832000000 3192000000 2207000000 509000000 2606000000 2737000000 13 4 9 476 783000000 1000000000 1000000000 200000000 157000000 200000000 P60D P60D 15500000000 12100000000 3100000000 2400000000 5446 110000 P60D 0.2 0.20 P60D P60D P60D P60D P60D 131000000 103000000 131000000 90000 90000 70500 70500 46000000 46000000 36000000 23500 30000 23500 30000 P20Y P20Y P20Y P20Y P20Y 3484 P20Y P20Y P20Y P20Y P20Y 918000 99957 7000000 2570000000 80800000000 629000000 19800000000 813000000 25600000000 5000000000 3910000000 108000000 84600000 29400000 37600000 29400000 37600000 758000000 593000000 177000000 226000000 2 2 7 6 P3Y 25000 25000 In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.) In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.) On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending. 1449000000 1833000000 58 58 1587000000 1553000000 20000000 22000000 4000000 19000000 3000000 6000000 0.5 2013 and onward 272000000000 254000000 93000000 100000000000 172000000000 160000000 3 P3Y 0.3 0.2 0.5 1 0.01 0.01 P012M 1400000000 200000000 1600000000 1 34213000000 2092000000 2509000000 561000000 878000000 2242000000 2156000000 3194000000 3373000000 293000000 471000000 812000000 508000000 708000000 668000000 7295000000 7597000000 97000000 27000000 42000000 -20000000 -8535000000 -8883000000 P11Y P9Y P19Y 1972000000 1856000000 -86000000 17000000 35000000 21000000 38000000 25000000 25000000 22000000 22000000 0 0 42968000000 43070000000 21594000000 20593000000 272000000 114000000 0 386000000 0.49 95000000 2000000 1 27000000 8447000000 7200000000 4331000000 5206000000 8476000000 7231000000 875000000 -1245000000 1.04 1.07 2109316331 2109316331 0 0 1884000000 1208000000 63000000 56000000 1947000000 1264000000 0.11 0.11 0.16 0.10 2177000000 2615000000 238000000 238000000 35293000000 171000000 0 35464000000 0.02250 0.01269 0.03566 0.03378 0.03125 0.00625 0.02 0.0075 0.06375 0.01375 2037 2024 2044 2024 1007000000 1150000000 27000000 26000000 799000000 822000000 63000000 -44000000 -43000000 3000000 0 25000000 46000000 79000000 87000000 26000000 28000000 45000000 37000000 51000000 53000000 197000000 242000000 0 0 50000000 25000000 140000000 114000000 0 114000000 0 114000000 78000000 68000000 1004000000 1719000000 34000000 0 84000000 22000000 140000000 6000000 0 48000000 60000000 114000000 12000000 21000000 197000000 37000000 880000000 14000000 1128000000 433000000 20000000 1237000000 67000000 1757000000 74000000 13000000 -3000000 -9000000 0 -3000000 9000000 -5000000 -3000000 8000000 0 -2000000 -9000000 -2000000 67000000 -335000000 -86000000 -75000000 -249000000 -682000000 -74000000 -64000000 -608000000 1128000000 1757000000 0 1757000000 0 1757000000 0 0 50000000 25000000 P15M 1620000000 1620000000 1668000000 1668000000 1669000000 1675000000 1.02 1.00 1.02 1.00 234000000 131000000 0.249 0.255 0.26 856000000 770000000 57000000 196000000 927000000 932000000 120000000 10000000 0.51 0.49 0.49 0.23 0.25 1074000000 1098000000 10492000000 10492000000 11530000000 P17Y P4Y P30Y P5Y P40Y P2Y 689000000 704000000 84000000 84000000 84000000 84000000 84000000 1798000000 1818000000 112000000 151000000 1555000000 -30000000 -39000000 95000000 0 0 7666000000 567000000 321000000 2247000000 102000000 3010000000 1419000000 7667000000 561000000 334000000 2253000000 107000000 2938000000 1474000000 1000000 -6000000 13000000 6000000 5000000 -72000000 55000000 3887000000 4281000000 2177000000 2193000000 541000000 559000000 84000000 -62000000 -510000000 -315000000 -1243000000 -338000000 135000000 -151000000 -504000000 113000000 1000000 1000000 1323000000 1341000000 3121000000 3159000000 2432000000 44000000 16000000 732000000 178000000 1004000000 458000000 2455000000 59000000 22000000 763000000 185000000 987000000 439000000 -219000000 -227000000 4637000000 4374000000 8806000000 8592000000 1563000000 1481000000 873000000 879000000 53198000000 53552000000 42968000000 43070000000 15962000000 17688000000 35293000000 1928000000 0 37221000000 0 8000000000 2500000000 3500000000 2000000000 2000000000 31334000000 29578000000 2506000000 4662000000 33840000000 8997000000 1376000000 23291000000 176000000 34240000000 9348000000 1418000000 23294000000 180000000 On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages. On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion, into a trust within 60 days. On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling. 1000 293 1000 53700000 8 2024-05-31 1856000000 1868000000 17000000 17000000 36000000 36000000 341000000 -1738000000 -543000000 -1018000000 843000000 1380000000 1590000000 1556000000 68000000 91000000 6 2416000000 472000000 176000000 159000000 491000000 370000000 748000000 740000000 2426000000 515000000 151000000 217000000 374000000 429000000 1346000000 1556000000 603000000 907000000 1924000000 2351000000 303000000 -294000000 -371000000 -757000000 -156000000 -192000000 289000000 294000000 -5000000 -383000000 -344000000 -39000000 -5000000 -2000000 2000000 -1000000 56000000 50000000 9000000 11000000 -75000000 -64000000 -11000000 -10000000 544000000 521000000 -61000000 3000000 3000000 254000000 665000000 -8000000 -30000000 1618000000 1659000000 5000000 18000000 292000000 365000000 2271000000 2272000000 18000000 25000000 2482000000 0 -83000000 -91000000 0 -91000000 374000000 103000000 1658000000 68000000 1590000000 1647000000 91000000 1556000000 14566000000 15056000000 7271000000 7459000000 814000000 0 92000000 130000000 29000000 31000000 29859000000 29985000000 238000000 3200000000 2800000000 6064000000 813000000 513000000 605000000 957000000 1031000000 1709000000 396000000 3000000 0 4000000 0 31000000 1210000000 606000000 5629000000 435000000 516000000 961000000 1031000000 1740000000 3200000000 4700000000 737000000 527000000 704000000 884000000 1081000000 1836000000 854000000 40000000 4000000 77000000 0 152000000 1988000000 5769000000 1127000000 6896000000 1591000000 567000000 708000000 961000000 1081000000 7100000000 7700000000 16556000000 16556000000 7200000000 8000000000 18426000000 840000000 923000000 5324000000 5085000000 0 0 P3Y 393460 1202060 401500 1249650 98.29 128.72 98.47 100.69 118.98 100.70 0 1378550 143000000 114000000 1000000 25000000 1000000 22939200 2 0 499000000 608000000 51000000 71000000 94000000 0 -1000000 148000000 54000000 168000000 76000000 33000000 -71000000 104000000 45000000 -29000000 74000000 -12086000000 -12350000000 23296000000 22958000000 -10900000000 -9559000000 1964000000 0 1788000000 30397000000 -35490000000 -10557000000 -3509000000 27000000 -9265000000 -5783000000 1892000000 0 1835000000 30367000000 -35386000000 -10230000000 -2816000000 42000000 -8535000000 -5761000000 1972000000 0 1856000000 29859000000 -35382000000 -10482000000 -2766000000 -20000000 -8883000000 -6097000000 1856000000 0 1868000000 29985000000 -35308000000 0 1000000 -1000000 95000000 4000000 87000000 4000000 556098569 554850007 35382000000 35308000000 0 0 1553000000 1554000000 1552000000 1553000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Sale of Accounts Receivable:</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative trade receivables sold, including excise taxes, for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$2,509 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2,092 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. PMI&#8217;s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$878 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$561 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the loss on sale of trade receivables was immaterial.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(pre-tax, in millions)</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statement of Earnings </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classification of Gain/(Loss) </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassified from Other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings/(Losses) into </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Cash Flow Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Net Investment Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(608</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(249</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(682</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(335</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of April 24, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of April 25, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of April 22, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smoking and Health Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Label-Related Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Label-Related Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public Civil Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the verdict and significant post-trial developments in the </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> pending cases where a verdict was returned in favor of the plaintiff:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil/The Smoker Health Defense Association</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Civil Court of S&#227;o Paulo found defendants liable without hearing evidence. In April 2004, the court awarded &#8220;moral damages&#8221; of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants appealed to the S&#227;o Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Cecilia L&#233;tourneau<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court&#8217;s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court&#8217;s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;">&#160;case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;">&#160;cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Conseil Qu&#233;b&#233;cois Sur Le Tabac Et La Sant&#233; and Jean-Yves Blais</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;">&#160;class on liability and found the class members&#8217; compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary&#8217;s portion, into a trust within 60 days. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court&#8217;s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court&#8217;s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 5, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Argentina/Hugo Lespada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires.</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Acquisitions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 21, 2018, PMI acquired the remaining </font><font style="font-family:inherit;font-size:10pt;">49%</font><font style="font-family:inherit;font-size:10pt;"> interest in Tabacalera Costarricense, S.A. and Mendiola y Compa&#241;&#237;a, S.A. for a net purchase price of </font><font style="font-family:inherit;font-size:10pt;">$95 million</font><font style="font-family:inherit;font-size:10pt;">, which includes </font><font style="font-family:inherit;font-size:10pt;">$2 million</font><font style="font-family:inherit;font-size:10pt;"> of contingent consideration. As a result, PMI now owns </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of these Costa Rican affiliates. The purchase of the remaining </font><font style="font-family:inherit;font-size:10pt;">49%</font><font style="font-family:inherit;font-size:10pt;"> interest resulted in a decrease to PMI&#8217;s additional paid-in capital of </font><font style="font-family:inherit;font-size:10pt;">$86 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Background and Basis of Presentation:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Background</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates and their licensees are engaged in the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products, in markets outside of the United States of America. Throughout these financial statements, the term "PMI" refers to Philip Morris International Inc. and its subsidiaries.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduced-risk products ("RRPs") is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI&#8217;s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To provide a greater focus on both parts of PMI's business -- combustible and reduced-risk products -- and to support PMI's transformation towards a smoke-free future, effective January 1, 2018, PMI began managing its business in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> reportable segments as follows: European Union; Eastern Europe; Middle East &amp; Africa; South &amp; Southeast Asia; East Asia &amp; Australia; and Latin America&#160;&amp; Canada. For further details, see Note 7. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior years' amounts have been reclassified to conform with the current year's presentation, due primarily to new accounting guidance related to revenue recognition, pension costs and restricted cash and PMI&#8217;s decision to reorganize its reportable segments. For further details, see the condensed consolidated statements of cash flows, Note 3. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</font><font style="font-family:inherit;font-size:10pt;">, Note 7. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;"> and Note 18. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">New Accounting Standards</font><font style="font-family:inherit;font-size:10pt;">. The changes did not have a material impact on PMI's consolidated financial position, results of operations or cash flows in any of the periods presented.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI&#8217;s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Contingencies:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Tobacco-Related Litigation</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them.&#160;Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i)&#160;management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii)&#160;management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii)&#160;accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To date, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of </font><font style="font-family:inherit;font-size:10pt;">April&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">: </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of April 24, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of April 25, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of April 22, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smoking and Health Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Label-Related Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Label-Related Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public Civil Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since 1995, when the first tobacco-related litigation was filed against a PMI entity, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">476</font><font style="font-family:inherit;font-size:10pt;"> Smoking and Health, Label-Related, Health Care Cost Recovery, and Public Civil Actions in which we and/or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Thirteen</font><font style="font-family:inherit;font-size:10pt;"> cases have had decisions in favor of plaintiffs. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Nine</font><font style="font-family:inherit;font-size:10pt;"> of these cases have subsequently reached final resolution in our favor and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">four</font><font style="font-family:inherit;font-size:10pt;"> remain on appeal.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the verdict and significant post-trial developments in the </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> pending cases where a verdict was returned in favor of the plaintiff:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil/The Smoker Health Defense Association</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Civil Court of S&#227;o Paulo found defendants liable without hearing evidence. In April 2004, the court awarded &#8220;moral damages&#8221; of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants appealed to the S&#227;o Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Cecilia L&#233;tourneau<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court&#8217;s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court&#8217;s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;">&#160;case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;">&#160;cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Conseil Qu&#233;b&#233;cois Sur Le Tabac Et La Sant&#233; and Jean-Yves Blais</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;">&#160;class on liability and found the class members&#8217; compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary&#8217;s portion, into a trust within 60 days. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court&#8217;s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court&#8217;s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;">&#160;case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 5, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Argentina/Hugo Lespada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires.</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pending claims related to tobacco products generally fall within the following categories:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Smoking and Health Litigation:</font><font style="font-family:inherit;font-size:10pt;"> These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-24px;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">62</font><font style="font-family:inherit;font-size:10pt;"> cases brought by individual plaintiffs in Argentina (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">34</font><font style="font-family:inherit;font-size:10pt;">), Brazil (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;">), Canada (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">4</font><font style="font-family:inherit;font-size:10pt;">), Chile (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">6</font><font style="font-family:inherit;font-size:10pt;">), Costa Rica (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), Italy (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;">), the Philippines (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), Russia (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">), Turkey (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">) and Scotland (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">63</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">66</font><font style="font-family:inherit;font-size:10pt;"> cases on </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> cases brought on behalf of classes of individual plaintiffs in Brazil (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">)&#160;and Canada (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">9</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first class action pending in Brazil, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of S&#227;o Paulo, Brazil</font><font style="font-family:inherit;font-size:10pt;">, filed July&#160;25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded &#8220;moral damages&#8221; of </font><font style="font-family:inherit;font-size:10pt;">R$1,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$293</font><font style="font-family:inherit;font-size:10pt;">) per smoker per full year of smoking plus interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the S&#227;o Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In February 2017, the Chief Justice of the Supreme Court of Justice denied plaintiff's appeal. In March 2017, plaintiff filed an </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">en banc</font><font style="font-family:inherit;font-size:10pt;"> appeal to the Supreme Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. Both appeals are still pending.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second class action pending in Brazil</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, Public Prosecutor of S&#227;o Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of S&#227;o Paulo, Brazil,</font><font style="font-family:inherit;font-size:10pt;"> filed August&#160;6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of S&#227;o Paulo, is seeking (i)&#160;damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii)&#160;damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii)&#160;reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities, and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of S&#227;o Paulo only. In December 2008, the Seventh Civil Court of S&#227;o Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ADESF</font><font style="font-family:inherit;font-size:10pt;"> case discussed above and should be transferred to the Nineteenth Lower Civil Court in S&#227;o Paulo where the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ADESF</font><font style="font-family:inherit;font-size:10pt;"> case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the S&#227;o Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of S&#227;o Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the S&#227;o Paulo Court of Appeals rejected plaintiff&#8217;s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cecilia L&#233;tourneau v. Imperial Tobacco Ltd., Rothmans, Benson&#160;&amp; Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.&#160;&#160;The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005.&#160; Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other Canadian manufacturers liable and awarded a total of CAD </font><font style="font-family:inherit;font-size:10pt;">131 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$103 million</font><font style="font-family:inherit;font-size:10pt;">) in punitive damages, allocating CAD </font><font style="font-family:inherit;font-size:10pt;">46 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$36 million</font><font style="font-family:inherit;font-size:10pt;">) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members&#8217; addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants&#8217; advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at </font><font style="font-family:inherit;font-size:10pt;">918,000</font><font style="font-family:inherit;font-size:10pt;"> members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys&#8217; fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court&#8217;s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court&#8217;s order for payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court&#8217;s ruling that our subsidiary make the payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau </font><font style="font-family:inherit;font-size:10pt;">case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">226 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$177 million</font><font style="font-family:inherit;font-size:10pt;">), in the form of cash into a court trust or letters of credit, in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$29.4 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through March 2017. See the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais </font><font style="font-family:inherit;font-size:10pt;">description for further detail concerning the security order. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants&#8217; alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants&#8217; alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members&#8217; claims for punitive damages were not time-barred even though the case was filed more than </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;"> after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Conseil Qu&#233;b&#233;cois Sur Le Tabac Et La Sant&#233; and Jean-Yves Blais v. Imperial Tobacco Ltd.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Rothmans, Benson&#160;&amp; Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.&#160;The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other Canadian manufacturers liable and found that the class members&#8217; compensatory damages totaled approximately CAD </font><font style="font-family:inherit;font-size:10pt;">15.5 billion</font><font style="font-family:inherit;font-size:10pt;">, including pre-judgment interest (approximately </font><font style="font-family:inherit;font-size:10pt;">$12.1 billion</font><font style="font-family:inherit;font-size:10pt;">). The trial court awarded compensatory damages on a joint and several liability basis, allocating </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> to our subsidiary (approximately CAD </font><font style="font-family:inherit;font-size:10pt;">3.1 billion</font><font style="font-family:inherit;font-size:10pt;">, including pre-judgment interest (approximately </font><font style="font-family:inherit;font-size:10pt;">$2.4 billion</font><font style="font-family:inherit;font-size:10pt;">)). In addition, the trial court awarded CAD </font><font style="font-family:inherit;font-size:10pt;">90,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$70,500</font><font style="font-family:inherit;font-size:10pt;">) in punitive damages, allocating CAD </font><font style="font-family:inherit;font-size:10pt;">30,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$23,500</font><font style="font-family:inherit;font-size:10pt;">) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members&#8217; diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants&#8217; advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at </font><font style="font-family:inherit;font-size:10pt;">99,957</font><font style="font-family:inherit;font-size:10pt;"> members. The trial court ordered defendants to pay CAD </font><font style="font-family:inherit;font-size:10pt;">1 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$783 million</font><font style="font-family:inherit;font-size:10pt;">) of the compensatory damage award into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">, CAD </font><font style="font-family:inherit;font-size:10pt;">200 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$157 million</font><font style="font-family:inherit;font-size:10pt;">) of which is our subsidiary&#8217;s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys&#8217; fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court&#8217;s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court&#8217;s order for payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court&#8217;s ruling that our subsidiary make an initial payment within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD </font><font style="font-family:inherit;font-size:10pt;">5 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$3.91 billion</font><font style="font-family:inherit;font-size:10pt;">) into trust, to secure the judgments in both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau </font><font style="font-family:inherit;font-size:10pt;">and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">226 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$177 million</font><font style="font-family:inherit;font-size:10pt;">) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">L&#233;tourneau</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. Such security may take the form of cash into a court trust or letters of credit, in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$29.4 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">758 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$593 million</font><font style="font-family:inherit;font-size:10pt;">) in </font><font style="font-family:inherit;font-size:10pt;">seven</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">108 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$84.6 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through June 2017. In March 2017, our subsidiary made its sixth and final quarterly installment of security for approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$29.4 million</font><font style="font-family:inherit;font-size:10pt;">) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court&#8217;s judgment or upon further order of the Court of Appeal. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants&#8217; alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants&#8217; alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June&#160;12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (&#8220;COPD&#8221;), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, below).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams v. Canadian Tobacco Manufacturers' Council, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Queen's Bench, Saskatchewan, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed July&#160;10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of </font><font style="font-family:inherit;font-size:10pt;">25,000</font><font style="font-family:inherit;font-size:10pt;"> cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Semple v. Canadian Tobacco Manufacturers' Council, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Supreme Court (trial court), Nova Scotia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June&#160;18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, above).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the sixth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed June&#160;15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, above).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the seventh class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">McDermid v. Imperial Tobacco Canada Limited, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Supreme Court, British Columbia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June&#160;25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June&#160;12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January&#160;1, 1954, to the date the claim was filed. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the eighth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bourassa v. Imperial Tobacco Canada Limited, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Supreme Court, British Columbia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June&#160;25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June&#160;12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January&#160;1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ninth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, </font><font style="font-family:inherit;font-size:10pt;">filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of </font><font style="font-family:inherit;font-size:10pt;">25,000</font><font style="font-family:inherit;font-size:10pt;"> cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Health Care Cost Recovery Litigation:</font><font style="font-family:inherit;font-size:10pt;">&#160;These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, &#8220;unclean hands&#8221; (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;">), Korea (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">) and Nigeria (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first health care cost recovery case pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed January&#160;24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a &#8220;tobacco related wrong.&#8221; The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed March&#160;13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Pre-trial discovery is ongoing. In June 2017, the trial court set a trial date for November 4, 2019.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed September&#160;29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed February&#160;8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Pre-trial discovery is ongoing. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the sixth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the seventh health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson &amp; Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Defendants filed their defenses in September 2014. Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the eighth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Government of Saskatchewan v. Rothmans, Benson &amp; Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Defendants filed their defenses in February 2015. While discovery initially was scheduled to begin in 2017 by agreement of the parties, to date, the discovery process has not started.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ninth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson &amp; Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada</font><font style="font-family:inherit;font-size:10pt;">, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Defendants filed their defenses in February 2015. While discovery initially was scheduled to begin in 2017 by agreement of the parties, to date, the discovery process has not started.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the tenth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson &amp; Hedges Inc., et al., Supreme Court of Nova Scotia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a &#8220;tobacco related wrong.&#8221; Defendants filed their defenses in July 2015. Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed May&#160;9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed October&#160;17, 2008, we and other members of the industry are defendants</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed May&#160;25, 2007, we and other members of the industry are defendants</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria</font><font style="font-family:inherit;font-size:10pt;">, filed February&#160;26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the health care cost recovery case in Korea, the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">National Health Insurance Service v. KT&amp;G, et. al.,</font><font style="font-family:inherit;font-size:10pt;"> filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lights</font><font style="font-family:inherit;font-size:10pt;"> cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately </font><font style="font-family:inherit;font-size:10pt;">$53.7 million</font><font style="font-family:inherit;font-size:10pt;"> allegedly incurred in treating </font><font style="font-family:inherit;font-size:10pt;">3,484</font><font style="font-family:inherit;font-size:10pt;"> patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Label-Related Cases: </font><font style="font-family:inherit;font-size:10pt;">These cases, brought by individual plaintiffs, or on behalf of a class or purported class of individual plaintiffs, allege that the use of the descriptor &#8220;Lights&#8221; or other alleged misrepresentations or omissions of labeling information constitute fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;"> case brought by an individual plaintiff in Italy (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">) pending against our subsidiaries, compared with </font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> purported class action in Israel (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An individual plaintiff filed the purported class action, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Aharon Ringer v. Philip Morris Ltd. and Globrands Ltd.,</font><font style="font-family:inherit;font-size:10pt;"> on July 18, 2017, in the Central District Court of Israel. Our Israeli affiliate and an Israeli importer and distributor for other multinational tobacco companies are defendants. Plaintiff seeks to represent a class of smokers in Israel who have purchased cigarettes imported by defendants since July 18, 2010. Plaintiff estimates the class size to be </font><font style="font-family:inherit;font-size:10pt;">7,000,000</font><font style="font-family:inherit;font-size:10pt;"> smokers. Plaintiff alleges that defendants misled consumers by not disclosing sufficient information about carbon monoxide, tar, and nicotine yields of, and tobacco contained in, the imported cigarettes. Plaintiff seeks various forms of relief, including an order for defendants to label cigarette packs in accordance with plaintiff&#8217;s demands, and damages for misleading consumers, breach of autonomy and unjust enrichment.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Public Civil Actions:</font><font style="font-family:inherit;font-size:10pt;"> Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;24, 2018</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;"> public civil actions pending against our subsidiaries in Argentina (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">) and Venezuela (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April&#160;25, 2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April&#160;22, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the public civil action in Argentina, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Asociaci&#243;n Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina,</font><font style="font-family:inherit;font-size:10pt;"> filed February&#160;26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the public civil action in Venezuela, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Federation of Consumers and Users Associations (&#8220;FEVACU&#8221;), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health,&#160;Constitutional Chamber of the Venezuelan Supreme Court</font><font style="font-family:inherit;font-size:10pt;">, filed April&#160;29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response&#160;to this notice.&#160;The plaintiffs&#160;purport to represent the&#160;right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products.&#160;In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their &#8220;sales or benefits&#8221; to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Litigation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">in the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB </font><font style="font-family:inherit;font-size:10pt;">80.8 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$2.57 billion</font><font style="font-family:inherit;font-size:10pt;">). In May 2017, the King of Thailand signed a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. Trial in the case began in November 2017. In March 2018, acting on a request from the Public Prosecutor, the court suspended the&#160;trial proceedings indefinitely and struck the case from the court list. The case may be reactivated by the court or upon application of a party.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB </font><font style="font-family:inherit;font-size:10pt;">19.8 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$629 million</font><font style="font-family:inherit;font-size:10pt;">). The case is in pre-trial proceedings. The trial is scheduled to begin in the last quarter of 2018. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court. In May 2017, the King of Thailand signed a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. On November 29, 2017, PM Thailand received notices of assessment in the aggregate amount of approximately THB </font><font style="font-family:inherit;font-size:10pt;">25.6 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$813 million</font><font style="font-family:inherit;font-size:10pt;">) from the Thai Customs Department alleging that PM Thailand under-declared customs values for the imports from Indonesia covering the period 2001-2003. The notices include the Indonesian import entries subject to the proceedings discussed above and are in addition to the fine sought by the government in the criminal proceedings. PM Thailand filed its appeal against the notices in December 2017. We believe that all of the notices of assessment are barred by the applicable statutes of limitations and are otherwise without merit. In March 2018, the Thai Customs Post Clearance Audit Bureau informed PM Thailand that the Thai Customs Department will cancel or otherwise not pursue the notices. PM Thailand is considering whether further procedural steps are required to confirm the finality of this development. &#160;</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The South Korean Board of Audit and Inspection (&#8220;BAI&#8221;) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean affiliate, were in compliance with South Korean tax laws.&#160; In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.&#160; In order to avoid nonpayment financial costs, PM Korea paid approximately KRW </font><font style="font-family:inherit;font-size:10pt;">272 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$254 million</font><font style="font-family:inherit;font-size:10pt;">), of which KRW </font><font style="font-family:inherit;font-size:10pt;">100 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$93 million</font><font style="font-family:inherit;font-size:10pt;">) was paid in 2016 and KRW </font><font style="font-family:inherit;font-size:10pt;">172 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$160 million</font><font style="font-family:inherit;font-size:10pt;">) was paid in the first quarter of 2017.&#160;&#160;These amounts are included in other assets in the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows.&#160; PM Korea is appealing the assessments. The tax authorities have also referred the matter to the Public Prosecutor, who will further investigate and decide whether to file criminal charges against PM Korea and/or other alleged co-offenders. If the Public Prosecutor decides to prosecute, it may seek up to three times the underpaid tax for company criminal penalties and up to five times the underpaid tax for individual criminal penalties. PM Korea believes that it has paid cigarette-related taxes in compliance with the South Korean tax laws. In addition, the South Korean Ministry of Strategy and Finance (&#8220;MOSF&#8221;) filed a criminal complaint with the Public Prosecutor against PM Korea and its managing director. In its criminal complaint, the MOSF alleged that PM Korea exceeded the monthly product withdrawal limits that the MOSF had set in its notice. The Public Prosecutor will investigate the MOSF&#8217;s criminal complaint and decide whether to prosecute.&#160; PM Korea disagrees with the MOSF&#8217;s allegations.</font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Accumulated Other Comprehensive Losses:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s accumulated other comprehensive losses, net of taxes, consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.05068226120858%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,097</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension and other benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,766</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,816</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,509</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives accounted for as hedges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,883</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,535</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,265</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications from Other Comprehensive Earnings </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">. For additional information, see Note 3. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</font><font style="font-family:inherit;font-size:10pt;"> and Note 5. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Indebtedness:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Short-term Borrowings:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's short-term borrowings, consisting of bank loans to certain PMI subsidiaries at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, had a carrying value of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$608 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$499 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The fair value of PMI&#8217;s short-term borrowings, based on current market interest rates, approximates carrying value.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Long-term Debt:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI&#8217;s long-term debt consisted of the following: </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes, 1.375% to 6.375% (average interest rate 3.566%), due through 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency obligations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro notes, 0.625% to 3.125% (average interest rate 2.250%), due through 2037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,376</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (average interest rate 3.378%), due through 2024</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,240</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion of long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,662</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,506</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,578</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,334</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other foreign currency debt above includes mortgage debt in Switzerland and capital lease obligations at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.05847953216374%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Facilities:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 29, 2018, PMI entered into an agreement to extend the term of its </font><font style="font-family:inherit;font-size:10pt;">$2.0 billion</font><font style="font-family:inherit;font-size:10pt;"> 364-day revolving credit facility from February 6, 2018, to February 5, 2019. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI's total committed credit facilities were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in billions)</font></div><div style="line-height:120%;padding-left:6px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:84.21052631578947%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Committed</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Credit</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Facilities</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364-day revolving credit, expiring February 5, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring February 28, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring October 1, 2022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total facilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Financial Instruments:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Overview</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Canadian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble, Swiss franc and Turkish lira. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI had contracts with aggregate notional amounts of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$33.4 billion</font><font style="font-family:inherit;font-size:10pt;"> of which </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$7.1 billion</font><font style="font-family:inherit;font-size:10pt;"> related to cash flow hedges, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11.3 billion</font><font style="font-family:inherit;font-size:10pt;"> related to hedges of net investments in foreign operations and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$15.0 billion</font><font style="font-family:inherit;font-size:10pt;"> related to other derivatives that primarily offset currency exposures on intercompany financing.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective January 1, 2018, PMI elected to early adopt Accounting Standard Update 2017-12 &#8220;Derivatives and Hedging (Topic 815) Targeted Improvements to Accounting for Hedging Activities,&#8221; which did not have a material impact on PMI&#8217;s consolidated financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI&#8217;s foreign exchange contracts included in the condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts designated as hedging instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other&#160;liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,237</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">880</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts not designated as hedging instruments&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other&#160;liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(pre-tax, in millions)</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statement of Earnings </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classification of Gain/(Loss) </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassified from Other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings/(Losses) into </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Cash Flow Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Net Investment Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(608</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(249</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(682</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(335</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash Flow Hedges</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to certain forecasted transactions. Gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI&#8217;s condensed consolidated statements of earnings. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI has hedged forecasted transactions for periods not exceeding the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">fifteen</font><font style="font-family:inherit;font-size:10pt;"> months with the exception of </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> foreign exchange contract that expires in </font><font style="font-family:inherit;font-size:10pt;">May 2024</font><font style="font-family:inherit;font-size:10pt;">. The impact of these hedges is primarily included in operating cash flows on PMI&#8217;s condensed consolidated statements of cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hedges of Net Investments in Foreign Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges, primarily of its Euro net assets. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, these hedges of net investments resulted in losses, net of income taxes, of </font><font style="font-family:inherit;font-size:10pt;">$757 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$294 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, principally related to changes in the exchange rates between the Euro and U.S. dollar. These losses were reported as a component of accumulated other comprehensive losses within currency translation adjustments, and were substantially offset by the gains generated on the underlying assets. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, the gains for amounts excluded from the effectiveness testing recognized in earnings based on the changes in fair value were </font><font style="font-family:inherit;font-size:10pt;">$67 million</font><font style="font-family:inherit;font-size:10pt;"> and were accounted for in interest expense, net, on the condensed consolidated statement of earnings. The premiums paid for, and settlements of, net investment hedges are included in investing cash flows on PMI&#8217;s condensed consolidated statements of cash flows. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Derivatives</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in marketing, administration and research costs in PMI&#8217;s condensed consolidated statements of earnings. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, the gains (losses) from contracts for which PMI did not apply hedge accounting were </font><font style="font-family:inherit;font-size:10pt;">$95 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$(39) million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The gains (losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, the net impact of these contracts on the condensed consolidated statements of earnings was not material. </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain as of January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative (gains)/losses transferred to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(loss) as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI expects </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$30 million</font><font style="font-family:inherit;font-size:10pt;"> of derivative </font><font style="font-family:inherit;font-size:10pt;">losses</font><font style="font-family:inherit;font-size:10pt;"> that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These </font><font style="font-family:inherit;font-size:10pt;">losses</font><font style="font-family:inherit;font-size:10pt;"> are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Features</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s derivative instruments do not contain contingent features.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Exposure and Credit Risk</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limit and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 11. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:inherit;font-size:10pt;"> and Note 13. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Offsetting</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion of derivative financial instruments.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Stock Plans:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, PMI&#8217;s shareholders approved the Philip Morris International Inc. 2017 Performance Incentive Plan (the &#8220;2017 Plan&#8221;). The 2017 Plan replaced the 2012 Performance Incentive Plan, and there will be no additional grants under the replaced plan. Under the 2017 Plan, PMI may grant to eligible employees restricted shares and restricted share units, performance-based cash incentive awards and performance-based equity awards. Up to </font><font style="font-family:inherit;font-size:10pt;">25 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI&#8217;s common stock may be issued under the 2017 Plan. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, shares available for grant under the 2017 Plan were </font><font style="font-family:inherit;font-size:10pt;">22,939,200</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2017, PMI&#8217;s shareholders also approved the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors (the &#8220;2017 Non-Employee Directors Plan&#8221;). The 2017 Non-Employee Directors Plan replaced the 2008 Stock Compensation Plan for Non-Employee Directors, and there will be no additional grants under the replaced plan. A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to </font><font style="font-family:inherit;font-size:10pt;">1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI common stock may be awarded under the 2017 Non-Employee Directors Plan. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, shares available for grant under the plan were </font><font style="font-family:inherit;font-size:10pt;">1,000,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted share unit (RSU) awards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the weighted-average grant date</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">fair value per share and the recorded compensation expense related to RSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average Grant Date Fair Value Per RSU Award Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation Expense Related to RSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,249,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202,060</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.47</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.84375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI had </font><font style="font-family:inherit;font-size:10pt;">$196 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years after the date of the award, or upon death, disability or reaching the age of </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,378,550</font><font style="font-family:inherit;font-size:10pt;"> RSU awards vested. The grant date fair value of all the vested awards was approximately </font><font style="font-family:inherit;font-size:10pt;">$114 million</font><font style="font-family:inherit;font-size:10pt;">. The total fair value of RSU awards that vested during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> was approximately </font><font style="font-family:inherit;font-size:10pt;">$143 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance share unit (PSU) awards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance cycle. PMI&#8217;s performance metrics consist of PMI&#8217;s Total Shareholder Return (TSR) relative to a predetermined peer group and on an absolute basis (</font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> weight), PMI&#8217;s currency-neutral compound annual adjusted operating income growth rate, excluding acquisitions (</font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;"> weight), and PMI&#8217;s performance against specific measures of PMI&#8217;s transformation (</font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> weight). The aggregate of the weighted performance factors for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> metrics determines the percentage of PSUs that will vest at the end of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance cycle. The minimum percentage of PSUs that can vest is </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">, with a target percentage of </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> and a maximum percentage of </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;">. Each vested PSU entitles the participant to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share of common stock. An aggregate weighted PSU performance factor of </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> will result in the targeted number of PSUs being vested. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the grant date fair value per share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and the recorded compensation expense related to PSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PSU Grant Date Fair Value Subject to TSR Performance Factor Per Share </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PSU Grant Date Fair Value Subject to Other Performance Factors Per Share </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation Expense Related to PSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,460</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.72</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.29</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.</font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI&#8217;s stock at the date of grant.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.84375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI had </font><font style="font-family:inherit;font-size:10pt;">$57 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> PSU awards that vested.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the weighted-average grant date</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">fair value per share and the recorded compensation expense related to RSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average Grant Date Fair Value Per RSU Award Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation Expense Related to RSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,249,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202,060</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.47</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.84375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the grant date fair value per share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and the recorded compensation expense related to PSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PSU Grant Date Fair Value Subject to TSR Performance Factor Per Share </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PSU Grant Date Fair Value Subject to Other Performance Factors Per Share </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation Expense Related to PSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">401,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118.98</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.69</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,460</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.72</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.29</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.</font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI&#8217;s stock at the date of grant.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.84375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Earnings Per Share:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (&#8220;EPS&#8221;) were calculated using the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.635477582846%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to PMI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less distributed and undistributed earnings attributable to share-based payment awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,587</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,552</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plus contingently issuable performance stock units (PSUs)<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,554</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI&#8217;s earnings per share calculation pursuant to the two-class method.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> computations, there were no antidilutive stock awards.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Investments in Unconsolidated Subsidiaries:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI had total investments in unconsolidated subsidiaries of </font><font style="font-family:inherit;font-size:10pt;">$1,098 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,074 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, which were accounted for under the equity method of accounting. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses, dividends, capital contributions and movements in currency translation adjustments. The carrying value of our equity method investments at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> exceeded our share of the unconsolidated subsidiaries' book value by </font><font style="font-family:inherit;font-size:10pt;">$932 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$927 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets, excluding </font><font style="font-family:inherit;font-size:10pt;">$879 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$873 million</font><font style="font-family:inherit;font-size:10pt;"> attributable to goodwill as of </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, is being amortized on a straight-line basis over the underlying assets' estimated useful lives of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI received year-to-date dividends from unconsolidated subsidiaries of </font><font style="font-family:inherit;font-size:10pt;">$10 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$120 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI holds a </font><font style="font-family:inherit;font-size:10pt;">49%</font><font style="font-family:inherit;font-size:10pt;"> equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (&#8220;EITA&#8221;). PMI holds an approximate </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> economic interest in Soci&#233;t&#233; des Tabacs Alg&#233;ro-Emiratie (&#8220;STAEM&#8221;), an Algerian joint venture that is </font><font style="font-family:inherit;font-size:10pt;">51%</font><font style="font-family:inherit;font-size:10pt;"> owned by EITA and </font><font style="font-family:inherit;font-size:10pt;">49%</font><font style="font-family:inherit;font-size:10pt;"> by the Algerian state-owned enterprise Management et D&#233;veloppement des Actifs et des Ressources Holding (MADAR Holding), formerly known as Soci&#233;t&#233; Nationale des Tabacs et Allumettes SpA. STAEM manufactures and distributes under license some of PMI&#8217;s brands. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI holds a </font><font style="font-family:inherit;font-size:10pt;">23%</font><font style="font-family:inherit;font-size:10pt;"> equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The initial investments in EITA and Megapolis Distribution BV were recorded at cost and are included in investments in unconsolidated subsidiaries and equity securities on the condensed consolidated balance sheets. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s earnings activity from unconsolidated subsidiaries was as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">923</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s balance sheet activity related to unconsolidated subsidiaries was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Receivables</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The activity primarily related to agreements with PMI&#8217;s unconsolidated subsidiaries within the Eastern Europe segment and the Middle East &amp; Africa segment. These agreements, which are in the ordinary course of business, are primarily for distribution, contract manufacturing and licenses. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s earnings activity from unconsolidated subsidiaries was as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">923</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s balance sheet activity related to unconsolidated subsidiaries was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Receivables</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">471</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair values of PMI&#8217;s equity securities, derivative financial instruments and debt as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.76218323586744%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value at March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted&#160;Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets/Liabilities<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,464</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,221</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,928</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Fair Value Measurements:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:20px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 1 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted prices in active markets for identical assets or liabilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 2 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 3 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Equity Securities </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI&#8217;s equity securities, which are determined by using quoted prices in active markets, have been classified within Level 1. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI&#8217;s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI&#8217;s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI&#8217;s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 5. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion of derivative financial instruments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI&#8217;s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI&#8217;s debt, excluding short-term borrowings and </font><font style="font-family:inherit;font-size:10pt;">$27 million</font><font style="font-family:inherit;font-size:10pt;"> of capital lease obligations, was </font><font style="font-family:inherit;font-size:10pt;">$34,213 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. The fair value of PMI&#8217;s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, was classified within Level 1 and Level 2 in the table shown below.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair values of PMI&#8217;s equity securities, derivative financial instruments and debt as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.76218323586744%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value at March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted&#160;Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets/Liabilities<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">386</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">272</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,464</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,293</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,221</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35,293</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,928</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Balance Sheet Offsetting:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI uses foreign exchange contracts and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the condensed consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. See Note 5. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for disclosures related to PMI's derivative financial instruments.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.635477582846%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:0%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Recognized</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amount Offset in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amounts Presented in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Not Offset in the</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Instruments</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash Collateral Received/Pledged</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amount</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">At March 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,719</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">At December 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,004</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Goodwill and Other Intangible Assets, net:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets, net, by segment were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Intangible Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, <br clear="none"/>2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, <br clear="none"/>2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,474</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,010</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">987</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,004</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,253</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">763</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,667</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,666</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,455</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,432</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill primarily reflects PMI&#8217;s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America&#160;&amp; Canada</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(72</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,474</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">561</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,253</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,667</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional details of other intangible assets were as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,341</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,818</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">704</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,798</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">689</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,159</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">704</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,121</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">689</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets substantially consist of trademarks from PMI&#8217;s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.64327485380117%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(dollars in millions) </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Initial Estimated<br clear="none"/>Useful&#160;Lives</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average<br clear="none"/>Remaining&#160;Useful&#160;Life</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 40 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 30 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (including farmer contracts<br clear="none"/>&#160;&#160;and intellectual property rights)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11 years</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,818</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-tax amortization expense for intangible assets during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Amortization expense for each of the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> years is estimated to be </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$84 million</font><font style="font-family:inherit;font-size:10pt;"> or less, assuming no additional transactions occur that require the amortization of intangible assets.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The increase in the gross carrying amount of other intangible assets from </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, was due primarily to the purchase of additional intellectual property rights related to PMI's reduced-risk products, as well as currency movements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Income Taxes:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI&#8217;s condensed consolidated balance sheets. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Tax Cuts and Jobs Act was signed into law. Accordingly, PMI recorded a provisional charge of </font><font style="font-family:inherit;font-size:10pt;">$1.6 billion</font><font style="font-family:inherit;font-size:10pt;"> in its </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> income tax provision, including a charge for the transition tax on accumulated foreign earnings of </font><font style="font-family:inherit;font-size:10pt;">$1.4 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.2 billion</font><font style="font-family:inherit;font-size:10pt;"> due to the re-measurement of U.S. deferred tax assets and liabilities using a rate of 21%. PMI is evaluating the assumptions used in the analysis, as well as guidance issued by the U.S. Treasury Department and the Internal Revenue Service and has not made any measurement period adjustments related to these items during the quarter. PMI will complete its analysis during 2018, and any adjustments to the provisional charges will be included in income tax expense or benefit in the appropriate period, in accordance with Staff Accounting Bulletin No. 118 (SAB 118).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s effective tax rates for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">25.5%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">24.9%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> was favorably impacted by the tax benefit of a legal entity restructuring (</font><font style="font-family:inherit;font-size:10pt;">$61 million</font><font style="font-family:inherit;font-size:10pt;">). In 2018, PMI's effective tax rate is expected to exceed the new U.S. federal statutory rate of 21%. PMI&#8217;s higher effective tax rate for the three months ended March 31, 2018 was primarily due to earnings mix by taxing jurisdiction, as well as the expected impact of Global Intangible Low Taxed Income ("GILTI") provisions of the Tax Cuts and Jobs Act, partially offset by the favorable tax treatment of Foreign Derived Intangible Income ("FDII"). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based upon PMI's current interpretation of the Tax Cuts and Jobs Act, PMI estimates that its full-year </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> effective tax rate will be approximately </font><font style="font-family:inherit;font-size:10pt;">26%</font><font style="font-family:inherit;font-size:10pt;">, subject to future regulatory developments. PMI is continuing to assess the impacts of the Tax Cuts and Jobs Act on the effective tax rate and income tax accounting, in particular the foreign tax credit limitations related to the new GILTI provisions. PMI will complete this assessment during 2018 and will make an accounting policy election on whether to treat GILTI taxes as a current period expense or include these amounts in the measurement of deferred taxes. Based on PMI&#8217;s assessment to date, no impact is expected from the Base Erosion and Anti-Abuse Tax ("BEAT") rules. Changes in currency exchange rates or earnings mix by taxing jurisdiction also have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years </font><font style="font-family:inherit;font-size:10pt;">2013 and onward</font><font style="font-family:inherit;font-size:10pt;">. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">New Accounting Standards:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for these goods or services. PMI adopted ASU 2014-09 retrospectively to each prior period presented. PMI elected this transition method solely to reflect the change in excise tax presentation in all prior periods presented resulting from PMI&#8217;s accounting policy election to exclude excise taxes collected from customers from the measurement of the transaction price, thereby presenting revenues, net of excise taxes. Based on PMI&#8217;s assessment, the underlying principles of the new standard, relating to the measurement of revenue and the timing of recognition, are closely aligned with PMI&#8217;s current business model and practices. As a result, the adoption of ASU 2014-09 did not have a material impact on the consolidated financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.65107212475633%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2017</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retrospective Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Excises taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,556</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,492</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in presentation of net revenues also impacts segment disclosure requirements, primarily information for significant customers and geographic areas. While there is no change in the underlying business or customers, the amounts used to calculate what is disclosed are different following the change in presentation of revenues net of excise taxes and the associated segment revenues. Prior to this change, revenues including excise taxes were the basis for determining if sales to a customer or in a foreign country met the thresholds for disclosure. On the basis of revenues including excise taxes and due to the fact that PMI is not responsible for collecting excise taxes in certain markets, no customers met the requirements for disclosure. On this basis, net revenues attributable to customers located in PMI&#8217;s largest markets in terms of net revenues, namely Indonesia (</font><font style="font-family:inherit;font-size:10pt;">$8.0 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7.7 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively) and Germany (</font><font style="font-family:inherit;font-size:10pt;">$7.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7.1 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively) were included as part of segment disclosures. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following the change in presentation and using net revenues excluding excise taxes as the basis for determining the disclosures, PMI had </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> customer in the East Asia &amp; Australia segment (</font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of PMI&#8217;s consolidated net revenues in 2017 and 2016, respectively) and </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> customer in the European Union segment (</font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of PMI&#8217;s consolidated net revenues in 2017 and 2016, respectively) that meet the requirements for disclosure. Additionally, on this basis, the only foreign countries meeting the disclosure requirements are PMI&#8217;s markets in Japan (</font><font style="font-family:inherit;font-size:10pt;">$4.7 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.8 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively) and Indonesia (</font><font style="font-family:inherit;font-size:10pt;">$3.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.2 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. For further details, see Note 7. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI recognizes revenue primarily through the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products. The majority of PMI revenues are generated by sales through direct and indirect distribution networks with short-term payment conditions and where control is typically transferred to the customer either upon shipment or delivery of goods. PMI evaluates the transfer of control through evidence of the customer&#8217;s receipt and acceptance, transfer of title, PMI&#8217;s right to payment for those products and the customer&#8217;s ability to direct the use of those products upon receipt. Typically, PMI&#8217;s performance obligations are satisfied and revenue is recognized either upon shipment or delivery of goods. In certain instances, PMI facilitates shipping and handling activities after control has transferred to the customer. &#160;PMI has elected to record all shipping and handling activities as costs to fulfill a contract and such costs, which have not been incurred at the time revenue is recognized, are accrued.&#160; For the three months ended March 31, 2018 and 2017, PMI did not have any material contract assets or contract liabilities. For further details on PMI&#8217;s performance obligations see Note 16. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Warranty</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, PMI adopted Financial Accounting Standard Update ASU 2016-01, &#8220;Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities&#8221; (&#8220;ASU 2016-01&#8221;), on a prospective basis. ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changed certain disclosure requirements and other aspects of current U.S. GAAP. PMI identified certain cost investments, which are applicable to ASU 2016-01 requiring them to be measured at fair value with the changes in fair value recognized in net income. At January 1, 2018, the cumulative effect of this change resulted in an increase to investments in unconsolidated subsidiaries and equity securities, deferred income tax liability and earnings reinvested in the business of </font><font style="font-family:inherit;font-size:10pt;">$301 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$63 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$238 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently issued</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 25, 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update ASU 2016-02, &#8220;Leases&#8221; (&#8220;ASU 2016-02&#8221;). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI has identified its lease management system to be used upon adoption and is in the process of identifying and evaluating the applicable leases. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">New Accounting Standards:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for these goods or services. PMI adopted ASU 2014-09 retrospectively to each prior period presented. PMI elected this transition method solely to reflect the change in excise tax presentation in all prior periods presented resulting from PMI&#8217;s accounting policy election to exclude excise taxes collected from customers from the measurement of the transaction price, thereby presenting revenues, net of excise taxes. Based on PMI&#8217;s assessment, the underlying principles of the new standard, relating to the measurement of revenue and the timing of recognition, are closely aligned with PMI&#8217;s current business model and practices. As a result, the adoption of ASU 2014-09 did not have a material impact on the consolidated financial position or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.65107212475633%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2017</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retrospective Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Excises taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,556</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,492</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in presentation of net revenues also impacts segment disclosure requirements, primarily information for significant customers and geographic areas. While there is no change in the underlying business or customers, the amounts used to calculate what is disclosed are different following the change in presentation of revenues net of excise taxes and the associated segment revenues. Prior to this change, revenues including excise taxes were the basis for determining if sales to a customer or in a foreign country met the thresholds for disclosure. On the basis of revenues including excise taxes and due to the fact that PMI is not responsible for collecting excise taxes in certain markets, no customers met the requirements for disclosure. On this basis, net revenues attributable to customers located in PMI&#8217;s largest markets in terms of net revenues, namely Indonesia (</font><font style="font-family:inherit;font-size:10pt;">$8.0 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7.7 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively) and Germany (</font><font style="font-family:inherit;font-size:10pt;">$7.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7.1 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively) were included as part of segment disclosures. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Following the change in presentation and using net revenues excluding excise taxes as the basis for determining the disclosures, PMI had </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> customer in the East Asia &amp; Australia segment (</font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of PMI&#8217;s consolidated net revenues in 2017 and 2016, respectively) and </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> customer in the European Union segment (</font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of PMI&#8217;s consolidated net revenues in 2017 and 2016, respectively) that meet the requirements for disclosure. Additionally, on this basis, the only foreign countries meeting the disclosure requirements are PMI&#8217;s markets in Japan (</font><font style="font-family:inherit;font-size:10pt;">$4.7 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.8 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively) and Indonesia (</font><font style="font-family:inherit;font-size:10pt;">$3.2 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.2 billion</font><font style="font-family:inherit;font-size:10pt;"> in 2017 and 2016, respectively). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. For further details, see Note 7. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Reporting</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI recognizes revenue primarily through the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products. The majority of PMI revenues are generated by sales through direct and indirect distribution networks with short-term payment conditions and where control is typically transferred to the customer either upon shipment or delivery of goods. PMI evaluates the transfer of control through evidence of the customer&#8217;s receipt and acceptance, transfer of title, PMI&#8217;s right to payment for those products and the customer&#8217;s ability to direct the use of those products upon receipt. Typically, PMI&#8217;s performance obligations are satisfied and revenue is recognized either upon shipment or delivery of goods. In certain instances, PMI facilitates shipping and handling activities after control has transferred to the customer. &#160;PMI has elected to record all shipping and handling activities as costs to fulfill a contract and such costs, which have not been incurred at the time revenue is recognized, are accrued.&#160; For the three months ended March 31, 2018 and 2017, PMI did not have any material contract assets or contract liabilities. For further details on PMI&#8217;s performance obligations see Note 16. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Warranty</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, PMI adopted Financial Accounting Standard Update ASU 2016-01, &#8220;Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities&#8221; (&#8220;ASU 2016-01&#8221;), on a prospective basis. ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changed certain disclosure requirements and other aspects of current U.S. GAAP. PMI identified certain cost investments, which are applicable to ASU 2016-01 requiring them to be measured at fair value with the changes in fair value recognized in net income. At January 1, 2018, the cumulative effect of this change resulted in an increase to investments in unconsolidated subsidiaries and equity securities, deferred income tax liability and earnings reinvested in the business of </font><font style="font-family:inherit;font-size:10pt;">$301 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$63 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$238 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently issued</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 25, 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update ASU 2016-02, &#8220;Leases&#8221; (&#8220;ASU 2016-02&#8221;). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI has identified its lease management system to be used upon adoption and is in the process of identifying and evaluating the applicable leases. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.635477582846%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:0%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Recognized</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amount Offset in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amounts Presented in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Not Offset in the</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Instruments</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash Collateral Received/Pledged</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amount</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">At March 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,719</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">At December 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,004</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.635477582846%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:0%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Recognized</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amount Offset in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amounts Presented in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Not Offset in the</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Instruments</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash Collateral Received/Pledged</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amount</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">At March 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,719</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">At December 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td rowspan="1" colspan="1"><font>&#160;</font></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(50</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,004</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Benefit Plans:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension coverage for employees of PMI&#8217;s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to substantially all U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans. PMI adopted ASU 2017-07 "Compensation - Retirement Benefits" on January 1, 2018, retrospectively for all periods. Following adoption, the service cost component of net periodic benefit cost continues to be included within operating income, while all other cost components are included below operating income, within pension and other employee benefit costs, including </font><font style="font-family:inherit;font-size:10pt;">$19 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> related to net postemployment costs for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and </font><font style="font-family:inherit;font-size:10pt;">$3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;"> related to net postretirement costs for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Pension Plans</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Components of Net Periodic Benefit Cost</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost consisted of the following: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> Primarily non-U.S. based defined benefit retirement plans.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Employer Contributions</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI makes, and plans to make, contributions, to the extent that they are tax deductible and to meet specific funding requirements of its funded pension plans. Employer contributions of </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;"> were made to the pension plans during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;">. Currently, PMI anticipates making additional contributions during the remainder of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2018</font><font style="font-family:inherit;font-size:10pt;"> of approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$46 million</font><font style="font-family:inherit;font-size:10pt;"> to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Product Warranty:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">IQOS</font><font style="font-family:inherit;font-size:10pt;"> devices are subject to standard product warranties generally for a period of </font><font style="font-family:inherit;font-size:10pt;">12</font><font style="font-family:inherit;font-size:10pt;"> months from the date of purchase or such other periods as required by law. PMI generally provides in cost of sales for the estimated cost of warranty in the period the related revenue is recognized. PMI assesses the adequacy of its accrued product warranties and adjusts the amounts as necessary based on actual experience and changes in future estimates. Factors that affect product warranties may vary across markets but typically include product failure rates, logistics and service delivery costs, and warranty policies. PMI accounts for its product warranties within other accrued liabilities. At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, these amounts were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Warranties issued</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Settlements </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Currency</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s accumulated other comprehensive losses, net of taxes, consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.05068226120858%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:55%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,097</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension and other benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,766</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,816</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,509</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives accounted for as hedges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,883</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,535</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,265</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI&#8217;s long-term debt consisted of the following: </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes, 1.375% to 6.375% (average interest rate 3.566%), due through 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,294</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency obligations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro notes, 0.625% to 3.125% (average interest rate 2.250%), due through 2037</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,418</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,376</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (average interest rate 3.378%), due through 2024</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,240</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,840</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion of long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,662</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,506</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29,578</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,334</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain as of January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative (gains)/losses transferred to earnings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(loss) as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (&#8220;EPS&#8221;) were calculated using the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.635477582846%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to PMI</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less distributed and undistributed earnings attributable to share-based payment awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,587</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,552</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plus contingently issuable performance stock units (PSUs)<br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,554</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.64327485380117%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(dollars in millions) </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Initial Estimated<br clear="none"/>Useful&#160;Lives</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average<br clear="none"/>Remaining&#160;Useful&#160;Life</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 40 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 30 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (including farmer contracts<br clear="none"/>&#160;&#160;and intellectual property rights)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11 years</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,818</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI&#8217;s foreign exchange contracts included in the condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts designated as hedging instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">433</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other&#160;liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,237</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">880</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts not designated as hedging instruments&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other&#160;liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,128</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movements in goodwill from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="22" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America&#160;&amp; Canada</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, December 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,010</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,247</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,666</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(72</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, March 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,474</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">561</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,253</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,667</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets, net, by segment were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14" rowspan="1"></td></tr><tr><td style="width:43%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Intangible Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, <br clear="none"/>2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, <br clear="none"/>2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,474</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">458</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">321</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">185</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">178</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,938</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,010</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">987</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,004</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,253</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">763</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">732</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,667</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,666</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,455</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,432</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional details of other intangible assets were as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,341</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,818</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">704</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,798</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">689</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,159</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">704</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,121</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">689</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, PMI's total committed credit facilities were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in billions)</font></div><div style="line-height:120%;padding-left:6px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:84.21052631578947%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Committed</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Credit</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Facilities</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364-day revolving credit, expiring February 5, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring February 28, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring October 1, 2022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total facilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost consisted of the following: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:inherit;font-size:9pt;"> Primarily non-U.S. based defined benefit retirement plans.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.65107212475633%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31, 2017</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As reported</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retrospective Adoption</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="padding-bottom:10px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Excises taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,556</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,492</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, these amounts were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Year Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March&#160;31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to: </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;Warranties issued</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Settlements </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;Currency</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at end of period</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment data were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,081</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,591</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,210</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,896</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East&#160;&amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">370</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America&#160;&amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,426</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's net revenues by product category were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Combustible products:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">527</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,081</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,031</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total combustible products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduced-risk products:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">854</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total reduced-risk products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,127</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total PMI net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,896</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Segment Reporting:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes and other nicotine-containing products, including RRPs, in markets outside of the United States of America. Reportable segments for PMI are organized by geographic region and managed by segment managers who are responsible for the operating and financial results of the regions inclusive of all product categories sold in the region. Effective January 1, 2018, PMI began managing its business in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> reportable segments. PMI&#8217;s reportable segments are the European Union; Eastern Europe; Middle East &amp; Africa; South &amp; Southeast Asia; East Asia &amp; Australia; and Latin America &amp; Canada. PMI records net revenues and operating income to its segments based upon the geographic area in which the customer resides.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI&#8217;s chief operating decision maker evaluates segment performance and allocates resources based on regional operating income, which includes results from all product categories sold in each region. Effective January 1, 2018, PMI began using operating income to evaluate business segment performance and allocate resources, replacing operating companies income used previously. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, "Revenue from Contracts with Customers." PMI adopted this standard retrospectively to each prior period presented. For further details on this standard and its impact on PMI, see Note 18. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">New</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Standards</font><font style="font-family:inherit;font-size:10pt;">. The amounts presented for the reportable segments reflect this adoption. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment data were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,988</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">567</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">516</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">961</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,081</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,031</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,591</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,210</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">708</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">606</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,896</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">740</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">748</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East&#160;&amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">374</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">370</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America&#160;&amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,426</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's net revenues by product category were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Combustible products:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,836</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,709</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">527</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">957</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,081</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,031</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">737</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">704</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">605</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total combustible products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,769</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,629</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reduced-risk products:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Middle East &amp; Africa</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">South &amp; Southeast Asia</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">East Asia &amp; Australia</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">854</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America &amp; Canada</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total reduced-risk products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,127</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">435</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total PMI net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,896</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,064</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note: Sum of product categories or Regions might not foot to total PMI due to roundings. </font></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's cigarettes and other tobacco products combined. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include reduced-risk products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues related to reduced-risk products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's heated tobacco units, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">IQOS </font><font style="font-family:inherit;font-size:10pt;">devices and related accessories, and other nicotine-containing products, which primarily include our e-vapor products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI recognizes revenue, when control is transferred to the customer, typically either upon shipment or delivery of goods.</font></div></div> Following the adoption of Financial Accounting Standards Update ASU 2016-18, "Statement of Cash Flows: Restricted Cash," the amounts for cash and cash equivalents shown above include restricted cash of $31 million and $130 million as of March 31, 2018 and 2017, respectively, and $29 million and $92 million as of December 31, 2017, and 2016, respectively, which were included in other current assets in the condensed consolidated balance sheets. EX-101.SCH 8 pm-20180331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2115100 - Disclosure - Accumulated Other Comprehensive Losses link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Accumulated Other Comprehensive Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2420401 - Disclosure - Acquisitions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Background and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Background and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Balance Sheet Offsetting link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Balance Sheet Offsetting (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Balance Sheet Offsetting (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Benefit Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1005501 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2411406 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411407 - Disclosure - Contingencies (Label-Related Cases) (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) link:presentationLink link:calculationLink link:definitionLink 2411409 - Disclosure - Contingencies (Other Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411408 - Disclosure - Contingencies (Public Civil Actions) (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Contingencies (Smoking And Health Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Contingencies (Tobacco-Related Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Contingencies (Verdicts and Post-Trial Developments) (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Goodwill and Other Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Goodwill and Other Intangible Assets, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Indebtedness link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Indebtedness (Credit Facilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Indebtedness (Long-Term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Indebtedness (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Indebtedness (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Investments in Unconsolidated Subsidiaries link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Investments in Unconsolidated Subsidiaries (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Investments in Unconsolidated Subsidiaries (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2421404 - Disclosure - New Accounting Standards (Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 2221201 - Disclosure - New Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - New Accounting Standards (Revenue Recognition) (Details) link:presentationLink link:calculationLink link:definitionLink 2321302 - Disclosure - New Accounting Standards (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Product Warranty link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - Product Warranty - Movement in Product Warranty Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Product Warranty - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Product Warranty (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Sale of Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Sale of Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Stock Plans link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Stock Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Stock Plans (PSU Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Stock Plans (RSU Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Stock Plans (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 pm-20180331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 pm-20180331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 pm-20180331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Fair Value [Member] Estimate of Fair Value Measurement [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Equity securities Equity Securities, FV-NI Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Foreign exchange contracts Derivative Asset Total assets Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Debt Debt Instrument, Fair Value Disclosure Foreign exchange contracts Derivative Liability Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Retirement Benefits [Abstract] Benefit Plans Pension and Other Postretirement Benefits Disclosure [Text Block] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments [Member] Operating Segments [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Combustible Products [Member] Combustible Products [Member] Combustible Products [Member] Reduced-Risk Products [Member] Reduced-Risk Products [Member] Reduced-Risk Products [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] European Union [Member] European Union [Member] Eastern Europe [Member] Eastern Europe [Member] Eastern Europe [Member] Middle East And Africa [Member] Middle East And Africa [Member] Middle East And Africa [Member] South And Southeast Asia [Member] South And Southeast Asia [Member] South And Southeast Asia [Member] East Asia and Australia [Member] East Asia And Australia [Member] East Asia And Australia [Member] Latin America & Canada [Member] Latin America And Canada [Member] Latin America and Canada Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Number of reportable segments Number of Reportable Segments Total PMI net revenues Revenue from Contract with Customer, Excluding Assessed Tax Operating income Operating Income (Loss) Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension Plan [Member] Pension Plan [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Service cost Defined Benefit Plan, Service Cost Interest cost Defined Benefit Plan, Interest Cost Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Amortization: Amortization [Abstract] Net loss Defined Benefit Plan, Amortization of Gain (Loss) Prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Net periodic pension cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Subsidiary And Other Korean Manufacturers [Member] Subsidiary And Other Korean Manufacturers [Member] Subsidiary And Other Korean Manufacturers [Member] Loss Contingencies Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Canada [Member] CANADA Korea [Member] KOREA, REPUBLIC OF Nigeria [Member] NIGERIA Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Pending Litigation [Member] Pending Litigation [Member] Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] The Attorney General Of Lagos State [Member] The Attorney General Of Lagos State [Member] The Attorney General Of Lagos State [Member] The Attorney General Of Kano State [Member] The Attorney General Of Kano State [Member] The Attorney General Of Kano State [Member] The Attorney General Of Gombe State [Member] The Attorney General Of Gombe State [Member] The Attorney General Of Gombe State [Member] The Attorney General Of Oyo State [Member] The Attorney General Of Oyo State [Member] The Attorney General Of Oyo State [Member] The Attorney General Of Ogun State [Member] The Attorney General Of Ogun State [Member] The Attorney General Of Ogun State [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cases brought against PM Cases Brought Against Company Cases Brought Against Company Damages sought, period of past reimbursements Loss Contingency, Damages Sought, Past Reimbursements, Period Loss Contingency, Damages Sought, Past Reimbursements, Period Damages sought, period of future reimbursements Loss Contingency, Damages Sought, Future Reimbursements, Period Loss Contingency, Damages Sought, Future Reimbursements, Period Damages sought, value Loss Contingency, Damages Sought, Value Damages sought, number of patients Loss Contingency, Damages Sought, Number Of Patients Loss Contingency, Damages Sought, Number Of Patients Statement of Stockholders' Equity [Abstract] Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Currency translation adjustments [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Pension and other benefits [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Derivatives accounted for as hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Accumulated Other Comprehensive Losses [Member] AOCI Attributable to Parent [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Total accumulated other comprehensive losses Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Non-amortizable intangible assets, gross carrying amount Indefinite-Lived Intangible Assets (Excluding Goodwill) Amortizable intangible assets, gross carrying amount Finite-Lived Intangible Assets, Gross Total other intangible assets, gross carrying amount Intangible Assets, Gross (Excluding Goodwill) Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Equity Method Investments and Joint Ventures [Abstract] Earnings and Balance Sheet Activities with Unconsolidated Subsidiaries Equity Method Investments [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash Flow Hedges [Member] Cash Flow Hedging [Member] Net Investment Hedges [Member] Net Investment Hedging [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Net Revenue [Member] Sales [Member] Cost of Sales [Member] Cost of Sales [Member] Marketing Administration And Research Costs [Member] Marketing Administration And Research Costs [Member] Marketing, administration and research costs Interest Expense, Net [Member] Interest Expense [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of weighted average grant date fair value and compensation expense related to share-based awards Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Statement of Comprehensive Income [Abstract] Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other comprehensive earnings (losses), net of income taxes: Other Comprehensive Income (Loss), Net of Tax [Abstract] Change in currency translation adjustments: Change in currency translation adjustment [Abstract] Change in currency translation adjustment [Abstract] Unrealized gains (losses), net of income taxes of $192 in 2018 and $156 in 2017 Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Change in net loss and prior service cost: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract] Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($11) in 2018 and ($9) in 2017 Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax Change in fair value of derivatives accounted for as hedges: Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax [Abstract] Gains (losses) recognized, net of income taxes of $10 in 2018 and $11 in 2017 Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax (Gains) losses transferred to earnings, net of income taxes of ($1) in 2018 and $2 in 2017 Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax Total other comprehensive earnings (losses) Other Comprehensive Income (Loss), Net of Tax Total comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less comprehensive earnings attributable to: Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest [Abstract] Noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive earnings attributable to PMI Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accounting Changes and Error Corrections [Abstract] New Accounting Standards New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Schedule of Tobacco Related Cases Pending Against Company Schedule Of Tobacco Related Cases Pending Against Company [Table Text Block] Schedule of tobacco related cases pending against company and/or subsidiaries or indemnitees Schedule Of Verdicts And Post Trial Developments Where a Verdict was Returned In Favor of the Plaintiff(s) Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Debt Disclosure [Abstract] Indebtedness Debt Disclosure [Text Block] Other Litigation [Member] Other Litigation [Member] Other Litigation [Member] Thailand [Member] THAILAND The Department of Special Investigations of the Government of Thailand [Member] The Department of Special Investigations of the Government of Thailand [Member] The Department of Special Investigations of the Government of Thailand [Member] The South Korean Board Of Audit And Inspection [Member] The South Korean Board Of Audit And Inspection [Member] The South Korean Board Of Audit And Inspection [Member] Number of defendants Loss Contingency, Number of Defendants Loss contingency, damages sought, value Loss Contingency, Fines Or Demanded Payments Sought The monetary value related to fines, demanded payments or other legal matters sought by government and other governmental authorities. Amounts paid Payments For Fines, Demanded Notices Or Other Legal Issues The amount of cash paid for the fines, demanded notices or for other legal issues during the period. Offsetting [Abstract] Offsetting Assets Offsetting Assets [Table Text Block] Offsetting Liabilities Offsetting Liabilities [Table Text Block] New Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Aggregate Fair Values of Equity Securities, Derivative Financial Instruments and Debt Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Statement of Cash Flows [Abstract] CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net earnings to operating cash flows: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Deferred income tax provision Deferred Income Tax Expense (Benefit) Cash effects of changes in: Increase (Decrease) in Operating Capital [Abstract] Receivables, net Increase (Decrease) in Receivables Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities and other current assets Increase Decrease In Accrued Liabilities And Other Current Assets The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid, as well as the net change during the reporting period in the aggregate value of other current assets, associated with transactions that are classified as operating activities Income taxes Increase (Decrease) in Income Taxes Payable Pension plan contributions Payment for Pension Benefits Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Investments in unconsolidated subsidiaries and equity securities Payments to Acquire Interest in Subsidiaries and Affiliates Net investment hedges Payments for (Proceeds from) Hedge, Investing Activities Other Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Short-term borrowing activity by original maturity: Proceeds from (Repayments of) Debt [Abstract] Net issuances - maturities of 90 days or less Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Long-term debt proceeds Proceeds from Issuance of Long-term Debt Long-term debt repaid Repayments of Long-term Debt Dividends paid Payments of Dividends Sale (purchase) of subsidiary shares to/(from) noncontrolling interests Proceeds from (Payments to) Noncontrolling Interests Other Proceeds from (Payments for) Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash: Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] Increase (Decrease) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Balance at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Balance at end of period Sale of Accounts Receivable [Abstract] Sale of Accounts Receivable [Abstract] Servicing liability Servicing Liability Trade receivables sold and derecognized from the Consolidated Balance Sheets Trade Receivable Sold and Derecognized from the Consolidated Balance Sheets Trade receivables sold without recourse to unaffiliated financial institutions and derecognized from the consolidated balance sheets. Trade receivables sold and derecognized that remain uncollected Trade Receivables Sold and Derecognized that Remained Uncollected Trade accounts receivable sold and derecognized from the consolidated balance sheets that remain uncollected by unaffiliated financial institutions. Loss on sale of trade receivables Gain (Loss) on Sale of Accounts Receivable Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Eastern Europe Segment and Middle East And Africa Segment [Member] Eastern Europe Middle East And Africa [Member] Eastern Europe, Middle East and Africa Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Net revenues Revenue from Related Parties Receivables Accounts Receivable, Related Parties, Current Components of Accumulated Other Comprehensive Earnings (Losses), Net of Taxes Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Lender Name [Axis] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] 364-day revolving credit expiring February 5, 2019 [Member] Three Hundred Sixty-Four Day Revolving Credit Expiring February Fifth Two Thousand Nineteen [Member] Three Hundred Sixty-Four Day Revolving Credit Expiring February Fifth Two Thousand Nineteen [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Short-term borrowings, carrying value Short-term Debt Committed credit facilities Line of Credit Facility, Maximum Borrowing Capacity Borrowings under committed credit facilities Long-term Line of Credit Individual Smoking And Health Cases [Member] Individual Smoking And Health Cases [Member] Individual Smoking And Health Cases Smoking And Health Class Actions [Member] Smoking And Health Class Actions [Member] Smoking And Health Class Actions Label Related Class Action [Member] Label Related Class Action [Member] Label Related Class Action [Member] Individual Label Related Cases [Member] Individual Label Related Cases [Member] Individual Label Related Cases [Member] Public Civil Actions [Member] Public Civil Actions [Member] Public Civil Actions Goodwill and Other Intangible Assets, net Goodwill and Intangible Assets Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Guarantees and Product Warranties [Abstract] Standard product warranty term Standard Product Warranty, Term Standard Product Warranty, Term Balance Sheet Offsetting Financial Instruments Disclosure [Text Block] Schedule of Goodwill and Intangible Assets [Table] Schedule of Goodwill and Intangible Assets [Table] Schedule of Goodwill and Intangible ssets [Table] Goodwill and Other Intangible Assets, net [Line Items] Goodwill and Intangible Assets [Line Items] Goodwill and Intangible Assets [Line Items] Goodwill Goodwill Other Intangible Assets, net Intangible Assets, Net (Excluding Goodwill) Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Equity Method Investment Goodwill [Member] Equity Method Investment Goodwill [Member] Equity Method Investment Goodwill [Member] EITA [Member] EITA [Member] EITA [Member] STAEM [Member] STAEM [Member] STAEM [Member] Megapolis [Member] Megapolis [Member] Megapolis [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Ownership [Axis] Ownership [Axis] Ownership [Domain] Ownership [Domain] Management Et Development Des Actifs Et Des Ressources [Member] Management Et Developpment Des Actifs Et Des Ressources Holding (MADAR Holding) [Member] Management Et Developpment Des Actifs Et Des Ressources Holding (MADAR Holding) [Member] Equity method investments Equity Method Investments Difference between equity method investment carrying value and book value Equity Method Investment, Difference Between Carrying Amount and Underlying Equity Investments in unconsolidated subsidiaries and equity securities Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Difference between equity method investment carrying value and book value, amortization period Equity Method Investment, Difference Between Carrying Amount and Underlying Equity, Amortization Period Equity Method Investment, Difference Between Carrying Amount and Underlying Equity, Amortization Period Dividends from unconsolidated subsidiaries Proceeds from Equity Method Investment, Distribution Ownership percentage Equity Method Investment, Ownership Percentage Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Balance at beginning of period Standard Product Warranty Accrual Changes due to: Changes In Standard Product Warranty Accrual [Abstract] Changes In Standard Product Warranty Accrual [Abstract] Warranties issued Standard Product Warranty Accrual, Increase for Warranties Issued Settlements Standard Product Warranty Accrual, Decrease for Payments Currency Standard Product Warranty Accrual, Foreign Currency Translation Gain (Loss) Balance at end of period Argentina [Member] ARGENTINA Brazil [Member] BRAZIL Chile [Member] CHILE Costa Rica [Member] COSTA RICA Italy [Member] ITALY Philippines [Member] PHILIPPINES Russia [Member] RUSSIAN FEDERATION Turkey [Member] TURKEY Scotland [Member] Scotland [Member] Scotland Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Domain] Loss Contingencies By Name Of Plaintiff [Domain] Loss Contingencies by Name of Plaintiff [Domain] The Smoker Health Defense Association (ADESF) [Member] The Smoker Health Defense AssociationADESF [Member] The Smoker Health Defense Association (ADESF) Award per smoker per year [Member] Award per smoker per year [Member] Award per smoker per year [Member] Cecilia Letourneau [Member] Cecilia Letourneau [Member] Cecilia Letourneau [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Cecilia Letourneau &Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Adams [Member] Adams [Member] Adams [Member] Suzanne Jacklin [Member] Suzanne Jacklin [Member] Suzanne Jacklin [Member] Judicial Ruling [Member] Judicial Ruling [Member] Appellate Ruling [Member] Appellate Ruling [Member] Appellate Ruling [Member] Under Advisement [Member] Under Advisement [Member] Under Advisement [Member] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Imperial Tobacco Ltd. [Member] Imperial Tobacco Ltd. [Member] Imperial Tobacco Ltd. [Member] Damages awarded Loss Contingency, Damages Awarded, Value Smoking and health loss contingency interest rate Smoking And Health Loss Contingency Interest Rate Interest rate applied on damages awarded Number of additional manufacturers found liable Loss Contingency, Number Of Additional Manufacturers Found Liable Loss Contingency, Number Of Additional Manufacturers Found Liable Punitive damages awarded Loss Contingency, Damages Awarded, Punitive Damages, Value Loss Contingency, Damages Awarded, Punitive Damages, Value Estimated number of members in class Loss Contingency, Estimated Number Of Members In Class Loss Contingency, Estimated Number Of Members In Class Payment period for awarded punitive damages to be deposited into trust Loss Contingency, Damages Awarded, Punitive Damages, Payment Period Loss Contingency, Damages Awarded, Punitive Damages, Payment Period Amount of security ordered to be furnished Loss Contingency, Motion for Security Ordered by Appeals Court, to be Furnished by Defendants Loss Contingency, Motion for Security Ordered by an Appeals Court, to be Furnished by Defendants in Equal Consecutive Quarterly Installments in the Form of Cash to a Court Trust or Letters of Credit. Number of consecutive quarterly installment Loss Contingency, Number of Equal Consecutive Quarterly Installments Ordered by Court of Appeals Loss Contingency, Number of Equal Consecutive Quarterly Installments Ordered by Court of Appeals Amount of security to be furnished in each consecutive quarterly installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished By Defendants, Amount Of Each Consecutive Quarterly Equal Installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished By Defendants, Amount Of Each Consecutive Quarterly Equal Installment Amount of security furnished by defendants in quarterly installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished Quarterly By Defendants, Amount Of Quarterly Installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished Quarterly By Defendants, Amount Of Quarterly Installment Period between addiction warning and claim Loss Contingency, Period Between Addiction Warning And Claim Loss Contingency, Period Between Addiction Warning And Claim Compensatory damages awarded Loss Contingency, Damages Awarded, Compensatory Damages, Value Loss Contingency, Damages Awarded, Compensatory Damages, Value Damages allocated to subsidiary (percent) Loss Contingency, Damages Awarded, Percentage Allocated Loss Contingency, Damages Awarded, Percentage Allocated Awarded compensatory damages that are to be deposited into trust Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust Payment period for compensatory damages to be deposited into trust Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period Payment period for compensatory damages to be deposited into trust Loss Contingency, Damages Awarded, Payment Period Loss Contingency, Damages Awarded, Payment Period Motion to secure judgment, Letters of credit to be placed into trust, option 1 Loss Contingency, Motion Filed by Plaintiffs to Secure Judgment, Letters of Credit Amount to be Placed in Trust, Option One Loss Contingency, Motion Filed by Plaintiffs to Secure Judgment, Letters of Credit Amount to be Placed in Trust, Option One Plaintiff requirement, Minimum number of cigarettes smoked Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked Individual Action [Member] Smoking And Health Individual Actions [Member] Smoking And Health Individual Actions [Member] Cases With Verdicts And Post Trial Developments [Member] Cases With Verdicts And Post Trial Developments [Member] Cases with Verdicts and Post Trial Developments Hugo Lespada [Member] Hugo Lespada [Member] Hugo Lespada [Member] Date Date Of Verdict Date Of Verdict Verdict Loss Contingency, Actions Taken by Court, Arbitrator or Mediator Post-Trial Developments Loss Contingency Post Trial Developments1 Loss Contingency Post Trial Developments1 Smoking and health loss contingency interest rate (percentage per month) Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Schedule of New Accounting Pronouncements and Changes in Accounting Principles Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Case Decided In Favor Of Plaintiff [Member] Case Decided In Favor Of Plaintiff [Member] Case Decided in Favor of Plaintiff Cases Remaining On Appeal [Member] Cases Remaining On Appeal [Member] Cases Remaining on Appeal Number of cases decided in favor of PM Loss Contingency Claims Resolved in Favor of the Company Loss Contingency Claims Resolved in Favor of the Company Number of cases decided in favor of plaintiff Loss Contingency Claims Resolved in Favor of Plaintiffs Loss Contingency Claims Resolved in Favor of Plaintiffs Number of cases that reached final resolution in favor of PM Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company New Accounting Pronouncements or Change in Accounting Principle [Table] New Accounting Pronouncements or Change in Accounting Principle [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2016-01 [Member] Accounting Standards Update 2016-01 [Member] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Investments in unconsolidated subsidiaries and equity securities Equity Method Investments And Equity Securities, FV-NI Amount represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee, which is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. The amount also includes investments in equity securities measured at fair value at the balance sheet date. Deferred income taxes Deferred Income Tax Liabilities, Net Earnings reinvested in the business Retained Earnings (Accumulated Deficit) Long-Term Debt Schedule of Long-term Debt Instruments [Table Text Block] Schedule of Committed Credit Facilities Schedule of Line of Credit Facilities [Table Text Block] Components of Net Periodic Benefit Cost Schedule of Net Benefit Costs [Table Text Block] Sale of Accounts Receivable Sale of Trade Accounts Receivable Disclosure [Text Block] Sale of Trade Accounts Receivable Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Product Warranty Product Warranty Disclosure [Text Block] Schedule of Accrued Product Warranties Schedule of Product Warranty Liability [Table Text Block] Contingencies Commitments and Contingencies Disclosure [Text Block] Investments in Unconsolidated Subsidiaries Equity Method Investments and Joint Ventures Disclosure [Text Block] Segment Data Schedule of Segment Reporting Information, by Segment [Table Text Block] Background and Basis of Presentation Business Description and Basis of Presentation [Text Block] Derivative [Table] Derivative [Table] Derivative Instrument [Axis] Cash Flow Hedging [Member] Net Investment Hedging [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Derivative [Line Items] Derivative [Line Items] Notional amount Derivative, Notional Amount Maximum length of time hedged in a cash flow hedge Derivative, Remaining Maturity Maturity of foreign currency derivatives - cash flow hedges Maturity of Foreign Currency Derivatives Unrealized loss on hedges of net investments Gain on amounts excluded from effectiveness testing Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Gain (loss) on derivatives not designated as hedging instruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Net impact on earnings Unrealized Gain (Loss) on Derivatives Derivative instruments, losses to be reclassified to earnings Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Performance Shares [Member] Performance Shares [Member] Performance Share Units, TSR Relative To Customer Peer Group [Member] Performance Share Units, TSR Relative To Customer Peer Group [Member] Performance Share Units, TSR Relative To Customer Peer Group [Member] Performance Share Units, Other Performance Factors [Member] Performance Share Units, Other Performance Factors [Member] Performance Share Units, Other Performance Factors [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Number of Shares Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Compensation expense for stock awards Allocated Share-based Compensation Expense Income Statement [Abstract] Revenues including excise taxes Revenue from Contract with Customer, Including Assessed Tax Excise taxes on products Excise and Sales Taxes Net revenues Cost of sales Cost of Goods Sold Gross profit Gross Profit Marketing, administration and research costs Marketing, administration and research costs The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies. General and administrative expenses include costs such as salaries of nonsales personnel, rent, utilities, communication and realized and unrealized gains and losses on foreign currency transactions. Amortization of intangibles Amortization of Intangible Assets Operating income Interest expense, net Interest Income (Expense), Net Pension and other employee benefit costs Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits. Earnings before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Provision for income taxes Income Tax Expense (Benefit) Equity investments and securities (income)/loss, net Income (Loss) From Equity Method Investments And Equity Securities, FV-NI This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item also includes change in fair value of equity securities. Net earnings Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to PMI Net Income (Loss) Attributable to Parent Per share data: Earnings Per Share [Abstract] Basic earnings per share (in dollars per share) Earnings Per Share, Basic Diluted earnings per share (in dollars per share) Earnings Per Share, Diluted Venezuela [Member] VENEZUELA Segment Reporting Segment Reporting Disclosure [Text Block] Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Other Comprehensive Income (Loss) [Member] Other Comprehensive Income (Loss) [Member] Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward] Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward] Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward] Gain as of January 1, Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Derivative (gains)/losses transferred to earnings Change in fair value Gain/(loss) as of March 31, Statement of Financial Position [Abstract] ASSETS Assets [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Trade receivables (less allowances of $25 in 2018 and $25 in 2017) Accounts Receivable, Net, Current Other receivables Other Receivables, Net, Current Inventories: Inventory, Net [Abstract] Leaf tobacco Inventory Leaf Tobacco Carrying amount as of the balance sheet date of leaf tobacco inventory to be consumed in the manufacturing and production process. Other raw materials Inventory, Raw Materials, Gross Finished product Inventory, Finished Goods, Gross Total inventory, net Inventory, Net Other current assets Other Assets, Current Total current assets Assets, Current Property, plant and equipment, at cost Property, Plant and Equipment, Gross Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Total property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Other intangible assets, net Deferred income taxes Deferred Income Tax Assets, Net Other assets Other Assets, Noncurrent TOTAL ASSETS Assets LIABILITIES Liabilities [Abstract] Short-term borrowings Current portion of long-term debt Long-term Debt and Capital Lease Obligations, Current Accounts payable Accounts Payable, Current Accrued liabilities: Accrued Liabilities, Current [Abstract] Marketing and selling Accrued Marketing Costs, Current Taxes, except income taxes Sales and Excise Tax Payable, Current Employment costs Employee-related Liabilities, Current Dividends payable Dividends Payable, Current Other Other Accrued Liabilities, Current Income taxes Accrued Income Taxes, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt and Capital Lease Obligations Employment costs Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Income taxes and other liabilities Income Taxes And Other Liabilities, Noncurrent Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer and amount of liabilities classified as other, due after one year or the normal operating cycle. Total liabilities Liabilities Contingencies Commitments and Contingencies STOCKHOLDERS’ (DEFICIT) EQUITY Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Common stock, no par value (2,109,316,331 shares issued in 2018 and 2017) Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive losses Accumulated Other Comprehensive Income (Loss), Net of Tax Total stockholders' equity before treasury stock Stockholders' Equity before Treasury Stock Less: cost of repurchased stock (554,850,007 and 556,098,569 shares in 2018 and 2017, respectively) Treasury Stock, Value Total PMI stockholders’ deficit Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders’ deficit TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Liabilities and Equity Net earnings attributable to PMI Less distributed and undistributed earnings attributable to share-based payment awards Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted Net earnings for basic and diluted EPS Net Income Loss Available To Common Stockholders Basic And Diluted Net income (loss) after adjustments for distributed and undistributed earnings attributable to share-based payment awards. Weighted-average shares for basic EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Plus contingently issuable performance stock units (PSUs) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted-average shares for diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Antidilutive stock awards (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Tabacalera Costarricense, S.A. And Mendiola Y Campania, S.A. Purchase Of Noncontrolling Interest [Member] Tabacalera Costarricense, S.A. And Mendiola Y Campania, S.A. Purchase Of Noncontrolling Interest [Member] Tabacalera Costarricense, S.A. And Mendiola Y Campania, S.A. Purchase Of Noncontrolling Interest [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Interest acquired Business Acquisition, Percentage of Voting Interests Acquired Net purchase price Business Combination, Consideration Transferred Contingent consideration Business Combination, Contingent Consideration, Liability Ownership percentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage Decrease to additional paid-in capital Adjustments to Additional Paid in Capital, Other Income Tax Disclosure [Abstract] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast [Member] Scenario, Forecast [Member] United States [Member] UNITED STATES Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Provisional expense Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit) Accumulated foreign earnings provisional tax charge Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit) Re-measurement provisional charge Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Provisional Income Tax Expense (Benefit) Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Provisional Income Tax Expense (Benefit) Effective tax rate Effective Income Tax Rate Reconciliation, Percent Tax benefit from legal entity restructuring Other Tax Expense (Benefit) Open Tax Year Open Tax Years By Major Jurisdiction Open Tax Years By Major Jurisdiction Stock Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Restricted cash Restricted Cash Schedule of Goodwill and Intangible Assets, Net, by Segment or Major Class Schedule of Intangible Assets and Goodwill [Table Text Block] Movements in Goodwill Schedule of Goodwill [Table Text Block] Gross Carrying Amount, Range of Useful Lives and Weighted-Average Remaining Useful Life of Amortizable Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Statement [Table] Statement [Table] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Earnings Reinvested in the Business [Member] Retained Earnings [Member] Cost of Repurchased Stock [Member] Treasury Stock [Member] Noncontrolling Interests [Member] Noncontrolling Interest [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance Net earnings Other comprehensive earnings (losses), net of income taxes Issuance of stock awards Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Dividends declared ($1.04 and $1.07 per share for the three months ended March 31, 2017 and 2018, respectively) Dividends, Common Stock Payments to noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Cumulative effect of initial adoption of new accounting standards Cumulative Effect of New Accounting Principle in Period of Adoption Other Stockholders' Equity, Other Ending balance Acquisitions Business Combination Disclosure [Text Block] Capital lease obligations, carrying value Capital Lease Obligations, Noncurrent Debt excluding short-term borrowings and capital lease obligations, carrying value Total Debt Excluding Short Term Borrowings And Capital Lease Obligations Sum of the carrying values as of the balance sheet date of total debt, excluding short term borrowings and capital lease obligations. Accounting Standards Update 2014-09 [Member] Accounting Standards Update 2014-09 [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Calculated under Revenue Guidance in Effect before Topic 606 [Member] Calculated under Revenue Guidance in Effect before Topic 606 [Member] Indonesia [Member] INDONESIA Germany [Member] GERMANY Japan [Member] JAPAN Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue, Including Assessed Tax [Member] Revenue, Including Assessed Tax [Member] Revenue, Including Assessed Tax [Member] Revenue, Excluding Assessed Tax [Member] Revenue, Excluding Assessed Tax [Member] Revenue, Excluding Assessed Tax [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Geographic Concentration Risk [Member] Geographic Concentration Risk [Member] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Customer One [Member] Customer One [Member] Customer One [Member] Net revenues Excises taxes Net revenues Concentration risk percentage Concentration Risk, Percentage Earnings Per Share Earnings Per Share [Text Block] Income taxes on currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Translation Gain (Loss) Arising During Period, Tax Income taxes on amortization of net losses, prior service costs and net transition costs Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax Income taxes on (loss)/gain recognized from fair value of derivatives accounted for as hedges Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax Income taxes on loss/(gain) transferred to earnings from fair value of derivatives accounted for as hedges Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax Calculation of Basic and Diluted EPS Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2017 Performance Incentive Plan [Member] 2017 Performance Incentive Plan [Member] 2017 Performance Incentive Plan [Member] Non Employee Directors Plan [Member] 2017 Non Employee Directors Plan [Member] 2017 Non Employee Directors Plan [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Share-based Compensation Components [Axis] Share-based Compensation Components [Axis] Share-based Compensation Components [Axis] Share-based Compensation Component [Domain] Share-based Compensation Component [Domain] Share-based Compensation Component [Domain] Grant Date Fair Value [Member] Grant Date Fair Value [Member] Grant date fair value [Member]. Total Fair Value [Member] Fair Value [Member] Fair value [Member]. Performance Metric, Type [Axis] Performance Metric, Type [Axis] Performance Metric, Type [Axis] Performance Metric, Type [Domain] Performance Metric, Type [Domain] [Domain] for Performance Metric, Type [Axis] Performance Metric, Total Shareholder Return [Member] Performance Metric, Total Shareholder Return [Member] Performance Metric, Total Shareholder Return [Member] Performance Metric, Currency-Neutral Compound Annual Adjusted Operating Income Growth Rate, Excluding Acquisitions [Member] Performance Metric, Currency-Neutral Compound Annual Adjusted Operating Income Growth Rate, Excluding Acquisitions [Member] Performance Metric, Currency-Neutral Compound Annual Adjusted Operating Income Growth Rate, Excluding Acquisitions [Member] Performance Metric, Performance Against Specific Measures Of Transformation [Member] Performance Metric, Performance Against Specific Measures Of Transformation [Member] Performance Metric, Performance Against Specific Measures Of Transformation [Member] Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares available for grant under the plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Percentage of voting shares that PMI may own, used in determining non-employee director status Non Employee Director Ownership Limit Represents the lower limit of ownership in a company by PMI used in defining Non-employee directors under the stock compensation plan. Unrecognized compensation cost related to non-vested stock awards Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Award requisite service period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Minimum Retirement Age Minimum Retirement Age Minimum Retirement Age Stock awards vested during period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Fair value of vested stock awards Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Performance period Share-Based Compensation Arrangement By Share-Based Payment Awards, Length Of The Performance Cycle Period, Which Requires That Certain Predetermined Performance Metrics Be Achieved Share-Based Compensation Arrangement by Share-Based Payment Award, Duration of the Performance Cycle that Requires the Achievement of Predefined Performance Metrics Performance metric weight Share-Based Compensation Arrangement By Share-Based Payment Awards, Performance Metrics, Weight Of Indicator, Percent Share-Based Compensation Arrangement By Share-Based Payment Awards, Performance Metrics, Weight Of Indicator, Percent Number of performance metrics used to determine the percentage of PSU's that will vest Performance Metrics Predefined At The Time Of Grant, Including Market And Non-Market Metrics, Used By The Company To Determine The Percentage Of PSU's That Will Vest Performance Metrics Predefined at Time of Grant, including Market and Non-Market Metrics, used by the Company to Determine the Percentage of PSU's that will Vest Vesting percentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Aggregate weighted performance factor that determines if the target number of PSUs will vest Share-Based Compensation By Share-Based Payment Awards, The Aggregate Weighted Performance Factor That Results in The Vesting of the Targeted Number Of Performance Share Units Share-Based Compensation by Share-Based Payment Awards, the Aggregate Weighted Performance Factor that Results in the Vesting of the Targeted Number of Performance Share Units The number of shares of common stock issue for each vested PSU The Number Of Shares Of Common Stock Issued For Each Vested Performance Share Unit The Number of shares of Common Stock Issued for each Vested Performance Share Unit Offsetting Assets and Liabilities [Table] Offsetting Assets and Liabilities [Table] Offsetting Assets and Liabilities [Table] Offsetting Assets and Liabilities [Line Items] Offsetting Assets and Liabilities [Line Items] [Line Items] for Offsetting Assets and Liabilities [Table] Assets Offsetting Derivative Assets [Abstract] Gross Amounts Recognized Derivative Asset, Fair Value, Gross Asset Gross Amount Offset in the Condensed Consolidated Balance Sheet Derivative Asset, Fair Value, Gross Liability Net Amounts Presented in the Condensed Consolidated Balance Sheet Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments Derivative Asset, Not Offset, Policy Election Deduction Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged Derivative, Collateral, Obligation to Return Cash Net Amount Derivative Asset, Fair Value, Amount Offset Against Collateral Liabilities Offsetting Derivative Liabilities [Abstract] Gross Amounts Recognized Derivative Liability, Fair Value, Gross Liability Gross Amount Offset in the Condensed Consolidated Balance Sheet Derivative Liability, Fair Value, Gross Asset Net Amounts Presented in the Condensed Consolidated Balance Sheet Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments Derivative Liability, Not Offset, Policy Election Deduction Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged Derivative, Collateral, Right to Reclaim Cash Net Amount Derivative Liability, Fair Value, Amount Offset Against Collateral Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Postemployment Benefit Plans [Member] Postemployment Benefit Plans [Member] Postemployment Benefit Plans [Member] Postretirement Benefit Costs [Member] Postretirement Benefit Costs [Member] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Postemployment benefit plans other cost components Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Anticipated additional employer contributions during the remainder of the current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balances, December 31, 2017 Changes due to: Goodwill, Translation and Purchase Accounting Adjustments [Abstract] Currency Goodwill, Translation and Purchase Accounting Adjustments Balances, March 31, 2018 Multi-year revolving credit, expiring February 28, 2021 [Member] Multi Year Revolving Credit Expiring February Twenty Eighth Two Thousand Twenty One [Member] Multi Year Revolving Credit Expiring February Twenty Eighth Two Thousand Twenty One [Member] Multi-year revolving credit, expiring October 1, 2022 [Member] Multi Year Revolving Credit Expiring October First Two Thousand Twenty Two [Member] Multi Year Revolving Credit Expiring October First Two Thousand Twenty Two [Member] Fair Value of Foreign Exchange Contracts Schedule of Foreign Exchange Contracts, Statement of Financial Position [Table Text Block] Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block] Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block] Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses), Net of Income Taxes Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Trademarks [Member] Trademarks [Member] Distribution Networks [Member] Distribution Rights [Member] Other (Including Farmer Contracts and Intellectual Property Rights) [Member] Other (Including Farmer Contracts and Intellectual Property Rights) [Member] Farmer Contracts [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Gross Carrying Amount Initial Estimated Useful Lives Finite-Lived Intangible Asset, Useful Life Weighted-Average Remaining Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Purported Label Related Class Action [Member] Purported Label Related Class Action [Member] Purported Label Related Class Action [Member] Aharon Ringer V. Philip Morris Ltd. And Globrands Ltd. [Member] Aharon Ringer V. Philip Morris Ltd. And Globrands Ltd. [Member] Aharon Ringer V. Philip Morris Ltd. And Globrands Ltd. [Member] Israel [Member] ISRAEL Estimated number of members in purported class Loss Contingency, Estimated Number Of Members In Purported Class Loss Contingency, Estimated Number Of Members In Purported Class Accumulated Other Comprehensive Losses Comprehensive Income (Loss) Note [Text Block] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Current Assets [Member] Other Current Assets [Member] Other Assets [Member] Other Assets [Member] Other Accrued Liabilities [Member] Other Accrued Liabilities [Member] Other Accrued Liabilities [Member] Other Liabilities [Member] Other Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative asset fair value Derivative liability fair value Receivables, allowances Allowance for Doubtful Accounts Receivable, Current Common stock, no par value (in dollars per share) Common Stock, No Par Value Common stock, shares issued (in shares) Common Stock, Shares, Issued Repurchased stock, shares (in shares) Treasury Stock, Shares Intangible assets, pre-tax amortization expense Estimated amortization expense, year one, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Estimated amortization expense, year two, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Assets, Amortization Expense, Year Two Estimated amortization expense, year three, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Assets, Amortization Expense, Year Three Estimated amortization expense, year four, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Assets, Amortization Expense, Year Four Estimated amortization expense, year five, assuming no additional transactions occur that require the amortization of intangible assets Finite-Lived Intangible Assets, Amortization Expense, Year Five Income Taxes Income Tax Disclosure [Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] U.S. Dollar Notes [Member] US Dollar Notes [Member] U.S. Dollar Notes Euro Notes [Member] Euro Notes Payable Member Euro Notes Payable Swiss Franc Notes [Member] Swiss Franc Notes [Member] Swiss franc notes [Member] Other [Member] Notes Payable, Other Payables [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Foreign Currency Obligations [Member] Foreign Currency Obligations [Member] Foreign Currency Obligations [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term Debt and Capital Lease Obligations, Including Current Maturities Long-term Debt and Capital Lease Obligations, Including Current Maturities Less current portion of long-term debt Long-term Debt Interest rate Debt Instrument, Interest Rate, Stated Percentage Interest rate, average Debt Instrument, Interest Rate During Period Due through Debt Instrument, Maturity Date, Description EX-101.PRE 12 pm-20180331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 13 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2018
Apr. 23, 2018
Document And Entity Information [Abstract]    
Entity Registrant Name Philip Morris International Inc.  
Entity Central Index Key 0001413329  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Document Type 10-Q  
Document Period End Date Mar. 31, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Entity Common Stock, Shares Outstanding   1,554,473,725
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
ASSETS    
Cash and cash equivalents $ 7,200 $ 8,447
Trade receivables (less allowances of $25 in 2018 and $25 in 2017) 3,373 3,194
Other receivables 521 544
Inventories:    
Leaf tobacco 2,737 2,606
Other raw materials 1,481 1,563
Finished product 4,374 4,637
Total inventory, net 8,592 8,806
Other current assets 907 603
Total current assets 20,593 21,594
Property, plant and equipment, at cost 15,056 14,566
Less: accumulated depreciation 7,597 7,295
Total property, plant and equipment, net 7,459 7,271
Goodwill 7,667 7,666
Other intangible assets, net 2,455 2,432
Investments in unconsolidated subsidiaries and equity securities 1,395 1,074
Deferred income taxes 1,150 1,007
Other assets 2,351 1,924
TOTAL ASSETS 43,070 42,968
LIABILITIES    
Short-term borrowings 608 499
Current portion of long-term debt 4,662 2,506
Accounts payable 2,156 2,242
Accrued liabilities:    
Marketing and selling 668 708
Taxes, except income taxes 5,085 5,324
Employment costs 770 856
Dividends payable 1,675 1,669
Other 1,556 1,346
Income taxes 508 812
Total current liabilities 17,688 15,962
Long-term debt 29,578 31,334
Deferred income taxes 822 799
Employment costs 2,272 2,271
Income taxes and other liabilities 3,192 2,832
Total liabilities 53,552 53,198
Contingencies
STOCKHOLDERS’ (DEFICIT) EQUITY    
Common stock, no par value (2,109,316,331 shares issued in 2018 and 2017) 0 0
Additional paid-in capital 1,856 1,972
Earnings reinvested in the business 29,985 29,859
Accumulated other comprehensive losses (8,883) (8,535)
Total stockholders' equity before treasury stock 22,958 23,296
Less: cost of repurchased stock (554,850,007 and 556,098,569 shares in 2018 and 2017, respectively) 35,308 35,382
Total PMI stockholders’ deficit (12,350) (12,086)
Noncontrolling interests 1,868 1,856
Total stockholders’ deficit (10,482) (10,230)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY $ 43,070 $ 42,968
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Statement of Financial Position [Abstract]    
Receivables, allowances $ 25 $ 25
Common stock, no par value (in dollars per share)
Common stock, shares issued (in shares) 2,109,316,331 2,109,316,331
Repurchased stock, shares (in shares) 554,850,007 556,098,569
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Earnings - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Revenues including excise taxes $ 18,426 $ 16,556
Excise taxes on products 11,530 10,492
Net revenues 6,896 6,064
Cost of sales 2,615 2,177
Gross profit 4,281 3,887
Marketing, administration and research costs 1,833 1,449
Amortization of intangibles 22 22
Operating income 2,426 2,416
Interest expense, net 227 219
Pension and other employee benefit costs 6 20
Earnings before income taxes 2,193 2,177
Provision for income taxes 559 541
Equity investments and securities (income)/loss, net (13) (22)
Net earnings 1,647 1,658
Net earnings attributable to noncontrolling interests 91 68
Net earnings attributable to PMI $ 1,556 $ 1,590
Per share data:    
Basic earnings per share (in dollars per share) $ 1.00 $ 1.02
Diluted earnings per share (in dollars per share) 1.00 1.02
Dividends declared (in dollars per share) $ 1.07 $ 1.04
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Comprehensive Earnings - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Statement of Comprehensive Income [Abstract]    
Net earnings $ 1,647 $ 1,658
Change in currency translation adjustments:    
Unrealized gains (losses), net of income taxes of $192 in 2018 and $156 in 2017 (371) 303
Change in net loss and prior service cost:    
Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($11) in 2018 and ($9) in 2017 50 56
Change in fair value of derivatives accounted for as hedges:    
Gains (losses) recognized, net of income taxes of $10 in 2018 and $11 in 2017 (64) (75)
(Gains) losses transferred to earnings, net of income taxes of ($1) in 2018 and $2 in 2017 2 5
Total other comprehensive earnings (losses) (383) 289
Total comprehensive earnings 1,264 1,947
Less comprehensive earnings attributable to:    
Noncontrolling interests 56 63
Comprehensive earnings attributable to PMI $ 1,208 $ 1,884
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Statement of Comprehensive Income [Abstract]    
Income taxes on currency translation adjustments $ 192 $ 156
Income taxes on amortization of net losses, prior service costs and net transition costs (11) (9)
Income taxes on (loss)/gain recognized from fair value of derivatives accounted for as hedges 10 11
Income taxes on loss/(gain) transferred to earnings from fair value of derivatives accounted for as hedges $ (1) $ 2
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
$ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Earnings Reinvested in the Business [Member]
Accumulated Other Comprehensive Losses [Member]
Cost of Repurchased Stock [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2016 $ (10,900) $ 0 $ 1,964 $ 30,397 $ (9,559) $ (35,490) $ 1,788
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 1,658     1,590     68
Other comprehensive earnings (losses), net of income taxes 289       294   (5)
Issuance of stock awards 33   (71)     104  
Dividends declared ($1.04 and $1.07 per share for the three months ended March 31, 2017 and 2018, respectively) (1,620)     (1,620)      
Payments to noncontrolling interests (17)           (17)
Other 0   (1)       1
Ending balance at Mar. 31, 2017 (10,557) 0 1,892 30,367 (9,265) (35,386) 1,835
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of initial adoption of new accounting standards 238     238      
Beginning balance at Dec. 31, 2017 (10,230) 0 1,972 29,859 (8,535) (35,382) 1,856
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 1,647     1,556     91
Other comprehensive earnings (losses), net of income taxes (383)       (344)   (39)
Issuance of stock awards 45   (29)     74  
Dividends declared ($1.04 and $1.07 per share for the three months ended March 31, 2017 and 2018, respectively) (1,668)     (1,668)      
Payments to noncontrolling interests (36)           (36)
Other (95)   (87)   (4)   (4)
Ending balance at Mar. 31, 2018 $ (10,482) $ 0 $ 1,856 $ 29,985 $ (8,883) $ (35,308) $ 1,868
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) - $ / shares
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Statement of Stockholders' Equity [Abstract]    
Dividends declared (in dollars per share) $ 1.07 $ 1.04
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES    
Net earnings $ 1,647 $ 1,658
Adjustments to reconcile net earnings to operating cash flows:    
Depreciation and amortization 242 197
Deferred income tax provision 26 27
Cash effects of changes in:    
Receivables, net (113) 504
Inventories 338 1,243
Accounts payable (62) 84
Accrued liabilities and other current assets (509) (2,207)
Income taxes (315) (510)
Pension plan contributions (25) (18)
Other 151 (135)
Net cash provided by operating activities 1,380 843
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES    
Capital expenditures (365) (292)
Investments in unconsolidated subsidiaries and equity securities (18) (5)
Net investment hedges (665) (254)
Other 30 8
Net cash used in investing activities (1,018) (543)
Short-term borrowing activity by original maturity:    
Net issuances - maturities of 90 days or less 103 374
Long-term debt proceeds 0 2,482
Long-term debt repaid 0 (814)
Dividends paid (1,659) (1,618)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (91) 0
Other (91) (83)
Net cash provided by (used in) financing activities (1,738) 341
Effect of exchange rate changes on cash, cash equivalents and restricted cash 131 234
Cash, cash equivalents and restricted cash:    
Increase (Decrease) [1] (1,245) 875
Balance at beginning of period [1] 8,476 4,331
Balance at end of period [1] $ 7,231 $ 5,206
[1] Following the adoption of Financial Accounting Standards Update ASU 2016-18, "Statement of Cash Flows: Restricted Cash," the amounts for cash and cash equivalents shown above include restricted cash of $31 million and $130 million as of March 31, 2018 and 2017, respectively, and $29 million and $92 million as of December 31, 2017, and 2016, respectively, which were included in other current assets in the condensed consolidated balance sheets.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Mar. 31, 2017
Dec. 31, 2016
Statement of Cash Flows [Abstract]        
Restricted cash $ 31 $ 29 $ 130 $ 92
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Background and Basis of Presentation
 3 Months Ended
Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background and Basis of Presentation
Background and Basis of Presentation:

Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates and their licensees are engaged in the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products, in markets outside of the United States of America. Throughout these financial statements, the term "PMI" refers to Philip Morris International Inc. and its subsidiaries.

Reduced-risk products ("RRPs") is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.

To provide a greater focus on both parts of PMI's business -- combustible and reduced-risk products -- and to support PMI's transformation towards a smoke-free future, effective January 1, 2018, PMI began managing its business in six reportable segments as follows: European Union; Eastern Europe; Middle East & Africa; South & Southeast Asia; East Asia & Australia; and Latin America & Canada. For further details, see Note 7. Segment Reporting.

Certain prior years' amounts have been reclassified to conform with the current year's presentation, due primarily to new accounting guidance related to revenue recognition, pension costs and restricted cash and PMI’s decision to reorganize its reportable segments. For further details, see the condensed consolidated statements of cash flows, Note 3. Benefit Plans, Note 7. Segment Reporting and Note 18. New Accounting Standards. The changes did not have a material impact on PMI's consolidated financial position, results of operations or cash flows in any of the periods presented.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2017.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Plans
 3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Plans
Stock Plans:

In May 2017, PMI’s shareholders approved the Philip Morris International Inc. 2017 Performance Incentive Plan (the “2017 Plan”). The 2017 Plan replaced the 2012 Performance Incentive Plan, and there will be no additional grants under the replaced plan. Under the 2017 Plan, PMI may grant to eligible employees restricted shares and restricted share units, performance-based cash incentive awards and performance-based equity awards. Up to 25 million shares of PMI’s common stock may be issued under the 2017 Plan. At March 31, 2018, shares available for grant under the 2017 Plan were 22,939,200.

In May 2017, PMI’s shareholders also approved the Philip Morris International Inc. 2017 Stock Compensation Plan for Non-Employee Directors (the “2017 Non-Employee Directors Plan”). The 2017 Non-Employee Directors Plan replaced the 2008 Stock Compensation Plan for Non-Employee Directors, and there will be no additional grants under the replaced plan. A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the 2017 Non-Employee Directors Plan. At March 31, 2018, shares available for grant under the plan were 1,000,000.

Restricted share unit (RSU) awards

During the three months ended March 31, 2018 and 2017, shares granted to eligible employees, the weighted-average grant date
fair value per share and the recorded compensation expense related to RSU awards were as follows:
 
Number of Shares Granted
Weighted-Average Grant Date Fair Value Per RSU Award Granted
Compensation Expense Related to RSU Awards (in millions)
2018
1,249,650

$
100.70

$
38

2017
1,202,060

$
98.47

$
35

 
 
 

As of March 31, 2018, PMI had $196 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

During the three months ended March 31, 2018, 1,378,550 RSU awards vested. The grant date fair value of all the vested awards was approximately $114 million. The total fair value of RSU awards that vested during the three months ended March 31, 2018 was approximately $143 million.

Performance share unit (PSU) awards

During the three months ended March 31, 2018 and 2017, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a three-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group and on an absolute basis (50% weight), PMI’s currency-neutral compound annual adjusted operating income growth rate, excluding acquisitions (30% weight), and PMI’s performance against specific measures of PMI’s transformation (20% weight). The aggregate of the weighted performance factors for the three metrics determines the percentage of PSUs that will vest at the end of the three-year performance cycle. The minimum percentage of PSUs that can vest is zero, with a target percentage of 100 and a maximum percentage of 200. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned.

During the three months ended March 31, 2018 and 2017, shares granted to eligible employees, the grant date fair value per share
and the recorded compensation expense related to PSU awards were as follows:
 
Number of Shares Granted
PSU Grant Date Fair Value Subject to TSR Performance Factor Per Share (a)
PSU Grant Date Fair Value Subject to Other Performance Factors Per Share (b)
Compensation Expense Related to PSU Awards (in millions)
2018
401,500

$
118.98

$
100.69

$
21

2017
393,460

$
128.72

$
98.29

$
17


(a) The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.
(b) The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.
 
 
 

As of March 31, 2018, PMI had $57 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.

During the three months ended March 31, 2018, there were no PSU awards that vested.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Benefit Plans
 3 Months Ended
Mar. 31, 2018
Retirement Benefits [Abstract]  
Benefit Plans
Benefit Plans:

Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to substantially all U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans. PMI adopted ASU 2017-07 "Compensation - Retirement Benefits" on January 1, 2018, retrospectively for all periods. Following adoption, the service cost component of net periodic benefit cost continues to be included within operating income, while all other cost components are included below operating income, within pension and other employee benefit costs, including $19 million and $22 million related to net postemployment costs for the three months ended March 31, 2018 and 2017, respectively, and $3 million and $4 million related to net postretirement costs for the three months ended March 31, 2018 and 2017, respectively.

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:
 
 
Pension (1)
 
 
For the Three Months Ended March 31,
(in millions)
 
2018
 
2017
Service cost
 
$
53

 
$
51

Interest cost
 
28

 
26

Expected return on plan assets
 
(87
)
 
(79
)
Amortization:
 

 

Net loss
 
43

 
44

Prior service cost
 
—

 
3

Net periodic pension cost
 
$
37

 
$
45


(1) Primarily non-U.S. based defined benefit retirement plans.

Employer Contributions
PMI makes, and plans to make, contributions, to the extent that they are tax deductible and to meet specific funding requirements of its funded pension plans. Employer contributions of $25 million were made to the pension plans during the three months ended March 31, 2018. Currently, PMI anticipates making additional contributions during the remainder of 2018 of approximately $46 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net
 3 Months Ended
Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets, net
Goodwill and Other Intangible Assets, net:
Goodwill and other intangible assets, net, by segment were as follows:

 
Goodwill
 
Other Intangible Assets, net
(in millions)
March 31,
2018
December 31,
2017
 
March 31,
2018
December 31,
2017
European Union
$
1,474

$
1,419

 
$
439

$
458

Eastern Europe
334

321

 
22

16

Middle East & Africa
107

102

 
185

178

South & Southeast Asia
2,938

3,010

 
987

1,004

East Asia & Australia
561

567

 
59

44

Latin America & Canada
2,253

2,247

 
763

732

Total
$
7,667

$
7,666

 
$
2,455

$
2,432


Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from December 31, 2017, were as follows:
(in millions)
European Union
Eastern Europe
Middle East & Africa
South & Southeast Asia
East Asia & Australia
Latin America & Canada
Total
Balances, December 31, 2017
$
1,419

$
321

$
102

$
3,010

$
567

$
2,247

$
7,666

Changes due to:
 
 
 
 
 
 
 
Currency
55

13

5

(72
)
(6
)
6

1

Balances, March 31, 2018
$
1,474

$
334

$
107

$
2,938

$
561

$
2,253

$
7,667


Additional details of other intangible assets were as follows:
 
 
March 31, 2018
 
December 31, 2017
(in millions)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Non-amortizable intangible assets
 
$
1,341

 
 
 
$
1,323

 
 
Amortizable intangible assets
 
1,818

 
$
704

 
1,798

 
$
689

Total other intangible assets
 
$
3,159

 
$
704

 
$
3,121

 
$
689



Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2018, were as follows:


(dollars in millions)
Gross Carrying Amount
Initial Estimated
Useful Lives
    
Weighted-Average
Remaining Useful Life
Trademarks
$
1,555

2 - 40 years
    
19 years
Distribution networks
151

5 - 30 years
    
9 years
Other (including farmer contracts
  and intellectual property rights)
112

4 - 17 years
    
11 years
 
$
1,818

 
 
 


Pre-tax amortization expense for intangible assets during the three months ended March 31, 2018 and 2017 was $22 million and $22 million, respectively. Amortization expense for each of the next five years is estimated to be $84 million or less, assuming no additional transactions occur that require the amortization of intangible assets.
The increase in the gross carrying amount of other intangible assets from December 31, 2017, was due primarily to the purchase of additional intellectual property rights related to PMI's reduced-risk products, as well as currency movements.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
 3 Months Ended
Mar. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial Instruments
Financial Instruments:

Overview

PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings.

PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Canadian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Philippine peso, Russian ruble, Swiss franc and Turkish lira. At March 31, 2018, PMI had contracts with aggregate notional amounts of $33.4 billion of which $7.1 billion related to cash flow hedges, $11.3 billion related to hedges of net investments in foreign operations and $15.0 billion related to other derivatives that primarily offset currency exposures on intercompany financing.

Effective January 1, 2018, PMI elected to early adopt Accounting Standard Update 2017-12 “Derivatives and Hedging (Topic 815) Targeted Improvements to Accounting for Hedging Activities,” which did not have a material impact on PMI’s consolidated financial position or results of operations.

The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2018 and December 31, 2017, were as follows:

 
 
Derivative Assets
 
Derivative Liabilities
 
 

 
Fair Value
 

 
Fair Value
(in millions)
 
Balance Sheet Classification
 
At March 31, 2018
 
At December 31, 2017
 
Balance Sheet Classification
 
At March 31, 2018
 
At December 31, 2017
Foreign exchange contracts designated as hedging instruments
 
Other current assets
 
$
48

 
$
84

 
Other accrued liabilities
 
$
433

 
$
197

 
 
Other assets
 
6

 
34

 
Other liabilities
 
1,237

 
880

Foreign exchange contracts not designated as hedging instruments 
 
Other current assets 
 
60

 
22

 
Other accrued liabilities
 
20

 
37

 
 
Other assets
 
—

 
—

 
Other liabilities
 
67

 
14

Total derivatives
 
 
 
$
114

 
$
140

 
 
 
$
1,757

 
$
1,128



For the three months ended March 31, 2018 and 2017, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
 
 
 
 
 
 
 
 
 
 
(pre-tax, in millions)
For the Three Months Ended March 31,
 
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives
 
Statement of Earnings
Classification of Gain/(Loss)
Reclassified from Other
Comprehensive
Earnings/(Losses) into
Earnings
 
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
 
2018
 
2017
 
 
 
2018
 
2017
Derivatives in Cash Flow Hedging Relationship
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
(74
)
 
$
(86
)
 
 
 
 
 
 
 
 
 
 
 
Net revenues
 
$
(9
)
 
$
9

 
 
 
 
 
Cost of sales
 
—

 
—

 
 
 
 
 
Marketing, administration and research costs
 
8

 
(9
)
 
 
 
 
 
Interest expense, net
 
(2
)
 
(3
)
Derivatives in Net Investment Hedging Relationship
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
(608
)
 
(249
)
 
 
 
 
 
 
Total
$
(682
)
 
$
(335
)
 
 
 
$
(3
)
 
$
(3
)


Cash Flow Hedges

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to certain forecasted transactions. Gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. As of March 31, 2018, PMI has hedged forecasted transactions for periods not exceeding the next fifteen months with the exception of one foreign exchange contract that expires in May 2024. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.

Hedges of Net Investments in Foreign Operations

PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges, primarily of its Euro net assets. For the three months ended March 31, 2018 and 2017, these hedges of net investments resulted in losses, net of income taxes, of $757 million and $294 million, respectively, principally related to changes in the exchange rates between the Euro and U.S. dollar. These losses were reported as a component of accumulated other comprehensive losses within currency translation adjustments, and were substantially offset by the gains generated on the underlying assets. For the three months ended March 31, 2018, the gains for amounts excluded from the effectiveness testing recognized in earnings based on the changes in fair value were $67 million and were accounted for in interest expense, net, on the condensed consolidated statement of earnings. The premiums paid for, and settlements of, net investment hedges are included in investing cash flows on PMI’s condensed consolidated statements of cash flows.

Other Derivatives

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in marketing, administration and research costs in PMI’s condensed consolidated statements of earnings. For the three months ended March 31, 2018 and 2017, the gains (losses) from contracts for which PMI did not apply hedge accounting were $95 million and $(39) million, respectively. The gains (losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.

For the three months ended March 31, 2018 and 2017, the net impact of these contracts on the condensed consolidated statements of earnings was not material.
 
 
 
 
 
 
 

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses

Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Gain as of January 1,
$
42

$
97

Derivative (gains)/losses transferred to earnings
2

5

Change in fair value
(64
)
(75
)
Gain/(loss) as of March 31,
$
(20
)
$
27


At March 31, 2018, PMI expects $30 million of derivative losses that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These losses are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.
Contingent Features
PMI’s derivative instruments do not contain contingent features.
Credit Exposure and Credit Risk
PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limit and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.
Fair Value
See Note 11. Fair Value Measurements and Note 13. Balance Sheet Offsetting for additional discussion of derivative financial instruments.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share:
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net earnings attributable to PMI
$
1,556

$
1,590

Less distributed and undistributed earnings attributable to share-based payment awards
3

3

Net earnings for basic and diluted EPS
$
1,553

$
1,587

Weighted-average shares for basic EPS
1,553

1,552

Plus contingently issuable performance stock units (PSUs)
1

1

Weighted-average shares for diluted EPS
1,554

1,553


Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.
For the 2018 and 2017 computations, there were no antidilutive stock awards.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Reporting
 3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting:

PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes and other nicotine-containing products, including RRPs, in markets outside of the United States of America. Reportable segments for PMI are organized by geographic region and managed by segment managers who are responsible for the operating and financial results of the regions inclusive of all product categories sold in the region. Effective January 1, 2018, PMI began managing its business in six reportable segments. PMI’s reportable segments are the European Union; Eastern Europe; Middle East & Africa; South & Southeast Asia; East Asia & Australia; and Latin America & Canada. PMI records net revenues and operating income to its segments based upon the geographic area in which the customer resides.

PMI’s chief operating decision maker evaluates segment performance and allocates resources based on regional operating income, which includes results from all product categories sold in each region. Effective January 1, 2018, PMI began using operating income to evaluate business segment performance and allocate resources, replacing operating companies income used previously.

On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, "Revenue from Contracts with Customers." PMI adopted this standard retrospectively to each prior period presented. For further details on this standard and its impact on PMI, see Note 18. New Accounting Standards. The amounts presented for the reportable segments reflect this adoption.
 
PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's six reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors.

Segment data were as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net revenues:
 
 
European Union
$
1,988

$
1,740

Eastern Europe
567

516

Middle East & Africa
961

961

South & Southeast Asia
1,081

1,031

East Asia & Australia
1,591

1,210

Latin America & Canada
708

606

Net revenues
$
6,896

$
6,064

Operating income:
 
 
European Union
$
740

$
748

Eastern Europe
151

159

Middle East & Africa
374

491

South & Southeast Asia
429

370

East Asia & Australia
515

472

Latin America & Canada
217

176

Operating income
$
2,426

$
2,416


PMI's net revenues by product category were as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net revenues:
 
 
Combustible products:
 
 
European Union
$
1,836

$
1,709

Eastern Europe
527

513

Middle East & Africa
884

957

South & Southeast Asia
1,081

1,031

East Asia & Australia
737

813

Latin America & Canada
704

605

Total combustible products
$
5,769

$
5,629

Reduced-risk products:
 
 
European Union
$
152

$
31

Eastern Europe
40

3

Middle East & Africa
77

4

South & Southeast Asia
—

—

East Asia & Australia
854

396

Latin America & Canada
4

—

Total reduced-risk products
$
1,127

$
435

 
 
 
Total PMI net revenues
$
6,896

$
6,064


Note: Sum of product categories or Regions might not foot to total PMI due to roundings.

Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's cigarettes and other tobacco products combined. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include reduced-risk products.

Net revenues related to reduced-risk products refer to the operating revenues generated from the sale of these products, including shipping and handling charges billed to customers, net of sales and promotion incentives, and excise taxes. These net revenue amounts consist of the sale of PMI's heated tobacco units, IQOS devices and related accessories, and other nicotine-containing products, which primarily include our e-vapor products.

PMI recognizes revenue, when control is transferred to the customer, typically either upon shipment or delivery of goods.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies
 3 Months Ended
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Contingencies
Contingencies:
Tobacco-Related Litigation
Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.
It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.
Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.
We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.
It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    
To date, no tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.
The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 24, 2018, April 25, 2017 and April 22, 2016:
 
Type of Case
 
Number of Cases Pending as of April 24, 2018
 
Number of Cases Pending as of April 25, 2017
 
Number of Cases Pending as of April 22, 2016
Individual Smoking and Health Cases
 
62
 
63
 
66
Smoking and Health Class Actions
 
11
 
11
 
11
Health Care Cost Recovery Actions
 
16
 
16
 
16
Label-Related Class Actions
 
1
 
—
 
—
Individual Label-Related Cases
 
1
 
1
 
3
Public Civil Actions
 
2
 
2
 
3

Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 476 Smoking and Health, Label-Related, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Thirteen cases have had decisions in favor of plaintiffs. Nine of these cases have subsequently reached final resolution in our favor and four remain on appeal.

The table below lists the verdict and significant post-trial developments in the four pending cases where a verdict was returned in favor of the plaintiff:

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
February 2004
  
Brazil/The Smoker Health Defense Association
  
Class Action
  
The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.
  
Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
May 27, 2015
  
Canada/Cecilia Létourneau
  
Class Action
  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
  
In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
May 27, 2015
  
Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais

  
Class Action
  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion, into a trust within 60 days.
  
In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
August 5, 2016
 
Argentina/Hugo Lespada
 
Individual Action
 
On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages.
The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
 
On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires.


Pending claims related to tobacco products generally fall within the following categories:
Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.
As of April 24, 2018, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:

•
62 cases brought by individual plaintiffs in Argentina (34), Brazil (10), Canada (4), Chile (6), Costa Rica (1), Italy (3), the Philippines (1), Russia (1), Turkey (1) and Scotland (1), compared with 63 such cases on April 25, 2017, and 66 cases on April 22, 2016; and
•
11 cases brought on behalf of classes of individual plaintiffs in Brazil (2) and Canada (9), compared with 11 such cases on April 25, 2017 and 11 such cases on April 22, 2016.

In the first class action pending in Brazil, The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In February 2017, the Chief Justice of the Supreme Court of Justice denied plaintiff's appeal. In March 2017, plaintiff filed an en banc appeal to the Supreme Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. Both appeals are still pending.

In the second class action pending in Brazil, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil, filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities, and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the ADESF case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the ADESF case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.

In the first class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005.  Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million), in the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.4 million) beginning in December 2015 through March 2017. See the Blais description for further detail concerning the security order. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than three years after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the second class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion, including pre-judgment interest (approximately $12.1 billion). The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion, including pre-judgment interest (approximately $2.4 billion)). In addition, the trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at 99,957 members. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award into a trust within 60 days, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD 5 billion (approximately $3.91 billion) into trust, to secure the judgments in both the Létourneau and Blais cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. Such security may take the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $29.4 million) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $593 million) in seven equal consecutive quarterly installments of approximately CAD 108 million (approximately $84.6 million) beginning in December 2015 through June 2017. In March 2017, our subsidiary made its sixth and final quarterly installment of security for approximately CAD 37.6 million (approximately $29.4 million) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.
In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of Adams, below).
In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.
In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).
In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).
In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.
As of April 24, 2018, there were 16 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (10), Korea (1) and Nigeria (5), compared with 16 such cases on April 25, 2017 and 16 such cases on April 22, 2016.
In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.
In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing. In June 2017, the trial court set a trial date for November 4, 2019.
In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Pre-trial discovery is ongoing.
In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. While discovery initially was scheduled to begin in 2017 by agreement of the parties, to date, the discovery process has not started.
In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. While discovery initially was scheduled to begin in 2017 by agreement of the parties, to date, the discovery process has not started.

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Pre-trial discovery is ongoing.
In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.
In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.
In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.
In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately $53.7 million allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.

Label-Related Cases: These cases, brought by individual plaintiffs, or on behalf of a class or purported class of individual plaintiffs, allege that the use of the descriptor “Lights” or other alleged misrepresentations or omissions of labeling information constitute fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of April 24, 2018, there was 1 case brought by an individual plaintiff in Italy (1) pending against our subsidiaries, compared with 1 such cases on April 25, 2017, and 3 such cases on April 22, 2016, and one purported class action in Israel (1).

An individual plaintiff filed the purported class action, Aharon Ringer v. Philip Morris Ltd. and Globrands Ltd., on July 18, 2017, in the Central District Court of Israel. Our Israeli affiliate and an Israeli importer and distributor for other multinational tobacco companies are defendants. Plaintiff seeks to represent a class of smokers in Israel who have purchased cigarettes imported by defendants since July 18, 2010. Plaintiff estimates the class size to be 7,000,000 smokers. Plaintiff alleges that defendants misled consumers by not disclosing sufficient information about carbon monoxide, tar, and nicotine yields of, and tobacco contained in, the imported cigarettes. Plaintiff seeks various forms of relief, including an order for defendants to label cigarette packs in accordance with plaintiff’s demands, and damages for misleading consumers, breach of autonomy and unjust enrichment.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of April 24, 2018, there were 2 public civil actions pending against our subsidiaries in Argentina (1) and Venezuela (1), compared with 2 such cases on April 25, 2017, and 3 such cases on April 22, 2016.

In the public civil action in Argentina, Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina, filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.

In the public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB 80.8 billion (approximately $2.57 billion). In May 2017, the King of Thailand signed a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies. Trial in the case began in November 2017. In March 2018, acting on a request from the Public Prosecutor, the court suspended the trial proceedings indefinitely and struck the case from the court list. The case may be reactivated by the court or upon application of a party.

The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $629 million). The case is in pre-trial proceedings. The trial is scheduled to begin in the last quarter of 2018. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court. In May 2017, the King of Thailand signed a new customs act. The new act, which took effect in November 2017, substantially limits the amount of fines that Thailand could seek in these proceedings. On November 29, 2017, PM Thailand received notices of assessment in the aggregate amount of approximately THB 25.6 billion (approximately $813 million) from the Thai Customs Department alleging that PM Thailand under-declared customs values for the imports from Indonesia covering the period 2001-2003. The notices include the Indonesian import entries subject to the proceedings discussed above and are in addition to the fine sought by the government in the criminal proceedings. PM Thailand filed its appeal against the notices in December 2017. We believe that all of the notices of assessment are barred by the applicable statutes of limitations and are otherwise without merit. In March 2018, the Thai Customs Post Clearance Audit Bureau informed PM Thailand that the Thai Customs Department will cancel or otherwise not pursue the notices. PM Thailand is considering whether further procedural steps are required to confirm the finality of this development.   

The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean affiliate, were in compliance with South Korean tax laws.  In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.  In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $254 million), of which KRW 100 billion (approximately $93 million) was paid in 2016 and KRW 172 billion (approximately $160 million) was paid in the first quarter of 2017.  These amounts are included in other assets in the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows.  PM Korea is appealing the assessments. The tax authorities have also referred the matter to the Public Prosecutor, who will further investigate and decide whether to file criminal charges against PM Korea and/or other alleged co-offenders. If the Public Prosecutor decides to prosecute, it may seek up to three times the underpaid tax for company criminal penalties and up to five times the underpaid tax for individual criminal penalties. PM Korea believes that it has paid cigarette-related taxes in compliance with the South Korean tax laws. In addition, the South Korean Ministry of Strategy and Finance (“MOSF”) filed a criminal complaint with the Public Prosecutor against PM Korea and its managing director. In its criminal complaint, the MOSF alleged that PM Korea exceeded the monthly product withdrawal limits that the MOSF had set in its notice. The Public Prosecutor will investigate the MOSF’s criminal complaint and decide whether to prosecute.  PM Korea disagrees with the MOSF’s allegations.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes
 3 Months Ended
Mar. 31, 2018
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes:
Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

In December 2017, the Tax Cuts and Jobs Act was signed into law. Accordingly, PMI recorded a provisional charge of $1.6 billion in its 2017 income tax provision, including a charge for the transition tax on accumulated foreign earnings of $1.4 billion and $0.2 billion due to the re-measurement of U.S. deferred tax assets and liabilities using a rate of 21%. PMI is evaluating the assumptions used in the analysis, as well as guidance issued by the U.S. Treasury Department and the Internal Revenue Service and has not made any measurement period adjustments related to these items during the quarter. PMI will complete its analysis during 2018, and any adjustments to the provisional charges will be included in income tax expense or benefit in the appropriate period, in accordance with Staff Accounting Bulletin No. 118 (SAB 118).

PMI’s effective tax rates for the three months ended March 31, 2018 and 2017 were 25.5% and 24.9%, respectively. The effective tax rate for the three months ended March 31, 2017 was favorably impacted by the tax benefit of a legal entity restructuring ($61 million). In 2018, PMI's effective tax rate is expected to exceed the new U.S. federal statutory rate of 21%. PMI’s higher effective tax rate for the three months ended March 31, 2018 was primarily due to earnings mix by taxing jurisdiction, as well as the expected impact of Global Intangible Low Taxed Income ("GILTI") provisions of the Tax Cuts and Jobs Act, partially offset by the favorable tax treatment of Foreign Derived Intangible Income ("FDII").

Based upon PMI's current interpretation of the Tax Cuts and Jobs Act, PMI estimates that its full-year 2018 effective tax rate will be approximately 26%, subject to future regulatory developments. PMI is continuing to assess the impacts of the Tax Cuts and Jobs Act on the effective tax rate and income tax accounting, in particular the foreign tax credit limitations related to the new GILTI provisions. PMI will complete this assessment during 2018 and will make an accounting policy election on whether to treat GILTI taxes as a current period expense or include these amounts in the measurement of deferred taxes. Based on PMI’s assessment to date, no impact is expected from the Base Erosion and Anti-Abuse Tax ("BEAT") rules. Changes in currency exchange rates or earnings mix by taxing jurisdiction also have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2013 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.

It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Indebtedness
 3 Months Ended
Mar. 31, 2018
Debt Disclosure [Abstract]  
Indebtedness
Indebtedness:
Short-term Borrowings:
PMI's short-term borrowings, consisting of bank loans to certain PMI subsidiaries at March 31, 2018 and December 31, 2017, had a carrying value of $608 million and $499 million, respectively. The fair value of PMI’s short-term borrowings, based on current market interest rates, approximates carrying value.

Long-term Debt:
At March 31, 2018 and December 31, 2017, PMI’s long-term debt consisted of the following:

(in millions)
 
March 31, 2018
 
December 31, 2017
U.S. dollar notes, 1.375% to 6.375% (average interest rate 3.566%), due through 2044
 
$
23,294

 
$
23,291

Foreign currency obligations:
 
 
 
 
Euro notes, 0.625% to 3.125% (average interest rate 2.250%), due through 2037
 
9,348

 
8,997

Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024
 
1,418

 
1,376

Other (average interest rate 3.378%), due through 2024
 
180

 
176

 
 
34,240

 
33,840

Less current portion of long-term debt
 
4,662

 
2,506

 
 
$
29,578

 
$
31,334



Other foreign currency debt above includes mortgage debt in Switzerland and capital lease obligations at March 31, 2018 and December 31, 2017.
 
 
 
 
 
 
 
 
 

Credit Facilities:

On January 29, 2018, PMI entered into an agreement to extend the term of its $2.0 billion 364-day revolving credit facility from February 6, 2018, to February 5, 2019.

At March 31, 2018, PMI's total committed credit facilities were as follows:

(in billions)


Type
 
Committed
Credit
Facilities
364-day revolving credit, expiring February 5, 2019
 
$
2.0

Multi-year revolving credit, expiring February 28, 2021
 
2.5

Multi-year revolving credit, expiring October 1, 2022
 
3.5

Total facilities
 
$
8.0



At March 31, 2018, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements:
The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:
Level 1 -
Quoted prices in active markets for identical assets or liabilities;
Level 2 -
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 -
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period.

Equity Securities

The fair value of PMI’s equity securities, which are determined by using quoted prices in active markets, have been classified within Level 1.

Derivative Financial Instruments

PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 5. Financial Instruments for additional discussion of derivative financial instruments.

Debt

The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and $27 million of capital lease obligations, was $34,213 million at March 31, 2018. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, was classified within Level 1 and Level 2 in the table shown below.
 
The aggregate fair values of PMI’s equity securities, derivative financial instruments and debt as of March 31, 2018, were as follows:
 
(in millions)
 
Fair Value at March 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets/Liabilities
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Equity securities
 
$
272

 
$
272

 
$
—

 
$
—

Foreign exchange contracts
 
114

 
—

 
114

 
—

Total assets
 
$
386

 
$
272

 
$
114

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
Debt
 
$
35,464

 
$
35,293

 
$
171

 
$
—

Foreign exchange contracts
 
1,757

 
—

 
1,757

 
—

Total liabilities
 
$
37,221

 
$
35,293

 
$
1,928

 
$
—
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accumulated Other Comprehensive Losses
 3 Months Ended
Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Losses
Accumulated Other Comprehensive Losses:
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:
 
(in millions)
 
At March 31, 2018
 
At December 31, 2017
 
At March 31, 2017
Currency translation adjustments
 
$
(6,097
)
 
$
(5,761
)
 
$
(5,783
)
Pension and other benefits
 
(2,766
)
 
(2,816
)
 
(3,509
)
Derivatives accounted for as hedges
 
(20
)
 
42

 
27

Total accumulated other comprehensive losses
 
$
(8,883
)
 
$
(8,535
)
 
$
(9,265
)


Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the three months ended March 31, 2018 and 2017. For additional information, see Note 3. Benefit Plans and Note 5. Financial Instruments for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Balance Sheet Offsetting
 3 Months Ended
Mar. 31, 2018
Offsetting [Abstract]  
Balance Sheet Offsetting
Balance Sheet Offsetting:

Derivative Financial Instruments

PMI uses foreign exchange contracts and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the condensed consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. See Note 5. Financial Instruments for disclosures related to PMI's derivative financial instruments.

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:
 
(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet
 
 
Financial Instruments
Cash Collateral Received/Pledged
Net Amount
 
 
 
 
 
 
 
 
 
 
At March 31, 2018
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
114

$
—

$
114

$
(25
)
$
(68
)
$
21

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,757

$
—

$
1,757

$
(25
)
$
(1,719
)
$
13

 
At December 31, 2017
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
140

$
—

$
140

$
(50
)
$
(78
)
$
12

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,128

$
—

$
1,128

$
(50
)
$
(1,004
)
$
74
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in Unconsolidated Subsidiaries
 3 Months Ended
Mar. 31, 2018
Equity Method Investments and Joint Ventures [Abstract]  
Investments in Unconsolidated Subsidiaries
Investments in Unconsolidated Subsidiaries:

At March 31, 2018 and December 31, 2017, PMI had total investments in unconsolidated subsidiaries of $1,098 million and $1,074 million, respectively, which were accounted for under the equity method of accounting. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses, dividends, capital contributions and movements in currency translation adjustments. The carrying value of our equity method investments at March 31, 2018 and December 31, 2017 exceeded our share of the unconsolidated subsidiaries' book value by $932 million and $927 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets, excluding $879 million and $873 million attributable to goodwill as of March 31, 2018 and December 31, 2017, respectively, is being amortized on a straight-line basis over the underlying assets' estimated useful lives of 10 to 20 years. At March 31, 2018 and December 31, 2017, PMI received year-to-date dividends from unconsolidated subsidiaries of $10 million and $120 million, respectively.

PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Management et Développement des Actifs et des Ressources Holding (MADAR Holding), formerly known as Société Nationale des Tabacs et Allumettes SpA. STAEM manufactures and distributes under license some of PMI’s brands.

PMI holds a 23% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis, PMI's distributor in Russia.

The initial investments in EITA and Megapolis Distribution BV were recorded at cost and are included in investments in unconsolidated subsidiaries and equity securities on the condensed consolidated balance sheets.

PMI’s earnings activity from unconsolidated subsidiaries was as follows:
 
For the Three Months Ended March 31,
(in millions)
2018
2017
Net revenues
$
923

$
840


PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:
(in millions)
 
At March 31, 2018
At December 31, 2017
 
 
 
 
Receivables
 
$
471

$
293


   
The activity primarily related to agreements with PMI’s unconsolidated subsidiaries within the Eastern Europe segment and the Middle East & Africa segment. These agreements, which are in the ordinary course of business, are primarily for distribution, contract manufacturing and licenses. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Sale of Accounts Receivable
 3 Months Ended
Mar. 31, 2018
Sale of Accounts Receivable [Abstract]  
Sale of Accounts Receivable
Sale of Accounts Receivable:
To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2018 and March 31, 2017. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold, including excise taxes, for the three months ended March 31, 2018 and 2017, were $2,509 million and $2,092 million, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2018 and March 31, 2017, were $878 million, and $561 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the three months ended March 31, 2018 and 2017, the loss on sale of trade receivables was immaterial.
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Product Warranty
 3 Months Ended
Mar. 31, 2018
Guarantees and Product Warranties [Abstract]  
Product Warranty
Product Warranty:

PMI's IQOS devices are subject to standard product warranties generally for a period of 12 months from the date of purchase or such other periods as required by law. PMI generally provides in cost of sales for the estimated cost of warranty in the period the related revenue is recognized. PMI assesses the adequacy of its accrued product warranties and adjusts the amounts as necessary based on actual experience and changes in future estimates. Factors that affect product warranties may vary across markets but typically include product failure rates, logistics and service delivery costs, and warranty policies. PMI accounts for its product warranties within other accrued liabilities. At March 31, 2018 and December 31, 2017, these amounts were as follows:
 
For the Three Months Ended
For the Year Ended
(in millions)
March 31, 2018
December 31, 2017
Balance at beginning of period
$
71

$
51

Changes due to:
 
 
   Warranties issued
76

168

    Settlements
(54
)
(148
)
    Currency
1

—

Balance at end of period
$
94

$
71
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions
 3 Months Ended
Mar. 31, 2018
Business Combinations [Abstract]  
Acquisitions
Acquisitions:

On March 21, 2018, PMI acquired the remaining 49% interest in Tabacalera Costarricense, S.A. and Mendiola y Compañía, S.A. for a net purchase price of $95 million, which includes $2 million of contingent consideration. As a result, PMI now owns 100% of these Costa Rican affiliates. The purchase of the remaining 49% interest resulted in a decrease to PMI’s additional paid-in capital of $86 million.
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
New Accounting Standards
 3 Months Ended
Mar. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
New Accounting Standards
New Accounting Standards:

Recently adopted

On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for these goods or services. PMI adopted ASU 2014-09 retrospectively to each prior period presented. PMI elected this transition method solely to reflect the change in excise tax presentation in all prior periods presented resulting from PMI’s accounting policy election to exclude excise taxes collected from customers from the measurement of the transaction price, thereby presenting revenues, net of excise taxes. Based on PMI’s assessment, the underlying principles of the new standard, relating to the measurement of revenue and the timing of recognition, are closely aligned with PMI’s current business model and practices. As a result, the adoption of ASU 2014-09 did not have a material impact on the consolidated financial position or results of operations.

The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the three months ended March 31, 2017:

(in millions)
For the Three Months Ended March 31, 2017

Net Revenues:
 
 
 
 
 
As reported
 
Retrospective Adoption
 
   Net revenues
      Excises taxes
 
Net revenues
 
$
16,556

$
10,492

 
$
6,064



The change in presentation of net revenues also impacts segment disclosure requirements, primarily information for significant customers and geographic areas. While there is no change in the underlying business or customers, the amounts used to calculate what is disclosed are different following the change in presentation of revenues net of excise taxes and the associated segment revenues. Prior to this change, revenues including excise taxes were the basis for determining if sales to a customer or in a foreign country met the thresholds for disclosure. On the basis of revenues including excise taxes and due to the fact that PMI is not responsible for collecting excise taxes in certain markets, no customers met the requirements for disclosure. On this basis, net revenues attributable to customers located in PMI’s largest markets in terms of net revenues, namely Indonesia ($8.0 billion and $7.7 billion in 2017 and 2016, respectively) and Germany ($7.2 billion and $7.1 billion in 2017 and 2016, respectively) were included as part of segment disclosures.

Following the change in presentation and using net revenues excluding excise taxes as the basis for determining the disclosures, PMI had one customer in the East Asia & Australia segment (16% and 11% of PMI’s consolidated net revenues in 2017 and 2016, respectively) and one customer in the European Union segment (10% and 11% of PMI’s consolidated net revenues in 2017 and 2016, respectively) that meet the requirements for disclosure. Additionally, on this basis, the only foreign countries meeting the disclosure requirements are PMI’s markets in Japan ($4.7 billion and $2.8 billion in 2017 and 2016, respectively) and Indonesia ($3.2 billion and $3.2 billion in 2017 and 2016, respectively).

PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's six reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. For further details, see Note 7. Segment Reporting.

PMI recognizes revenue primarily through the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products. The majority of PMI revenues are generated by sales through direct and indirect distribution networks with short-term payment conditions and where control is typically transferred to the customer either upon shipment or delivery of goods. PMI evaluates the transfer of control through evidence of the customer’s receipt and acceptance, transfer of title, PMI’s right to payment for those products and the customer’s ability to direct the use of those products upon receipt. Typically, PMI’s performance obligations are satisfied and revenue is recognized either upon shipment or delivery of goods. In certain instances, PMI facilitates shipping and handling activities after control has transferred to the customer.  PMI has elected to record all shipping and handling activities as costs to fulfill a contract and such costs, which have not been incurred at the time revenue is recognized, are accrued.  For the three months ended March 31, 2018 and 2017, PMI did not have any material contract assets or contract liabilities. For further details on PMI’s performance obligations see Note 16. Product Warranty.

On January 1, 2018, PMI adopted Financial Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”), on a prospective basis. ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changed certain disclosure requirements and other aspects of current U.S. GAAP. PMI identified certain cost investments, which are applicable to ASU 2016-01 requiring them to be measured at fair value with the changes in fair value recognized in net income. At January 1, 2018, the cumulative effect of this change resulted in an increase to investments in unconsolidated subsidiaries and equity securities, deferred income tax liability and earnings reinvested in the business of $301 million, $63 million and $238 million, respectively.

Recently issued

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI has identified its lease management system to be used upon adoption and is in the process of identifying and evaluating the applicable leases. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
New Accounting Standards (Policies)
 3 Months Ended
Mar. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
New Accounting Standards
New Accounting Standards:

Recently adopted

On January 1, 2018, PMI adopted Financial Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for these goods or services. PMI adopted ASU 2014-09 retrospectively to each prior period presented. PMI elected this transition method solely to reflect the change in excise tax presentation in all prior periods presented resulting from PMI’s accounting policy election to exclude excise taxes collected from customers from the measurement of the transaction price, thereby presenting revenues, net of excise taxes. Based on PMI’s assessment, the underlying principles of the new standard, relating to the measurement of revenue and the timing of recognition, are closely aligned with PMI’s current business model and practices. As a result, the adoption of ASU 2014-09 did not have a material impact on the consolidated financial position or results of operations.

The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the three months ended March 31, 2017:

(in millions)
For the Three Months Ended March 31, 2017

Net Revenues:
 
 
 
 
 
As reported
 
Retrospective Adoption
 
   Net revenues
      Excises taxes
 
Net revenues
 
$
16,556

$
10,492

 
$
6,064



The change in presentation of net revenues also impacts segment disclosure requirements, primarily information for significant customers and geographic areas. While there is no change in the underlying business or customers, the amounts used to calculate what is disclosed are different following the change in presentation of revenues net of excise taxes and the associated segment revenues. Prior to this change, revenues including excise taxes were the basis for determining if sales to a customer or in a foreign country met the thresholds for disclosure. On the basis of revenues including excise taxes and due to the fact that PMI is not responsible for collecting excise taxes in certain markets, no customers met the requirements for disclosure. On this basis, net revenues attributable to customers located in PMI’s largest markets in terms of net revenues, namely Indonesia ($8.0 billion and $7.7 billion in 2017 and 2016, respectively) and Germany ($7.2 billion and $7.1 billion in 2017 and 2016, respectively) were included as part of segment disclosures.

Following the change in presentation and using net revenues excluding excise taxes as the basis for determining the disclosures, PMI had one customer in the East Asia & Australia segment (16% and 11% of PMI’s consolidated net revenues in 2017 and 2016, respectively) and one customer in the European Union segment (10% and 11% of PMI’s consolidated net revenues in 2017 and 2016, respectively) that meet the requirements for disclosure. Additionally, on this basis, the only foreign countries meeting the disclosure requirements are PMI’s markets in Japan ($4.7 billion and $2.8 billion in 2017 and 2016, respectively) and Indonesia ($3.2 billion and $3.2 billion in 2017 and 2016, respectively).

PMI disaggregates its net revenue from contracts with customers by both geographic location and product category for each of PMI's six reportable segments, as PMI believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. For further details, see Note 7. Segment Reporting.

PMI recognizes revenue primarily through the manufacture and sale of cigarettes and other nicotine-containing products, including reduced-risk products. The majority of PMI revenues are generated by sales through direct and indirect distribution networks with short-term payment conditions and where control is typically transferred to the customer either upon shipment or delivery of goods. PMI evaluates the transfer of control through evidence of the customer’s receipt and acceptance, transfer of title, PMI’s right to payment for those products and the customer’s ability to direct the use of those products upon receipt. Typically, PMI’s performance obligations are satisfied and revenue is recognized either upon shipment or delivery of goods. In certain instances, PMI facilitates shipping and handling activities after control has transferred to the customer.  PMI has elected to record all shipping and handling activities as costs to fulfill a contract and such costs, which have not been incurred at the time revenue is recognized, are accrued.  For the three months ended March 31, 2018 and 2017, PMI did not have any material contract assets or contract liabilities. For further details on PMI’s performance obligations see Note 16. Product Warranty.

On January 1, 2018, PMI adopted Financial Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”), on a prospective basis. ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changed certain disclosure requirements and other aspects of current U.S. GAAP. PMI identified certain cost investments, which are applicable to ASU 2016-01 requiring them to be measured at fair value with the changes in fair value recognized in net income. At January 1, 2018, the cumulative effect of this change resulted in an increase to investments in unconsolidated subsidiaries and equity securities, deferred income tax liability and earnings reinvested in the business of $301 million, $63 million and $238 million, respectively.

Recently issued

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI has identified its lease management system to be used upon adoption and is in the process of identifying and evaluating the applicable leases. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Plans (Tables)
 3 Months Ended
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of weighted average grant date fair value and compensation expense related to share-based awards
During the three months ended March 31, 2018 and 2017, shares granted to eligible employees, the weighted-average grant date
fair value per share and the recorded compensation expense related to RSU awards were as follows:
 
Number of Shares Granted
Weighted-Average Grant Date Fair Value Per RSU Award Granted
Compensation Expense Related to RSU Awards (in millions)
2018
1,249,650

$
100.70

$
38

2017
1,202,060

$
98.47

$
35

 
 
 
During the three months ended March 31, 2018 and 2017, shares granted to eligible employees, the grant date fair value per share
and the recorded compensation expense related to PSU awards were as follows:
 
Number of Shares Granted
PSU Grant Date Fair Value Subject to TSR Performance Factor Per Share (a)
PSU Grant Date Fair Value Subject to Other Performance Factors Per Share (b)
Compensation Expense Related to PSU Awards (in millions)
2018
401,500

$
118.98

$
100.69

$
21

2017
393,460

$
128.72

$
98.29

$
17


(a) The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.
(b) The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.
 
 
 
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Benefit Plans (Tables)
 3 Months Ended
Mar. 31, 2018
Retirement Benefits [Abstract]  
Components of Net Periodic Benefit Cost
Net periodic pension cost consisted of the following:
 
 
Pension (1)
 
 
For the Three Months Ended March 31,
(in millions)
 
2018
 
2017
Service cost
 
$
53

 
$
51

Interest cost
 
28

 
26

Expected return on plan assets
 
(87
)
 
(79
)
Amortization:
 

 

Net loss
 
43

 
44

Prior service cost
 
—

 
3

Net periodic pension cost
 
$
37

 
$
45


(1) Primarily non-U.S. based defined benefit retirement plans.
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net (Tables)
 3 Months Ended
Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill and Intangible Assets, Net, by Segment or Major Class
Goodwill and other intangible assets, net, by segment were as follows:

 
Goodwill
 
Other Intangible Assets, net
(in millions)
March 31,
2018
December 31,
2017
 
March 31,
2018
December 31,
2017
European Union
$
1,474

$
1,419

 
$
439

$
458

Eastern Europe
334

321

 
22

16

Middle East & Africa
107

102

 
185

178

South & Southeast Asia
2,938

3,010

 
987

1,004

East Asia & Australia
561

567

 
59

44

Latin America & Canada
2,253

2,247

 
763

732

Total
$
7,667

$
7,666

 
$
2,455

$
2,432

Additional details of other intangible assets were as follows:
 
 
March 31, 2018
 
December 31, 2017
(in millions)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Non-amortizable intangible assets
 
$
1,341

 
 
 
$
1,323

 
 
Amortizable intangible assets
 
1,818

 
$
704

 
1,798

 
$
689

Total other intangible assets
 
$
3,159

 
$
704

 
$
3,121

 
$
689
Movements in Goodwill
The movements in goodwill from December 31, 2017, were as follows:
(in millions)
European Union
Eastern Europe
Middle East & Africa
South & Southeast Asia
East Asia & Australia
Latin America & Canada
Total
Balances, December 31, 2017
$
1,419

$
321

$
102

$
3,010

$
567

$
2,247

$
7,666

Changes due to:
 
 
 
 
 
 
 
Currency
55

13

5

(72
)
(6
)
6

1

Balances, March 31, 2018
$
1,474

$
334

$
107

$
2,938

$
561

$
2,253

$
7,667
Gross Carrying Amount, Range of Useful Lives and Weighted-Average Remaining Useful Life of Amortizable Intangible Assets
The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2018, were as follows:


(dollars in millions)
Gross Carrying Amount
Initial Estimated
Useful Lives
    
Weighted-Average
Remaining Useful Life
Trademarks
$
1,555

2 - 40 years
    
19 years
Distribution networks
151

5 - 30 years
    
9 years
Other (including farmer contracts
  and intellectual property rights)
112

4 - 17 years
    
11 years
 
$
1,818

 
 
 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Value of Foreign Exchange Contracts
The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2018 and December 31, 2017, were as follows:

 
 
Derivative Assets
 
Derivative Liabilities
 
 

 
Fair Value
 

 
Fair Value
(in millions)
 
Balance Sheet Classification
 
At March 31, 2018
 
At December 31, 2017
 
Balance Sheet Classification
 
At March 31, 2018
 
At December 31, 2017
Foreign exchange contracts designated as hedging instruments
 
Other current assets
 
$
48

 
$
84

 
Other accrued liabilities
 
$
433

 
$
197

 
 
Other assets
 
6

 
34

 
Other liabilities
 
1,237

 
880

Foreign exchange contracts not designated as hedging instruments 
 
Other current assets 
 
60

 
22

 
Other accrued liabilities
 
20

 
37

 
 
Other assets
 
—

 
—

 
Other liabilities
 
67

 
14

Total derivatives
 
 
 
$
114

 
$
140

 
 
 
$
1,757

 
$
1,128
Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings
For the three months ended March 31, 2018 and 2017, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:
 
 
 
 
 
 
 
 
 
 
(pre-tax, in millions)
For the Three Months Ended March 31,
 
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives
 
Statement of Earnings
Classification of Gain/(Loss)
Reclassified from Other
Comprehensive
Earnings/(Losses) into
Earnings
 
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
 
2018
 
2017
 
 
 
2018
 
2017
Derivatives in Cash Flow Hedging Relationship
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
(74
)
 
$
(86
)
 
 
 
 
 
 
 
 
 
 
 
Net revenues
 
$
(9
)
 
$
9

 
 
 
 
 
Cost of sales
 
—

 
—

 
 
 
 
 
Marketing, administration and research costs
 
8

 
(9
)
 
 
 
 
 
Interest expense, net
 
(2
)
 
(3
)
Derivatives in Net Investment Hedging Relationship
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
(608
)
 
(249
)
 
 
 
 
 
 
Total
$
(682
)
 
$
(335
)
 
 
 
$
(3
)
 
$
(3
)
Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses), Net of Income Taxes
Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Gain as of January 1,
$
42

$
97

Derivative (gains)/losses transferred to earnings
2

5

Change in fair value
(64
)
(75
)
Gain/(loss) as of March 31,
$
(20
)
$
27
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2018
Earnings Per Share [Abstract]  
Calculation of Basic and Diluted EPS
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net earnings attributable to PMI
$
1,556

$
1,590

Less distributed and undistributed earnings attributable to share-based payment awards
3

3

Net earnings for basic and diluted EPS
$
1,553

$
1,587

Weighted-average shares for basic EPS
1,553

1,552

Plus contingently issuable performance stock units (PSUs)
1

1

Weighted-average shares for diluted EPS
1,554

1,553
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Reporting (Tables)
 3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Segment Data
Segment data were as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net revenues:
 
 
European Union
$
1,988

$
1,740

Eastern Europe
567

516

Middle East & Africa
961

961

South & Southeast Asia
1,081

1,031

East Asia & Australia
1,591

1,210

Latin America & Canada
708

606

Net revenues
$
6,896

$
6,064

Operating income:
 
 
European Union
$
740

$
748

Eastern Europe
151

159

Middle East & Africa
374

491

South & Southeast Asia
429

370

East Asia & Australia
515

472

Latin America & Canada
217

176

Operating income
$
2,426

$
2,416


PMI's net revenues by product category were as follows:
(in millions)
For the Three Months Ended March 31,
 
2018
2017
Net revenues:
 
 
Combustible products:
 
 
European Union
$
1,836

$
1,709

Eastern Europe
527

513

Middle East & Africa
884

957

South & Southeast Asia
1,081

1,031

East Asia & Australia
737

813

Latin America & Canada
704

605

Total combustible products
$
5,769

$
5,629

Reduced-risk products:
 
 
European Union
$
152

$
31

Eastern Europe
40

3

Middle East & Africa
77

4

South & Southeast Asia
—

—

East Asia & Australia
854

396

Latin America & Canada
4

—

Total reduced-risk products
$
1,127

$
435

 
 
 
Total PMI net revenues
$
6,896

$
6,064
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Tables)
 3 Months Ended
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Tobacco Related Cases Pending Against Company
The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 24, 2018, April 25, 2017 and April 22, 2016:
 
Type of Case
 
Number of Cases Pending as of April 24, 2018
 
Number of Cases Pending as of April 25, 2017
 
Number of Cases Pending as of April 22, 2016
Individual Smoking and Health Cases
 
62
 
63
 
66
Smoking and Health Class Actions
 
11
 
11
 
11
Health Care Cost Recovery Actions
 
16
 
16
 
16
Label-Related Class Actions
 
1
 
—
 
—
Individual Label-Related Cases
 
1
 
1
 
3
Public Civil Actions
 
2
 
2
 
3
Schedule Of Verdicts And Post Trial Developments Where a Verdict was Returned In Favor of the Plaintiff(s)
The table below lists the verdict and significant post-trial developments in the four pending cases where a verdict was returned in favor of the plaintiff:

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
February 2004
  
Brazil/The Smoker Health Defense Association
  
Class Action
  
The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.
  
Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
May 27, 2015
  
Canada/Cecilia Létourneau
  
Class Action
  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
  
In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
May 27, 2015
  
Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais

  
Class Action
  
On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion, into a trust within 60 days.
  
In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date
  
Location of
Court/Name of
Plaintiff
  
Type of
Case
  
Verdict
  
Post-Trial
Developments
August 5, 2016
 
Argentina/Hugo Lespada
 
Individual Action
 
On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages.
The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
 
On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires.
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Indebtedness (Tables)
 3 Months Ended
Mar. 31, 2018
Debt Disclosure [Abstract]  
Long-Term Debt
At March 31, 2018 and December 31, 2017, PMI’s long-term debt consisted of the following:

(in millions)
 
March 31, 2018
 
December 31, 2017
U.S. dollar notes, 1.375% to 6.375% (average interest rate 3.566%), due through 2044
 
$
23,294

 
$
23,291

Foreign currency obligations:
 
 
 
 
Euro notes, 0.625% to 3.125% (average interest rate 2.250%), due through 2037
 
9,348

 
8,997

Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024
 
1,418

 
1,376

Other (average interest rate 3.378%), due through 2024
 
180

 
176

 
 
34,240

 
33,840

Less current portion of long-term debt
 
4,662

 
2,506

 
 
$
29,578

 
$
31,334
Schedule of Committed Credit Facilities
At March 31, 2018, PMI's total committed credit facilities were as follows:

(in billions)


Type
 
Committed
Credit
Facilities
364-day revolving credit, expiring February 5, 2019
 
$
2.0

Multi-year revolving credit, expiring February 28, 2021
 
2.5

Multi-year revolving credit, expiring October 1, 2022
 
3.5

Total facilities
 
$
8.0
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Aggregate Fair Values of Equity Securities, Derivative Financial Instruments and Debt
The aggregate fair values of PMI’s equity securities, derivative financial instruments and debt as of March 31, 2018, were as follows:
 
(in millions)
 
Fair Value at March 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets/Liabilities
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
 
Equity securities
 
$
272

 
$
272

 
$
—

 
$
—

Foreign exchange contracts
 
114

 
—

 
114

 
—

Total assets
 
$
386

 
$
272

 
$
114

 
$
—

Liabilities:
 
 
 
 
 
 
 
 
Debt
 
$
35,464

 
$
35,293

 
$
171

 
$
—

Foreign exchange contracts
 
1,757

 
—

 
1,757

 
—

Total liabilities
 
$
37,221

 
$
35,293

 
$
1,928

 
$
—
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accumulated Other Comprehensive Losses (Tables)
 3 Months Ended
Mar. 31, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Components of Accumulated Other Comprehensive Earnings (Losses), Net of Taxes
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:
 
(in millions)
 
At March 31, 2018
 
At December 31, 2017
 
At March 31, 2017
Currency translation adjustments
 
$
(6,097
)
 
$
(5,761
)
 
$
(5,783
)
Pension and other benefits
 
(2,766
)
 
(2,816
)
 
(3,509
)
Derivatives accounted for as hedges
 
(20
)
 
42

 
27

Total accumulated other comprehensive losses
 
$
(8,883
)
 
$
(8,535
)
 
$
(9,265
)
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Balance Sheet Offsetting (Tables)
 3 Months Ended
Mar. 31, 2018
Offsetting [Abstract]  
Offsetting Assets
The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:
 
(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet
 
 
Financial Instruments
Cash Collateral Received/Pledged
Net Amount
 
 
 
 
 
 
 
 
 
 
At March 31, 2018
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
114

$
—

$
114

$
(25
)
$
(68
)
$
21

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,757

$
—

$
1,757

$
(25
)
$
(1,719
)
$
13

 
At December 31, 2017
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
140

$
—

$
140

$
(50
)
$
(78
)
$
12

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,128

$
—

$
1,128

$
(50
)
$
(1,004
)
$
74
Offsetting Liabilities
The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:
 
(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet
 
 
Financial Instruments
Cash Collateral Received/Pledged
Net Amount
 
 
 
 
 
 
 
 
 
 
At March 31, 2018
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
114

$
—

$
114

$
(25
)
$
(68
)
$
21

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,757

$
—

$
1,757

$
(25
)
$
(1,719
)
$
13

 
At December 31, 2017
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Foreign exchange contracts
$
140

$
—

$
140

$
(50
)
$
(78
)
$
12

 
Liabilities
 
 
 
 
 
 
 
Foreign exchange contracts
$
1,128

$
—

$
1,128

$
(50
)
$
(1,004
)
$
74
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in Unconsolidated Subsidiaries (Tables)
 3 Months Ended
Mar. 31, 2018
Equity Method Investments and Joint Ventures [Abstract]  
Earnings and Balance Sheet Activities with Unconsolidated Subsidiaries
PMI’s earnings activity from unconsolidated subsidiaries was as follows:
 
For the Three Months Ended March 31,
(in millions)
2018
2017
Net revenues
$
923

$
840


PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:
(in millions)
 
At March 31, 2018
At December 31, 2017
 
 
 
 
Receivables
 
$
471

$
293
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Product Warranty (Tables)
 3 Months Ended
Mar. 31, 2018
Guarantees and Product Warranties [Abstract]  
Schedule of Accrued Product Warranties
At March 31, 2018 and December 31, 2017, these amounts were as follows:
 
For the Three Months Ended
For the Year Ended
(in millions)
March 31, 2018
December 31, 2017
Balance at beginning of period
$
71

$
51

Changes due to:
 
 
   Warranties issued
76

168

    Settlements
(54
)
(148
)
    Currency
1

—

Balance at end of period
$
94

$
71
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1
New Accounting Standards (Tables)
 3 Months Ended
Mar. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The adoption of ASU 2014-09 resulted in the following change for net revenues to reflect the net presentation for revenues, excluding excise taxes, for the three months ended March 31, 2017:

(in millions)
For the Three Months Ended March 31, 2017

Net Revenues:
 
 
 
 
 
As reported
 
Retrospective Adoption
 
   Net revenues
      Excises taxes
 
Net revenues
 
$
16,556

$
10,492

 
$
6,064
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Background and Basis of Presentation (Details)
 3 Months Ended
Mar. 31, 2018
segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of reportable segments 6
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Plans (Narrative) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2018
USD ($)
performance_metric
year
shares
May 31, 2017
shares
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized compensation cost related to non-vested stock awards | $ $ 196  
Award requisite service period 3 years  
Minimum Retirement Age | year 58  
Stock awards vested during period (in shares) 1,378,550  
Restricted Stock Units (RSUs) [Member] | Grant Date Fair Value [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Fair value of vested stock awards | $ $ 114  
Restricted Stock Units (RSUs) [Member] | Total Fair Value [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Fair value of vested stock awards | $ 143  
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unrecognized compensation cost related to non-vested stock awards | $ $ 57  
Minimum Retirement Age | year 58  
Stock awards vested during period (in shares) 0  
Performance period 3 years  
Number of performance metrics used to determine the percentage of PSU's that will vest | performance_metric 3  
Aggregate weighted performance factor that determines if the target number of PSUs will vest 100.00%  
The number of shares of common stock issue for each vested PSU 1  
Performance Shares [Member] | Performance Metric, Total Shareholder Return [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Performance metric weight 50.00%  
Performance Shares [Member] | Performance Metric, Currency-Neutral Compound Annual Adjusted Operating Income Growth Rate, Excluding Acquisitions [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Performance metric weight 30.00%  
Performance Shares [Member] | Performance Metric, Performance Against Specific Measures Of Transformation [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Performance metric weight 20.00%  
Performance Shares [Member] | Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting percentage 0.00%  
Performance Shares [Member] | Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting percentage 200.00%  
2017 Performance Incentive Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)   25,000,000
Shares available for grant under the plan (in shares) 22,939,200  
Non Employee Directors Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)   1,000,000
Shares available for grant under the plan (in shares) 1,000,000  
Percentage of voting shares that PMI may own, used in determining non-employee director status   50.00%
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Plans (RSU Awards) (Details) - Restricted Stock Units (RSUs) [Member] - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Shares Granted (in shares) 1,249,650 1,202,060
Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) $ 100.70 $ 98.47
Compensation expense for stock awards $ 38 $ 35
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Plans (PSU Awards) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Shares Granted (in shares) 401,500 393,460
Compensation expense for stock awards $ 21 $ 17
Performance Share Units, TSR Relative To Customer Peer Group [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) $ 118.98 $ 128.72
Performance Share Units, Other Performance Factors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) $ 100.69 $ 98.29
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.8.0.1
Benefit Plans (Components of Net Periodic Benefit Cost) (Details) - Pension Plan [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 53 $ 51
Interest cost 28 26
Expected return on plan assets (87) (79)
Amortization:    
Net loss 43 44
Prior service cost 0 3
Net periodic pension cost $ 37 $ 45
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.8.0.1
Benefit Plans (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Postemployment benefit plans other cost components $ 6 $ 20
Employer contributions 25  
Anticipated additional employer contributions during the remainder of the current fiscal year 46  
Postemployment Benefit Plans [Member]    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Postemployment benefit plans other cost components 19 22
Postretirement Benefit Costs [Member]    
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]    
Postemployment benefit plans other cost components $ 3 $ 4
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill $ 7,667 $ 7,666
Other Intangible Assets, net 2,455 2,432
European Union [Member]    
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill 1,474 1,419
Other Intangible Assets, net 439 458
Eastern Europe [Member]    
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill 334 321
Other Intangible Assets, net 22 16
Middle East And Africa [Member]    
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill 107 102
Other Intangible Assets, net 185 178
South And Southeast Asia [Member]    
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill 2,938 3,010
Other Intangible Assets, net 987 1,004
East Asia and Australia [Member]    
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill 561 567
Other Intangible Assets, net 59 44
Latin America & Canada [Member]    
Goodwill and Other Intangible Assets, net [Line Items]    
Goodwill 2,253 2,247
Other Intangible Assets, net $ 763 $ 732
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2018
USD ($)
Goodwill [Roll Forward]  
Balances, December 31, 2017 $ 7,666
Changes due to:  
Currency 1
Balances, March 31, 2018 7,667
European Union [Member]  
Goodwill [Roll Forward]  
Balances, December 31, 2017 1,419
Changes due to:  
Currency 55
Balances, March 31, 2018 1,474
Eastern Europe [Member]  
Goodwill [Roll Forward]  
Balances, December 31, 2017 321
Changes due to:  
Currency 13
Balances, March 31, 2018 334
Middle East And Africa [Member]  
Goodwill [Roll Forward]  
Balances, December 31, 2017 102
Changes due to:  
Currency 5
Balances, March 31, 2018 107
South And Southeast Asia [Member]  
Goodwill [Roll Forward]  
Balances, December 31, 2017 3,010
Changes due to:  
Currency (72)
Balances, March 31, 2018 2,938
East Asia and Australia [Member]  
Goodwill [Roll Forward]  
Balances, December 31, 2017 567
Changes due to:  
Currency (6)
Balances, March 31, 2018 561
Latin America & Canada [Member]  
Goodwill [Roll Forward]  
Balances, December 31, 2017 2,247
Changes due to:  
Currency 6
Balances, March 31, 2018 $ 2,253
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Non-amortizable intangible assets, gross carrying amount $ 1,341 $ 1,323
Amortizable intangible assets, gross carrying amount 1,818 1,798
Total other intangible assets, gross carrying amount 3,159 3,121
Accumulated Amortization $ 704 $ 689
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,818 $ 1,798
Trademarks [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,555  
Weighted-Average Remaining Useful Life 19 years  
Trademarks [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Initial Estimated Useful Lives 2 years  
Trademarks [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Initial Estimated Useful Lives 40 years  
Distribution Networks [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 151  
Weighted-Average Remaining Useful Life 9 years  
Distribution Networks [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Initial Estimated Useful Lives 5 years  
Distribution Networks [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Initial Estimated Useful Lives 30 years  
Other (Including Farmer Contracts and Intellectual Property Rights) [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 112  
Weighted-Average Remaining Useful Life 11 years  
Other (Including Farmer Contracts and Intellectual Property Rights) [Member] | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Initial Estimated Useful Lives 4 years  
Other (Including Farmer Contracts and Intellectual Property Rights) [Member] | Maximum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Initial Estimated Useful Lives 17 years  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, net (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]    
Intangible assets, pre-tax amortization expense $ 22 $ 22
Estimated amortization expense, year one, assuming no additional transactions occur that require the amortization of intangible assets 84  
Estimated amortization expense, year two, assuming no additional transactions occur that require the amortization of intangible assets 84  
Estimated amortization expense, year three, assuming no additional transactions occur that require the amortization of intangible assets 84  
Estimated amortization expense, year four, assuming no additional transactions occur that require the amortization of intangible assets 84  
Estimated amortization expense, year five, assuming no additional transactions occur that require the amortization of intangible assets $ 84  
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Derivative [Line Items]    
Maturity of foreign currency derivatives - cash flow hedges May 31, 2024  
Unrealized loss on hedges of net investments $ 371 $ (303)
Gain on amounts excluded from effectiveness testing 67  
Foreign Exchange Contract [Member]    
Derivative [Line Items]    
Notional amount 33,400  
Derivative instruments, losses to be reclassified to earnings $ (30)  
Foreign Exchange Contract [Member] | Maximum [Member]    
Derivative [Line Items]    
Maximum length of time hedged in a cash flow hedge 15 months  
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Notional amount $ 15,000  
Gain (loss) on derivatives not designated as hedging instruments 95 (39)
Net impact on earnings 0 0
Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]    
Derivative [Line Items]    
Notional amount 7,100  
Foreign Exchange Contract [Member] | Net Investment Hedging [Member]    
Derivative [Line Items]    
Notional amount 11,300  
Unrealized loss on hedges of net investments $ 757 $ 294
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Derivatives, Fair Value [Line Items]    
Derivative asset fair value $ 114 $ 140
Derivative liability fair value 1,757 1,128
Designated as Hedging Instrument [Member] | Other Current Assets [Member]    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 48 84
Designated as Hedging Instrument [Member] | Other Assets [Member]    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 6 34
Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 433 197
Designated as Hedging Instrument [Member] | Other Liabilities [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 1,237 880
Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 60 22
Not Designated as Hedging Instrument [Member] | Other Assets [Member]    
Derivatives, Fair Value [Line Items]    
Derivative asset fair value 0 0
Not Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value 20 37
Not Designated as Hedging Instrument [Member] | Other Liabilities [Member]    
Derivatives, Fair Value [Line Items]    
Derivative liability fair value $ 67 $ 14
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives $ (682) $ (335)
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (3) (3)
Cash Flow Hedges [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives (74) (86)
Cash Flow Hedges [Member] | Net Revenue [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (9) 9
Cash Flow Hedges [Member] | Cost of Sales [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 0 0
Cash Flow Hedges [Member] | Marketing Administration And Research Costs [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 8 (9)
Cash Flow Hedges [Member] | Interest Expense, Net [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (2) (3)
Net Investment Hedges [Member]    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives $ (608) $ (249)
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]    
Derivative (gains)/losses transferred to earnings $ 3 $ 3
Change in fair value (682) (335)
Other Comprehensive Income (Loss) [Member]    
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]    
Gain as of January 1, 42 97
Derivative (gains)/losses transferred to earnings 2 5
Change in fair value (64) (75)
Gain/(loss) as of March 31, $ (20) $ 27
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Earnings Per Share [Abstract]    
Net earnings attributable to PMI $ 1,556 $ 1,590
Less distributed and undistributed earnings attributable to share-based payment awards 3 3
Net earnings for basic and diluted EPS $ 1,553 $ 1,587
Weighted-average shares for basic EPS (in shares) 1,553,000,000 1,552,000,000
Plus contingently issuable performance stock units (PSUs) (in shares) 1,000,000 1,000,000
Weighted-average shares for diluted EPS (in shares) 1,554,000,000 1,553,000,000
Antidilutive stock awards (in shares) 0 0
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Reporting (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2018
USD ($)
segment
Mar. 31, 2017
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 6  
Total PMI net revenues $ 6,896 $ 6,064
Operating income 2,426 2,416
Combustible Products [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 5,769 5,629
Reduced-Risk Products [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 1,127 435
Operating Segments [Member] | European Union [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 1,988 1,740
Operating income 740 748
Operating Segments [Member] | Eastern Europe [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 567 516
Operating income 151 159
Operating Segments [Member] | Middle East And Africa [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 961 961
Operating income 374 491
Operating Segments [Member] | South And Southeast Asia [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 1,081 1,031
Operating income 429 370
Operating Segments [Member] | East Asia and Australia [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 1,591 1,210
Operating income 515 472
Operating Segments [Member] | Latin America & Canada [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 708 606
Operating income 217 176
Operating Segments [Member] | Combustible Products [Member] | European Union [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 1,836 1,709
Operating Segments [Member] | Combustible Products [Member] | Eastern Europe [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 527 513
Operating Segments [Member] | Combustible Products [Member] | Middle East And Africa [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 884 957
Operating Segments [Member] | Combustible Products [Member] | South And Southeast Asia [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 1,081 1,031
Operating Segments [Member] | Combustible Products [Member] | East Asia and Australia [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 737 813
Operating Segments [Member] | Combustible Products [Member] | Latin America & Canada [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 704 605
Operating Segments [Member] | Reduced-Risk Products [Member] | European Union [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 152 31
Operating Segments [Member] | Reduced-Risk Products [Member] | Eastern Europe [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 40 3
Operating Segments [Member] | Reduced-Risk Products [Member] | Middle East And Africa [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 77 4
Operating Segments [Member] | Reduced-Risk Products [Member] | South And Southeast Asia [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 0 0
Operating Segments [Member] | Reduced-Risk Products [Member] | East Asia and Australia [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues 854 396
Operating Segments [Member] | Reduced-Risk Products [Member] | Latin America & Canada [Member]    
Segment Reporting Information [Line Items]    
Total PMI net revenues $ 4 $ 0
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) - litigation_case
Apr. 24, 2018
Apr. 25, 2017
Apr. 22, 2016
Individual Smoking And Health Cases [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM   63 66
Smoking And Health Class Actions [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM   11 11
Health Care Cost Recovery Actions [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM   16 16
Label Related Class Action [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM   0 0
Individual Label Related Cases [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM   1 3
Public Civil Actions [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM   2 3
Subsequent Event [Member] | Individual Smoking And Health Cases [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 62    
Subsequent Event [Member] | Smoking And Health Class Actions [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 11    
Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 16    
Subsequent Event [Member] | Label Related Class Action [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 1    
Subsequent Event [Member] | Individual Label Related Cases [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 1    
Subsequent Event [Member] | Public Civil Actions [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 2    
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Tobacco-Related Litigation) (Details)
Mar. 31, 2018
litigation_case
Loss Contingencies [Line Items]  
Number of cases decided in favor of PM 476
Number of cases decided in favor of plaintiff 13
Cases Remaining On Appeal [Member]  
Loss Contingencies [Line Items]  
Number of cases decided in favor of plaintiff 4
Case Decided In Favor Of Plaintiff [Member]  
Loss Contingencies [Line Items]  
Number of cases that reached final resolution in favor of PM 9
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Verdicts and Post-Trial Developments) (Details)
 1 Months Ended 3 Months Ended
Aug. 05, 2016
ARS ($)
Aug. 05, 2016
USD ($)
May 27, 2015
CAD ($)
May 27, 2015
USD ($)
Oct. 30, 2015
CAD ($)
Oct. 30, 2015
USD ($)
Jul. 31, 2015
Apr. 30, 2004
BRL (R$)
Apr. 30, 2004
USD ($)
Mar. 31, 2018
Brazil [Member] | Smoking And Health Class Actions [Member] | The Smoker Health Defense Association (ADESF) [Member]                    
Loss Contingencies [Line Items]                    
Smoking and health loss contingency interest rate (percentage per month)               1.00% 1.00%  
Brazil [Member] | Smoking And Health Class Actions [Member] | Award per smoker per year [Member] | The Smoker Health Defense Association (ADESF) [Member]                    
Loss Contingencies [Line Items]                    
Damages awarded               R$ 1,000 $ 293  
Brazil [Member] | Smoking And Health Class Actions [Member] | Cases With Verdicts And Post Trial Developments [Member] | The Smoker Health Defense Association (ADESF) [Member]                    
Loss Contingencies [Line Items]                    
Date                   February 2004
Verdict                   The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $293) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.
Post-Trial Developments                   Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.
Canada [Member] | Smoking And Health Class Actions [Member] | Cases With Verdicts And Post Trial Developments [Member] | Cecilia Letourneau [Member]                    
Loss Contingencies [Line Items]                    
Date                   May 27, 2015
Verdict                   On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $103 million) in punitive damages, allocating CAD 46 million (approximately $36 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
Post-Trial Developments                   In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $177 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)
Canada [Member] | Smoking And Health Class Actions [Member] | Cases With Verdicts And Post Trial Developments [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]                    
Loss Contingencies [Line Items]                    
Date                   May 27, 2015
Verdict                   On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $12.1 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.4 billion)). The trial court awarded CAD 90,000 (approximately $70,500) in punitive damages, allocating CAD 30,000 (approximately $23,500) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $783 million) of the compensatory damage award, CAD 200 million (approximately $157 million) of which is our subsidiary’s portion, into a trust within 60 days.
Post-Trial Developments                   In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $177 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)
Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]                    
Loss Contingencies [Line Items]                    
Punitive damages awarded     $ 131,000,000 $ 103,000,000            
Payment period for awarded punitive damages to be deposited into trust     60 days 60 days            
Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]                    
Loss Contingencies [Line Items]                    
Punitive damages awarded     $ 46,000,000 $ 36,000,000            
Payment period for awarded punitive damages to be deposited into trust     60 days 60 days            
Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]                    
Loss Contingencies [Line Items]                    
Payment period for awarded punitive damages to be deposited into trust             60 days      
Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]                    
Loss Contingencies [Line Items]                    
Punitive damages awarded     $ 90,000 $ 70,500            
Compensatory damages awarded     15,500,000,000 12,100,000,000            
Awarded compensatory damages that are to be deposited into trust     $ 1,000,000,000 $ 783,000,000            
Payment period for compensatory damages to be deposited into trust     60 days 60 days            
Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]                    
Loss Contingencies [Line Items]                    
Punitive damages awarded     $ 30,000 $ 23,500            
Compensatory damages awarded     $ 3,100,000,000 $ 2,400,000,000            
Damages allocated to subsidiary (percent)     20.00% 20.00%            
Awarded compensatory damages that are to be deposited into trust     $ 200,000,000 $ 157,000,000            
Payment period for compensatory damages to be deposited into trust     60 days 60 days            
Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]                    
Loss Contingencies [Line Items]                    
Payment period for awarded punitive damages to be deposited into trust             60 days      
Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]                    
Loss Contingencies [Line Items]                    
Amount of security ordered to be furnished         $ 226,000,000 $ 177,000,000        
Argentina [Member] | Individual Action [Member] | Cases With Verdicts And Post Trial Developments [Member] | Hugo Lespada [Member]                    
Loss Contingencies [Line Items]                    
Date                   August 5, 2016
Verdict                   On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $5,446), plus interest, in compensatory and moral damages. The trial court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
Post-Trial Developments                   On August 23, 2016, our subsidiary filed its notice of appeal. On October 31, 2017, the Civil and Commercial Court of Appeals of Mar del Plata ruled that plaintiff's claim was barred by the statute of limitations and it reversed the trial court's decision. On November 28, 2017, plaintiff filed an extraordinary appeal of the reversal of the trial court's decision to the Supreme Court of the Province of Buenos Aires.
Argentina [Member] | Individual Action [Member] | Hugo Lespada [Member] | Judicial Ruling [Member]                    
Loss Contingencies [Line Items]                    
Compensatory damages awarded $ 110,000 $ 5,446                
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Smoking And Health Litigation) (Details)
 1 Months Ended
May 27, 2015
CAD ($)
manufacturer
plaintiff
May 27, 2015
USD ($)
manufacturer
plaintiff
Jun. 20, 2012
cigarette
Jul. 10, 2009
cigarette
Mar. 31, 2017
CAD ($)
Mar. 31, 2017
USD ($)
Oct. 30, 2015
CAD ($)
installment
Oct. 30, 2015
USD ($)
installment
Aug. 31, 2015
CAD ($)
Aug. 31, 2015
USD ($)
Jul. 31, 2015
Jun. 30, 2015
Apr. 30, 2004
BRL (R$)
Apr. 30, 2004
USD ($)
Apr. 24, 2018
litigation_case
Apr. 25, 2017
litigation_case
Apr. 22, 2016
litigation_case
Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                               63 66
Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                               11 11
Brazil [Member] | The Smoker Health Defense Association (ADESF) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Smoking and health loss contingency interest rate                         1.00% 1.00%      
Brazil [Member] | The Smoker Health Defense Association (ADESF) [Member] | Award per smoker per year [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Damages awarded                         R$ 1,000 $ 293      
Canada [Member] | Cecilia Letourneau [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Number of additional manufacturers found liable | manufacturer 2 2                              
Estimated number of members in class | plaintiff 918,000 918,000                              
Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Punitive damages awarded $ 131,000,000 $ 103,000,000                              
Payment period for awarded punitive damages to be deposited into trust 60 days 60 days                              
Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Punitive damages awarded $ 46,000,000 $ 36,000,000                              
Payment period for awarded punitive damages to be deposited into trust 60 days 60 days                              
Canada [Member] | Cecilia Letourneau [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Payment period for awarded punitive damages to be deposited into trust                     60 days            
Canada [Member] | Cecilia Letourneau [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Payment period for awarded punitive damages to be deposited into trust                       60 days          
Period between addiction warning and claim 3 years 3 years                              
Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Number of additional manufacturers found liable | manufacturer 2 2                              
Estimated number of members in class | plaintiff 99,957 99,957                              
Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Punitive damages awarded $ 90,000 $ 70,500                              
Compensatory damages awarded 15,500,000,000 12,100,000,000                              
Awarded compensatory damages that are to be deposited into trust $ 1,000,000,000 $ 783,000,000                              
Payment period for compensatory damages to be deposited into trust 60 days 60 days                              
Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Punitive damages awarded $ 30,000 $ 23,500                              
Compensatory damages awarded $ 3,100,000,000 $ 2,400,000,000                              
Damages allocated to subsidiary (percent) 20.00% 20.00%                              
Awarded compensatory damages that are to be deposited into trust $ 200,000,000 $ 157,000,000                              
Payment period for compensatory damages to be deposited into trust 60 days 60 days                              
Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Payment period for awarded punitive damages to be deposited into trust                     60 days            
Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Payment period for compensatory damages to be deposited into trust                       60 days          
Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Number of consecutive quarterly installment | installment             6 6                  
Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Imperial Tobacco Ltd. [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Number of consecutive quarterly installment | installment             7 7                  
Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Amount of security ordered to be furnished             $ 226,000,000 $ 177,000,000                  
Amount of security to be furnished in each consecutive quarterly installment             37,600,000 29,400,000                  
Amount of security furnished by defendants in quarterly installment         $ 37,600,000 $ 29,400,000                      
Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Imperial Tobacco Ltd. [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Amount of security ordered to be furnished             758,000,000 593,000,000                  
Amount of security to be furnished in each consecutive quarterly installment             $ 108,000,000 $ 84,600,000                  
Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Under Advisement [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Motion to secure judgment, Letters of credit to be placed into trust, option 1                 $ 5,000,000,000 $ 3,910,000,000              
Canada [Member] | Adams [Member] | Pending Litigation [Member]                                  
Loss Contingencies [Line Items]                                  
Plaintiff requirement, Minimum number of cigarettes smoked | cigarette       25,000                          
Canada [Member] | Suzanne Jacklin [Member] | Pending Litigation [Member]                                  
Loss Contingencies [Line Items]                                  
Plaintiff requirement, Minimum number of cigarettes smoked | cigarette     25,000                            
Subsequent Event [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             62    
Subsequent Event [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             11    
Subsequent Event [Member] | Argentina [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             34    
Subsequent Event [Member] | Brazil [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             10    
Subsequent Event [Member] | Brazil [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             2    
Subsequent Event [Member] | Canada [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             4    
Subsequent Event [Member] | Canada [Member] | Smoking And Health Class Actions [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             9    
Subsequent Event [Member] | Chile [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             6    
Subsequent Event [Member] | Costa Rica [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             1    
Subsequent Event [Member] | Italy [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             3    
Subsequent Event [Member] | Philippines [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             1    
Subsequent Event [Member] | Russia [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             1    
Subsequent Event [Member] | Turkey [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             1    
Subsequent Event [Member] | Scotland [Member] | Individual Smoking And Health Cases [Member]                                  
Loss Contingencies [Line Items]                                  
Cases brought against PM                             1    
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Health Care Cost Recovery Litigation) (Details) - Health Care Cost Recovery Actions [Member]
$ in Millions
Apr. 14, 2014
USD ($)
patient
Oct. 17, 2008
Mar. 13, 2008
Feb. 26, 2008
May 25, 2007
May 09, 2007
Apr. 24, 2018
litigation_case
Apr. 25, 2017
litigation_case
Apr. 22, 2016
litigation_case
Loss Contingencies [Line Items]                  
Cases brought against PM               16 16
Korea [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, number of patients | patient 3,484                
Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Lagos State [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, period of past reimbursements     20 years            
Damages sought, period of future reimbursements     20 years            
Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Kano State [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, period of past reimbursements           20 years      
Damages sought, period of future reimbursements           20 years      
Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Gombe State [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, period of past reimbursements   20 years              
Damages sought, period of future reimbursements   20 years              
Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Oyo State [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, period of past reimbursements         20 years        
Damages sought, period of future reimbursements         20 years        
Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Ogun State [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, period of past reimbursements       20 years          
Damages sought, period of future reimbursements       20 years          
Subsequent Event [Member]                  
Loss Contingencies [Line Items]                  
Cases brought against PM             16    
Subsequent Event [Member] | Canada [Member]                  
Loss Contingencies [Line Items]                  
Cases brought against PM             10    
Subsequent Event [Member] | Korea [Member]                  
Loss Contingencies [Line Items]                  
Cases brought against PM             1    
Subsequent Event [Member] | Nigeria [Member]                  
Loss Contingencies [Line Items]                  
Cases brought against PM             5    
Subsidiary And Other Korean Manufacturers [Member] | Korea [Member]                  
Loss Contingencies [Line Items]                  
Damages sought, value | $ $ 53.7                
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Label-Related Cases) (Details)
plaintiff in Millions
Jul. 18, 2017
plaintiff
Apr. 24, 2018
litigation_case
Apr. 25, 2017
litigation_case
Apr. 22, 2016
litigation_case
Individual Label Related Cases [Member]        
Loss Contingencies [Line Items]        
Cases brought against PM     1 3
Individual Label Related Cases [Member] | Subsequent Event [Member]        
Loss Contingencies [Line Items]        
Cases brought against PM   1    
Individual Label Related Cases [Member] | Subsequent Event [Member] | Italy [Member]        
Loss Contingencies [Line Items]        
Cases brought against PM   1    
Purported Label Related Class Action [Member] | Subsequent Event [Member] | Israel [Member]        
Loss Contingencies [Line Items]        
Cases brought against PM   1    
Purported Label Related Class Action [Member] | Aharon Ringer V. Philip Morris Ltd. And Globrands Ltd. [Member]        
Loss Contingencies [Line Items]        
Estimated number of members in purported class | plaintiff 7      
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Public Civil Actions) (Details) - Public Civil Actions [Member] - litigation_case
Apr. 24, 2018
Apr. 25, 2017
Apr. 22, 2016
Loss Contingencies [Line Items]      
Cases brought against PM   2 3
Subsequent Event [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 2    
Subsequent Event [Member] | Argentina [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 1    
Subsequent Event [Member] | Venezuela [Member]      
Loss Contingencies [Line Items]      
Cases brought against PM 1    
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.8.0.1
Contingencies (Other Litigation) (Details) - Other Litigation [Member]
$ in Millions, ₩ in Billions, ฿ in Billions
 3 Months Ended 5 Months Ended 12 Months Ended
Nov. 29, 2017
THB (฿)
Nov. 29, 2017
USD ($)
Jan. 26, 2017
THB (฿)
Jan. 26, 2017
USD ($)
Jan. 18, 2016
THB (฿)
defendant
Jan. 18, 2016
USD ($)
defendant
Mar. 31, 2017
KRW (₩)
Mar. 31, 2017
USD ($)
Mar. 31, 2017
KRW (₩)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
KRW (₩)
Dec. 31, 2016
USD ($)
Thailand [Member] | The Department of Special Investigations of the Government of Thailand [Member]                        
Loss Contingencies [Line Items]                        
Loss contingency, damages sought, value ฿ 25.6 $ 813 ฿ 19.8 $ 629                
Thailand [Member] | The Department of Special Investigations of the Government of Thailand [Member] | Pending Litigation [Member]                        
Loss Contingencies [Line Items]                        
Number of defendants         8 8            
Loss contingency, damages sought, value         ฿ 80.8 $ 2,570            
Korea [Member] | The South Korean Board Of Audit And Inspection [Member]                        
Loss Contingencies [Line Items]                        
Amounts paid             ₩ 172 $ 160 ₩ 272 $ 254 ₩ 100 $ 93
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2017
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2018
Income Taxes [Line Items]        
Provisional expense $ 1,600      
Accumulated foreign earnings provisional tax charge 1,400      
Re-measurement provisional charge $ 200      
Effective tax rate   25.50% 24.90%  
Tax benefit from legal entity restructuring     $ 61  
United States [Member]        
Income Taxes [Line Items]        
Open Tax Year   2013 and onward    
Scenario, Forecast [Member]        
Income Taxes [Line Items]        
Effective tax rate       26.00%
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.8.0.1
Indebtedness (Narrative) (Details) - USD ($)
Mar. 31, 2018
Jan. 29, 2018
Dec. 31, 2017
Line of Credit Facility [Line Items]      
Short-term borrowings, carrying value $ 608,000,000   $ 499,000,000
Committed credit facilities 8,000,000,000    
Borrowings under committed credit facilities 0    
364-day revolving credit expiring February 5, 2019 [Member]      
Line of Credit Facility [Line Items]      
Committed credit facilities $ 2,000,000,000 $ 2,000,000,000  
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.8.0.1
Indebtedness (Long-Term Debt) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Debt Instrument [Line Items]    
Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 34,240 $ 33,840
Less current portion of long-term debt 4,662 2,506
Long-term Debt 29,578 31,334
U.S. Dollar Notes [Member]    
Debt Instrument [Line Items]    
Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 23,294 23,291
Interest rate, average 3.566%  
Due through 2044  
U.S. Dollar Notes [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Interest rate 1.375%  
U.S. Dollar Notes [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Interest rate 6.375%  
Euro Notes [Member] | Foreign Currency Obligations [Member]    
Debt Instrument [Line Items]    
Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 9,348 8,997
Interest rate, average 2.25%  
Due through 2037  
Euro Notes [Member] | Foreign Currency Obligations [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Interest rate 0.625%  
Euro Notes [Member] | Foreign Currency Obligations [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Interest rate 3.125%  
Swiss Franc Notes [Member] | Foreign Currency Obligations [Member]    
Debt Instrument [Line Items]    
Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 1,418 1,376
Interest rate, average 1.269%  
Due through 2024  
Swiss Franc Notes [Member] | Foreign Currency Obligations [Member] | Minimum [Member]    
Debt Instrument [Line Items]    
Interest rate 0.75%  
Swiss Franc Notes [Member] | Foreign Currency Obligations [Member] | Maximum [Member]    
Debt Instrument [Line Items]    
Interest rate 2.00%  
Other [Member] | Foreign Currency Obligations [Member]    
Debt Instrument [Line Items]    
Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 180 $ 176
Interest rate, average 3.378%  
Due through 2024  
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
Indebtedness (Credit Facilities) (Details) - USD ($)
$ in Billions
Mar. 31, 2018
Jan. 29, 2018
Line of Credit Facility [Line Items]    
Committed credit facilities $ 8.0  
364-day revolving credit expiring February 5, 2019 [Member]    
Line of Credit Facility [Line Items]    
Committed credit facilities 2.0 $ 2.0
Multi-year revolving credit, expiring February 28, 2021 [Member]    
Line of Credit Facility [Line Items]    
Committed credit facilities 2.5  
Multi-year revolving credit, expiring October 1, 2022 [Member]    
Line of Credit Facility [Line Items]    
Committed credit facilities $ 3.5  
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Narrative) (Details)
$ in Millions
Mar. 31, 2018
USD ($)
Fair Value Disclosures [Abstract]  
Capital lease obligations, carrying value $ 27
Debt excluding short-term borrowings and capital lease obligations, carrying value $ 34,213
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details)
$ in Millions
Mar. 31, 2018
USD ($)
Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member]  
Assets:  
Equity securities $ 272
Foreign exchange contracts 0
Total assets 272
Liabilities:  
Debt 35,293
Foreign exchange contracts 0
Total liabilities 35,293
Significant Other Observable Inputs (Level 2) [Member]  
Assets:  
Equity securities 0
Foreign exchange contracts 114
Total assets 114
Liabilities:  
Debt 171
Foreign exchange contracts 1,757
Total liabilities 1,928
Significant Unobservable Inputs (Level 3) [Member]  
Assets:  
Equity securities 0
Foreign exchange contracts 0
Total assets 0
Liabilities:  
Debt 0
Foreign exchange contracts 0
Total liabilities 0
Fair Value [Member]  
Assets:  
Equity securities 272
Foreign exchange contracts 114
Total assets 386
Liabilities:  
Debt 35,464
Foreign exchange contracts 1,757
Total liabilities $ 37,221
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Mar. 31, 2017
Dec. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Total accumulated other comprehensive losses $ (10,482) $ (10,230) $ (10,557) $ (10,900)
Currency translation adjustments [Member]        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Total accumulated other comprehensive losses (6,097) (5,761) (5,783)  
Pension and other benefits [Member]        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Total accumulated other comprehensive losses (2,766) (2,816) (3,509)  
Derivatives accounted for as hedges [Member]        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Total accumulated other comprehensive losses (20) 42 27  
Accumulated Other Comprehensive Losses [Member]        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Total accumulated other comprehensive losses $ (8,883) $ (8,535) $ (9,265) $ (9,559)
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.8.0.1
Balance Sheet Offsetting (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Assets    
Gross Amounts Recognized $ 114 $ 140
Gross Amount Offset in the Condensed Consolidated Balance Sheet 0 0
Net Amounts Presented in the Condensed Consolidated Balance Sheet 114 140
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments (25) (50)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged (68) (78)
Net Amount 21 12
Liabilities    
Gross Amounts Recognized 1,757 1,128
Gross Amount Offset in the Condensed Consolidated Balance Sheet 0 0
Net Amounts Presented in the Condensed Consolidated Balance Sheet 1,757 1,128
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments (25) (50)
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged (1,719) (1,004)
Net Amount $ 13 $ 74
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in Unconsolidated Subsidiaries (Narrative) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Schedule of Equity Method Investments [Line Items]    
Equity method investments $ 1,098 $ 1,074
Difference between equity method investment carrying value and book value 932 927
Dividends from unconsolidated subsidiaries $ 10 120
STAEM [Member] | EITA [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage 51.00%  
STAEM [Member] | Management Et Development Des Actifs Et Des Ressources [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage 49.00%  
Minimum [Member]    
Schedule of Equity Method Investments [Line Items]    
Difference between equity method investment carrying value and book value, amortization period 10 years  
Maximum [Member]    
Schedule of Equity Method Investments [Line Items]    
Difference between equity method investment carrying value and book value, amortization period 20 years  
Equity Method Investment Goodwill [Member]    
Schedule of Equity Method Investments [Line Items]    
Investments in unconsolidated subsidiaries and equity securities $ 879 $ 873
EITA [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage 49.00%  
STAEM [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage 25.00%  
Megapolis [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage 23.00%  
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) - Eastern Europe Segment and Middle East And Africa Segment [Member] - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Schedule of Equity Method Investments [Line Items]      
Net revenues $ 923 $ 840  
Receivables $ 471   $ 293
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.8.0.1
Sale of Accounts Receivable (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Sale of Accounts Receivable [Abstract]    
Servicing liability $ 0 $ 0
Trade receivables sold and derecognized from the Consolidated Balance Sheets 2,509 2,092
Trade receivables sold and derecognized that remain uncollected 878 561
Loss on sale of trade receivables $ 0 $ 0
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.8.0.1
Product Warranty - Narrative (Details)
 3 Months Ended
Mar. 31, 2018
Guarantees and Product Warranties [Abstract]  
Standard product warranty term 12 months
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.8.0.1
Product Warranty - Movement in Product Warranty Obligations (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance at beginning of period $ 71 $ 51
Changes due to:    
Warranties issued 76 168
Settlements (54) (148)
Currency 1 0
Balance at end of period $ 94 $ 71
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.8.0.1
Acquisitions (Narrative) (Details) - Tabacalera Costarricense, S.A. And Mendiola Y Campania, S.A. Purchase Of Noncontrolling Interest [Member]
$ in Millions
Mar. 21, 2018
USD ($)
Business Acquisition [Line Items]  
Interest acquired 49.00%
Net purchase price $ 95
Contingent consideration $ 2
Ownership percentage 100.00%
Decrease to additional paid-in capital $ 86
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.8.0.1
New Accounting Standards (Revenue Recognition) (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2018
USD ($)
segment
Mar. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenues $ 18,426 $ 16,556    
Excises taxes 11,530 10,492    
Net revenues $ 6,896 6,064    
Number of reportable segments | segment 6      
Revenue, Excluding Assessed Tax [Member] | Customer Concentration Risk [Member] | East Asia and Australia [Member] | Customer One [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Concentration risk percentage     16.00% 11.00%
Revenue, Excluding Assessed Tax [Member] | Customer Concentration Risk [Member] | European Union [Member] | Customer One [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Concentration risk percentage     10.00% 11.00%
Indonesia [Member] | Revenue, Including Assessed Tax [Member] | Geographic Concentration Risk [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenues     $ 8,000 $ 7,700
Indonesia [Member] | Revenue, Excluding Assessed Tax [Member] | Geographic Concentration Risk [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenues     3,200 3,200
Germany [Member] | Revenue, Including Assessed Tax [Member] | Geographic Concentration Risk [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenues     7,200 7,100
Japan [Member] | Revenue, Excluding Assessed Tax [Member] | Geographic Concentration Risk [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenues     $ 4,700 $ 2,800
Accounting Standards Update 2014-09 [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Net revenues   16,556    
Excises taxes   $ 10,492    
XML 96 R84.htm IDEA: XBRL DOCUMENT v3.8.0.1
New Accounting Standards (Financial Instruments) (Details) - USD ($)
$ in Millions
Mar. 31, 2018
Jan. 01, 2018
Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Investments in unconsolidated subsidiaries and equity securities $ 1,395   $ 1,074
Deferred income taxes 822   799
Earnings reinvested in the business $ 29,985   $ 29,859
Accounting Standards Update 2016-01 [Member]      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]      
Investments in unconsolidated subsidiaries and equity securities   $ 301  
Deferred income taxes   63  
Earnings reinvested in the business   $ 238  
EXCEL 97 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

/L2\KP;P^F@<#,=] M-1H%<_CQ%B4FP_XE31GIIG_\XV Z':IA,.E/$<*+8#*;PR]PIJ/16%:TJ0.< MWN0RWR)&%%B:I[S!9=.7&!,"E.SO49ZPLK@&;-[%:/]/R%_OG-G!-Q@$ );" MWH0K4=]?8,\V4^9Y$5@]!E6?*-?&#Q2E;O(HTN()D/9(6"/! @VP0(*/X!B- M?6$T'9^N0U2>L 8ZF8UY^@U/_\!8[5)5S]UDM$S/T[\(X(24-Q1DS3X.5OD'.\#-QAG=6B&YP5>4"5:! NS;5[,#*\^BB$3:H140S ME>>CT[GH(*S1U*%N5E#>H\5;QC!>"B])T.HQJ)$P]S8 (BW E(=%6<*%U6T, M=!C0[4&+=2++HYBN#2OHXP+U8HL%;QU7-BBB47Y'Z!*G.ZV?DE.Y]F25-I\% MM2Z5I9,L:Y946[ZN1UF(I)N@)BW.I!U5& E+RL&^CMA>B:MEB#B#FNY$-1KS M%D=3 W6J?JPR*HF/!UNP 8X0C0'/)C-,/"LI"4TGQ^:NF?4;&6X(P[UO;)B] M;U373<_*DP7L0H%E_;HK&+$\ 7;SM7UA'6) M32(F"3V/-@E9>80\%.:&FIND450BM9 %ZQS2B&04M'.0J:*G7J-/\D%=<<8R M1>Q'5^.*933P! ?K0/6.2G.EN)'N%J:*(B"ISTVS3'A?0,J M84J.]_,4[:UL&$=91-J1%2TPCOD"L>]#DV7.7=5Q,[X@:+_C;>@<3B5& R!] MVVR-4*:#EJZ6$LHE+BM0?]=H-FTB+J/68UI.8\'P@13MUHNCHJQ-H#-/B.XD M<[DQ4+'+1!EJV;II71)35S7K>-/Z&>RBY/SVM?8"K['W1[LQ*[BCH0R0AXB/>)GW3^MJBX\:@ MH[/_ Y!ZJ'DW1P1@9:Q45SS&JKL_P+51DUX'NI/0((7@, 2%VP+IXD:/K*Y' MFNTC1X1.7UVC!Y6-P%9IJA!.E.,,AY)P@8BUM5WHSCY![50=>J AW**=.W8S M*PT"W<,+3BRP*"KDR]*(]UH*'9F625$N37EL470YR5C7/@MO0$FYX1B1NI7" M/^5KDJ&UK[75ZL"FC*&MZ$(%(SJ4L( <*D>H0PYL;9&F9O;8_6D>CETEL1.\ M$UM.RH_6>Q;^R$H[*;+#-_ B/3^$9^&4^H%^P*N@"?K&B6J$=:UK+Q3!FJEU\/,3ZH>,AX*_&ZX/ B*N; M!W-:'?TZ&4WXUT4PG.*OEY&F62NQ>Y'YJ.TT7VL/%E*I+=:UT<7/#EQ,/20) M_0SLY0IL@>',UE+,4J9;:-(+K((@7O6:$]%3)O+&KD23$ >7#;PGC8-(\/ZZ M2;4*1][VC&OO,Z(TR-'DBB9.24Z*1&;!9M3#;$^*H[A(0O')/2[RK!TKCN,8 M%C6I$UT#X17[&4K-!5$G#B\E2NP*H\34>PHN0%6J_IS]9@^EZ1KLQ6&:3E5$ MGZW/4, PA9AS\!$U(958V)5U_9I1&V,5VN\7Y^M3M <]V&=TT)X4^*'\%5CF M*B1:Y]B5J(J=J[1CI@ +!5\?(%^S/F[B';8X?HXTEBL,83 W)\>0?@IKERB0 MG((VL7 Q!X=DV)#(..2Y;"^[XG6YU] )S"7%&3?<4W^A/$YM^-2PQ=]"/1@B M_BKB>-_:M-JS0/[,4ZSLHY=.3Q9B6T=%OY"*P@79U&^C+8=)WN09U@JEOL+[ M:YG5HQO/,JHWFK,P02WHG9Q6C%)PH*?L\%YE0?%QHYN50^TQ5^@PM67O'7Y< M=;$17EKQI)XQ>U_KBDJT03P'%9=[1*#\EHYD*?;L2^M_=K^0NZZ!>F8F/G,G M]LD#RBYZV O&!!L6>= (_M+@C#YG&>U'>A9RZ+/&J4NQ:S^_2)#7KYW5M\DR M?#![Q,^Z=*O_/AX*YY_.Z2>(G([@^\B(),1Z8\HG9E3X8+"@7T%1:Y>X#EGZ MN.]/0W\?3_H\R8R7/A@^9>D#5Y9V/C&C#H)^?TR_SL;-Z $0RTHCZ/R4>OA^ MY7C\ZV^*CO..+##*'8>#PK!X_L_P]R,>EL,7\$3/.\4=L),O]N>H_#G\A 4, M?P8AN!:9 !_-QAVQ"=H0PM3 $W"--TSKLVROHN 1$V)F;*[RI;O:D&H@QL(2 M;=1X2;3Z[R;(UA5"U&DNZ[I6/]S'Z&DB^ MPC $8FV ]?.S7N08[=5&A N..[..A3E$=? MHMC:_/G[2(#QJ>+KIV5VNF:+KV ORZV/DH-^C18,^YVG3G0G2];HTQPOOK)G M)N(R43A*F%GFX;5ZO8U)@#YEVS7_&0LQS?+B],-2';_Y_\].3.6_U^>;-?@7PGU:2E!1%&D5!W(I 'DAO^,,].92VVYN#5 MA^7K=[;H($P(CV-.4RJ=4NZ8V$OT_"-)2,=D#X5[PTBEK>B6\YHL#C>%/@ _C79002;)6CC>X[*>IZ M_&[Y:GFI_SPA37Q+7FTJIXKXWP3*#R%KJY$+'I1;D@3$',JSO-HM0<)%H+AM M<<0*J;L+1#HB(HE7% )LW5>YY@[Z"//<-2*/.^BFQ"]?P7&+]@&!B]_ MEGH-LF>M=<%$9]]?G:D/?[9OZO@7LT:*2E:7Z"X(F6[IBO90.4$T+1]!_(X:0#V0(><>& MD-LM[/,B&RY(X, M Y)N;.^R;1CP:]+@4PHLW&')HALO7^M= MO%XG_)1T05MN,.U0/]B35'F[$M(I^1:=4A-ULJ*"@V9PH MJ@;9 R.$.[>?*WBN]667*RVU"DE%H^0PXS8UD@A517#\")[IQ#62V%)3;4)1 M!%/6Y>LK20Z6/*W".=4G/+I'@-_SU@LLM65L2UBOFN]R>DNH;0P'20R;67/K M D/R*>(X2M"A3HGHN8.-A/U8$SUA8X6OXTLQA\+@@&N_P)96]S0X-;M(DH#K MAL._-QG5@&9?O8D[;TRN:R\CF4.TT4UWZL\!CC/9LW'RCM\-Q;B0^*6FCIB8 M?N?F:1Q.VCH!)0K(?:;*AQW+,[XMK* T1XVX6#7"?,*66^,X0)!"&X@3AE0 M_K#>@!/=5E@FI6W:5@AM1N,X,/EP:]-V6LQEK=.9*NPX/F6!=PK=-9^-J^%Y MA]-R&@9\E-DBF:HU8$O(DO(/UA2E;QZ9C5O@,\T./XLS=IG84A+UR^&F+8,: M@R*?>,,^P\\@[MVC(7F=/(%]"/K\<)_(;MWHIC.$;?' XW(R$+[1R &UREH[ M")D.L+_!V@"?=LMM+"3&,) B:QW^!O<.I8E=BR3)O74*-ZS7)Z<'(K(^GOEL M[IP$'<_$R8IMTZ)1VY7&/X75Z.KR)!V88#Y'!_[:73XZM'FCPA^,!T0F*A.( M2/.8?;FDB7()T>:"U%!7^6AG2";2DNP][JV76X!F8CH2KI3Y%$!H>;EGQ-XG MW4M\X8!-8&6EK2:0#3'F@DO@J+]P79Z'^O??5B'U:Q)UH?9XO-<$61];ITN= M__C^"O-D*>2CYF RX7]2F\W)R:P0T8K0I5I5 HF_G$MQG:QMJ73 H@KMHX7#Z>UFT+LFD5^KZ ML$51T7C)U*O7#*_D,CFK!QU<&:Y6>16UPH<$'C+]%0X!I3W:MA0FFD\\AYC& M"CI"*B49',>DY#:;].D>YF!0KBA[U,DWU+8.C-&^HRXU*W*'Z%#E:PSB?MAA M6'6BBTZ9(DRF4I"DCF$3$.XB215W1 C2_1SYMDF%0 UL"M_5X;S:3BOQW&71 MME*YX=(&22#K!08?;AEDA\C/> M'2G2,2<#DW+,H1 OW'LLA3UF4S68SM55A&'73*J.)^CE.!Z,T8MBHET&QC7B MS"XAT&9>2G2;#9KQ/W#E) NXX;$731*Y-5NJ^6"([%N5/27.N@9L]%:YT MFQZZ@CI@$8UFKAF(#%)PM_.0:L4!<%CC#-15;]D3&PUP[BP)U0-%N81_^*_A M>/ -FK=FWX3R'),GXJ^:^G!F"IH]%Q.'*TNHI\XZ.QIZT8VD!MSH#K>F$0T5 MFM(E/7E_*>A>V3W :8!I>\9=2YM0EZC\*B/"Z(J(AC!N]D&%9V%9@,J5YA3! MR(YD&YQEXU PK>:4! =V8.">Y[:#68,#_1#=N\5.KG0/GY:8,?V,QF(\C]=Y M3J4GJ9O5(ZC2-=4+TJTY%':=[2@J+75K>#J()-];'VW;@.JG'?&?Y=5/5,SS M% NIB[U7%\+A\@KD49B20)=SO8HPKCAMDH)FDF1=!5OA:I00D]=$ MS9SP_I62+U<^2%4'&O5:/DP88K&?'R WK+&>GHE'3 M6A1F5P4/+J1#/-W5.@'H2>)4RK"'962U&M:9P]?U:W,J)EM*>)&LDX)XQ-IK MHC[=B1\M[!'4_6;.W9%E8!44+9(&++M)$9?';@ONP=P8074IV(-IF1B/1,%8 M7-*L8!*YR;E/JVNYK^,R*JH.^&UJ(/GKKJ?T\8\=, M-2+6#_%"&)>#$'2,HR@D\0L>O'1ONUIJV'@^BM>TWD+N2?3H#\=LS_?W' /+@!X#XZ4$*I+#&E+OY- (IJ/V+JL4=[M[LZYB=:$ M;J\OXN)-E-WDX0ZH**)U6#CQ>CD1_C1S%EN[;@:W,151#QMXJHO.\P2A;$5Q MPD"QV0LJVQ"+A4DV!"EL5">0"XEOC(5BH-C[31IBZO)KO7X7 M$]MW$!?:@^"C>"W\P@Z-%3&%ZGCU0JB(7VF44D3+2 KKNB/#/%1K5IVGZPRP ME&JG'LV=@@ID9)OU9FXY25,N%6NB^D8WKL/Z+MV,Q&6#L FS<&/:0-4CM>"2! M= * Q>&(5=R!,1J?(Y:QG7(QPL'@JT:*H\NTO)4?="*NINR+D?WX<[ M[(.CCL8.LK,'H#=_$O9[=VE4QW_W@T=&8^D8]F*2W@JR\3B0%VG35[ L>0!! MDOK .QR,*(9>C;86(1&YP<)^;J*)E'V*/PF_YX0\QA.NF^HT9R[DF)#JL'I3 MJ%O0UTFT(5=E(/PNT"(C7<542&=I;'^N@.DX4JC4 5GCV(AI I0V;*]C^[+N M6PWW-(R3PLD1F6%$.>/XIN\RB/X*%J?DH?;Z3-%\_V24=(PGX;#$(QC6* A[%36 M*MV4.8]"_G#C#Q"#[K/\H^"+XUC6+=31M!_;:$Q*>F TRQ)2=8V%4RNPTAZ: M2*\F-5%,D*#ZEL5MO-,MQHV!,]NP;BEZ(&?#BTW8U8SUS'J#IFFR]H+(C.9B MDW-@)\%#*RQ*SV7QW4%)Z_7K;)G,"@T'%J^SPEAPK=C4F%,[;%'!9YB3**B- M3]X@!!)99 ^+ 3$T_=6 ZD$B*FW4K;V$W@3XO:!46O;/M-C9GP+^]!#8M;@(6, R,1]Q3$MC\Y6 MB#^*:I0F&PI(M:$U=$,K[;329DB_&1M.S19I17S^>_OR &ECJ^JZS*#6Z#FP\GIH'_R0J>\&%[USK=#.$NQZ3CV0R<% MHL/,B.NS$:D4>KQSE%D2.'KN9FPM(1-;::,0CS%*?%?*/?^,0'YJ,,-OBTE/ M5Z*T4I=3"EC';)V($4^L-(3(3@@*RP..N\M^Y1 *B0KG],^Z!.9"@'1M'FYM M"$:GL&5885CL=(:5-OE0W<%OE\L+J8]*I8B(GNEAR62"='#[S3,2 M.7![ '"LKO $ )7-:\*4S02M<%(9GY91G'T_ U$?XVCXTI#6P%;\=>K4VC B M>DG'KH+LS/AC[%763+$!&;7O!E4<34>UD)C1O#/FPO@8Q-,&%,56FN,Z=5,& MUB/.A9<9DA1]9]\LKU[JRZJ'/L G 2@Q-#3H+35/ZZ8&PX;3 3^TMS[+;T) M!YTRC9>4"UT(P1;NQ=;^3!LDW$!*&LE=74(,.Y$HQUQXYG;BJ1^WKLUI0G[S(ZR^(MBU1IBF[U>@&H MPG7,DB65!0+_LF"[7;QY$15#-@;5'2K6I7$*4+,L2Q50,V!H.U&>Q0.@L+[D ME2FE;H:4O%)3UBY;Z<8]//"#EB[J32,L>=%PUC7.;3D9LK#K-\3$;/H9MIB) M":KD$R+>GW%;CA8#M 3,+B1(X:03BJY4Y<-P4L2[)*>-_B_52? MMLF+ @ 9_?%#E$TQ6\7EX B+UV?@DHP%MNQDS\8 IW7_&*OY45_T4O:RG+HB_4*UR6 M4V[F E[&\9=4S$N_?.:NZ+6LZ-)?T9)7U))I, B&XT4PG?3),M_OS?I4(X9! M"U\"5>U/\;/%O#>>4746]8\_IU_]6"X^YUCPI?:3N+(17A^N+O%@C!#.045T M5C2<.@Y/#AN):XTTQRKXNYG/MTP;G0=%2C MQ2@8TZD/AO,>E0J"XQ\NJ/P/;>A#YR&)U(J+D#I=+AUP8^/()070$TU76U&Q=TF:FLCPV$"%V7YV M;^J?ZH 9KQPYD6C=&%FDFRC1C$=J,N+HKG,=M$.?#^'A M*>'[BIWZ9953M9I=HLO@ ESF6);H>(8I^$O.-I66F+A%"B\=C]1X+-ZNPIU8 MQW^-5#DZ#"RC?DGU

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end XML 98 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 99 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 101 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 329 300 1 true 142 0 false 19 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.pmi.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Earnings Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfEarnings Condensed Consolidated Statements of Earnings Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings Condensed Consolidated Statements of Comprehensive Earnings Statements 5 false false R6.htm 1003001 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsParenthetical Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquity Condensed Consolidated Statements of Stockholders' (Deficit) Equity Statements 7 false false R8.htm 1004501 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) Statements 8 false false R9.htm 1005000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 9 false false R10.htm 1005501 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 10 false false R11.htm 2102100 - Disclosure - Background and Basis of Presentation Sheet http://www.pmi.com/role/BackgroundAndBasisOfPresentation Background and Basis of Presentation Notes 11 false false R12.htm 2104100 - Disclosure - Stock Plans Sheet http://www.pmi.com/role/StockPlans Stock Plans Notes 12 false false R13.htm 2105100 - Disclosure - Benefit Plans Sheet http://www.pmi.com/role/BenefitPlans Benefit Plans Notes 13 false false R14.htm 2106100 - Disclosure - Goodwill and Other Intangible Assets, net Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNet Goodwill and Other Intangible Assets, net Notes 14 false false R15.htm 2107100 - Disclosure - Financial Instruments Sheet http://www.pmi.com/role/FinancialInstruments Financial Instruments Notes 15 false false R16.htm 2108100 - Disclosure - Earnings Per Share Sheet http://www.pmi.com/role/EarningsPerShare Earnings Per Share Notes 16 false false R17.htm 2110100 - Disclosure - Segment Reporting Sheet http://www.pmi.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 2111100 - Disclosure - Contingencies Sheet http://www.pmi.com/role/Contingencies Contingencies Notes 18 false false R19.htm 2112100 - Disclosure - Income Taxes Sheet http://www.pmi.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 2113100 - Disclosure - Indebtedness Sheet http://www.pmi.com/role/Indebtedness Indebtedness Notes 20 false false R21.htm 2114100 - Disclosure - Fair Value Measurements Sheet http://www.pmi.com/role/FairValueMeasurements Fair Value Measurements Notes 21 false false R22.htm 2115100 - Disclosure - Accumulated Other Comprehensive Losses Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses Accumulated Other Comprehensive Losses Notes 22 false false R23.htm 2116100 - Disclosure - Balance Sheet Offsetting Sheet http://www.pmi.com/role/BalanceSheetOffsetting Balance Sheet Offsetting Notes 23 false false R24.htm 2117100 - Disclosure - Investments in Unconsolidated Subsidiaries Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiaries Investments in Unconsolidated Subsidiaries Notes 24 false false R25.htm 2118100 - Disclosure - Sale of Accounts Receivable Sheet http://www.pmi.com/role/SaleOfAccountsReceivable Sale of Accounts Receivable Notes 25 false false R26.htm 2119100 - Disclosure - Product Warranty Sheet http://www.pmi.com/role/ProductWarranty Product Warranty Notes 26 false false R27.htm 2120100 - Disclosure - Acquisitions Sheet http://www.pmi.com/role/Acquisitions Acquisitions Notes 27 false false R28.htm 2121100 - Disclosure - New Accounting Standards Sheet http://www.pmi.com/role/NewAccountingStandards New Accounting Standards Notes 28 false false R29.htm 2221201 - Disclosure - New Accounting Standards (Policies) Sheet http://www.pmi.com/role/NewAccountingStandardsPolicies New Accounting Standards (Policies) Policies http://www.pmi.com/role/NewAccountingStandards 29 false false R30.htm 2304301 - Disclosure - Stock Plans (Tables) Sheet http://www.pmi.com/role/StockPlansTables Stock Plans (Tables) Tables http://www.pmi.com/role/StockPlans 30 false false R31.htm 2305301 - Disclosure - Benefit Plans (Tables) Sheet http://www.pmi.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.pmi.com/role/BenefitPlans 31 false false R32.htm 2306301 - Disclosure - Goodwill and Other Intangible Assets, net (Tables) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables Goodwill and Other Intangible Assets, net (Tables) Tables http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNet 32 false false R33.htm 2307301 - Disclosure - Financial Instruments (Tables) Sheet http://www.pmi.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.pmi.com/role/FinancialInstruments 33 false false R34.htm 2308301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.pmi.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.pmi.com/role/EarningsPerShare 34 false false R35.htm 2310301 - Disclosure - Segment Reporting (Tables) Sheet http://www.pmi.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.pmi.com/role/SegmentReporting 35 false false R36.htm 2311301 - Disclosure - Contingencies (Tables) Sheet http://www.pmi.com/role/ContingenciesTables Contingencies (Tables) Tables http://www.pmi.com/role/Contingencies 36 false false R37.htm 2313301 - Disclosure - Indebtedness (Tables) Sheet http://www.pmi.com/role/IndebtednessTables Indebtedness (Tables) Tables http://www.pmi.com/role/Indebtedness 37 false false R38.htm 2314301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pmi.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pmi.com/role/FairValueMeasurements 38 false false R39.htm 2315301 - Disclosure - Accumulated Other Comprehensive Losses (Tables) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables Accumulated Other Comprehensive Losses (Tables) Tables http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses 39 false false R40.htm 2316301 - Disclosure - Balance Sheet Offsetting (Tables) Sheet http://www.pmi.com/role/BalanceSheetOffsettingTables Balance Sheet Offsetting (Tables) Tables http://www.pmi.com/role/BalanceSheetOffsetting 40 false false R41.htm 2317301 - Disclosure - Investments in Unconsolidated Subsidiaries (Tables) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables Investments in Unconsolidated Subsidiaries (Tables) Tables http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiaries 41 false false R42.htm 2319301 - Disclosure - Product Warranty (Tables) Sheet http://www.pmi.com/role/ProductWarrantyTables Product Warranty (Tables) Tables http://www.pmi.com/role/ProductWarranty 42 false false R43.htm 2321302 - Disclosure - New Accounting Standards (Tables) Sheet http://www.pmi.com/role/NewAccountingStandardsTables New Accounting Standards (Tables) Tables http://www.pmi.com/role/NewAccountingStandards 43 false false R44.htm 2402401 - Disclosure - Background and Basis of Presentation (Details) Sheet http://www.pmi.com/role/BackgroundAndBasisOfPresentationDetails Background and Basis of Presentation (Details) Details http://www.pmi.com/role/BackgroundAndBasisOfPresentation 44 false false R45.htm 2404402 - Disclosure - Stock Plans (Narrative) (Details) Sheet http://www.pmi.com/role/StockPlansNarrativeDetails Stock Plans (Narrative) (Details) Details http://www.pmi.com/role/StockPlansTables 45 false false R46.htm 2404403 - Disclosure - Stock Plans (RSU Awards) (Details) Sheet http://www.pmi.com/role/StockPlansRsuAwardsDetails Stock Plans (RSU Awards) (Details) Details http://www.pmi.com/role/StockPlansTables 46 false false R47.htm 2404404 - Disclosure - Stock Plans (PSU Awards) (Details) Sheet http://www.pmi.com/role/StockPlansPsuAwardsDetails Stock Plans (PSU Awards) (Details) Details http://www.pmi.com/role/StockPlansTables 47 false false R48.htm 2405402 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details) Sheet http://www.pmi.com/role/BenefitPlansComponentsOfNetPeriodicBenefitCostDetails Benefit Plans (Components of Net Periodic Benefit Cost) (Details) Details http://www.pmi.com/role/BenefitPlansTables 48 false false R49.htm 2405403 - Disclosure - Benefit Plans (Narrative) (Details) Sheet http://www.pmi.com/role/BenefitPlansNarrativeDetails Benefit Plans (Narrative) (Details) Details http://www.pmi.com/role/BenefitPlansTables 49 false false R50.htm 2406402 - Disclosure - Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetGoodwillAndOtherIntangibleAssetsBySegmentDetails Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 50 false false R51.htm 2406403 - Disclosure - Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetMovementInGoodwillDetails Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 51 false false R52.htm 2406404 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 52 false false R53.htm 2406405 - Disclosure - Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetRangeOfUsefulLivesAndWeightedAverageRemainingUsefulLivesOfAmortizableIntangibleAssetsDetails Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 53 false false R54.htm 2406406 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetNarrativeDetails Goodwill and Other Intangible Assets, net (Narrative) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 54 false false R55.htm 2407402 - Disclosure - Financial Instruments (Narrative) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails Financial Instruments (Narrative) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 55 false false R56.htm 2407403 - Disclosure - Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsFairValueOfForeignExchangeContractsDetails Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 56 false false R57.htm 2407404 - Disclosure - Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsCashFlowAndNetInvestmentHedgingActivitiesEffectOnCondensedConsolidatedStatementsOfEarningsAndOtherComprehensiveEarningsDetails Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 57 false false R58.htm 2407405 - Disclosure - Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedInAccumulatedOtherComprehensiveEarningsLossesNetOfIncomeTaxesDetails Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 58 false false R59.htm 2408402 - Disclosure - Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) Sheet http://www.pmi.com/role/EarningsPerShareCalculationOfBasicAndDilutedEpsDetails Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) Details http://www.pmi.com/role/EarningsPerShareTables 59 false false R60.htm 2410402 - Disclosure - Segment Reporting (Details) Sheet http://www.pmi.com/role/SegmentReportingDetails Segment Reporting (Details) Details http://www.pmi.com/role/SegmentReportingTables 60 false false R61.htm 2411402 - Disclosure - Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Sheet http://www.pmi.com/role/ContingenciesNumberOfTobaccoRelatedCasesPendingAgainstUsAndOrOurSubsidiariesOrIndemniteesDetails Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Details http://www.pmi.com/role/ContingenciesTables 61 false false R62.htm 2411403 - Disclosure - Contingencies (Tobacco-Related Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails Contingencies (Tobacco-Related Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 62 false false R63.htm 2411404 - Disclosure - Contingencies (Verdicts and Post-Trial Developments) (Details) Sheet http://www.pmi.com/role/ContingenciesVerdictsAndPostTrialDevelopmentsDetails Contingencies (Verdicts and Post-Trial Developments) (Details) Details http://www.pmi.com/role/ContingenciesTables 63 false false R64.htm 2411405 - Disclosure - Contingencies (Smoking And Health Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesSmokingAndHealthLitigationDetails Contingencies (Smoking And Health Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 64 false false R65.htm 2411406 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails Contingencies (Health Care Cost Recovery Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 65 false false R66.htm 2411407 - Disclosure - Contingencies (Label-Related Cases) (Details) Sheet http://www.pmi.com/role/ContingenciesLabelRelatedCasesDetails Contingencies (Label-Related Cases) (Details) Details http://www.pmi.com/role/ContingenciesTables 66 false false R67.htm 2411408 - Disclosure - Contingencies (Public Civil Actions) (Details) Sheet http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails Contingencies (Public Civil Actions) (Details) Details http://www.pmi.com/role/ContingenciesTables 67 false false R68.htm 2411409 - Disclosure - Contingencies (Other Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesOtherLitigationDetails Contingencies (Other Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 68 false false R69.htm 2412401 - Disclosure - Income Taxes (Details) Sheet http://www.pmi.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.pmi.com/role/IncomeTaxes 69 false false R70.htm 2413402 - Disclosure - Indebtedness (Narrative) (Details) Sheet http://www.pmi.com/role/IndebtednessNarrativeDetails Indebtedness (Narrative) (Details) Details http://www.pmi.com/role/IndebtednessTables 70 false false R71.htm 2413403 - Disclosure - Indebtedness (Long-Term Debt) (Details) Sheet http://www.pmi.com/role/IndebtednessLongTermDebtDetails Indebtedness (Long-Term Debt) (Details) Details http://www.pmi.com/role/IndebtednessTables 71 false false R72.htm 2413404 - Disclosure - Indebtedness (Credit Facilities) (Details) Sheet http://www.pmi.com/role/IndebtednessCreditFacilitiesDetails Indebtedness (Credit Facilities) (Details) Details http://www.pmi.com/role/IndebtednessTables 72 false false R73.htm 2414402 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.pmi.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.pmi.com/role/FairValueMeasurementsTables 73 false false R74.htm 2414403 - Disclosure - Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) Sheet http://www.pmi.com/role/FairValueMeasurementsAggregateFairValueOfDerivativeFinancialInstrumentsDebtAndContingentConsiderationDetails Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) Details http://www.pmi.com/role/FairValueMeasurementsTables 74 false false R75.htm 2415402 - Disclosure - Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsOfAccumulatedOtherComprehensiveEarningsLossesNetOfTaxDetails Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Details http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables 75 false false R76.htm 2416402 - Disclosure - Balance Sheet Offsetting (Details) Sheet http://www.pmi.com/role/BalanceSheetOffsettingDetails Balance Sheet Offsetting (Details) Details http://www.pmi.com/role/BalanceSheetOffsettingTables 76 false false R77.htm 2417402 - Disclosure - Investments in Unconsolidated Subsidiaries (Narrative) (Details) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesNarrativeDetails Investments in Unconsolidated Subsidiaries (Narrative) (Details) Details http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables 77 false false R78.htm 2417403 - Disclosure - Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesBalanceSheetAndEarningsActivityDetails Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) Details http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables 78 false false R79.htm 2418401 - Disclosure - Sale of Accounts Receivable (Details) Sheet http://www.pmi.com/role/SaleOfAccountsReceivableDetails Sale of Accounts Receivable (Details) Details http://www.pmi.com/role/SaleOfAccountsReceivable 79 false false R80.htm 2419402 - Disclosure - Product Warranty - Narrative (Details) Sheet http://www.pmi.com/role/ProductWarrantyNarrativeDetails Product Warranty - Narrative (Details) Details 80 false false R81.htm 2419403 - Disclosure - Product Warranty - Movement in Product Warranty Obligations (Details) Sheet http://www.pmi.com/role/ProductWarrantyMovementInProductWarrantyObligationsDetails Product Warranty - Movement in Product Warranty Obligations (Details) Details 81 false false R82.htm 2420401 - Disclosure - Acquisitions (Narrative) (Details) Sheet http://www.pmi.com/role/AcquisitionsNarrativeDetails Acquisitions (Narrative) (Details) Details http://www.pmi.com/role/Acquisitions 82 false false R83.htm 2421403 - Disclosure - New Accounting Standards (Revenue Recognition) (Details) Sheet http://www.pmi.com/role/NewAccountingStandardsRevenueRecognitionDetails New Accounting Standards (Revenue Recognition) (Details) Details http://www.pmi.com/role/NewAccountingStandardsTables 83 false false R84.htm 2421404 - Disclosure - New Accounting Standards (Financial Instruments) (Details) Sheet http://www.pmi.com/role/NewAccountingStandardsFinancialInstrumentsDetails New Accounting Standards (Financial Instruments) (Details) Details http://www.pmi.com/role/NewAccountingStandardsTables 84 false false All Reports Book All Reports pm-20180331.xml pm-20180331.xsd pm-20180331_cal.xml pm-20180331_def.xml pm-20180331_lab.xml pm-20180331_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 103 0001413329-18-000023-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001413329-18-000023-xbrl.zip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

BNT7G%0KPT2UI"8+!570CM$MP&5&77,(LY9@ID MF4\MVG '7:5Y@N,O0I;,\U-9NU'(\4VX(0);+,M",0=^OQ%=X_W$C1@M K6) M! P*^K8(]DWWP07L&Y;%/%XL4X3?@> -5/=W6:J#IDIF6H(_$JR1ZH/832\% MH[V_H;?&(=YO06UM(#*6V#G%QF2LO5>2G(J]N4!MS*77%G13!MQBP7P<@ M3''#@X5$DQ8[@EUK&U U:<3=]0699K""!3651[4D MW+HR,TC+16Z[.(7@MXM#>3IA:SNJPX9P B\(W_U?F_XCI@S,'@BD^CO40/)M MV)(\Y[IWR8:T:HH.(,=SX7<^UH+T7CTV4TE!I()9'#WECJAB!DE4MKE13N:M M[=1UT5X_&CEJ*G#8TOX>@ YYQ(G7,V\2"9]!)X%K\WB3-^LB.BH1ZAI B1'MUMS#O\#:#Q*L"/.- M+[& WO5AD$?;D6!AU[3U7;&Q8EQ,A<7J2D'DD##R:;P2ZN+5Q0I29[ZN-,NE MPTCWC#TDFW30N,\H/R'#X>F8+(E7X$_^KJ[?YEX?BQI\F P15T=E8$59,:DU MO57''YZ3O"IS*MMX'C>641TG"2F61&D$U_/$1ZWM*![+NQ3*M59=&J[" +'> M.=^BC/D%PDE;"M];J JRFA0X3VZD0I9IP5&8C.PF4:P=O/T$ I35> 1T/Q.HY3G>^Q0>/\KG97"* M.'?9ZN86 9?"H9Y% \$Q(A/X!Y%V5(\CE_7JD*RS[B;K:DV];N75E&2Z6?X5]R(-CE5) M.M1_B<%_T$H>"U72#XL(@#"FJ)(8HJ3;1#=M*34ECN\HA"9FH:7D M%.&X>PG-6V1,H0%VO]QH@2H]R$\H0O1$M\D>BD\4)&!1&CT7 M8?3<+!YY/?I(!(DMJXAK?^,^=5P2>I7*W7BB#]M<^\AF(9N#A-@M3$HV]LY! MX+=@]_X2K+"CW@'DRI3/PJ(/1_?L]#NZ<$\O57:3_SYR1DB#O43+EAU*Q2UQ!?5(Q$'>C+!K>;=% M-?$6.YOKW;TM6RJNO*L2?W#XYRYAV$9 H) ?1,!@C^>.?EH")B5X(V$.% L9 MYVZNT+Z(2S)SA?9SBV7YL*GX,Y-*\M+?D0@E9+F_%R-^#F,^+F#]%'1-^H#<*YI_Z;:%SG)([K&87LHF$L$&S9/ M/'%5DOH)X!B85:+*SLN0\\*&(\87N2]6Y3WH7 KU4HZ4+4RWESV&R5IM]R M6^[8)&,ET1H)^70&VO,2DDD6JY-]'M@PB[8(N$X*D4:EH&QL8 M.;FR":_E!-^44ADWM(CO2N*-T-C;9N&ZN& M\;1C.%3:@T?VQI&E4LX4]Z=U5=23&P9/UK)JHZU=@PJNJR1@OH]]KE*BD A[ M+=6'XW242RU=^,W=W147667QFNT2$P)S'O*<]'?D?=RUN$V=PL(CT04[O'0= MP8:Q@I7_%!6PY.?:"*4L]F<6EJ&J5PEVX'6F:/)H3G6Y!#\7_<1$AS4)A'>" MLQSPG;9'MMQ2\PEFO\I*IB>8+;T3//T)Y>??F1_4*3ZS\5KT[T,)SQP\:Z * M2#4BM!&AC0B]182>F@2]$VS^"07HWP*0,W5*T-R +?''863H%P>>ON:P[KWYX>DFKN]UK>$))_^4ZM6R5Y*Y%X.?&_3!CPXS]].;>]0!;DB8ZH-*G[V"9> 4HV2]IB)]0MSE+';F9PKF>DO>JQ&>G[B_R[62IY3VR\2O MTZS/QFMI]HP'/Q)$ELNG:TUFE2^P&;TFRMQ(U -:SP@VSJ1E/G215B6A;&I% M1%>)-1'7.$%!=KL(HP)V@C0'$F*?F2ST(JOE?O C<#\PTWLA20XR[._?T[3[ MWU!*G=?84D)('JJ\I>FB0D-W^[I;3O(01?RM3&^IMG?N9W;/Q' M9/]Z9$"A6#>VD6,+RKDSM#*6"<($LE_(RNNW\YW0&+DD/IQS52O6NZY'%/[! M[)SW81L\#R93#RVR.LP*5T!Q627O:WE)I]6UNO5,%_228&&*041KK!CO8'UT M+\$8M2R:'OTW86L4\N6OJ'YM\6LXL6 BHR"GWXCJ66!%=' W$< H>4"%K_W@ M2L6N@>^QT08=^LT*OF_@80>KC_Z1@:0Y^R8-CA%:&^_JX<_O.ZJ@YQHLY,N= M@X6SU=- M#* SS=)N E",IW$1XM=@XASEX7;5+^%5=:W$,;+ 7BD ,P!=G > MI&2445:J"$YS"N#C**V:CD04%1#1 !)8IK2"&Q=5QL'[ R*F$I_)8ML^:HG' MJ\E>4=]<%A,/5-'JM.2Z4DFHRV)A<1'&Z[P4)+F]JGBNS4*KRCBDXG8W5AZO M*BI>K"*.Y;CEFM1'.+PHU Z,DZS3MI7($:$;_3A,Z>U&ZCSWRN L>KQJNC69 M9ZAG C/D ^N'ZX46G:RV'O5VVO(RNK;?D=)VDK[>.\<%K1;=J M*18M;-23(6"=59YK)"!(@9I,_"T;*FM,]"$*&?>.Z[@W?>EJT[T[Q'R*1=_! M&8%]>+^RWEY]H74#CBWZ[&%D ^EQK04(VT] MW M3:0,19,>&FN6H,NQ2-V*-5635H$/=8& E)?O\AO#6+E@B+3@,R]ID;9XRXYT MVNP-MMA9D:.0"]+(N=)=D5Q,+*(;'GDJM0N30#L>HR_YKO$1U7O$H%4]4J^/ M+>3J:R,G*7.GD& I&@?4P909WL;P@@A-$&PUYSH8,"GX>VP6)#'&<6?PQSKP M@]_<.=Y_8S(^XKMXT\;GVK7+/8HOBL\S%O 1CL=%^R#*J*@=R@?.MMEAA^O5 MROE>P*!!B)VED MS:X4=(\\U=WEF WX3L1!.*9Q3+([LJ51R*%]9[[^/8+ U M'E&Q$-6:$-]2='$%*?/=O!B<"C]8"S>OU">L\;P.%N_Y*AJ8C4 C>)HMLBCU M]+_31J*)&4DAZ_CZ\6(R M,E4@>\FU5%I"=,R3 :-BT*:&-F^E&$Q*O!GS1=.Y5.JTJ+5H6P?)X+JP%1E!G*SS@E-#*>)X>R,X3QF=S>C+B^.F-TAZ2T,]7)'MU(W M-SB?=KBDDW>BC=#^Q7W^>\*]TYO^0>)2-7%3$Y1_>Q1AE607V\STOX.=?&H-L<\/[QG\P/(HRS? )/'8;PM:_4JA81 M&<"W%^=VOFT0+26-?0P3C@_;;H@V8+:N>D[/+7##?B4 "%:3 Q_>J39&KJD9 MRW*:0 TDHHAUR<@*8@\B[/'K1JL4N:?,XT4"KT??=J=]*H!]:F E\5,07U5S M;FE*B_!2;JFR-@NA>R.P5+8K*[;[$CB'50!R0&-5UX4R5'$(#R\X69KU\= %2-7X!,#>Q_!5(M85LS(L\02NVW#8"E%?T(TYW\3(!J^ M@,U%1#&-;N7J=U 5#2'#@R)R0' M.4PVN3(8I<1.YG-QUE(IV-)FR=;ELTCL>+3"'^.#"+7;@$A+F"BU(\"W%#1L MT?>+:XE31G0B1S 'B@%1[(N./L)OP^*9QGL0JC 2=57:%N?T3'9E6>%=8?0- MT)MGBR7A11@QG.EY]D5!O$?9YS*G48R5PSNR7VQ%A]16.FX,Y!\RK4K+"I.4K"9B$N5:C#+6:!J57-+,M9N/YE MX%WF+I_+]Z1J&3G$\P*'4B;@L(8.1K*6"ISE%C!9.%O"6,U@ Q9N$9Z%ZU:YH.13IA,O)VO:Q0%6=;FKN8 M(S]:J&9%N(.8VYD]93-O*3PN?B%!M?-).& M]G?0S?D/H_S)%;?BY?DM76#M5%A>:(1P595@+8CP-,,F$$, M_85,W(]P&D7(^:GG?9*V#8K6,4<>3VMC;SC5LO[@7V(6,Q?.WQ*R\,GW%4AU MJN_Z:GSQX=4;A=3DXKI[M?J/>D%,'CA MUT_IZU^!58/(1J!/L(ZT>4(*%^?%?W- X,/' ? M;SS (E4M$.IE-"=0]IEP*;0OF$#DR;_0U#"+NB)0V:3UGQ4),^E4& M'X4LHD8.E(F0B7%IX&L M$4NF5TAR7)7:O[D46BXO_&O@DOLE*B'*J@2H/7QB=RSMR@G23%_@H+G#TQ(G M (.JGK#NB!\Q.^.(#%@.@X#GYC)PP:].P+3,W9<3;$U99<'R5*?&]R4*F68E M!T;DAEL:N9+[Y\DV[P<+57U17$R0%W?;/6&:Y62"&Z4923 [,(^/P8'";93O M/P_KV4^K?6YILSHOI+P^Q+T9X]SLUSK--Z*WK[P.*%O[_AU)GI?($6@,X;CP MJU0R,D=V,\7-1:(U3;Y2U0Z.EB !37*'35SE4H/@&W:<#5DI2E0$ MR: 7%(61R_P7\Q*A=.SMTLO_#D*8U/<0G _M2[@$R_QW"4R!.= AQ8[2!9MT M*ZE=+>?%K#!N!OXQOD]<$I*U76$IKK@'P3PPL>=@Z[,?(.Y!\]$[U<0S./^6 MO( QP!'P'5?<"J.[GWF'< 8S]$M;5XQ^@:;"J 7RB4\!.Q&2RF3 ]J+R9G24 M1)A!$\9MSN>DF>1VE4KW+K Z-I>R$5R;Q/F1"[RI]XF!P46)I6WK24;G/\&=M])@R*,S/3KEV-KWSQ?O1:S\.(#L&L4[&W4Y8_W M0\RS#_X<"!:Y;)=AUD;#K'.>M\M$>%Q)Q[O:9=O:'\60-,GH0"I;3)V]O4R* MW*#I> \R)I[*EB@;"K1=N7"6(:P%:3H\J;6@#T["6N@9@UHOV;XI9@T0A)36 MSBXJX^]I40%W5T,#W&D/ZTC\-V$$X(7M0L5RQ*J\]:2ZG(F/2'4]%ZOM2_Y- M R5E\_L?[&.@4D6BB-(LB'D7BU M&8DO8T"7%.M,)'>CL&^9Y[P3.OJ5W MZCW[F:U5X,QWIMK2*8H7+^$\YDJMW$]/ZV>9&E"\H:ZGXB_3 ?QM50/, MC-5,5((V;W BYCR),%/,9L&EO&P@!(N*U:O'2,5$Z>6^K7B6LJ>5+B]P?9XT MN;0SU5-)S8>XL*Y"3+I/15BD9!34QCR1E$'5!T6@9!6$D\Z,L'IG'E>W<:.M MZ[CI\LF-N$+K"J47@NZQJE(JA3*?H,0>7[&^R@@M51+)=@)$U(8)R+I$ H)A M0GEZI-)U%Y=1HPBJ<."E-\=I:IB-HXP:SY-A2YVX5((D"I:Y6G#RD!58R M%->NBX4@BF^33%?TU*DNJ&\)68"ZH(Y\&D$4W')2#(:;8 M"O9ZFG\3UCE*@>VK4/DK+,6H.:V!FOZ(:#G]3:'R)"Q2,;VIU1))\@J;K/![ MF(TH<9!Q.$J5O $B ^+X2]FNAIP*&E;4"**$)DNW3<@]W(X4 "3]27>>.*[Y9I8.7= "LKWP:/O.^X"GE$IHH@#0U=5.1___;OFDR.OG$"%H=A M=NNU."@/(ZS3VDBIM]LG0,I!W;8;8M.(0T4GN1ZQ?WU$/0G^A--]0*H*@R L M^;/]G&PIH&@BY:LHUY5,5QI+5L,!"19'J24)*@:OXHB+DH'GSD4\DWDD5Z,5 MP1S(Q,';/=%*2R(YVH8 7Q@7P3"HJP(R-XR*]J#4,U3D!49;>$%11J>2SU6F M:]KP(+4Z)1QT6W"+\H$8#0RY DL2AB:.>=K:K"*"C+=KR?Q3YEH6/Q2F.KK3 M8/XKO:GP(:D57A&B$VN A]^6RA YP5FPP!0=W63]L,O#%R^-)!J)/@7=!YH( MP\_D^R8;L:B0 RW*5:G6LE?%/A=WGPWP5B8?E21"RGI&)YP=[Z].5B6C"X MA-?$GJ+P>V3,O M.P-JF,*-X0H:59^5E'LKCSFXQM1[-,HH7'I5+B)VJ.S)OMD(_53=%-G/AL1E M'O6GSA9Q4II#82%= U7R'2Q9V'JL;!H@?!X/&QKLLR3":%V4]J*EWR8Q< A7 ML%D4PRII*3A/U"THC"Q$;#;CXJUY!..Q M"!:%^.%-@!@]F)T71+)O(YXM47M!(5K @0E!U($I3J=!J!94)9S"SW0U%I8B M(YN8X$O"HK(3_1S$Y#82&XW%C5*MIU&*1QG^,"NB^\T,KO[]Y[=)=+9D;/-N M%*SAO)-6M/WY**!;N<(-'(M*!TG(OP,O#;W ^?'7__V?/^>>W(1\!7H:1#^X M8$#*ST&<_9;J&, ?W_CB+Z^F8XS$_$/_S_?Q*\V=PP>@]<_,8;_3MX83>VB, MS/]G[UV;&[>1-M#/N[\"-;4Y.ZF2'8FZSR2IDF]Y9T\FF9UQ=FO/-XB"+&8H M4DN0]GA__>D&2(JR)%L74 +E3FTVEL0+T.@[T$\/>M<7%]U.M]YO7+;KE^VK M3O/-ST^XO,B=M\K8_"8>V.<0UGTM=Q_J.%_Q\-[3:D)E#O'M:=F.ZR;31-LP M?<1O@9CL5\59R]7XMB(8?_KX85'A%N:G)?MA>/!&\63=_W>>;U=[X#ST@%B]=J][]X/59+A M#/$5^$R*=]D?10["J16&&.5_H6^* PM^>M-HOF$1*"G](;_XAW@T_S-:^8AT M,GJ$[?9W[Q<>5'C#JH<^O;]QW-N=2H^>)E^5R;\@2PJ&P^5^*K_#,([#Z?L% M385&HJB&BI_U]0M?J?(5]4VJ,-)K&K-O3+DP+*NK?W$:!=WY5,>499W5@]Z" MWY;F7>3WSSM-J]:I*C3%[#ZZB^\FW@ALD-FME[*$R"T5D*/^2Z0HS'AA;$ F=+W:<;4[N/&GC"3W. M(TP]J$R3*95@$3FMTP7&Y7\ML6WANK\=C*V>H=*.Q%!,9Y0:;SNU>M^8\7V1 M)'.I*8](QCG&6-Q'BL@&193Z(RJ-:F,BPAXM50:E2E!A[5JWLPR_:(4*JP2O MD7XC_4;ZS6K]UEM&("7]9ER_;1^IGU9 _@DWWM.R0;TAGT-J696=J[0AR(?K ME)!]VR*75H*BWI-57G?(2 )SV@+36X'530)# D,"LU)@FK5VO4\" M4ZY36W(87X&S0.J^*Z$:!'E898*5IHG",L1V[V2]I M.Z-$-KBI789?L=P)T:9T@?6B7Y6,* GVZQ+LUG(G)].,6141Q?NVKH0CR27) M/8[D.N6?L7@MDGNL+/TB?1UKZ7L;*I#H:",;LY1_+4L.DI$A)O1XEU6ZV24F1DB(E90.3D9):I:3Z M-:=#2JJL/<,?%+C(JNL/%OL? )JGG,&5AZ>C/^+E"^W!/B-(N93>.&T(D\*1 MKP(/NN91X"$VEOK'PBE6;4ET[D6AYF4PQPATME$:)H=2+D 6(O"[:G& .\Z" MN_.>L_ ((3"WD2<]UH*HHZMS!$^/,SAQ5*\^10Y4R,41DLLDD)6>@J;B^7H MF>J!F)S(NRV#REQ9N2RJG*<]4L3X%T$(&T0NA\2H5@*%D MNEU37LB[[QC4"PXVDY7H#3N-&)?_@*->SGCO,NISQF[PR,4H!PS4R/LI_IZ$ M548\.=8\+ZOI^(4^ \T^^3S8N_7D?"74J-NEC?HFQ_S[$&#CL=45U3N-'F5Y ME*/^R;G2"MFGCQ_^+A&P=;G?Z@=7TQZ%T. MG%,%)?P 'X>PVHC :1!ZL%R_Z,LDC.*S6$13=A%&D4(+K!9P(G;GGD]BF$\B MQT/T=/^D(0^^@E/!M5W/FCC ^9==A4BG&0QBYIA/>?15X63#I=AY%!'$T3;.&P?()WRP.R+U?&J] MW?10K[1@K%RE_VN(*AK7 JU\=;3]@'2S?;KYJ:3[.7.A._0<*/'NN97Y2/J[ M\53_X));N& <6P.XKAO!N&XNQ]2;.NX.+=[CK[:(+^'G?P1 M07XMV.98BF;U%E$9(+XO';>D0L3-@2:/0,OG>;($H,E-?2UB1V+' [#C%AYS MQ0I+S8/1+ QO'@*FONR9R02FNN^/\R_G;(0.9X2]B3 UT#AO=MO?84ZOH_]Z MR[$)^YU83"*PYGF[T_GN^YK>"IQ$V.(95K75,J9G"..+,+X.?%SI]#&^G&;- MZ9EVF?O(PJ&? M=MQ\8=>>@*)*"8@/$_!:1Q_B'^*?G>EC77K$6 ;$:96> ;E.HC!+?=3/.XY. M?33/&\[ZU(=S[K3KRZF/YN&Z6Y J.##DQU$A/?JU9LM<^M[VMCD4E9-P'5"X M>K7^ =H2G8IP53%@/+1+\>7!DU@/QP-W[EETP6- S\(YK]?K:SV+QKG3Z2][ M%HZQA"WIN!,&+6[46N:V^4]%8Y%$O&J):':-P=Z?BD3LD"]XX9B*12[U4\(7 M3;UQ2Z_+W=<>D&AV>V7:\@JM2G55WD&)?%Q=V3.'Y;TKT4Y%Q9+HDN@>4G3- M.3FO7G3->T?'=X+F=-J[,M/X[J9]U#M=C53""(_>86G[8MG[T;U;4HF6QEV;'],]M")M MU3H=RQD]+>Q5\INIC@1TH_&0D))N&47R'1[?4CU[ MOCQX\?]$Y".D*/[K\ADBO3*8NQ3%ZF 3P-9JM-8CHZHGE0Q[NJ(YP0[,] )X M5>$I"R;.6LC0*8_NO$ /DB=QF'VAG13U38HJ6C^OMWNM;K_==!J=9K=E&ZKH MOM"4S?UN=_I'!>8\[ML;>[Y^3]HW>B<)*_K4Y4]U1=OP">-31!,@4A&IB%1$ M*B(5D8I(1:2J!JFJDPXR1"?]$2]?:'9S&8F1%[,;"&Q]+_;$'MW-*&^UF+<* MV#]XD/#HD3E]G052[6"82FN($=87AHP'C-]%0G=.A<\P)I'V=%7'Y<(Q\V)I M)NOS-^>\SH8F^W0U.ZVS$7]DD;@/_7M0$\S5_#36_/2H^PC?B&&D"-')Z S MS;]LJR_[9I)&Q'E&&D&5GLNLI2T_XQ#SL6XXG7HQMD%:Y!]L.?@ PL*X3#LC MO6[]M&# .^:,J/JXLOW)<*/V)\]-8^,Q5RZAJS-BO=:YTZBWG4ZST>[V^JVN MN6QMVTBVMKMERFZIA]1Q\YV'??VQ$)'*..%GHY9[W<.[?9P)NX(Y8WQGW:&9 M X/,FCK";+9ES_*#==27^5L[R,5A!JC<0%M'-X^6=T@W;+X-5I6V1T_>UIM] M6W)T%D;@O;U#">$U@6F-0BP9UZ$7SR-/TWIY:JLFG4*V[B2KG8Y!?40 MV?Q@]KFY"N=*\\Q.[F_U3FM8:' ^)G[LG3T"W3>R.4X/C8YCK._-\7=VCFX^ M3A?VTCEOF^*35ZVH*E0W7%D-][L;AT,1,;57X!R_8)X4HZ4EW\=%Q3&G40EA M;W]57%;1WR$S' O(Q*9U[ZW:)1UOG78ZL66P3K4>G+B5B$)MJMJL1@*C9S"! M\0+-*L%!!FV2Y:?[+-\/I:-+JXXN846JT >3@I"!1('4@-Z1#+P\B'W@9RF> M.]-44Y6<>,8/O 4O*E[+I^ JQMFIIWON^>KPRCB,YN\Y?UX,TK]__"&19W>< MS]Y=B6%\Y4G7#V42B5M8P0L_=+_^_->__#B_)/+N>>S=BP^!C*,$CR/*03#Z M/S&Z@S<.7/A)#7W%MUC@FEV[Y_//O M8$7O/?%P[.%54EOC:>9P)K _BL1R^RF/O@I07F$22V\D\/ R*KD_ @]5VY=8 M70=?#J;P2)?7V(,73^"N( '=&" @C?W3.U/'J)(:[_@ ?<;ASG NA-Q="/($,+T:P@"5H 1S"8O,7 M\6VF=!Z\8JXIUSR8@^).),QW^*C&,X-IN=Z,^_XCOA1L0>+.GY@.!.G&(D]^ ME7"!Q$P;D$*=G1[["9 FG3+.YNEHQ3=WP@.8Q]*P)0X!C ]73PO'8REB]6?^ M\I1DGL3.=HRS&8]B-4I?Z"8X(S;*YROQ#35\Y@R<1O>QQD:AT'?"? L7KB$, MVC Y$V[BZZMF203#4(.X67G#?Q-@W?&C(@7<.P%;!+-T7;20^.446!IH!W/& M9>;JX=[8@T'C\'WD-#$>"[1=(D!@VJ&('X0(%,M,M&4KO# WRL"M4[@6?U7O MQ$F'P*@<,25<,5.@MOIBU08(V#U_)+P@\-$5P*=!=_'_V*E #+1F>9L-:EP^*>F %P*CP&V MN$.)0H(J8Q7SK_@.?%\F8IK0<&T@02RUK,%KIR*>A".D*I>P;#*GSR*58>(# M",/P/IQX;;YV2O:1?UTN42$4WZ"<*B:!LV$%70X#!ZZ.X$<@)B@N5P\!&!=> MA+>*:"HS_;+ZD9H]AB)C"UVOC;".8_3D0<^,\"%,_)$2(/4P38,[9&8@&7A9,KT" M!@?WAT";_ZFZ$1A<%*##2343)DT9:#$):^A[J/MP_9!!8.AGQ>]@*1]X-,KU M<*Y^T0M&AI6U91TM'_A,<_#23^$LY7\\)*ZER,=S2V,189$0E@C)9U[&WKY9 M_^.;[VLKC-G\7C0](*AW^"WJCLPNX _Z6>DL;3MO%AXH$@IE9*#5")@$+\4?(R2%"M M^1X/0,?Z/@ER?/(%)3NON].-T+2I-/3& J519I(;#;/6V8K MUF#TFJ,.-H?N> M8NW_%#Q@'7GD[LGA9MXV7499F'FHT,Z*3K=R(K1NA >E;GS1_<\""7 H%A1O MZH6_E"\B)V'C\5YG?FY>V=M8*.SU4^]% M'M$67H5>=W;O/'U7R]_4>)\JPI&G7= )AWEQB*?0Y<9(#+C(C9&K8&[9;8WN M>XFV0FT;*)Z=QWK AY[N]Q&E0:R2X+F8$A^:V@[&D()[$41L?J+2+$^7Z!F' M,?6=5!R!_A/\ C$1>E4+ZSKD/JPK1$\3@2D=?E##;SV*XJ83*1EHL6:N.GK^ M^/YN[-DO39HV2/A7J6"XWS_O-.J-9J?5=IQ6H^N8*QAV&F;P'8]<\KLO1N%Q M;S_RZVGRN]_>JO3HJTW[2DV^(H4R56I'0R>U%V":]SIT7 (MG^N< M[R<.I(08A!B-&*UD1OO5X\-#5/:3);"+.M8)J&7T*5< =TH86$TOZ_@I'V[7 M[@;H)7#7#29*_X6)4N(GTD^DGZSD)])/6^BG4HK?;7))S9[15P]"+-/I1EBF M!FM_2;"K1K]R1?TBW5/]@GNJ[-+G4JJ#J?&JDR0G0U/K>')C9,C#T-).Y,BL M'&_#?]2./P?8.)J@!*/P]0Z,R> A0ZAD&R;M:?>1X)K"Q5YYJY7%57:TSW M$ ZAE80[&2;_7=4'Z>J?6!5B$_,>G7EWH4^U@<8)G'YC4K7,.;:59AF\K\Q= M5-)>I+U(>QE'IFR1]B+M9;'VHL!AF\"!NVZ4($#6]@>=B8/)_I+]/7CTT&R2 M 28#3.K+(E8D];4QJ1I]L::(IZ*/.Q6^6U/9OO8FZ#/'!%&".R7CPE7;?NZTJJM M*H0[-E>O/!-\R@2WCE,W-L+[[/@<-Q=FKD'Q.A*#*G7%H$C]4[B=KS#JN9085Z)N.T ^[E &6>),IOEPQN5]RQNPYC[;)0W M:2S)H=B5P*]3]9T*8:O4%K-"9#TM?MV%?M;O,ID#L=B7+3=U(LXE0.J_A MU+][7Z#BGXF,O?'C\0EYQ/'>A!&+)X(MC6_+AZ5LG?*[&O1(N&&D.LF^0SKH M]\632 @VA9LGDHE@)$;S1IW[CD&]X& S6=E*=*<1\V!TR%$O^W>[C+K&/GW\ M\'?)7"XG##T#-8U Q,P+[H6,$<=D%;0)\Z8S[B+T";*=&V+!I11XR"%0.E.A MHL@8_J,O#\<,1"F ITCU!C>U'X2;)QZ,,PY#L3HO9"A\_"4Q9< MB?J3.E+\7'Q-$$93[B_8R09>DS]8Z4[F"M]/K_GI3?V-^@R&PRV5QIN_7] MC?J>]U?Z]7M3K]*SW_;U%2UQ2[5-VW -^RF<3292$:F(5$0J(A61BDA%I")2 MG3BI-LI,[I A>#8%6[G\0/G!?\^.X'^_VX\,6DK]3<=P,^MZZ$ ML;Q-(_7Q05NK8>B/](/>SB)Q%O-O->8%#&[WO3"0WV_ASWU]=$?.6.[=+G4GIC6"3B2.(XXCPA'AJDWFI)5E*RB9"?Q M#_$/T>=@)NXRE*JV77*?X&O*4$%."2IHBZ(G\^Z?)D?/:3C&1,H68=C7WR.Y M(+D@N3 4!U$*AG:[7NVFC76$(XXCCB/"'=KP?N315Q'#V&J,CZ9>X,E8-S]4 M70,C(87"TG4AB*/]5YN\5Z-$/*I;:ZZ=\*EG^TFP2+!H+__P>_FTRT:[)*]@ M%\ Z^A#_$/^<$'W*M&4?$'E.R)B);S/L#%_#GO+5)95UK'2ZNPIO'=-LEW3S3=/CMI="JA>QUV[ M=-KK%D>G9>XP XFCE=;0.G$C^A!]Z/@"\0_QCX7TV6UG:<'T.TNFO^0@.GT] MWO-"#_(C>A"W8UBU0)\II#^MF7EY\C<0F4+"-&[QD[N[(W M-;>*%BK!J25%]M75NG890%*]I'J/IWJ;S;8UU"352ZJW4JJ7J$Y4?RU4)S># MW(P]W QK:$E.!BE>4KQ6,S0I7E*\5>#37:IG?HCYT!>KKM])&_D[ )$4J.-[ M@3B;"+4R#:?^G5E5:>G@]$>\_)T7 VNX^DF77$[8#9@-5;+S L1M96E8D(<_ M$QE[XT>CX_WT\0.;<,F$*F,>,2^(0S9>>X21P:\3I#:+)R*_SDVB2 3NX_P& MQ+#RLLKHB,>"19[\*EF$157P&GB,"UJ+>X%ZB,NE^C;B@8378-75.6._P,]2 M/9 7V(='CS$7N2C<181#@[F"B' MGZ8S6)= @2-SUTVFB1Y4"'.*U,^1F(A >OW,2Q)ZOY@SZ4D2^>J=ZT^*H M&8]@JF(61K$B)@/ZYNBAW?<2QS7",G'<9 Z4EE2OEC'\!\O/) X*>"> %R - M!NJ+)>[94[-18TZ]L7P>@Q]L:Q$(&1^;,I?#F1FG-Q M)CBOF4)\,[#"ZA4P;C-#7:L 8.!<01UXD2Z>-/*^C_P1^,QI&7D8",TM4->; MSG"\0%J@M12:Z90VF$7>E$?P&!B_ZR_R,@P#Z/8!%\^8%U5KR:@6Y@X7UX-+K) K5Q6#718S6#M96J48CBB"> M1$)D6E<$*.?*OC$P:V;4I)&G&#.P:F5,#:EKR.8O*%]8]T7>0(=0)G[J*VE? M2P'H*!8)P!4#1Y-_PR]-V:3M MKDBYB'Z*D#M"C:@8J*:&H]XIDR%887#4U?S"\1B4 M"AL^JH'?J5#B3@1H,_#%P5-GGG20,8%/J8U^/)^&"8HY\)3VM,91.-5<-AYK MQ@R$A+ 2% *N D0$X5T SU0*(8N#V)#+^:(5V'7,O8C=LC^30L0^.WUL%'E;+)_J"J_DD5$2O%^1HZB53<'*YI]ZBY0-8._9S][2V MVD*KV+7H$NLKS+O$R\MT$@Y;N3[Q[TI5%J!KCCW.RGJ]QTEWJ9_1TO'@$6P< M&+/ F/][XOD%]8D6%I0F.NEN[FH' MV;!3C8,R#)$OG\U\+]4^VC'+9_H>OX@$3K&6FL9(P#J@)M;J_*TVS-_K2:ET M3/CT*4OIK^D6*/R*\;88M0&PY"G;*P\D3GGHDP\3#Q87149 M@_7$W"-*S..R+!ET-OIM6Z.1M\W^]R6&(ZG'LFI5GFJ5E9X]+FFV+Q",ECS\ MU/$O>/@+&GBE=@6-/,_K+V?N=C'D#]JV#4-_M$[F+3&-53/EIE3]IMJ(K,%) M60,5 CW9(YAKG TCL 7W@SUPO6$UA5\CT%4E!#J%>Q:.&=5GWS3I/!RP_EQ\ M:!!&4^XO'.1HX#7Y@]4I!_!$?3^]YJXW1@?KWV=]F!$1=S2#,IWF5_O']Z &0^Q&*U M:7Z(I+NR>G;S>E4]P":,Z,53*BL/W^C[&_O=WNP<]?6-9J5>;P;;UH)"]U0X MV_ 8HY:\?* X(AX1CXA'Q"/B$?&(>+LCJ+R.T\7ZX]*6QC_GQS\ MV(.0XG,AC3PH[!GKC9#+A3WC7U4>Z-C3K&0:9;ZCE*;0PBA+JQ43^1ONVF/^ MGZ>'.C V+IS0G:1+S/42/YZS6]S2'XM(SB/PIT.(PWEXC<]>W-5WPP@SBA"D MXX.?WKN\QY\>//4@>#_/62X;#^-J2P7/+&PTUS7G5#BFDGWXMZKWKJ1VY2;YE/HV UTZZH- M_%+V$VY5GO^CSO-?OY#G/U48]-YNU.SM%5%L#KE_$.'>O*3QX+RZ<@>'"&N$ ML,N;3$:$'&9K4[^-,LMLL6X/_6#PC?_!@X1'CVQSU5F&EJ3J^LTZE52^>KYE M#I:RTBRS4Q*"A)"$T 2I^AM;4!)"L_[%@E@V*N]'%%*3;U5R[_L?LK1@FCF, M]-GJ+$6XBTM\_;DE8X<1_AJV.&11) M>VT+I@1_4$4^WZ>9P:WW5(X!RVD+^0X&L%D>3M_3U/X:ZL(QK22S.FGO+P>4BLU=->*(DMU.NO KO='=MR2?D8TC3Z MX])!\\M0P3;@7&\$CY-HC[/B90U=W?<4_J0@HUX@XRC11<>C4-498[DR'K5P MY],;I].KSM)$8N3%[/K;+)1)I)%TTN\^>_)K9?BAMH]K.9B,9X+CMP!8JD1@:+$(W"$W.<'P5&$@I=6(Z2C/A]L7CZA)H" MU$30(1R%[TV]>*[W"BAIJ5R/O0#N JVPP%8^(K$A.(;"ZE('M&%$@GF@;O3B,))J'");S3D9U-#B210F=QK].)%J-.G/?#:+ M0ABBQO+(2(?34%\ ?:3P41/A@?U@E+)\$B9R_F[U&P.F$!%6$L"K9OB&*?]3 M@:W!5 )E5V%"0QY\U:]:I(07)RF,MWRZ(%41J!M<['^]F+NW27:^",%^"X&I M&XT5D FFR<(^"H[,J7C>D.4%1M(3:)8V@0ON*U7Q92+ AO^N3#F*@YD9**Q& M6/54/D:>=!/PGC0V><$*K50//R3R[([SV;OYOOZ'^4,&P2BMR)G7 M@%W!,'RE26Z! R_\T/WZ\U__\F/^G/SGW\=8#P:^G1+PSQIU[1)!Q;Y,P"VZ M0/C(3_Q1O2A_E%(B\.&S&/_TYN8*0X1_-OYS>_6&>2/X E3;6?/ZZGI0;UQW M+]N=]F6_VVLU.YU>I^<,!H,KY^+RS<]/9*E(\!=J8U:%M@NBB#4JARH:>!IZ MZ*(I+XL_OL1(KT_ @7M4-1%^T<)]'P*F<>\;W=H2[IU$MIW RF!UG#:.:,_! M;GX"M\";L8]A!":5?5@P:Q\"]UP]D'TJ.!?P+? ]2B\N('NK0)/2ESGU]_IZ M^"7_KO'^>Q7DL/PG+ 7TN9L. ;YVGGE#!EV(&&D/$+1B(!*$1?5R!T%$+'5E M7AIGI(^'_P3@6OR1_Y(/00?>4Z"8NEL=^X&U\;!P34QG?O@H5,DB*!1/14"* MA#+#&5SX%M[L(71PP8$ZTQ"SRO/Q\NGP!QZ-]#.6KQ7_3539H+KFG/TQPS$9 M4<>.84RXE!2@RI?Q%:?@/<$#4;Z1N+!6GI0)3"]97@/L1[)_&N< .9IL[>^Y MYZO21K1OFF]63,L@G)_CU/K-?LVI+V]-[/*XW;U.4K:[*EM?AKMH7&TBBVZ( MYBWDO-\@6+M.=12[\B"<4J'22DV\YMIE!3W7T,_<\E1QUWL[#-2 0A^H@#73 MT^!?ZD>GS9F &5*D^*F8#N$1:9B*&O\B!/6*7\PG]C )\485$;-QXOMG,;A: MN15(]1P&JP@WC_%L&,U2SP9#\3G,9_@0P.ST:#!!AG%B]JF6:L692M%)%5U" M3 K!@R$5V*Y_9RR9B]2*0P@74*,/%3WO0Q4MS\('35 ."Z=RHMH2Z,FAG8M] MG2JXQP@FRU2H8#MU_W/"*XQB!=>;TQ.-M3G#URC1[JVT=?O_SQ?>K06CB7JM%>%S$D*C'YBD#) MM2-L%<9L-B13 +*I;E7:-"U!68I%-W 5SDN]?^=>3R#U.-1 M]&17>&JAL O["58(?80!^@A$\SU+]XK.V'7JC'U>=,8&VAG;"1G,#.*Z%6@W M)9R2W@Z,Z7 TLX9"C9K3ZMM)5G@6 MRI(ZP!:"+'J!*FK71V#QX3,86CC*#M+K9]72.@%X3OPX0WW@/QH\PFF&<(\@ M*)+Q<9S.#L\5+DRCAD4-R0SF.!(\GF"Q@^1#S\?*-?@E$MR=9.=3<;/>%#NW MS7"ND2/@=KC;IW$&>5/$(ON/*6\Z$X-:V,AC&K5FMU=KK]A,WXF,A7.Z6IVF M.G1^3OD)?@C6$2$GI/E"U5(1B M^&F+49NJC\)P,RN.^E0PJR%S1:0PZ\0WX2:(L9'%;(7+(D360/0PC$D@/!'W M.4YA=GL1/&W,TRIU':^A6IA%8B0@)IKJRO)8UT=CD3@\0PVLIB-";EM$=X81 MW<+TW$=0&AIN;0&UH'C-5& H*Q6NI2?C54@?M\KC^3*'.F"?19Q$ 7M[^^7S M]SJR1L@36"/^A'XS(:(43PWY$6))#O\;RM!/P#L<VLF:C15$J_+[KY? MQGIPDR@2@?MX%H@DCG2]_ P/^L"<@@0^\Q&J4\P8 (&Y*J%/&[P#!1[B"8,O M10WX%X%)%2B "]PJ/8T;9X8,3>-DP'5[CH&XZJ\%+Y@)UQM[+G"4 DE;"1JC MNV_AK2IY8F;.CN$YIVJ%W]U%XJZ0%I$%4B;[92U\R<,OG.A5+JZGT1 MX0Y;FK4^[* !%/([RR-(#<(\ZFDI?\( MF*UR9;8&HV)FQ37+QUC 9GP@FPWZ8C(9C MY/"5LR_60KO22!-['AVCT>]Q>Y-0/@CEX[0P#PCEXYC41[]E-;#'EV3XIW!5 M)';[Y?,"3OB-#F(1^D,MBQEG%.^3R6S-FF"OU6=]:9@QI)V<,B3,,<,9+$#6?"**&(&J.1Z%6O5%KKTB*$H P6V4 M4&UY"G ;C4;OO$^0&R0Q)#&;[[J==_HD,20Q)#$;.JX-DI92 R""=#H!6)$2 M(#3ZS5J+ )T(BH:@:/;S^)S>>=HU2=#C? MUQ8V,!A3&<5%J^J!WP65T'">G!(\4]_,Q];?;4H+M^V\?=O9<&-_AW$]CX\0 MI\6,4QY]%3'3O<+3(YYRO@F.E^'YB!6'_+'4O5!^-WQDBJ&ZIC#JC*SYQ8XZQ.8/GX"$U;G MMOWP(6.I6>2Y8E5AGBYH2&N^,B@@-7HCK/%J#Q,3FJ.9^PG-<>\CH$0J(A6A M.1*:HT$TQW;7)C#'3]N .2X7;#Z!<"3PPZJ&FB;'2SW8]]4X&,H(7:%HY(F! M&92%!7"A.6;?\X*3_?WC#XD\N^-\]N[*DZX?(M[)[^/B.>7T>/(E:""ICJ5? M8##_B3\B')&\!::]\"'B^OFO?_EQU:/FMQ0?.H@@(+M3B$;RXG'IL>H,=/YH M1/1!X?@LQC^]N;G"%?UGXS^W5V^8-X(O()X\:_>NFXUZO=EWZJWVU:#9@W^; M%RVG>75UW77:G3<_/Y&^+2*D57X,"6^UA+?B5=\9(L99EAB99V-L-3>KJM/9 MUI7AGZDRW/[*\+Z9/(ZS9WGNGGF@XQ8G(V-6=_2-?8OZJ;2:2JLMJ]6CTNIC M4O_?F<U06U6"O[.2N:))J76YWZF:I3J3KUJ!UV6_U:9T7/!ZJ&H-HA MJAU:+33U^GF7)(8DAB1F0VHTJ9J[7(>.JNU.X+!Z*>Y=W:G5J=Z.2ARHQ&$O MHO1[YRVJ8]L:-\U./E)$_[48\7\A&IQTMU#\-5NTM*M4=//5[H(.*)'+W2*UN)M+>KQ0B<"Z43@=B>3J,<+20Q)S):GSJG'"TD, M2"DW *)3YR=P\I%ZO%@B@Q7B&8L-UPF=EJ4>+R1&)$8F2C>HQPM) M$4G1?L:(JI\L*=VH*O#N@DJH2.,/ZO'R:I::>KQ0CY?BPE+!V3JS3@5G52P- M(E(1J2PJ.%L-DF\ V;X(FG_-HP"(+C^)2-VU#?Q]O^/TKOO]F^Z-4V]?MUN] M[DU[X'2ZW7:[5[]Q;DJ'OS>TL.JC!CL'_O5'2S5M"5C6"-^N7Y'1;'Z>.109D>8X[&\S;\JIO[_^]"7_ MU'C_O:[. C7B)OK(XMQCT_5:\&GWBJV3<:FT7]#OG7>:[1;(6<_IM3KFW*:N M$;>I>V1(]"/7 E5J]"=22E12DFNU5M[I_'11S#I'.*]^W-/I-Z%N&G:K2L(Q MR3*1[/J%DG"3!S%L8LG>;M3L[>6M6U8LD;Y%6<[GT]L'Y]4M#_,38;<@[,8[ M)-L).28P[:PU,;[E\IN(YZXUC^/(&R;:V\0BGX\?CAG KUV"S9GR)/8T]S@9 M6@:ER@!-;;<[I9.K$ER#]U7F$'8E*$IRN(T<]LNOJ:L$U^PKA]L[',?W*[;; M0]Z?QK\**;&/LW8Z<-L]&#'@E\(W:UT3E0$\T[OU,YV43O=U=_&U7P+H*#E" M+N% N"DI/A5YI-5^3:N]0[CW0C1=IISW2CI&3W*^C\]EX3[: M_B3,V_UFIX)3M.2YK[2=?W2Z$8M1^VO+\E.,^L**&ZNL/945KUR<:@OA/_F) M5"=*87@BB/U'YDF9J.1@L8)#5U@D@1=+]O;3ES_T^9I#R>A!U^JXPGUT%\L6 MQB3^(OZRF;_VM3AFZL[M-2S/N?"[)3EW%.<2"OR/X?*URI'R%18Z\_+<#B"8]5),&]@,$OQ0WCF^EQ*-A7Q)!SM M7CU^Z 7*SO$O#7C+A[D;MI"SJS?;%J,VT[Y-M3=+8O5\W:4-.$M5R@4AS"CV ME(?CW6>!LQ:1Y]EIN;IT;0GH0ITH2$[\^%'QZPM=O_Z8G#M7+0OZE?=>K=WV1BT3K5PM$ X5"-_!$ J9>-4R>.79"AA M17D$"LBZ@M*C&] C0O\,XLU5QPO.A15.G6=$.J_6;AO4:/_)T-P_!KNF##1T-BVV\ZMFJ4OM,M49^D@C#R MQF.!$@,T%?&#$,%3(7XB*EG;7SY%J<=UTXZ5NB05((P&!42)(,0QB"XL-X1K M^+L9PO2Z?5O7K-=M&A[:D[/[=V$X>H 78/=D4X:5E-(*:PNV:RB09X'1P5C] M#[456!)X;,31VSU#SU>=3(&%N$^-8T$4-//_G8$8>=,41D6,$Y_Y\ )S:]=8 MKCG::9F M8P\R*FS1[#DRY4DNSP,=-0V_C[Q^$9./+AW GAPI!;J+ [/%'SB M/$DWCL+I@1SZNJUZ'$+9,FVOK=%UU;(!*B8-?6!:;F;A6_WO#+FXF2<4@WEPDB>W0[8VYO_[_+[1:"N#[>#(E(7 MZ,<"!< ZS2"V^J;,C2%MWC9%#M FX=1S%PCR)70]/1VGV7P?S_]D(] RMWS( M7^S(;@/PHSF%3'B2( M6)Q$Z7[3O(Y6IND5WW-5'U\93E<"$@\CN _3"[;JRE>OVYUF>;K]H[CC,_"6 M)+O*. <33Q?_TCFQ2<8U>C(\0\Y[+%"Q5OC.S-L\> MG:DH>&JC7K<-,+5S9,#43J4!4P\[^HI4S3U%0S>J7??"GR3PTX.#GUJ-UVO8 MGJJ/YB%[[0#W/#I^9X6!48].NY*P3S<\/&UGG6$9SC2BWD3B7@2)V 9;[. ' M]ZTO73I8D\=]8"VL0:[H.P,^MK%L>PVK<5L MD=,R#%IJ/!=8E()6^24W2WL^Q23L/$$8"=TW*0ZW21-2DO 2<*>F6:4SIYY MKCV;4>Z;ICORZRLU>LKR'#3+4S&RVIO;I4R/*A;+L[JKCWL2(3]82J4K1?X<12R)5]4E%>P![$?RS*C? $/%@6P 6$=7:K!F[P]'G\:RYC$07L.HG"F6!2W&E$ MO!06X2.X>;Z^BJG'X[]L,(Y WK*+SQ%Y08K"B#)P%UU$H!X$PN@%/'H$>4HB MJ4J.AHD$JDJX6N'EY9/4^*KS0H6:!DD!V@\+VI%Z@9 M(]#WO$IUCLO!?9])6#=O#'- 5!=,+V65+ IF!0F/:"R*KLL@,;H40HCMT= V M!CK; !YM&U"TWO7U5>.BU;YI7%RW+[KUP66[<=&^Z39O+KJ7O4:W=% T*G*@ M_'VE1D]9'BIRJ&)NES(]5.1 M10ZG<7*?2$4G]XE45.10-=>0BASL>5#7=WD;C#MCYCH*?NQ"A7=2%9:B-08\#NX)FJ(_UC+^"!JSL?R#A*TMZF MV.]$#&-#+05="]HJU](VN08VGN:/[^^VDOTM/=E=^*JBNU[]YGFWXS1Z3:?9 M[G6ZK9:Y/;"&F9/R3K5WD8Y\SO\U;:%9=ONK7OG#3O[T-D]-.JVT^&S!FETDIZC2,^7.4S! M.A[]/8;;U_XXE")2VWAKI268)?%+ N"0 ) V"H ?P2A&2YO;LSEVT5(0&Z; M-K?+3.9KT_I\":$]![I/=)[I/([U'>J\*>J^,K"GI/SHPM):P!;0?@B/+7SR*JN/ MFNU:JV,L"6O+4I:=1R4U0&K@U-2 P:YM&*UUV]VC\Z8M MXENV#T7"2\*;TZ.W&QE[)?HO), DP"3 9'U)>$EX3UQXR?K:)\#[IAV]%^CX.C7@P>EG"].55/6RGDA52!XWNS7',;:']!)E;&&% MPWIHI(9LH)\MO$=J:)4:,GJ>S=S?-X,-G,?[I MS_7Q03]W&/JC]TJ\1L(- M(QY[8? N"4!R\>WIR2R@&U.$8^D:3$40OP 2L14C%N3[ST3&WOC1;.YW(AA/ MXDD(%\ ,[P6[2[P1#US!1F(,HY-LC'.\5W/DDL5P0WX.;19Y<&$\X3%["!-_ MQ(:" ,Z(C<.(\4!##3/X>\9!Q<4ABR,>R+& '_.<\R-[R_%XFQ?K1W[/ MO$"]"3X%KC?C/CY@&LJ8\=$]#V)^)\)$LBF/OL+#\4UX=?ZJ^7/A.?!DI6_] M1_UJX%=821AJ_"!$D#UCQE%3PZM@^5BHWSZ=+RD;\5B<,X;TRBG$?1DR(5&U M>7("I.)%8DT\$?'(G3S6V,/$)]:O90FA:=FT^.18I!QZ(,S]X((*&O 7.'[ M*7O 6ZIER7J,\V#KI6+7W\^"-XLF[7FL3?V/1OF]^ M\=;;3]M8_Y?TX((WBJ3;2UG\BOS!&NQL;T<(=]GVFF?):O&?21@#ORME))42 M<95RU,I"*HWCC5"(W1Q-O:AXP";O[R7M+"0]DI$CRXCS"F3D]R7#$X)A0DL, M]BU3%5J":DPF:"$D^^^"8*$82;!I/H_6"-&3&[P@%T%EG-#F!&&F,@ @P'@X9)T>5\5N3.]Q:W(Y+2>&:CY/%^^OCA[Y+- M0M]S(=B2N%21&/O"C?,X3^:A5AX199$&CW4\"0N?KF@DD%DP;)G!.\/1.3,Q MUG.EP8-7SS@..8#!$NY2N!URE/<*0X(F= 2JI2RE GNS$@M9\-8:9P\189OTT^/ MQ)1[ ;XRU72>R)0WO[N+Q)VRASR*'O&:M730*%J##HOA,);6&F!M[ M@"_U"XWHE;\Y7087^:!(S.@IF)++9YXJ7Q$<=\2&P%7*U*-SS5?$-3N-N]FJ M.8VFV;&#!V+D01\QHIZ?R-_8%F8Y@REDC1HX]$R .E0KM;R MV M+N3;$43>_:),-J%(SU7TOGD8[E%Y?U!;S198;!J\O^E"X+DJ+75D?O/D>AAZAT_MNVUV4A?L;Q[V]5>G1[WE[M9>.5KXJ MD]]N,W3#>O^3@<93'XMG-=6#WN(1 >VGR^^?-8?6-7ZL=-'$YLU%#D_+YWG2 M%1BC&Z5@X5@PA'G*'V5KW5#B2>+) _"D/M(XI^,GM:NX+K<'6G2@-@W67?!Q M?A)RW24?L@.2ZR[0I0P__+J(/++JRK=IJ$\:G:3G*-+S97X<:1V/_HX'#]?^ MF.\GKI46M;_X@@ X) D +8*0/$8X%Y.]![I/=)[1]=[!L^$D-XCO4=ZC_1>)?2>R<0< MZ3W2>Z3W2.]50>^5D34E_4<'AM:WQ9JC_1 \P2%W@JB0DDIWB>-L)IPUQ"*. M(XXCCB..(W@"L[[OBRU]J/K(F/:BZJ.*51\UV[56QU@2UI:E+#N/2FJ U,"I MJ0&GWR0U0&J U, K5@.-;H-T .D T@&O6 <0'H')[<67=F7MR?95'*^@.H2V M3G]O7K9V2"(?MV*TUFUWC\Z;MHAOV3X4"2\);TX/,_V>#WNVB@28!)@$F*PO M"2\)KP5$)NM[4@*\;]K!*0LOPA8":T@(?[&CJ7G6>X&.KU,#'IQ^MC!=254O MZXE4A>1QLUMS'&-[2"]1QA96.*R'1FK(!OK9PGNDAE:I(:/'64@-D1JRE7ZV M\!ZIH95YK+[3(RU$6HBT$&FA4SK0\UIT42'S]D/,A[Y8>?V*OW_\(9%G=YS/ MWMUP+_H7]Q-QY4G7#V42"7D+4[[P0_?KSW_]RX_YA5[ ]?C_H= QE$R%4$L MY_?DMZBC,_#ALQC_].;FRJDW>O]L_.?VZ@WS1O %=^,S9W!YT6@[[?95H]>^ MZ'<&EU>=>JOC7%\W^Q?7]?:;GY\L09&&"?PRE?K\P*M_M>(,XF M0NG.AE/_SM02JH\/^KG#T!^]5ZPR$FX8\=@+@W=) %R(;]>ON. ^4%"P+Q,A M8O;[>"Q%'(-4+B,>[#L0]3KV+!<=@#Z[L_AS@RO(XY^)C+WQH]'U5)>_\V)X M@YO5YT7>/2SHO6"Y#+""$%@XDZI17MWWZ>,'ED@0[O':TWB,!R/F@7X!)14S MD++B;W'(IE[LW>&W'GP6WV9*->$/^D$2[IT_=>E9\.8HG+)XXD6CLQF/XL?Y M-6XX!1,!7[AQ@O#.\#T.T^4R%B,&(P@D_ 1"+\\9^Y(,9$+(A9H30&_1CAV=6F-/0 QQ? 1 M1BR8LLMX1ZCT"@M=-XG4A/%7<0]WX"A&8LP3/V9P%V<+O$L6J8M_\>QI .V5A *.ZBT(IV9!++Q\^O!P<5REP0S-0IIPCV8>I0I6H4)'PEZ'O MPR^1!N .@;AXV8,73]+Y%.G'YL^'Z4R1.K"<$[WFDB4!,D;DN? (7%,AV&\A ML%;[?%FQFE$TFVF7740+)\A&

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

]"TK7R=9.B>L'T M0A0@$90]X(@2%HO'(ZRA54B%"0\UM'1F\M3"[)PG5*^J^)>X61N/61Z2^U,5K(5<2UC*KL/SB\%7BH;^ 6!Y":> M;4;-K=/S9'PW-2C2P'-&\;.XYYAST:ANV+=E:64Z52K;60^8RSXQYJ2&C!%N'!/74 M:RN$P91#0C$S0/88;#ZK!9$(H,L\'60M)PY)%4CMF6?$$42?ET#.I::7:D.T M%VKE\T.)(;Q,'CD-1%"TWC$="R$1I;GTTJV_0P9@\^K.YSEEEIXE]0#J_KB2 M.G9<2=UDP.LP1( HXYAJ2X11"*O@.UN#H+8#S$Q)@'W9$H;NQ?:;.R*VWUS& MF$,*!_.'\$A5*S!QCA%B#8E5K0:82I!>;+5A:!3!2UB7C5EOC<9*JF"O"&-C M23.O@\91D$BB+BOQI^Z>8TIH>MO?_[+J[K=;HDU)Z+SW0%(6MU0<94$DF LL MN>>O+[.^V'U^R91'!NM *Z.UY0Q"^CQ#COL-@#3=YZ\LI&K[_/40&?0^?[J M.]8 :@",%L2'A2G@^P**I++/8$D*=[FRC"L&W.O!DWU6 M>R 10!<:]F0&2RBLE8P3(#T@P3U]GJ,4\&)+KE667?7X9R.DODU6#-,F&! 9 MAA8,-T)2!(' EB@5=WA,+&ZP&2_VZ+*"X56Q_SH87@^&[L6FCXE-WV3:06^= MH4"!>$2(8HVV81&A1(L;X,X1#&\HMMHP="\VHXZ(S:A,8JL,PC%CDPMA+$4* M;L?K)&Q>Q[BS4W#IQ58;AA[$]N:8V-YD*DR001>&A@/9' \DVRT3,;VNL=@Z MN\VK ['5A:$'L1U3DN8F"_J<&V ]09(XI;T"\9CF9KS&Z.:EHSN[J:L#L=6% MH7NQ77TX(K:K#QDEQEA#+.7A/YPIY^5.J5/AF^]:='8G5WJQU8:A>[&].U:\ M]]W?,D$YEUX[0;A$F 5#VH#M>($@S2M^\ M%L"Q#*-52&BS,Z'"_S<6F[@3\JEZ?J:'[^3(:EAT%A,X(5B@%B _#.4/)I/*Z4?&N@.I(W =CG#5:9QRCP''." 5*4*RL]7KGIT*(AQD#[T!2 M=3C0"KM+9L.@8M^708(4R_-#^7LQW^0JKDNI+0JU6)2CR3IG,1\7B]NC*W?5 MYEG0D1 B8:QS2BDC(7>[H)7R<$ 'TCN14-DY9'WMB+6]$8,$#T''1!(".58 M$V-WLPI+:9_1P'-NC[=&YCSRKI04=; 6N&0$ DN4-SXPV R&:A&D M$%G5ZQ":(?0M(>0NPB-.V D(.@-]%[QAO$0WK_[:)!A),@THSZ97!^IM,_W-5?"Q&Y63Q M?C5_4P2[(A^YY9O\?3Y;%OEL_/?PQW]]"D9H,#Z/5H-JW%V&XHDL###'QE*O M. M53F?^,\C]K^OQI-XX^7-*G1]=_*XX;[',\L(T)!P9XV BDJ-=WFET@ \Z/A+ M,Q&5R5%I9C,_/A;3:;XL3DCOT*-9K% -F0A+&;582H4XVTT8&]]\*Z0SR;6# MNDR*1U_?:,)+W9B4%!I@+?3..F(X]3MOP;>XQZN'.%N2+S4-,(T^UE]G 2DU M_C19K,^R'?M8]SZ:&8RQ0YAIZXFD)KH?V_7( <*:GQGJ(4362GB)$&F6]#DN M)O%+)?$O4:;DU0<:?I2MKWQRP7-8'KJ39<]3&5&80&TTL280S%&#Y#:TZY0' MS;-VZSO%Y_"3VD/2C3 WPSEH^G[Y2,:L%=Q JAD*[C]'6B"W';,%W@W3Z6F% M?ID4BLL0XZ!\EK-(+\'Z=_40]$RPW#Z4'_/1J'RS'/]X4R[O'_+90HK7_+1N)SET[$IYX\_'ELR4_6>40VXHH;%ZS@4U-#8 MG=?GA'&Z3RX<7V6;"[$\-VR-"'1D8#?Z;\?(4:5E9BDAF@%# [@"255JCYF6]OU1&. @)5/OZQV?3+/J%+3Z$]Q+1WA7!GDM65,[7!1:OAESQM*I.P4IL;'@SY[ M_31?+"K<2WFZ70:M9)1-T%P],*.3E&S=(+T]U6 M0!FR@&/ #.+,!5W&P):/GF P(-_]H*Y^T[AR>DIHSK1BV_PA#T[H.J.]&/^6 M3U?5B^;O:YS9P#.I(89:*8J]CZ??M[.F2#8G1$^?> >E]!/@E$21?S&JJ]FR MF!>+Y4V^W"?S>AUDSG*KC>*",@"]$02J;5:D9[;%G?;=;94E503=897@@/?3 MVU7$XOI6C<=K?//I+_EL=9N/XG(V7_AR-1N_F1RX,J--=QD!6ECC#0F .FZD M4XB]\!PT+^S1759X4E[TA5P*EGRNI]ZM(N:?BN>?'EH;FG23<8>=U2Y&5@PT MV$A+M@?HO":@^>FC[K+)NV1%^51$&^12L.27,F)\6\[?%Z/5?+)\ MNHY0%^./3S'I+Y^&9U?SY;+\6/C5?#99W,=?K0MAC//9LIHJ:?F.( )"$.': M$"ZI=DAKN0WH>P! [',I]/X)2QVLUE/H[Q]GE0-Z[;=BS+O"!4RX.,4XPIZ^!(<\L:PYG'L MSJH-]F#W]HII.L7FO_I*]&=?R8=2OWPE^M57HAYBW<7K6Y>/[O=->HW&JYG7 M4(2]C2DCVD"&"?;824DQ 0AL,YV\(*C%CDQGI1E[T)Q#Q?],K-\-?]]4]WWD M75&]]D R*1P&4&$K!(#8" ?=2YQ6BN:1*W@A,>SA@YZ"U!OC6!?+/XIB%L,O MZUV7?^9A"NNP7?"P)@^56%FIIPQ#R*!!R#*@=?#1%>!B9X5+T&)#\Q(BX?V@ MEM[#C9LWQ6P19?'4,O!UJ*N,(&\]848AHBF-Y]"QWX5RK&Q>* ->2*R\#]@Z M"'X4\U%07>$G:KH62M$HYO%U+QE&6@J)L -:>0@\DW)[WZ*W5+>X3?@R@^2I M$>M%36R6N[@LVN*Q7$S",*]FR_+#?+6H9NRT>D/F/?$X..7 6JLA!T;3;>*P M9U"WL&*^A9!ZMVCVPJ^VP=93768X++Q>6.BTA8QXA9G>Z5?K6^S4PS0=X%UF,#E9=&61?_W,X&AA\V)\,W$7YO@55"!WTRC4&R77WJ MQ;)#?C,0W,K@5$+FF)"$4ZZY?OE06QQ1@9<9 ME.\>PQ<&_<=/7\ 7)O+[^A=[?O[6LG3GA9'(AKN*; *\JMUAP:H WT M1!LJ>//B'O7#OOETVD@%5!;2J4-J31!9?]MQ2N/E7T;3$Q&0-99["C'1CC +@7((*HADGU>7I#C- M6%FRIV^LJ(=,;VGM"6\I,.L2-QQHS3S5@L72H)- $ SKABE M4@COC1**<"^Q->>ZQJ#!51:595GU'H/$T%TB>X ,'Y815&$JJ4#!Q(8,*"J8 MCK/LMS1?FSLNDG.C'C"-#S;98C09QUB>SS^5\U?7-QVMA7ZZ818658V@H98* M3U%8>:WBT@1#FRG)A.FU9$W+JLJ515%VB%#_'W>+(LN"@L UB2!G%",N+>$< M*1=O 3-M<@3J[^4.PQQHC,VYI-ZTN*X S D%J&4>@6!>PT#M[8H6E**]>&.@ MB22KE=]-#-VE,8=@SZDU\4(90H'$4B@'H/HH%T=T,K0 MEUT DR*>O$X3"N-9E--/,<"]-D7*V^5]]U>,@MH@$D#15>>LD4USH8LC)^(Y0@H*WVDH0Y MVF ]!PQ[-/X&3(7&@/5"A>5]'O[O4_%^]7%1_&M5S);3IYLB']T78S^9Y=-U MTU643V*5DF@(&9'Q/!=AQAI$.982.\.! 2A84AJ+YG45SI$SV ,)^T2[MUVN MWXIYS)M=J-GX7;E8?HCU"&WQJ9B6C^N#,]_:)E2P.X,YP8%PV%**M60 (D:8 M#ZZ$4ZI25L"P-Z&<0A9CP2STFA*K%):,.$LDHYR8%C=C][<)55E(U3:AZB$R MZ$VH%]WC/H4_8@#N1/#I0(M,:(<8P$Q(@*D-QA5#L7H,1\3(6)+_PK:C*LNX M[ *>O@()>T9[,I9PL$TFB8E>MU.8\+BI CT2 DH+ 73A;_Q" U&M17J:(MT M>)DLXE9!3ZCF0F)J- _&#(H! 6,Y-Z[%;8%=!J7ZXT@]>,Y$@9-W$>U]/J-, M(:$8HX'K89TV@D*E""8HNNNBQ:V@G44T$LCIN.0;(=.;U)?YG[(=#;3(DQD ?IY82@;Q0%@DC!4:&]7G?^UDMB$0 ]4:"C;GZ M>K2GM?^A-IF61' )E;!H[6P+'?Z^60*]D)=K0[07ZIHFLT9+S2 ) M+BB@'B+I@$<6R3!5H"!MOLIV%LM/+[;:,/26_M'SO3EAL@BXL/QP;2F61$)A M-#0,BGBJ7?6YL7-.P[PSQ,[#FQ17H3BYWGFRD #C/)<2,;TU-6FP3B[46N]" MTC4N2TF,ZN72"W/@ :;,$<:H=UY9ZKA@P)( @#&])C5U<=-.%^2IAUFCS(8. MKU^12@1WQH37 4&U!QJPF(LIG;(68-=K\+?]]2N595'K^I5Z&"61\,O-/PW$ M?*!Q9FB\M\XPJQRD"/+@OT2M%JN(NYB5/SS7H&-9IP'J/">2ZI]?-%P"[3'# M 2/*@1/*(PZM"^ A"TQSTZ!^1:FS6I5MD;G$$VB.NYBH33C'U*#@!AOKMA8. MQDA?C+4Y'/CUD#1QID$GO,@YL3'!Y*J98"^_"'P$99 M' "1 [3V6D-?=H!,\P,H_YPL[T^E;)X\DU*]D\Q[SBS!1&I,J: @K)?,6:B! M$3:HJ>87+=H-6-!,9I,)_F;8EFNYK,B7QV5]OZ',X_B>1WM#$&2 M&N U8LASS+PEEC@QP&AQ4JDF0:69]&)U]LGT/U?%QV)43A;O5_,W1;!'\Y%; MOLG?Y[-ED<_&?P]__->G8J&G^>3XU]RTNPQ"8I'S\1Y)0:56VFGEE;086(^L M:%ZWJKORL"D9T!-N:;[P?:/-CX_VY W*B5^2*8.494([8"4-QI&R4B K'8MI MV]0WK_397:G8+C5*KV@V8MG?5G?EFV+QF(_S8SSYZK',>:RI-0$6'3>UH5(: MZ&#^6A(SYUK<0M-=2=>$DFZ+QR55J' ::RB(1,%SI9#38.-"%N:):%!UL-I1 MF43?]# "/HVQN;0Z ]H0;7#X'PJSU,&A(?@Y9A&W/XB^^'!/$TE6JT20&+I+ M8P[7U'#@B1(44JJ0-@$( !@W80&SMM>LKW85*A+SHAXP?8G][ZO@U@9?]F85 MNKX[>0I@W^.9HHX9Y V@2%!&A- Q_2:8Q]@XJ4R?YPW;5;*H+*(R.2K-0GN/ MC\4TUHP](;U#CV9>*LZ YXP*1(G#@E AA&&..!_T4G.CO8?@3BO))4*D6=K? MN)C$#Y3$OT29DE??9?A1]J:XRZY[*A%4LF#>*%G*B"BJ2::0NL@1+K74I G#:=.Q%H/@48K MYM5#T$QAI7ZNN/YF.?[QIES>/^2SA0Y3#KC%U([Q7;&XFHU^#/_X^X>K7_+1 MN)SET[$IYX\_'EMD4_6>416-!&[9& M!#HRL!O]MV/DJ-(R [@*21 M4/]UE8X:1 .@QWU(&N<:%W,-^F_ZWNI%X5:+,K1 M9!V4R,?%XFA1^,K-,RJ,@\;X=3F*N$N% 9 8.,.T=QH,**K6B83*SB$[7_8- M53%I@",O>+!F8/C#:D<-MBI6.*7-KW-(;N5U+-HT %UV(HYG%A@DC=?84J%) M<%K"2)V+9I6&I+FOESP5JVLR] 1AO]D2E%H]J9MP_TZ MH5+3#!GH5J@P1LAI9#4@S6,ZYRB?W4!7=('2F73(YU=Q_Y9/ M5]7K+N]KG"F!B4>,Q>-!E!(BL23,Q7OKE%68-7?>NTNO[EPWM,S*>;%8WH25[[#/7K&## D K4NBK;])-1H52$H?US4)/H1>"&0PQ$0QIYCEL7@BC MNR3I+M>&Y(AUSH9W^5-':T02X]2^)E'L5L$>7QU%)O'.HJXTPZ"11WBA :7"Y%,?98 M*H.=MD@T7T/$-\".1*AUH#^*^2CP-/Q$3=*E$2ZB'6*/Q0ZL(6C^5BLHQ7WB[+#_/5XD!< M*N4;,HDL%TP#I!6G*):KLEZZN$4*C%4MT@\@^ 8XU"V:O?"KK;ERJLO,2VNH M4@X"**G!7A$MA-)24T!80+XY@RXD,MHG?"DH\TL9@;XMY^^+T6H^63Y=1[R+ M\<>GS6V;BW5P;EE^+/QJ/ILL[N.OUONKXWRVK';/8XJ MN>>A-'VCR^?Q,ME%^.#>W^?SHI^WF'PZ6DW7T[J^U?EB,@HSMI/I*BP8[O'$ MY7F)Q[).S>OH73Z?S-=V]B]%OEC-US7O^WR5NKN;%W?!NMO]]OK6!M7Z*8^N M8KQ]<19/8%W-%LOYZOG>PH^1?;NO:QGWER?ANFXQV3LRCY&+>2S &6T4Q)!HN,41!\NRQUWFHS*^DI-ISOQ$11 M:J6JGX$FAXB:!-F^MD+?E?.UH):[X>_^8B>+2/PPD9,GPVOTDFF'L$#28 &" MAZ. 512B@/86 #M7.>2CD%LO)PSIOL16' MZG2364BUC[78*'6:$ DA(ELD. /-=W ["UQU2J(.L>M]T=)/N[_^;5+,P_OO MG][$E+;J=O61#C*(.0LZ'G/*,6*(2^#9[ALB9+"7I@[*O$X'<._T>AW5^GH: MU8VC*OUDBD9H,:!0!4TMF+-QBVJ#!?#07XREG43@A_C4(93_WO0:NA$^?%:= MF4U7L\?5.:Z$-*]DV?WZ,6RX)X"(X$=)A-1N M]J#%DM"]2W%6/M;53XN7Q( =^,_NKCL;9$!$GPKX8/W;7Q8,6'0J3NK MG'G;:RW>JG71TPKNJX4F!5#]FQ>O8*ED8[QZ/D.<;%?=SP^51L?WGNE/X7]?@*BY_#)QH/^;RID*M?K8-,(,2A 9XAQRF1 M6DB(A-4("1ITKZJTZ78&!/33L_QOBLUYF<7]Y%$_7-/3:R#=L' M$!]T O^AB9[(,CK6+#,:!Z?/2:<@H?'"4!_^P;AQ&&C:IG)$QZG[0V10!9(W MQ+U_-R@>@HM6WLO5IY48]G6SS,0+L8#3PD!+#<'"4>8,L8P1"AR^M*+V::5[ MD#+= WG)G/)6&BH M3.YF[L_1?3Z[VXW[]*;_L789 H B";C5-A@? BEO#(/ QFO^1+!*AA> 2R.Z M+W?Y$X+4OX:HNI8WL'A.=YAA*;SA >^X >HY%^$3I%8SK)C30;$.-<_Z0FVA MY!+IBZ][1GMR.3O8)C-<6^049T9J3#""UM+MLJZ8@M^0?912XN69\+U,DE&N M=?QT!8Z[+AHK%*:.E*2<.DM<\_M#^C:8SD*A>NCUQ9!MT/1YW"?MI[W/9T) M0+4"0@!!K6%:$,:]ET!CZQ 98"I4 CF5Z9'I2^K[XN,G17^X4>:YIA))&&=' MM0&2,@N"PD08$L'\ /,>TLL_&3Q]D>" ]7;"+#[2*E,&:D0E-BH 2+602 @F MN)+8"P=DGUG3WYKMFP[V,]/KI/UQM%T6K"^ /-.0: THC(6:95CF,>;" !$^!C.@.RX3RZ5,A4EO[DFY6%[? M5I/P5\]FR"H),0L6G554RX@+< 0Y#>/16MO\G'!G9FDW<-*_3U=E%6-U\^BG0&<06SDTQ*N]FD_^.!?&_3L;;@+=)[ O_?"XN M%5SRIAL\#5^WD5-4KLX2"@12B%JNO>2<$@'T L.G#-+JQ^4A\+?:;Y83&XG MQ=@'(:C1:/402W@7XVMS%2]YZ(+#35^9*2@TAQ11+"TE$&G+B0HVH37:$>B; M7R38F>ET9A[WA'2GJ>I[DJI?U3T_D!4PH 3HE]&^J97WO*==)C7T,!;"Q/'4 M0'";,?/.&ZD)0-"J2I7V.DI]V0YV\6H&.I\&V17O[XMB;RSR=7;(+J)IBT40 MZ/K9RD7(D[\T0X9J["D3@!@:/D8A.-!6"*VA\L#V64.A8CIS*[XVM\()L8NK0$R>^I2R<^M*MDW.:&,A+YI1%P3>7X:MTQ%*LD AP&*=< M\/P-9:!/+94H2[D3QM2#Z;*SE"664"'&N=62,AC\!.H,\SC6U\ >#3#;)HWH M:F4IUP.IYX2\5POO"0MF?X-,,R84#JK06!>\6*F!5T8;(HEW\=[9H689#]!V M28+P^?A3-9_SJR;AN^,(:0:D@&&NG+FP?&X7626B;L99C-7B>>@O)MI)NZ1" MZ\QXY; R3EJEJ2'I2]Q[[.\3ABDAYID MR',JI#,24TX55L)JP2$.TR9:6]=<\!TG_P[0)$V$\3E9=-*H.-PHDQX[J(E& M+N '+/9@:UDA(#RXU,/^[:5:@2;=0'BI3*+6$@M(4.=0D8U098)$$EGJ*"18!06R< M)2:X;T8-L$)["G&5G:#3J_SK"/ZS.0F+A89!LUDEJ1%.:QV^'!RT(,<&R#YC M8V>6> M8&J7\;EXZ&LU7Q>=EA ^G^!YMDGF% 48(K<_B\6 ^.T84Y% B2YVU MS;.0.DOI32C*Q.CT^O%6D?[Q!IGGP8"1T(/ 4ZH]U!QAPC50$'BC;?-#&IUE M\';U&;?%IO_MSU=98U_<%5!I&_1P\\QCQKD,4X[G<2'FRJ*@RSAA!$!K^ MC+9ZS=M-O MR$]P(01!2@ G@*%/P>4Z,0#G 3,X&\CCX937!X-\NZ5):[;@/ MCB:ES 'LE-1@"P_@JKE%WUNIV)IBKI,I60^:8< M,&^&?4%T&B'62V]K@M>WS)!!AFZ'1XQO*>_14 JTB7?^8*D5,SBLT=NY8L![ M33=)DO=8472U\A[K@32(HY$]5F<5.*S9&%BMI!%68AG3?3;H" MEGYY; ;CMTF9B[%1 M!LF4\S D34%49(1R7ALMPO0@#PLQ<-NY.:";W]=VAH*HE>54J2!J/61ZRWM, M7!!5&6F0="K"QH%'R@7PMK/T9KA9D GEGPR>2SNRJ"V,S*3P'*)YR&8L<%OLUPCA!' A+N83K.9H5"&#MN$;"NVJ@%H>P"BLH@J M'("H!TM?XKZ)$;03J_SNF0QZJZ#Q5%JMN5#QX#+=S@%1W[S"9/V4I+,L[$V1 MZ%6:)S_:5T]E4GHHL1!>6D MYQ'E+_F?DX?5PTEA?O9<)K@P AH8C^=J'!Q2*W<)&LB+ >[^-))$F0Z#>O)< M%*,?[\I/8;+19X_2Q,]_CW+$K^2X^>FK5>5M&2'-I^JA7,WVI7B>:)%A#I@! MG JM)13.*VVW7)<,#+NBR9O&*41I4>E_*^^FB%#%J$Z^7,TGRR=XY&,^UBP3 MCAI.& Y&B=1,AD]#DNU,@WG2W%'J(4VSN?P[@*8_%;X9WZXJZ.9PT>C5$=G% M,394:I\%(Q7H>#@%>P,1H$J0G=+4 RPHGM*6G2!4;\G^+XNYOS%3#[,\]DB M'SW7J%__:Q-^WNY'J?ED$5W3 ,3L[EV8=SE^6RRO;S_D?QYA5P]OSP@ 3L4+ MO8BB3@D;K\3=XAZ6^>8JJ[/C*2FY.3R$!Y')\KJ>^0:0JUGQ1@EL'S+6??%^.]WKV<'5Z/5!C7)YM C.L7A;XC=EQ@/-'; !0JDX9 8' M8_I9ZI:T",BR2^#N>='LBYV_SN9%/HT?X]*BTW/Z\9;IKQ-1BNT\/I2Z>'UMP\8$>5O\N83HEW*V MO#]&FC0OR+B7R! FB":&KZ-\<.O;*>A!\PBEN 1NG07$OD\L_N'4WQ6.P#:+1\/JRD*_,:I?_?^U]6W/;.+;N^_DQ>^-^>3E5N/;. M5!*G6*!*$:'=7=74*UVEV <6PY!S)RT0WA"@A5;4^-A"62)G ML<"ME*VQ!+9W;1W<%<6T_8L!D(!9:0!F3")LPQ87.TH8Z7'.BDHM4SS3,%;O M./I,B(\ZH?0YJT$#Q0E'?)OA!27&.&4YX5!9K+'$4#9P>>*[9WAD2S =#T>U M-/KTP/_2]LAFZB=CO-J]H""$<:BM4@0@ 1'1$IOF/)&8VG''$Z0E\)G#&2]JL5 C=O7I:MD37T8I!"7%_R04:N' 0 M><\4L\0H;H0UNEFIYV;DHDX:(IY3J:$;7J^90T8IQ(R/,2YJ0T]9/KDW8@/]?F>"E( MQ?7H#;PRH^,F#M+H/KV@1+9;E^X5W.+JCD =4 M:L$1!H ]4-UE;45PG)TOP&_5^"DREOBRO2LTKN\Q4.;-F^6ZND?'/8D_ZA=* MUO63!56$0P-$T.$-UE)"K?<(6\2[UW!+'M9]>9X?"1'&PN;[D+KG,$_+XET^ M5V"IM&5:.&&5#EJ!" );@RSUH+NK*7EX^OC9.P,!G>Y]P]>N6 1O/HJT\_ M^/9(($K+D07W#BHAM5%,4<2@(DY2PCRD!)H@072)0#FPBD_3VW*V6917UT=F M]5PXR%GC"\]E6(+@P"ALA1 H]H79K8A[D+-/Y\%(CN24J89':=31%WL#^6]E M=5-/[F[GT\GBA(_AV3&%T@I1#<-=$"1H!9WPEC7 $ I'%V8,LD\#LUZ7,""VX"6A4 MI<:EDWW?35;KLE[>?_U8_[T##Q:2&H^%ID93 * /*^>@F9^7/4KO#Y:-GXYN M22#I1+)W\]EL4<:/QVS!ZSHLXACAGGV\ (YRZ*GW1@.I*0$B",:[N4K9H_;H M8%GS2$,>#AG'"N M1T?UP5+,DQ(R'32=C]#XQ(88Z \-5SM3P]G M>K2R'"Q[.OF!F@293G1\.UG/E^I;&0^", ,S64YF1PEY9$!AE4$:$>0\9(Y1 MK*CT>^$/DN[9H(/E$B>E9#IHLJ6M[S3](Z)K\TC!L+,<&\:HD\)(;"%"S0JT MYMV+' SAHAW$-M83DEQ$/6!TOB^L,%_>M"!XF^%%4/%,6+#CS'F),67*['=' MV!PY.\5D7D^NI7-9G1A322@44LX;'6&T*%/$[X1T9Q-AH M$D][4.>IP2@)$G\BEX2W"BDF'6+<(.@-%,@TP!"/;FH.0[ 2VP&'H2]AWF##5K]!"HE^J$:$V[UG;G;DB]3JYX84Z(_,SP4IT0 MG@NOO/3>70!)\2Y=$L"R66=$) IR"553B!N8STHK_8'E.A3?/\"3H@.Y$L% MS.6=$(8:B8C3C"K$#$<24-=H+]KCG#U/+D'(=-!"4$ T!1IC;14Q"(7@!#[^6K4W3]_ 2=$!TJF M@R:W$^)XZN21IPNE* 9<>:VAYT!P[<&>11WK88T>3(I-9P?KC\<8G4V*!1$N M'"Y*$0HI!%A;WJR 8 /'2]%.='C.P70>#+D)^:AB?3AI/FSJZ>UD5:KI--;R MCLDSLW]N[OO;KM37U3:'NP7M.[RU<,@!;[4&2"GHF+/*--6HS4"%N49^&"_IQW)K(7]H6^G]3U M-B_ON MT^+2Q@[^_]*2V+=RNKK^LRNM-$&6^EZOP\#_*^Q13RE@$NE'9", MBQ@M3QAHU=%M:)?TD86T]U*?>DGA >/1LN-$$'>YBD HC3T2W#E(2,&DTXRH<#+$]ES=**,*]Q-; K-5MVCO;!V&)]FR7 M ^K7SYL>(J.< -'Q33TT0FA*(*886V5ICW27(3W[8^2\\X#,Q5A!\9H% ;O^ MU^JD^__IHX7%%INP1: EA#+BA1$<4"@0XL#JK+=A2Q5W,)I52:'*5B5H'M3W M^==-A/]C5+I.,\%S0PI@ 9(^B J,"NJ8D,2XZ#B/=: M$R,,*,C%#(D@Z^08 MVRG>NW!R/ZF_Q>H_]^4P5_?A[.5B44[7F\GB0XR%J-<_3G!"@K<6SCDDPK(U M$(+RL'P(K5,V9LQ@873W5)#!PA>&9I;\J.8Z9+8VGA,ZV/Z9(L"#D#+(,:0H MXT@C:+A00GL;_A/=XR$&+JR>0,V\%J8L$\\Q50!#A&Z#+%/:!II M:7T>!+E(^2Y ^FWS[20Q?WJNP!IRY9D.*PEZ%6(B<"Q4V$&-HI=R1!5Y>U&B M2H=!-GI._FA'S\?/%9H3:GB05)$V-!Q&6F%J;3B88HHS,=VWYV "?A)Z]L!@ M!,:AW^IJU='XO1U::+3M/!N;O2+JO-!0.,&#I!(#28QHY6@:C8[?W]&2&*_+ MV7V*ZT*+U.CABE<7 LC'!9!HC=^*:3U>G>AH<'%-@S"JQ",;;; 8BIQ[Y9 MG?9VA&$&"2CU#.U[09.-\$G+#@&(&.)8:H-P^"'J2Z)9(^4]HDP&\@@.(@'T M1.5E%I51080V4$/C+ $& RC#WYLU$J%?B!30G7:MJ\MT0^IU+$ M_D[TDH_Q?N^/?=43AD[18.%&,IMM+-'?JJ\K-5U?74>:;:^KNT6Y?I1P]Z&N MOL\C:\>>:[O;S/UQ%]B]U.4RH'TH$S?U)PJ/B;WV7(0H67X 5,X([-)/>MSM^LPQ#/H;U9.#,L[]86$1=$!B\$ I)HH"$E#:( M!7U0CL+[!8UTFS9_3+EN_Y("H*"B M!D%4>D(1T@S9!RE$*=(]:BMY/;)4?#4X2+E89>M!;7,V'1]08 6Y\=9B@@74 MF/M']DEE>\1A)J]DEIH%D@#2+4\C?#!\^'_+2=UDJ/UM4\]7L_ET_+&?EUR N+*H/Q[)BP,8S#3" ;MX/FF!F$FW6"(+U<.D8B M,;6J87 9=?S$H46><*(\-Z00AGJ'+>=8,VFP\!*0/2S ==<6!JY;D8#0+5BG M T2Y9+J#^R<>T?5)"_JIH05"! ,<-J 7-J@\2$,CFQ5[0?FXW2O]"=F",Q+@ M]6?@E%&Z7,;'("FL6.%?RO_9+&=A%I_F?ZQ_^&I3V\F/C^7W:O$]VCVVTPL* MS+R.2<3EUWHSJ7_X^?7Z]O/OU>?;:K.:+&?OPU+69?E\RX>A/E58*)@R#GIH MN,>..(,<45R%'V,5O^[YO8,Y>]*1O1H5MIWX[UTXW^91MSHQT\^_!S'IAXL1 MZ(\G?/_KJ^71=A5IOU$@';0]B34$3@6"F"!9ZH8\4,&<\2,7Y+B+@CH(JUU- MUU68BI_7J_4O,PV_Z,-B[=Y=>*@,D=HK( A!1@LF QT$1(!C3WHT;Q@L*>42 MK#4(F)<4JW8YH;JJZ^KWN-S)7?B7]8\S1:SG7E-P"Y33)B N@EY, &5@3X.8 M\O]"[LA!U/Q$H.6RZ[VMEC>?R_J;#;^YM,4MSN'-4ZL9!:E(!1;HISW 00E$L=B.<_O)#Y,?\:8ZVHKOX+.%9XY8)(43+!P\S@J+ MM=2 &X*@57B$UIZ4=$L"2B?2??I]OEKY>K*B1]3^8+24EX5)@DNM^?,Q@VXBIW<^GBP>?&%E &>X8 RQAEE(H ML5+& Z@<"W^Q?5)[!FN&FHP'AH$HFY6L6MZL=V:.S^'+I^(4#CQ>$"B"V)A3 MTB@)X8C#+U2_ZD?)$VPQ#'0OC7-<[."!D;/8A>UEL/1!'E6:$Z,D=CZKB-X^ M*B$#7YP'3"=Q;Y?B8S9U72ZG/ZZ^+N8W]\'QQR2_4Z.*P*SA>N->"*DI=B"< MHD8XI$3@;ZY4UA+ +3T?/4E0#05.KMU\7GEWXL+R&8<" 4N%%A)AB8S!!@+D M:8_#_'PI_V*7?%;H#4(.(8P%Q3"BB12F$G("6<6 29&>6]G);6YT&0BY3=ZK@;#&-.KN/& M6*IEP$5*2#!%3G ILSI$.]3];DV)HW7U>23=+'??.].R!04[%J D642 MXOK=9+VIMRE=)U2H/J\ND JW%-"048FH T8Y:Z6W01#UC $TPCKPJ0,D,D,X M+J;;K:8WA^W>4]"P:APT)(*AIAQ("22"4"HL.,'<=O>+9G+3Y&*G;GB-BW=Z M,TT1:QM2BI4'X4\3JZ-+[QC!3##L^X@@F7Q#N;CE3* N$U 1V]C5Y6H=JRML MRZ+-/@0]//S#Y*9]K-ZQEQ1:"PS"40LT%Y1"H[D)JI3S&CMIL.ON2<=;X0G &55@PQ,I0IK3@R,0DPG"F M$A#^WYE)DM?1R,,D:7#*%8+_?E+'NCW?RTO'W[\=I.*%-=%2A12,5?X@YUI; M2PGSD- PC7:I_?G6V[WBA349O=IREYH14O6A/RW((&W?#Z,W#**'U8XV.0!)$F+[_B M!0:>6J4P":HV0D9Q:1J,O$_MC\YKK!""-& I'.8;( M:2N=HAKN)4+/1NC)S:<<)0+M$NS3DCT*)SE4T?HF$ 3A!+:.[!4"1V%W'UK> MZB-)R7\F*+EL4,,VL?U>KM9125^]67Y9!@5^52WFLVCF_[3YNIK/YI-Z?N&/ MZ\EBLIR6GV[+,KJOFLX *M;;CH;$"UOF/DUOR]EF$;C(_7L3#X]R?5O-'JVM MC9FN_4L*")V50BO H"%<40-:N(Z3KCLYXDH$@U+$K9TDW*[^5R4_H T<=R MVTWLPZ0^$=S\[)@"8&XL8$(A1[5% #A%FC4BID:8NY!!X$P%5RZ6V#7U6GTL MI^7\>Q2*?I[VZ=CDEF\H/",N;#(A.:., :LP?-AL&([0H):!788!;UC+2RNC MQ&@"@W*;'R@.Y)&&:>N=DAQQ3:##DDOI@,?MNJJ^;/,#%BJ<;4X2)IA&5%C, MR3T"UFG1(_W@\YDSH28YI)FGIOR2;7V^,!"X("CTUAZY!!&X3B0 M#<3>$#/RV*8\A'[:\7,(1%\['XW31O("V2>%+>7@8G^KJMGO\\7BJ"6EQ&T[=2@52:HA@>I&ZC>?U5&"[O^]<$8&'%/IF-EKH[O4W!M-B!R!;5S@Z$>?39^7>'2UY^O! 9BW"%/#/-+< M2TDHYLU\+! C#-M(3Y[N>'2BS[OR9G)7+>9'BY,]>:A@$G,$J0 V5OH@P 7V M:>:E/&BE)>?-(DU/IWZ89+,9GU6"S'(&D#2*0N2)LI MI>0EZ65(V;'&&$-*&L209=1(9*55#W@H,T)-HQ,ECM<8.PN#;/3L5&-,2<$H MTN$"DDY!JJ6"N%D+TF2$Y7V2T+,'!KGH>?7[LJQ7M_.[$_+23\\56D-@L=2. M!_X$BMFPIKT.94CWZE\#EVT=6&;J U)V@I\T##YYLC"6:8%,V G 0(F]55HU M'B6DQQY#UY$VSU&X%R8OG]:CE*&WXU/ M-NJ,Z&$#T7D G+?75N7TOVZJ[_\]*^=QFY'X0R07>;2[PJ^*M^7-9.&6Z^;D,9P;?:':!CBWD_GV3/SZ2,% M9)@+S0W!0B#'L:2*/81:2#?.B[$7^E52*%X&&4=UYUV$>GG]5LA++\-D"#,4 M>PH)8OO98,V[U^)+?M%U!_*@A^J\A7?S@$R6DYMMK)5;V_)[N:CN[N+?;+E- MPKQ>Q5^O/I:K5;6II^7J?ZI%+&+\3EGUL?GYF.\DU>NC,QX*SX#F!"$, @*. M-U@$ :*[()K<3G&#(!TK+;X.CFXL^?T@;4 M]?5\,9^LR]7CE $5#N+I]K=A67^K JG^'A[?U$?3DWJ]MV#*((J(T]A(SF4X MU1^$/,%ZN*L'"Q?)P(DY(4T8F7=BJTQ^W2KA'^KU_#_;\N[/UKP>]'L%$U'+ M,(8 !9V'S!"*&[2,=MW5I,'B8 9DP#%!?>E[^_M\5BYGJZO:SE?K>OYU0:\H-FYO-D2XNRHP6&WV"][!23"\+$?MS<:M^D&T?D=! M >520,R]=MX!2['<'_?&@^YVA<'*MU^,C_K#-X*\SB&+;;TO?]_EPX9S_%,\ MUB?U+.NW_'PY60;!9O%0CW]UZ036GV;ZH:Z6X)CSJIE>+8&X\!4#2H'YBU"D89%VZGLF![O;> MP"OB.=,,0 @UI#(6>;W'BP'27>-(G!R;D3.JR^$[ZE1:-?OG9GY53.QS=/Z#0-BFTM@C)W5KZ[5 MK-HVFCD9C'CH\0(Y[I4$ @NOL$5A[VO9K,P@C,;IM1V8BM5@P+TFUAB5)_@% M<,1E..& L/SE+FH'X?EP9IYDC5;C"^@)58AY2RS$A$'-*6O6CIS)&C703IOL M1\+#U8"2@I30PAJ-O??_\JF<[AKO^K^_?W..U?2Y=Q1.4"\A">IVC*[ B"GO M=ZN"RNH15N7/+R(/C6JNP\26UV5=EV$!01\/$M@?;^>3K[%@>2P<51XK-G9B M9"$Y!4X9&AN.:P0QE"ZMOA]J!9AGGDMFKL:D1_+:75S_\*_;(S'V%.;(.H B@7"0=@!W ;[C*H M!& :^'9;Q?:9 M>ZUS_KUTU]?E=/VYGH0MN"7/<;&EVPL+YZ617$MNM:04 X:TV]_D3.8,8'\! M\DL6D,?+@B?+!71]90$E8] * C$3BGN $!$-0M:*D3M=AV:+WES8"^6_^/%7 MI$8IA;T6-KP,^YG)8GIO\-U&X.\LF[]MYK/8DO3-\GXQNKRNZO)S=3>?,L!. MRG'=7UI8Z8530EHH!=3"<:-P8Q R1HTHS3D?0U070C<7#Z;M>$F=,Q@R(JR" M%L8H,$>:-6)&NA<_'+@:UV5DNU0X9N.5I"T/N;,:P; CF+/8,Z$E9LT:8Z3' MN 6P!+1KW?NP&U*ODRM&*0:-B1GZ,$%3SV9[SM4_[GE@]Y>GY-_]NGAC#]#Y MX1\+3:EW"AC@C:2,,"++][<,1LOWM0\&$0]8HA@2V4#'!#6SD M6@T Z9Z9.EQ.?G*RG0U#-GVO6L;4Q7JKJ'R6=D&I_O@C0_=XCH&:29^4N$X-+80#Q#IE ML=VV7D;1 YL'.'/5F.5UL M8@4VM5J5X;_9Y\D?QVKDG1Q60&T!=%A@(@6 %@ @]F*0]3T*7@PFQ*IQ?Y.9E2I0=D;P8Q\3YGB\5/(PJE">" M*,_#G>DU% QCUL2]:&4,>W$BY/D4/,45O=%ZO=SQ4L3%BS+%99CAP3CSR]Q/ M^J-/CBT8]A8SX0RDWAM!2:P+W$C<'.?L,-]5\.A"P6I8G+(=%)O5NOI6UN=S MQHF1A7&>2DW##4RH8Q8*R%&S7@9I=[[()Y FX(NT*&4/*]";U7P9).B=F?=4 M*LS1<057QB-'K>8:R\CS3K*'M;J3S[?,& =<)IHJB@DAM'O-C;4VR8_OC$OXYH5^G1R+5!W::N M[LK)\LNR39;9@:<+@QTE/JP 6.@EPH[;O654.=#=FC1T/$%'*J?#(A>-WTW^ M6=6-M'E*3OOUX4)C[+RA!/B@HP A@R"J]P@%GNY,8?X:A;/> .9BB_>3;^75 M]4_3/7E//SNF((!:SAV7GH-PL%EE$=^OD3,\;DFM#]&>%E%(#-'K9(=1BG"C MX(($,ESSQ:ME>4QT^^6QPDA$C( :>.4!@HP+] &*$2< )<*Z2 9)KJ^Y< MF3Z@8:IH.9JN_S%?WS;3/^3&/K*).[RMP$@&."V51$NOB/7(-/Y70S3,6ED@ M5SFPKE5UALNNV8^X$&%7ONF/WTC.HT,A%]W/HT-O*S@408]ST&H@G"60.],$X1N! M2'=Q8\3E"0S%7]D,+&7B$P8X-*ZQ&'#!)XS%KL9(H-I'?K11;W?UF M&ZSUV.4X*2&0V;2<303SZOIC>5?5ZZCH-V;:8VK.LX,*$Q 2W#HB.5;<*&4I M;%;)#>KNN!JL8=@%RPNF@O&!67+50QVROU.@P6P3SN!)74^6#ZUF!_W(N^K[ MEN1OED_^X>KK8GZSW<\G.CREG<_[^&?,ZL_YT2&)&F6VJ^L=)ZT^EM-R_OUQ M==,\7QL4S=WFO=_-8;/D^H4'!VXRYO*\9M^%,2QSB^3I:/@# PJ'M.<<>4"# M1N,!P(C3!A*L<,X\I[,<6X.2_U<9OS]T&17")Y-M$]A\<$C!N%(&AETHN!3" M>6G5'C L[?C3)GN1[207]$+I-?+#*#U:8V&#RY#_*IRIDZT>M],S3P:X/#.B M8!XA2IC!'FMG-&5 V?WI2?*F.+2.6.Y)JFH(:'*1?J?J7=6?ROK[?'HJ7>[0 MXP5C%A%NC9?4N6B6T$XV*Z.&^HS.BM&*!PF R\P2L2G8;K*G;X-GQP2V9U B M3('@E"D>X *\6:,F3HU;/.A'ML,\D RDU\D0HY0/1L('*6)>JF]?-ZOU/!QF MS3R.QKX\]WA!#!!2&0T59P@AHAS.&#E"/")+W&AB@ /1=[PPITO#L1!XLS2$K$5,!D3RI+4JLV""Q:>4YC MDT:)!0H@[0&+11LS!@.,5FY+A5[F1*)$M4@EPRZ<61(JIIQQ# HMFC5:Z5$O/P(=[$@J,/2[^<7)CL^*2\= MW9) THED[^:SV:+<9CHN9^JZ#HLX1KAG'R\D0$%\Q1HC;AGG$&J]/Z \ MU# M[2Y0TK8#^5(!TXF(GZK-^C;J&O'/U>HR,1P84P(2[AO.@$GIJ,=;: O)P M3O#NIH_!8B:3$C(=-)?.V X'1M UO2,02J-9F*/9V_(]QMTMWH-%,R8_4),@ MTXF.;Z-W17TKXT$09F FR\GL*"&/#"BHUY :%$X.X0(+(AQ^\1!9TL-A=7Y! ME4M0,ATT+S4P.8C\V$@1W7P4>4D8 ZA9)0 ]9*.A9=IA(J:2(?7GR:EA"GAE M.3$68 ,(),#OW0 >TNYI_T-+U\-PT/ 09@^+>+./AD0^3'_%7ZO=)/7O;)ER\ M]\L++*RUT!,6N3D(4 1![SER0=+!'K5+U1X\F/S4,E?/K?.,$/-^WRBHTD%" MP$))QXE'6''*=C@BHF5WKU+JP/.,+/-\6'I6L$<=K!Y/JUBEXE0$VJ/'@HK" MPD4$.,-02!?T2Q-NC-WRD4$YNS)T]6#F8H"G,2C=8+#QP MB&H*)(NRH^$*D3TD!BD^;J=E-\(\0]U>B+QT.H_2#7D)\B:PN:E(NP]EO54& MMGV>8_YZD"KC5([9WEH,#-H?<90""[R#X00S$ 5U8C=_!EUW!7JX2+*.!*@& MQ*4[7=]72_?M;E']*$L[K\MI0'?5BJ['!Q:4$RB)@D!PA"R!5-!&/$* H!%V MT$Q$UZ2XY#J&[X6*TQUS?GJNT%I)Z&#@1J$%U@A0OH<(JZPEZE^8!-8'QVQQ M0YVQ>5C=OY=%W.ME;;+X%:JX^?OIR,T#LZKB",.:N,8C1H%5[1 M\!?:K#5(E2-,S[@LR7_Q8J4#-YLB_:!.;'$ZG<;[S(B" XH\DII*#(B$3#AF M][N6:# ^R7U4S),&UF[Q:@=QB#]7RR/=AUJ.+)C3 GI@(?(X<'WX#S\P/B3= MFZSG2QG)+.X/@^P0O/&LC--V:*$ADYP*115E1,BH,+S='L@>>>+ASQBDA/*0Y@.(8E M(;"9*?0H:];V<8D@/?A5:G@Z$;(5_9[.BR**):;*(GM?^'IPJ,P^JE"$NAC,?J1!JJ_?UD%1RGW-6#'HJX0P@71T1&,F236"VW\WN6OG!F1'-6+$D][O?7 (!L] M)W^TH^?CYXJ !5,$2BXI1RC,GXJ]+S?\I;M!9#!+61)Z]L"@D_#[R*+VKHR& MV2..ZF./%Q1SJ*+D9Z46*,CIT%G/"6(X,"&FW1OKG)^Y]T+$IH1PIB/],4/% MD0%%X$8D#"% >L$AL%8Z=S]?RUQ@X7%*2FE(<(*>O1 :/V5')2>-B:"#$+): M3Q;;0^BV6@04/Y;K37TTGNRL5Q36$TX55E '?'2\N4BXMPA&4-DH38Q'BDI% MG&.T3H=4&NJ;35V7R^F/]^4FYH9O#3B;Y4PMEYO)0LW^N5FMR]F37+#?ZNKW M]>W'R;I\2!"<_GLS7VTI=+2Z7;[O%]X(I1"')L#HN&7 *!#0)$1RH0SO7HEC M"'/:T'PW%IC3,.VC7ZB; -%J_>FNG,ZOY]-WY62UJU*A MDS!P(%_CZO=E6:]NYW=OY]_FA[BOS;!"2:QYV)\2"2\P).$::NQK6 #=W=H[ M7/V'_!PT )*Y3KMFTKM*U(?!"XO[7D99>(O3:JNN_>S@7JW?5^O_+=7.N[&08?07^_9_'\M[ M):^!*PCR\VIVK/GT(-\KD/+&"@4@59 RJ@QPH,&6 $4ZL_APA?M>X)6>D 2= M[O.=N_%CN0Z7R796-X=JGSSS9($LP# (',Q0'R9I/+5B/T--NC/)<#4!+W)K M)P!O]*>7"TR\_O%FN5K7FZUS[6I]6]:?;R?+J[NMR>KOV_/]S?*>O8#]TJ7:GH[+[\? M5 E'/N.">DRD0,0"SA!V&&"^%_6 X]TK],A7M*M>%Q$S;[M?9_Z/\1\@K_VP<#4 M2.-<7FVWVW7<:VH=]NKG^;?RZGIKWWZSW/G!WTWJ?Y6QQ<7[:GG_\V[LE[!8 M_2.,BJ!,EC\^5[;9N??;/BYK^.'3E^T>_\=\L8A7:4O?](5F5W IK/?6 M,(^!P)8ZQ_>6?1ZN]^[[XC5Y$%\NQ;(J,5]/$^7K03M57%B ZV,\+E8/JS^E MHZ3^7N$\H99YP"6%DE&O(-V+MU;TL+[#5^MNO# -$LHZSUYL84>JFYNZO)FL MR_LK[2=QS4^BKRSNT8_E:A/VRGP91NR65UT']>KSI+X)VWOO9GU:FV);V>0< MX>C"4RVL4]XY@;!6 @D.*.3J@4:BNWD+OC*GZFL@7Z;-:;&QP.S?3PEDCRZD)Y #"5U&OIL?5,"+#'0)$^R?2O MR=-Z(;@?6&Z %A/[M@P?5IO[;?=76X;C7(-B9Q 6HSZ$I=(A9: %W,:&K1 3 MTFJO#(36!/ MQMR6H5M98!8.=Q++&5-BJ*-8>J-] ![2!BSW=,L7TQCAM8L<+0L\'DXCL9K M^ )JJQJIJ: *2VTE)H[%/%AGB&5,:$F$B&W!#8L]++EBE$HAO#=**,*]Q-; M"Q5?/:]><&OVR5%]-3'B?S%[>^B%]=(KJ[$+"I<%1%BM&-","(R HEF;7'8L M)#PJ5CX/SURN_ MG@=K7]?3@]'E\Z>/'\O%M@O@YZIIQ/FA+.O?ZFISUS*/\;S7%081PS5#4HDH M\WC)J/%(>Q(@U%)U3Y4=KJE+7ZH==-@,"ELZ%ME&XOQB[FN;=]WR/060'L6X M-P4\H) @02S'ACC(,446=5<+ANL(,S!3I,1K-!)1Y_BOK0=S==%@VI^G4$A) MD:,B_%]YJC&4F,E8A\,XQ"!Q6;AKQQZIID%V +1H]S?F'W/79EV$$SSN.<^ M_N6>:\<;#DOBF?>!;H *!(204!E!/45!#/)+;"V I//A3Z:X M)[$8*J<: LIS.DR&=L^U9IG!W'/G@?T*W7,86,:L1$0A2I61&F$K-(]5!PT@ M[7;MRW;/M6:!H^ZY\W ZYUNR3 MQ3V7%O&_F/T,/T.0I@E'EE"FJ4.!$@H2X8SDED%HNC?*SN>>&Q4KGX=G+DX= MIL\G"/<7)9BZ<)51Y,/V=5IZZ"1'$'C7/&ULY+UM<]PX MEB[X_?X*;M^)W:H(NXL@ 0*Y-\K=:;9;WZUS^! M/Z=_2JK51;U8KJ[^]4]_^_2:?N)OWOSI?_Z/__8O_\?KU_^+?7R;B/KB_K9: M;1.^KN;;:I'\OMQ>)_^^J#:_)9?K^C;Y]WK]V_+K_/7K]I>2YB\WR]5O_VS^ MY\M\4R7?-LM_WEQ<5[?SM_7%?-O8OMYN[_[YIY]^__WW/W_[LK[Y<[V^^BE+ MT_RG_6\]^Q/FJ]?=C[TVWWH-LM)/B?9PM6EL6QCI?OS;=S__>][\ M-"C+\J?F7_<_NEF>^D']L>"G__7+VT^-GZ^7J\UVOKJH_O0__EN2M'2LZYOJ M8W69F#__]O'-L^C*G\Q/_+2JK@S?'ZKULEY\VL[7V[?S+]6-AM%\VO6ZNCS] M$3?K]:-/, R5AB%0&(;^^PL?O'VXJ_[U3YOE[=V-IN>G'O@] &^_!QL+74/" M.Q^0YUA]^H&!\7[60[<*B_C[CPR,N>UH1SV*^,3_U5O]M]X/FT\_(;V-\)ZI''UQ]VU:K1;5H1//11R?+Q;_^2?]M M=K]Y?36?W\W4?+G^^_SFOA++S<5-O;E?5QOZ9;-=SR^V,X )P@!*C AF,,42 M,#1X^8K"].=8T&T.5\\Z5!M7->HP/XI^IFN^F^ M\]I\YW4*=H'VO]NP])3<^B(LN2U7-R:IJ->[#OFHW]#U15*O%]5:)SO=+\W7 M%R\TRNXG?KJH=02_V[Y^U#XFZ8GA2AVA\[7\:'=.JMNL-:+J\=]R;81[\$:=&)*/YS?SX6%@9EWCB'L MX6B8-&;IM^5F5@C,I>)0,J5HJ5#.\3YR%5!*K\C@:2NRWA]A2AI0.D73L'S% MW)=01XD>@$LWX76F,:ZJGN;'1BM[,CLQ!>SKS7.Z%H0E9[4Z)-EOMM4MO:WO M=6P7]>U\N9JEN.0Y24M :"HH IF&T)D&6&1>DM7'X"AY:O)KB\Y7OGHQ[%VO MQR4W1 ;Y,J]#5>W?<>56O?M3/3%E"^+2R]5\7[YL->Y#O38K+G2[QW "S"_5 M[9=J/6,RRU66%TA)S%'.*$^S#@$$J'21NI!V(RO>#FHRWR;/#=(6J*/X!:7> M3@/'8MU-"@,0'D45'=@[(XXQVF :&AG%LSI^#W933+G9+F_GV^K]I04$ 1!3 M!2P00I)!6 *0P0X"+E+L(IE!#0^7)?J)8UB6[=1Q-(+=Y+&#F=27T])'%_[. M"&249IB&0L9QK1Z@&WO/\^W_^I=EM=:_?_WPMOJJZ39E.\AQHX&&,/><[NMCM%L?,$X%#L^I;/#L3&G@L\0Y7=E& ( MKJ>A?*&=>GZ",!QGSFIWO/3W/8Q='4^164G)4P2H3D=)(05*.PRI LI+]()8 M'E#['B^2'F4Q1V.WWXQBF+9P5,?!F\%[CM&!Y[@J:4.9C5@&I7YBFAG6M^>D M,P*#S@KZ9G5WO]TT@@UV&2K*!5.84)BE#-$"EZP4G46)2[\DT<-.9'7\M_O: M[)__L%Y>5)MDN4KHQ7;Y59=U\_5OU7:37-;KY,U"M\WR8GZ3M.O[/QVM[B<_ M--XDX$?/BKM7&SCJ9&3Z_5/'%MBK9,?E2(7T&9YLI+ 'NQ,3OCZ>/"=SO=GI M(VK9SB(H"9498C)CD#(IL1!DO[V&,[\MD!YV(HO:I^75:GFI%6NU3=YOKZMU M\O[+IEI_-5N,=F.MTZTLI&Y9T^RO6S$8#J5;V81T*_/2+5=VIZM;SIY8Z)8? M.WUT*^^4$J8XPT30(I.(,)9+_<$\15#N]Z,SFEI-8?I^=F1A:C$EFSTH.XGR9NJ\( U!DIO\[/@Y MX-%*]/?7[]Y$IFFQNVRJN2-J5+H>(;%7[>8\A]FVN5Q]K3;;9JOFE_5Q5;LW^CI,WW-+)T6U7GZ=FU7B M-B;,.,Z@8#B5E%.49U1)ME_'0J+(9U^K]9?:-G]T_GB7$72,Q+XNK=?5\DH/ MF&^[8:";M0EYE@+M3YQ=RAB5,3>)/D!I*_AA,\&G1)Q)_+PYFT:>YP^_#M1W M I6@,YQC1IC*6%'2@@@()=U/S.),CX'M_L(O_]KI12M.F=TS-Y"=&1;-I67) MO($7J.Y\F;B>]690S@+6F1,I+GV*2FM*IR$R ?RP+2(=F;&5G:.YN'.5JT@5 M+7*.%4PA0;DHLXSNC:=V-65@DY%+S2.4CA-AH2BU4Z<1V'23JB. 4YL7L^/N MC(X%)G\:HA;:J3IJAW6MS+YLWZRTB6:68&]_ED*9(:*8PESI&A#H!&^_>[I0 M0KH6:'Y6HM=I!IAK1>9)F&UA%I\IU_KLRS8Y0)I$BO4,2V>+MWZ\3D.)>GOQ M72D7@A7W6: CR9ME&&.*8):E%,LRU[;X?L:I0.Y*XV/C#S@?Y$2AZZ10+.Z\ M9X8Z0 ]CS0X=,6(U1>3#X%0TIIIH:9.[HYH Q9+WV,H\AZK2@%+K)CEJNYJN+I9E]:S>)7>Z_\7+I M-J5ZS;M.LR9_&HH5RAFGNLR1(UL-X_7M7;7:-,NU=+7X6&V7[4'7$Q4AT14@ M2 EDF40$Z/(02"HY% 7.^I" ?&SHS!&+Q/8T!&\:R.WVL=+Z34YEOCS8'!#[6VMD?1 M]=$#FL_5MRW3+/TVPV4IBARG&+&4Z"&K"B6[<5NDR.GN<&\0O !%GF)!58$1 M127C3"L)I4HPIDH1>T?E#EKR07_7,3V)Q[N=7DZ"K MRWI]VP:(+A*4!2QQIE.EK("PH&;S?-%(0*$ *A1Y>8.CE1D(,<.40BJQUA6M M-IAP2EA&(2O24D9<7-H_6QL[W=^#B 2@PJ M.P7R)^R\E@_"E9MX.])T)O?:5!=_OJJ__J2=-&D7-'\QZ@*/LJWG"#@A*+VY M&E=!^L.O _495XW@E5DFNGFS6E3?_EH]S" K&<,\Q2DK"9,4*IQW?3X'0+B) MQ--/3W,$*2,EQCQ'I<(4801A!@1GDA,2^RZ+7???H4H:6(G&Y:H3SJ39"D5, MOKR4PIZJ8%KQA(.S8N'+UU34PAO_=W+1CPD;O>#WZ[59P]>EUOSF?U?SM5PM MQ'Q;S8C.RHG^2,Q%IC(I)"IDU_L1M+LBXJP!F;&48YB*4I:HP(3F1&8I+E$& M"18X=FZQPY6TP!*#3.?CB\1@LU<.?_I>%H]!F'/3#R_2 FC(5&NN+5S5ZX>9S$&6$Y7I, IS)0N!=/VS&PNRR*A;]O'D MLQ4U+W@"Q9!$B!'".."$"D%%F4/')7/OW*/!E'2@7!,/1[9LTXYX1'DE'98< M!B%_KM$(5M)>/2A,$U9418"LTPAP&B9%PQ ##*>ZF)*Q7[P=C^U9\#8:X ;+R\/ M_FB4>,XHGV4CP&@_]O>98>Y%R?CCVP]VW;,KN(_H#]5Z62^ZG(+E0F=EV89)G5=>;/?SK6GT9RA77!HRN@M&09EP)C DG&),G!4&.\1>51 M,7B29C_NX_'E*0"V5 74@D<JKAN<]7&80(Z<)&,(RT!!(E4<8*"6&)1%K$GFG8 M#X3CJKE!YJX:SM39ZT9,UCR5PYZP@-KQA(<7U,.7M>GHA[<')Q2D'QON&M(J M5FL+<"$@+W16DP.8"UK(@NZGZTEN=7/W>0N,*96EE)>Y9$B/+IKBK.!9@54! M)<6QUSF>#HM=7.VE)$X$NFI)+.[ZJ8D5;<'UY(@+*T7QX6YJFN+EP[.JXL^( MC:Y0;6C1&+N97^E:J0"2IUFAI"!4AU1L+O-NAT(I"ZM7C;__5)ES(G(D%"XI M0@ 2I 1392IRR#$#L6]BV(-)#!I[Q7"DYF65B,>*FS)8$A) "QYY_,SX]V-E M_#'OB;ONVQ^<]T34M[?UZM.VOOCMT_5<=XOW]]O-=KY:+%=7,X!TZ:T+':TD MH$0I!"78QSX("''<(''.%,Z+,B^$@MHSA$&FG164;2G(E2\HPI2 M( &=8*% H+!$#I;0]D^+] M^?'&T@Y2LL*1XEQV2*"23C>SQ; ?.2WH()O+F[\?@D>P M7R5?'O8_\6N#W?%EFRBM8ZEW(S>,HQ1&:9,X6NE.[#D9C=A,$U'8F!X^%=_H M;-K?4K#:U#?+16.Q>8>&?EMNS"XTA7&F4@0!5IK-#*/.6$YSJ]WI/4U$5M=' MJ-IWHG1:HX$Y2JV'+2]%3:RR-C*$V+;3>>F-+HZ_B1& P M@.:\1-Y JM/"<-(=1SZGJCRN;KRH/5Z\V*K/^[MJ/3<)UBZGVNR>ABU4EB%8 M\%SE3'*&BI3NJUT(N=/CTKXV(FO/'E97CVP\7Y#VYM!.>8:@STUX?)B+HCO/ M4'-&=OJ2.0W5Z>U%';:+.5XKM:X7]Q?;]^M/U?KK\J)JDJNB$!G$@JL229E3 MLY>O[$PACI33E5$^!B*KS0Y3^WKO#I=?9>5'GYW61&?.36B\2(MS8=,)8L[( M3"\>IZ$Q_5QX>HE2?SXWWZY MWVR77VZJSNHNI8(\)27E#%!<9%D&J03[,HZBG%L^U>MO(/J,SAY8LA]*;G55 M/_[.*\]@U+E.Y8S,FO7E=<.PYW=CG1^++U]2]ZS/)V0X"$6C7T<7P(4Z8)>Q MUMV/E?[X:O%QN?GMB2E58$JT#<5R8;AS$][Q:;-6WF'H\U->3QI?EMYGG3XMO?TY&EUZ [A0!^PSCMO9 M=+]I+D;^N:JOUO.[Z^7%_*8I]AE4C"J,*$>@S$FFT^I]BBUY#IPVK7E;B2S" MQWB\YO9Z\&=7<0]#G9L&N[ 69TO8GOQ^F=^[V9L=4=>;^N[ZKYZF\KG2GOLBJ $<,YDZC @B!( MB2SV!:W,N-7]('T^/[+6=)"2!I/G=@DOWNQT)C9E;@KCRE84C3E!R1EUZ4/@ M-'2EEP=UN.YD/64EYQL]$E>MK7UQ1B4Q>]HAEAG)AB+5I.5OE\=&P% M:2$E+2;WB18OMEZQ5M]/]?WVVFR=,7]6QN)FV1E+.8/F:!2D"HD\9TRD M\) 48ZN==3U-1%;@!E+3]_?@$H/.74MZ\?BB"@]%H9L.3X0]:RT>BD4_-?9G M\V4]/N/Y:44.0=7HFAS$B3IH]W&:/S"?;P+ O;FKY&9O2R?=!2B5A "4G!7: M M\?WU!Y;G6FHI^% 683VJYO-NONP?F5S+XD6LTN#,"?^R1#2QT=CSJG28_"BTFX2XK3?S\]%].1I=#$.X4,=LN=82_%;C'Y MHB /1:*;(C_FSTC)*.Q9:_)0+/J)\F,VYWLV>XCQ&8=/JW$(AD:7XR!.U$%[ M3;^;*8^NDGJ[7%7-'0NS'.208%( :MX=XH(4XLATX;8],83!V/,9YRYI2WXU M.-L;1?RV$O4D^[R"C\:SXZ1'?XH'N2ST%&TO;T *P_HT]@R$=>F%"T4#\&6K M?._NC:R^OVQMF]ORNOL=9J#,QVZ%-S.A+.KS)[QIPTB%^E>PQ)QWH1*,>5@H]:#VCD3$;:1KB M&=7#>K@N[WFWWYO5A3;]MMYL9HQF%$+(N,2(0"%YIFUUMPCFTNF:+9_/CRR7 MAYOIE@TFSXO\7 BS$\+87+D)W8&F%D[R@P'TXTB7]QTH.2-2?0B7;!JI?^R_: [U$8L-Q9>=[7V,G:5>3SMZ &$'-]GA31K R1'BOH]1!&D)RSFVT1K! M<;(M*/^1'YZPH/+95R[C1^<89:G*4)EGI:*8"#SO#-;%*75^;U@QB+KT0Y?.YS\ M;E#HSZ>='@U*I9LNN;$8YW+F%]@YHTO!B)V&/H5SY^F-S6%YLM6K[ZO"0U'X M=K]G@V@#"IG_YQB30BH%TLXVHWYO-ZLYU1C@A-.56H2)%40C$) M.IL 0:?'-/I9BKY3MH&27&@L?57-B4!?-8O%77\5>]6]IY'PU"A_AORUZG4 MGJ8BJU.')8@\N7'HJT_1Z LA4'L^IZ!0QTPY2907Q5/5*#]G7A2I'ASYJY3\ M=E==;*O%QVI[OUZ];RI;LQ%LNYFQ3*=N69HI*$F6=Q!2$4N9JOJ:JY_ MU5>U>IBV&H1E.PB/45J/Q0Y;LF[ )?4JN3-5S[S!UU?6^I#N*W*QV0XH>7OR M6ZR[O6!)-[E&S[?!0%+X/)].PAB@6:8JDR%<>U$T@_%G*Z%T\1_WFZU9J5#U MFMZ:(U3_:,Y.T2^;9F_M# D%0,F*DHB2I% 6''3;,YC48NZ2Z_6W%CG=.\;T MSVZZ&(!).S$TBLQHPM7LD=_5E8K".LM??@42G?*Y_4TQ#!J-X]F(V%XJ]4-+X8;VL MUT>3AWQ=+9;;F>Y3&>"8*RJ *+#^:[$'@U.1]IO-"P(A]IX1@RK9!%R)"$-\ M& 4=@/,88MHVRO&*1O)#"WUBXGJ:WQXZV[/!_AB2V]=)1_4-PJF_$.MT[$.E M(2R6%[OO-O.B&62,4*8D+B7%N$@IWJ\LERF7LZTYG^XKO9Y&G<1VC\\I,[W; MP=)_:?>9A=!<7XY]578 >D/HJN&[P[G_ITG)Z6DBG02T9UM,53+[NO6B2 ;A MS586>7U[NVRF##;F:KIZ94[85JN+975T*FP_?9 BA1'+- C.*2HS3I1$L% M%E30TO86L[!&XPW>(YSM=8K'2!_M3QMI6LV)R#.#-TZ#3&,$1_*M'J)+NXUE M4\@^LMP>YI1@-PYR9O'K1%4;'3Q)R1JYY,3D.7^CI1!^U==DJSJ):SM]75_$9J0]N'YOPF M*K#B/,OSDJDRRQ5$$G86 )!6U\CZ?&YL33%PDA:/TUEM+X[.*TAL>AQEPX&9 M,WJQJ2[^?%5__4D[9Z0"FK\8A8!'"G'"\1.RT(>><;6@%_*Z?^>P'_7MA^^. M3.9(E303:2;R0@E0$HY4]_%0I5:ST\X?&GF\=_W9Z92T.S,O#_1HI+B-I(P_MOU@UST[@_W[=O=?-LO%9FB 9NT M:)-'<#V>= M)_'E)&9%S-\'YH]!M_Z+>2+1[OK 7CGZ+)_?LJ3D1$")Q._JS M(U&QP&T[1%)UF+F1^T4UEP8A^,7R?VANW41KJK1:E_E#T^M7WK](RM?& M %._+:RDP>5_8[6WK$"X )"I@B"NLK*DZ7Y1&S'D=/FDOY5QE,>K$.Y!I;?Z1& QB/Z, M4@$_RX^;!CER.ED5[+G)3P1B.LI.N-O%=#C=>_?CPS7ATXF<9X=0%<>[>_VWA]]_-,98PBSC+%"I[) M#$%"]T) TL+JO)O#QT4>K^^65]5ZZ3MB;>BP&[&!F7 ;L>_>_"P_OADLK+[[ M^B.NUZ6V^55LX+U:3O?WF^:"45%2E( 4.12E)"6 "E5 M[LMX(IW>5_ R$'N?RQY3TH+RV]7G19U=71V=-;=A[TQ8G'TL)T@YMX&E#X?3 MJ*G[N?!TRTI_/GQ593<]J$MT!"$E A.8Z@H>2Y;M-\:DF=.4G:>)X97%;^N< M)X%^ZA*!N][Z,LY.N9/$.&B,(Y/35!E7)U[0&2].')[W7"Q75P>;NYG"#")) M60FP+F% 3E.D"KJ?*83<:JZ@KXW(6K.#E1P-'N\G/?TXM%.;(>ASDQL?YF(] MXWF*FC."TY?,:2A.;R^^?ZLS "ONV0V?;W9OIYL*C#$LL4ZEJ !%";KBC.,, M.3TB[/'QPV4U!E+/:LF>--=L)@I?WIF,#561LYB.$*L,QIF]:6A)'P>>S5P\ MN?!3D*,-%&5)4BQ8*0 V+]>!0H!N+I8SC'OHB(.1@=6DQ\8J?QY]I"42A3T% M9N1"Z3$QUD+CP>44Y<;'C;.BX\V+Q3&BS]<5W6KN5M7#S]6J6L]OWE^^G5_5 M&U.G5=T6"UA* C$N14DRF4$@,M99!0+FEN>(@MB*+$0:8]*!3'8HD_>728.S MF8BHW,^\A"'YO#R-P:^;2DV86NOS1(-3['>@* C5+Y\MLF'CA/J'YG'TTT5A MO:GC]+9>(>&O\U5];)20K"12B(QCI3!'!+'N."M7O+!:#0QD:J2 8&"&%"UG MAKW"04QRPT2#T7GM%0MB\ALV%+CP[!<)GG!A'PA\29QD'/!VYGP8Z,>19Q3X MN=:VCJURC!DE4E$.2B9+D!>R6[_A*0.V]PX&L352'&APAA0L=Y*](D%4?L.$ M@@E0VRL81*4X;#1PHMHO'#QEPSX>>/,XR8#@[\WYB-"3)<^0\/[A41@"&,R$O?Q[,CA)\??UY;ST]V+(5_BO[E?'1F%!6)%""06A)<= Z-ZP M+T *T&>-P-746-*O80:5*5>&_<0_(KF!U']L7OOI?T1^ P< !YX](\!C+AQ" M@">)TXP!OLZ\$ 1Z<>1]2_C;Y:IZLZUN-[.< \D4++*TH+ L"&(4[\-.RMWV MJ?B;B;U3Y<2[; 9PFX YOGU7Y@(MV4WI?#86[YWC-T;N-*?UHGLG4E M@",OW=KMRXU%9FJVQVS8NKZ_NM[2J_ERM=GR^O9NOGJ84<@Y*5 .+/.)P?BSR^-]./QY<3Q>:=/YXL!2!H]30SA0QVR MVU@+\),[S\7\=GY5;3XUMC_,S9VXR]LO]SK+:EY?;I].GY52B )B!20I6 $9 MRO8'3+F4U':6.(KMR.GC#F2R:5"^2NX:5$E]F=QIQ,GZ$61K-8K3"B_J^^@- MT"OM?'B5=*WQ:=<:!G3R&+7^9H-[Y+:PCAFCMXE?-(G3-B]'&Q^Z3L>AJ,2/ M'J'B>ER8$:Y/BP2)<0.U3*PHY]="_>+<\Y2Y1[H ]$\Z MUH7PSR[:!6/2\[&[1V#^/K^YKV8,,R"EHB7FB(*"(E9T5^WRO 0]WOWTL39P M//MJ0/5Z[,Z'49]9_MADAHY*?S_+[!#/WWU/F/7V27//5FS?H7&[+Y,QA>6^6ED?8%]>OI42P3& M; IU)E2,T(9+4L"+4>HKWD(D-!1 M0'!$%YL-LO+Y4532[^_UV8M('Z>?[FI9KDN M4G+)E9*%8CSC'**LDP=89L(E6>J'1!2PD%HC,Y(1Q'-48BF AH%1"K.2Q+X, MZ"GXI+YO!,%21GYMG' \(Q"YZ>R4?3JMYJ;OD1LLBL+WXOJ,S@_3AM-0^X%\ MK<<8)9Y35&WM;:S7*S,EUEQE++ 0!2@I$S M =6UF<[]=O*0:3!.#R:?M80$ M!HI)I01)$6&09"#7>J3C6X:UX[$?1MC-0!U >5U8WI-,QWF^Z#RZ::DSA7'G M\DZQ8S.'UXO5::A;(%^>F[,+P)"M.CTQU3T+DP&1"XS3$E/" >&0PFX@I6GI M]%#+:0MIB?)2 $DQR%"6YHQQF3*) 2.8Y=&?:7DZE#RO.O=DSTZ&XA/73WY& MNN7\)"UG=*$V.?U?+6Y:?(RNOB/^\WV]O"&/,D0025$ M7(=I8=Z[ Y)U0X;KC,Q%<"Q-*E!00"5B.:8(YGJ,4J%':Z[RE-"4Q=ZMS>_7 M:[-JFFP/&)/Y'N3&\]FH4'P[SS<.1;7_]**JU]7R:I7LF3_@--=QK)=?[K>F M#DBV=?)AOFX4;I0'J.Q8M9M0#-$LT]# T$X]/UT8CC,/E135Y7)5+5BUTG_9 M?M"]>?,="$DXPH4N3[4^0P!4H13:C5[&@7)*SQQ-ISDNTAP0FJ49DH+07!8T M%SIT9(BQ+/;E'Q],U6Z$!F'>63>')MU?/W=(DQW4I,'Z M1Q!1"XKMQ#1D6TU.5(,Z][RXAN?00V3?5=N?=0XR$3'.>YA(2Z'3ID(?8O[1H:]HQA-[WY3[89JD(M#LJ]WO^ M9K)B?)ZU?AN>')F?G*R&\LM]4Y,7<[[;F ZIN^U2^_O54WMMJU&_^YQXNY_?^IX_<%OV]0DNT+/'56#]H)!-ER%:B6'O5B#=XQI1*SQ M:7AA!]=([6*_N>OIV2H-XN9^H H>?MDH M4&VV.J-5HLA(CEF&])^$8<7W:J?#M]LNL#"0H-G^#)C91H4 ,A,H6:7/]79^8V:4]D+63O=?/!*RFZ;@<-U"-DR3V>XUFUQKN86C4^=,7R5[ M)Y*=%]\5,8\=23I/AM[+%H+]LYO>!FW>:025H9W^;AO=")S;!HR?ZWKQ^_+F MAJX6VI(>2$N-@6H5VV[$U^7>W/HC"-010'LUG>/2!-6JC) >MHA[^< MF#RC"W%:9!K#/Y)O]1!]VFTP/S7\KMK*;SNIV>/K(( R*P5CL"S,@:!<-(A M_M%F6 _0$':B.EH;N&EJ8/JCJ*H+E6=$-4J+3$-3X[A6#]"C715U8?:'++?5 M6UW??:?LW\&949 57&+,,:%9EC+SOF(WF"E-G=;AG(T#G$F2<:7_H\U"G:Q! MH1BFA!48Y##V%F*=N+Z>WYJ4]A]-5;4\#/7Y;JA?K0@_&_V8Y23-29Y3RC%%(4"80HD7)"'1["FN/SG&-I5U7B94[AJ'>KR(?@/7>M7B#<1+9 MH0UW#L5W3_*G(86AG7JAX ["68"L[VB5O4N'FANJ)4:(YXQRF.,280$9/"0F M(',Z_.!AGJ28@#*G.%4"E3S7-.@$R80+RBDF3B^W]]S]>HPK6/;G37OO?' ( MQL-FB,Z-,732^ RE?FEDW_:9AIK&=- ^U0S#I=O]*K]4V^M:(_E:[4[WT]7B M_ZEUSO5W_<6]'@;[:54*4J8(+3"&")9 (%;H9"@5)2B5SH-M:[_09N,-]-VM M(BW4Y AKLPC6:0QVJ8:8SP:-Z=O,$D%HL]Q_;GZMN6:59^ MFQ&>0EABA+."ZUB=RHR(SBR'S.,:I1[&(F='Z:2U';9LKO_MHDH^75?5 M5L?J[?+K]+<1=*=[TFKHH<[=C+HRY.M[AWV5[]9:8&][[37 M'-#4$G 8[BQ&,7? C[5R MO=>M!\9G@/T7C3&/F#>%H/ M/S0"Z$5W[IL][(!]K-HKES;7RSOVT)[EV-^(^;9NCX.PAU,?]G&Y^:V]PA>6 M(DV10.9,.,MRP4J).GFAB#G=(S<@;,DQRLT5PSBC".D4%0*8\4PI2 !B$D3. MW4[KTJM']T1\>=AKU+'+K\P_[,Z3'=Z?ZOQN_O7DIR?&>;_[V*?4G7I$J^GW MI!#![7$G&N4Z]^'8=XUYXW:!"8?(D8FQB:A3:+L^ =C8;.Z5I@P5#/ 29)AG M !4HA;+3.$Y$.OM:K;_4?8+FWA1G.8&9+"4%$)%,E$I_46 N\Y2AC#C=8W>, MJI]&[4*1QVWT_7CUCQU1" V@]J/<1W^.($=!=N9UNA+J[HJ%Z'GRXRY3YE59 M4Y!\UK^_NYZ:$VTIE8QPH/,QF!.)BFXXI3*W>BKGJSI%9M);G>Q)C*Q.WQ-DI4X]>)V:.O5Q MY5EUZLV/]7Z9]OIP^>WB6G>UO=W==4LYX91*6+*<"H[S(N?9/MHKQ7.GK3%G M+>DV0%F98L$$09!D5'%>@%1[R3$!6>Q#)]TMZAVZHP'F=>U;3UHMM[X,QJCC M+A=_,N/L9SG'T[FM*T'XG89>!?+EZ8:4@ S%FW=MDCNLBU"@4P+(!6-,I@KC MN1ZE:T]F+23 MQ6%(#*%\HU2LS])S1M[Z4SH-!0O@1QVZL[GIT/%EZ=KN+K\4-,U(KK)4$ (+ MH)-+#KJ1@_0@>4BHVY*<\:0PLQ]#^Y MYZ*I^C*D.,URAK*4ZGA=EH+ ??Q.H=/RX3D[E .6H3+G5.=VB)$R(Z0@F):Y M(C(MB\AUV+,[\;RFKWH1:J=+0W'I)DS>-$8ZF_\L1V>D*02ST]"F()Y\=_0^ M%#L]U6E7#;($YGOWKO0U0863I/NYRTAG!$%:2%I5J TYTRG M$0214A6Z[J19[)FB,T/+:[JH)ZV]5"H"H\%T:I2YH[,\N6N5([^35BM77^ST MRHLAZ\']_9HHT"04YPQV\Q]%FJ9.5W\9$DIW:Q.+'35L:%"/58D<,G%$- M'YZFH1%>R)\^<^#MO?5<%9F(_>2, 61>S[+L^*$HLYPXCLJ6XZ2Q&U%Q M)HR?\G%NLMB;NVFH10_\3R>)>S+QDG+RH0N'I/R].HS+OIEE_)-(7]46S MF:6]EVJ2Y#^"Z-X(KY+YXU8P5R"LNU:X,*!MP\G=K0D1),UW <*5EA-Q(QJS MXX:3>&[5D7ND\WV_S0M>\MM=M=IT[R$3@'(H> FS%)<9@S*7W9Y*73*G3C<# MG+908"7,/;:29!!Q"DJ@2O,^.4USG&&819]8:T$E.U3M.R]^::PGA;:3:;'9 MTS<2!GM25K.SIGUH7$:F6U/'[Z_3KR*]^4LB"I^K"[JJ]7R'^9* MWN<>[Y:7EY6YH*K:O=2J4YB9I%DF=:W$2EJ464&P%/O!# 'LU6U#:"@OO": MM12,KL[LLMV]'>>6 L ;1YE,)-QQHV?=D/^X$JB M=:!Q)GGD3=+=UMG^1J5_1Q=A1^^F!U3E:,T>0,-';?-HBO]R\^_6C=N??Y7L M7>Q>ZVYJAPD%"\]V\@TML;O%'R 01:? )6P-TQZA@MS-?+-97BZKA=*4']TV M_YZ_T15*_3Q#P@3\\9M_IAQ[TE/.'XE1#O7 MMGGKWA\CZOFV5(_(%[US_#&B7WP:'"/@0.UB'07WMP>_OS12JW6VF>IO3CI6 MBV::_]/U?%U]F6^JQ8?Y0WL/<7?3<$Y3D8%,$ Q%B8"N0VE[L0O.$2NLMX_W M1,&R5%(LTY(AB*2.3(!D,A<*E J6&8NXN^KH"^^SZG2, TY$>T9R-FG"C,DQSXZTAAGQO@Q/+I>FRMS&C#LX? S M.X#T]_EZ<7CRH!0,(EB %".<2D6*4BO+3EA4KMQFW -C$XKPE%%S32)!L-1? M"5PJ9>[;XTBQV%OO/UU<5XO[FT9Q?J^65]=&9>9?J_7\JDJNM"/;Q+S(DES. ME^ODZ_SFOFK6Y2^.Q:G:K9&M=R*E\ZG-D4#-C<.NV?30/< ]M$RM\?O$FN-X M\BCN'+MC[FT_$7B2QJ?1GY8)W#2686G(3C"].#6H]V<"U_"M8'U;8C*HNV _K"N+Y=;4W[/ M]^Y?;HKQW.*4,:G[U?O+S_-O'ZKUTCS7=[&N=(8BJO;/PP-Y5,H\SUF:DC(# M+ ,4[8&)@CC5KP/ B5RRMDLY%X]RA4ZMDA]NVJ6<5\FJ:G**93MLM_-OU>:? MW<1LB):S$\&)-9J;>%IL-GC7MI7V8K1TKS_%9P1VP/:;AC /Z7 ]VEBQ/@#' MFPN^M13=K]?5ZN)!FUEMVML?YXO_N&^O0SI,JIK[9S4&A 14I>0Z>:5[\Z*P M>B(ZN-'(HMZ"-7N3.KC)$=[D -A6Q,.S?EZJ1R7<39"MN;81X\BD6Y][&X]\ MOW-O01OAY?-O3O2YP/0 M;L\!72\W.L\6]VO]OVT4[6+JC".,""422\E2!K)29/NHB757=)L/F0+BZ!,M M?UOIQ..FV95[I?&^4+Z8K_\)E)D1#3.^FY6X?P*HV'T#AREO!NT3_>J?J7:& MX 52]RA0YVERY&K3#8Z=QTKJ9S/FAQ7E?;Y;I9]#_V M]A"],<$\2W-.*&<4IUG!5>=%3A$*M2XV!O;(\9'>FE7K?[1:J"N!+DI66D>_ M#Y)M\#0_TTQ>+)O?NFCWHC]3J/[P3P#\^*A2_>&?RA_#5JJC]:O^JW93[U(# M!>W^JHA_NY_? M+"\?S)UOF_81),N\!*2DE-C#?[C=T>QAP3YV#5[=&Y#!UT M%P?7DOG%A3D:;8Z]ZF@^WR37C8/!ZMT!&KMOO3NM=@X^*7SD8'+PT#1UZ^.D M]]4$:!VORG:X/C'MV#@H$]:5[="MTS?F'1;PNMGF]ZLC+\Y-/><8$2QPSM,< M,Z91BR+K@)9*D1"A+B*\R!'NYT?+H,>WP-@0!EE%ML+889IKV$?@]4J ( M8:*490G25$-&A>+[LQ.9DK-5=64.AW\>:D;6#Z:5W.WOJGKBD;7T_=!$MQ]W M$Z[MG.IEM5ZW9^>[LPSGIE8?SZS^4S;&O*IG1QAB[C1BX\>*=58SH4]"W_2" M7(_FB3;[V:\S3#O,#<) T%G,$*T1\NC=#!"*2ZAK0X@PR;,28U#NSPF3O)AM MZ^W\IG_(LC;H5%GML5EKT6?S*TEMHW#VEV)GX MZ6NKNTL>I]$<^;)_JO$[JYW%_>'UW=GUXZ/KG^O'!]>[<^LS7N09$06D A5Y MFE(MRZ1#60A>N@CET-@&T=33:NKZ6.3 C6:GMU-N+S=IMA3E/\P%#X%;YHST MC]4'IA$E1O/^N^V[!J[\AR )6?02DHS1C.F.!9GI8I M95U?J(6V7SR8=?W@33ZY>I[:W%05D=2&<_S-?5:CJRZB>9 MUL1/7@[M/;&7.D=V;&6,MMOM]OUNFJN)S@\FZ%24B+. M80$XRC-<$@H+2*%.G3%)";6MD(/:C#<:#S"3'J7_>M$^(6"N&V]AO5D=_\QR=;&\NZDV MAZ<$E.)0I33+2I1I7"@': ^-I:73SNY! ,4N/JO?DR,-^+35H]_]29AAFL9. M>"?7*FZ"_*1!'CO0:'.GT\O5XQ_LO$A^'>VAEQ#[EDLG3'67\Q)RNX]M/FFVGRH5F:5C397]FU-JCE?/33/'QT0I42"G&8I M*A1+02X14'GSX!2BM$206][AVQN'E(KQDA#"($>( 2*+(L,9RIE*909B7^M[ M_+S8SH/#6X;&AV3G1++S(MFY87W?;/R6.A\2IM9(;I%@WS[O'=O'Y;VOX9O, M^M;@236=WT7"QT-LNVO"[B6^BZ8)[W9-.-\UX<6N"76@_\E<]'+_9;-<+.?K MI3E>L-8Q?U'=KI;;JGH^0WOYPN&^S)X(T4.VU^C7$@_G:3W\:/"(PW^OUHOE M19,4F)LO/J^7\QM1?:UNZKLF60!/H)0E1*4J :$\3SE!F4*\TXB"0>8<@%T! M<)S)O! H+7"),"H8@1E N2I$B0A/8U_P=*SL'?1$8T\,^*1!GQS#3_[]NEI7 MR;S[X>3W^4:'@NW]VMS:\V:5J/E7+0Y&9*XK,1C<=LI)YA.$9CN81;1^I>BK.Q6F)" 3::BZH2"D3/&V&C[70<)J8,[-1/9F>OOP;@A._ M@7(4](H<@$+RDE*2YU(4,)?=2-$HA-.3\L_8*)""0B?42*0,44BH$"5C#- T MRPG-8E^A_4;7@5]T]K^J-JZOM_N2YB,OL*O W4/.PUMU@77#[//?YF1(H.",9Q!"25FI8#R\,$% ML-KP[_!QD77R\_5\>6,6X]U&O0L?YQ4Q$A5N&OCY+_3-6_I.^*11F^KBSU?U MUY]VCK19U.Z+IPG4P=D30]J#B7$'L0_@VKO5K9.=S]>5J.[FZ^9&F/KRTUUU ML9S?O%E]K3:=1FSJ2RT:/]=?J_6J_:EN'.S4@Y= M=?HXM3;T2S:':LN74]0 ?)Y.:(=LJ-'3WT&=K4<9#"X1^U-]O[W^:[VNYBM6 MS]>+]Y?T?K'%%"6)0YDC@]) PIY%;/-P0W.D 4 M;M F+=RDP6N6 1O$S1K@ ;.78H=L 9NX.A+Y[A'T#\2[2TPR':RB MG#U#S\:S""1/(7+%<*N.W#G=EN3,,4Y>-WO!S?N_[^Z-K?>7HKJL5HOY:KN9 M"58B2;0M A% 0@+)V-ZN_H;+XEQ_:Y'C3XNH??VGP^2V7!> 4+N%NV&Y= LG M!EMR!.Y5.U2NML^HG)M5R56W>KT5U MJS/Y:O%A_M!L!=)*>W5M-C;D.OC),LM%"9E$J,3[G+[DA%HFU4%M1M:T9C!> M' _&Q?QV;@ZD;1I\K]HGSZQSN;!\OYA"CT9U7\EKD";OUTF'->G )BW:D1BW M3IY'8]X_=[ZM5]5VOG[8O>+7'=W8UHEY,'6CNW[7%G==6YA]V,T"YTUU-;]) M;N=;,\9V8R/Y\I!<'6:8S,Q2^\.';^K?F>LDKEXOM\MJ\^<>J;@+WZK.FX_MPY?W>>K>MU8[NR^J[?+"P.D7?13#D0,9O36K:1L]=)<+:^V,0.^+(6M<9MWBUCXF:;!M MR'IU"%@[P":([3:!-!K9@AZS":QCV+A-X1_(YDU?-_72Q7QSW73YYNE9L^3Q M-)2M=JVD__GR231;-CXEB_8U-_/+=\VC6'W"E#.EIV-5O)89/6!%=*T>H&<[ MO@MS>;FIMB9X[G>/%V6>9Z( .54@!Y@Q@8MF:S+.F 2E[8U,)SY9T"S7-2," M.%.H()AP1F'** 5IJA2.N'7F &:\UW^_X^/,E$4/\J8Q1]''@:?OAO3EPF,L M;/1?-D^.'PF2H(! HP$GU;\F&TM/ <7S_JR:.SOL2FT%MK6F0]CC<&EYX35-G)4!^.)R=) MO9QY7I[Z<^0N56^7\R_+FV;VXHEE+'7"@( V6>)4PERJ(NW&F59-IZ4?&WM$ M$H:YE"D2#"F!*M/^=0D+8!'S^I:*+8"W#SYH;Y97CRT_WMTYQG!6E>%!#3%.8,9RG@. M2P3T<$R+'#@I77#CL=>\8]\HZ4FYG0J.RK:;))Z]*?)5T@)-?MW].<4[(4\R M>D8OHS7.-,0SGGOV]SJ&X-%65M5\N?Z[65AK\U2Z6AP)^R_5W)SN7;Q??:PN M[M=FPE'_P+MZM>Z^9//-\KM<"!5EH;(,*ID2D6= M[!6/JZMU=37?5HGQ+6F<:W:^R_^\7VX?DD\&>^/>JZ.GS,TT_GRUVS._V:[O M#U?1FI/8;KH^1IO;*?_$F]LM-AS:-]E!WT6%/?RF_8X=&#V7#M\ 9T+)B*T] MC6 S)@'U9$:>6\#2N>RV&4CO+_E\?=C\OZ#_$@_OWGW M';PW;RGO4AG"MO;>M"G9PS_*\,A<6K^/M?B/^TUSM'7SN=9IEF9J>6,>Y6I? MYS(;&C_7KE I5QDP%\T2BK.4$0FZQ\L%1Q(YO? Z"L#8Q?C!)[.A>-UYE:RT MMNS?&=3_4N_%I-F[=6EBLN/KX>,TL)WN3[YMW2+#DV;=.]0\;?CHM4/SSW^4 M&!*CD L1+U%DL,76J&_K8B1Q9CJ$UTWSS(W"NM\7V8--._X3H":1&D[_Y;1B+93>DZD,D/'.XAP)Z!W6TZMF>Q3,2&*$IIJ&&,1RKHW?C MOAJIJ^AJ^=6L6F]F7'+* *>5&!1TMFIV[2Q\A='%EM4P+=MA M>@S+>K0>@7EEYCK[2J 3D;ZJ%YS!D$)W!&YL73N"XB1E/OQ.5;V\?'E1L/P9 M\MOKPH3_X,^CB##)*B(2E MDBIE1-'2K"_L[&9E@69?J_67VK^^=+7G,M*.H=FO->X F=NG#**^6N5,J*]> MQ60RB&;MF?WP K,#"=<3PIS$RY?LJ0J8MS\OBE@_IBPNYSIIZ)G ' -ADK)- B&"@XWB\]< #MTJ^H$*)G93N@R## M%7H7+=AD[G!!1-PF.:^.X[=%/\'L0)OWY[N6.3Z:;>X6;V_YVD%WNKHC;LM8 MW_^?Y\?S[L<%]8U2XAF-GJ M9H0MDB_W6W-'6/*@/]M<)/9*#[GD]^KFQORY[6&TO613VSPUH(V536T69C6$ MWY?;ZV2[GJ\V\XOV^9;M]5S_Y+I*+F[TSRTOE_JG-)S#WKGY?@-*C[O*O+O# MB8 ]2.\:_>ZR 5RL!QRM 4H6@V>_0%?MQ0S S ;:"JFVPI03:FT.4V?:Y'3LQ$F7.[T]6))/S/5WT?U=M9V4I!3+/Z)(LXV69&Y"\>?5-M^(2&G0#4E/&'IWC:2_?-%-61P7)*W,R:.PD[#E2W?8C M]6V9:8A>#,=>WH\4AKOPA^YG7$BA)"Z19(H7")<8I1T 5@VV]8:JIT\!C3K MM&=SC]!Z2)O3>NU5^4>'\YQFDZ+S;B>@(U'N)J >Q^FG>H;^C&)&:(II*&8, MQ[S/RCMRUU,Q=T] GSS@J/(\+S.*92ISB@DO*"WVT@U*%>":DC[FG10TZ#4E M;][]77Z*<4U)K];HI:=#-4107=V#GL(1&XM)XU MW#U1\[FF%_]YOUQ7&I+6_^W#!]WIS2/'YAK+._,C,U+@3!4%)AG@&DI.B8 = M ,*SS'$N,9SAZ%5]=]:E6;==++?W:]<<-23-EC.. _/;[V6S;9WL8"8=SE=) M@_154]OOP0X\.VE-XKDYR_ M,0V]C.'8T_G-6-QYZ^.;E<[;M$B_67VZ_[)9 M+I;S=;L"3B\OES=F*\5F5D"8 ZA2(KF2G$B:D^Y&*0$Y0SV5,@2$Z)K9AK)V M="]7R?U*=ZI-?;-<-)M--D? FP%>M;G1I-A7LZGLF:)_8<.;&+&[(])@_?5R:F"<236DD\+=0W=,M,2UN#>/:.I<5CL M*:?-XEWS&I3:\?+9[ M ":KGL_1Z:Z>O1MFTNK9WSL[]0S$8OA%K5E>,ID"2%+ =/*;XTR([BR+1M@"X,5YZ"6KH'1'7ZJ:ZOI4D'4IZZ:8AF[&<,Q[ M'[>1"&.2EA#*5'",$1$XP5UW2JTI<.%UX%\'\>%L U)MW]!V/ ML 6@5VOTTM.A&B*HKNY!3W@+P!EBW:4V1"M-6G*#.&@GO>&XM"[WCW+EC]7= M+HE^?VD>HMR;SE%19#A5)(<@I6G)2]J=65((U\:Y:L'ASO'0W#NF7=/S3ACL7^<7F?_'! MF-27/S;OH8ZFGC;,G:OK0Q(_#84,Z]+3"CX\7WU5L!&"SUH'#(9?FK&^NGJS M^JQ[6?5+O=I>;]ZOWU:;S0RI A A.944ZO\JQ8O=1= RQ1RS19S!_T7]?)C08;1C?#M5,_31VEB4+J[5'D,RZ\ M2CHGS%1-XT;2^F':[^VY]AM4D6UY]U#KX$TZ;24/[ZZERD?BV2<"O-F)U_O+ MM_7JJL,TRV%:4,PH+57),"D$+D!GF/*4^6J\I[G(*FZPM$*P,#G8W0ZPOU[[ MLNJNR ,0VD=S.W@F&AY8-A#'$]/3E%G*94^^IR>(?1TZ(WE!N+(5M6-]?62N M@(!S+K*\5%QI'06B9)VY J2.N_F]S41?G7\B8NO*7*_F)F'^'-H)5USRO.3J M44XXJD0]1\X98>K-YS3DJ+\;=>!^YK>-2)?O2S/%N5KHS UD+$T%*S-:%B+% M*96\LR1D:7GE:A\+T05G#R5Q5QHORMSV_@3GJM_^'JTN>SSC[-XY(L1BAXX/ M?=.0DUX>/+/3QI\-GZ+LL./\E^6J-G/NGZ[GZ^JZOM'4;68P%SR#+)=*IN81 MW PBV0% @ '?XJRGV=@+%?.;*OGA3O_K=7-'CAY0^\,U#\G&(#5'/7[ZH=T[ MMZI7S15I]L%W MGD;+PB]06TQ$(B,X=J80#,I='T%5];K9)'EB[7DF(,PA+ 0OMUM[#ZU?69\E3Q#IZ-4AFB8Z>IE M$.\L1#,+6 GK".1[Z:I'ML1I[H',0^NFF(:*QG#,>Z^A(W>VVBF; ME[K?7\IO[2,F'^?;ZOW*8#+_-9=X?-5UK);UC[HF6B\OMM7"_ -=+1Y_X^@G M9PP6%.8E2#DM\BPO4BSS#BG$#+IDIF/@BYR]MBZUS\WL7HY9FQ=ANI?2ZU4C MUJ]:R:X.P)M+']9[MYI_=]/I45K;3M"GWM!NRG]HX\Z?Q#ADVI8W;=N$A2.L MKY*#&^T_FL9^^KVC7Q@V4$1HG3,1910J:S,S5Y]R"!74G50)(9.&^BC (@RBR>@- MX18N]H+_?5AH,2>G;MT?:^^]#[EGU#YJ6TU#SN.Z6 _8]]T%V3M(G$:LO[ZY M7^C2Z#@W,5^0G0Y MA(D)H8X;8 (4'>?"D;DV:^?ZDZ*G]7[X_-YP #ZT/%*)B11SK1OPO$$#L M?0T9#QP9'D;>68;R4HB2,*D*\WP%*;OY.%!*CG;R+E>6&\#CHG$7]PZXC[17 M6C1>%O7_'TF$;?/\5Y (:U^#2H0;PR])Q-WMS&Q&KB_IQ45]WR"YJ+2M+S>' M^1_%307%Q;,(9?NGW/Q@0O88%+A/),?ZI@.2VSK&"E MRI%(6.E!LQ5;#^$.7') 9S.)&I[,17UQ;S9+S\6ZL()4Z+;^=^/BBD,!<1@ (E$A*P51><$44*R$2BCB]D^QS"*1# ME-QTD-S*0A_&[&J]R&0Y*O2>I[C3/I4P_JII$3]7&@#M:-K+.7 MS^OYHCJ(U*?Z9J$K>5&MJXOZ:K7\1[4P+FZO*W[TE-$N@_]T754ZH]+R59:$ M*#UH4BCR@@&.]B$9(:OG2<,@27&FZSZJ,EP"1#))"H6H_A)(7G+F]O2%AR(U M'B3KO0N;1.-<-#,CBR,WVF, VI'DV).D*XM:7ZPSIB$:\,4$=6)MYR:0;;,= MI5:?NE83?^A6L\Z$)]9Z?KGR,X/O]^7VNKXW=V#H?$R/:/,"V/UJWKW.M.AV MZ,]U\ZPVV^7VWEC=G!FTC]YT^[)K_DU#PY][I.+]&^%TLCY@XXZ>S@_I:SW& M\/$-ZYL3H+;7\^W'ZG:^7%6+OZTNZIN;RLR7S!C)=&V"T[PD>^' &8,I9DP]_T*5.:<"EB4.&6$IF6I*Z6)A'$#7_^8P=\\];B#[QL# M@K:1:\0>JWGZ1>K-,Z&Z:9D.>O*WB;6-;UP>JXWZQ.-Y-W-U&$XO)<5GXNMS M0\Z<_;((Z@'#LT-;6(7E&&T[M7 X-Q;!7B#3@DA\,O!\- MN6=6$(:=!'R9M#.3@@$9G\8D84B'ZFB]TW$!XN*Z6MP;D[)YU_R72E?>BZ,G MT3^W@Q!@3(166B9+P%F1IA 4(A4E(!@+()P6)<*8C+U0L4/9'%ELGWQO@2;' M[\7_VF"U7"D-S;GELL;P=#LN=01A.LXBB!5WYQ9&PI(_#1T,[=33!908G%G, MOLCY1NO$2MZOZ[OJE^5B<5.9;S7/PJ^7%_-?JMLOU7H&L.)26TXY3E-F#F>" M8F>7H$)926$X:Y%5<(VF!/S$XE&G;2P]S_R:^N _2:2 M4/2_.(DR O-N@OB$]&>('HU@ZYF0$8CVF_5X3/BK1XS/]XSWF(>P8^+TG$-@ M%D>?7PCM3QVKOP5.I-\N5]6;;76[F0$@S4Y&JJM9#C%%N%"\ \!48;7T'L'L M-!)J@S=I (?.JAT:(%!F'8?[*-FU#>WCI-A[$ONDV>XM\0=)M3T<=J#.#N!&X8S-SW;86I7GG:HDAVLH=_[>(:=,T+5G]%IZ%( /[Y[ M\B,,,[:J\_T,ZV.S_'Z]UNHW4P64K%"DQ 4JBE30'&2==9@#Z:)!H6Q&5J2/ MOJLYP3BUDZBM:K9(=S6/6R).^,EH6F?QK*%MRK.FZG]:U2 M-8[[V_O&A8IPD#>+L0524)297^GJAR7/("T4!!(IA1A#)12I(E04*(4Z28T]-6I MUJNF>FJ7:CL7=I?#/W(BD?.UN0QATZ[R5IL?7R4F\=._^7G^S55GH[>B:_T[ M?@/Z%\4OM5P+OUN=;Y>A$N-$TG@Q6KGLQ;E5#1VW-:6@A9:TF'S6]WOP:6=[ Y#HYN@^C(812.?)>B,^O4G=1JZ%L"/.G1WZZ]% M]-MR,TN%P(J9)_N@$+!D4*?"G;DB+$H-DXL3E=KW-RPD!H/7OHH3=N;1&VVF\^0E)DH M\J*D.(7FS#8EJ#,+&')ZMZ.WL7%RH%?);GS]VL(,H$=N%/OK4C1V@Z1&]L0. MIEK'A#FJEQ?7TU4Q/W??Z\_7]?UFOEJ\T\"W5;7:[9<1 M>:J0H#2'C)$LXQ27O(.I5&9]4\0HX"*K9E[ UXOY@UG ;9U(+MIA7NW<2#H_ M$O0JT6.Q=-^W-U*KGA?>/T2#N@EUXT^RJ4['Y7<-W#B6 M:,^2SK6D\^T/T^CVIUPGW_B>!V#'[ 06!UICT'YZW^FX+3SZ-M61W:\G,M(" M5%3[[6." Y*E&05*< ;^/_;>MKEQ&UL7_2NHNK?.[E0Y&;Z3V.<3 (SGM/I M[MWM9&J?U"T5+=$V3V31(TK=\?SZ _!-LEN6 ! @F;UOJI*T937QK&<1#Q: MA84XQCA-^W@GIH,7<.1;FFH]^;UN M\;Q)W1:929,F0]))$0_E=G>3;Q]QN=V6W\0V_2+T&7$9A(Z;QEZ"4I8&J&O) M@9ZW^)IO;TOI5 >-%E3ZTS$8^4UP >I'+F^/X+:')2Z^VVZ?14SS-5OOWSYO M;HY)R60#RQ0J)A [YX6'O+.C03A]-O<6C8G UV!WS4$ [IDF$7H;X MT]',!86QBV 8^XGG.B@)4QKTZ04T=$.U$$SIT=9CK\/H _;U+M#2AA!>IE!= MZ(QRIRADY>:^B;E>2MIT:B6I1M*^\'Z'-ZF]YMMZ).V;RJEWD2F(BGE;08H(K0\Q$LF=*[G& M$&8>0H$59%XMH<((:J/HNA"&:+VXE MC<^PFO+,F5SI+9OQ2=;;@I$@>\ .BA0+IW=$S!(X^0Z'87-*2R^:_)5>KQM; M9U6%EG41V;9-##WH(1ZYIF%,?(@"G[&V,Q%&I:MD2[3$'->+*"$D1F&8.EY" M8L^-DLA/D!\QZ%H>#4YU' $2M"C5UGC+&FQK^6P/3E[U%[;7!S% 0W^$1QRZ$& 44AI&/@(X@ '41!1B#&-X\CV)G--27>8_+B7 MJ O10#8OZOIX1"JN*,R'0VD='X]+/0D?PNEE%3]K_6D!-T/8Y-IMR(S2\(ND ML63SHN&C&0$D* @#!S%('<]EO!T>];1]!%/IRJJ7&R(L=E/L03^,^=0C=1%T MO( X'G$]<7ND,]Y2S:O.,G0A09M9A16:,4C57IV9"Y\:BS)C\#IX04:+7Y5% MF3=8N+0@,Y2\R=7=H"FG%F+,\".A\I_VM^MB27BSZYI'_F1 M&Z>0=EW&8&V,2A2$,7$@3/TIA%"00\L?;OM>XP05J8/H+ M OKL713P48A3T^VI.9,6Z5&XT]/F4QP.$.*W+#VMOX-YF5QVAUM0FGM+%"^J M*LO5MV*]1IO5-7]K-O>%N*Z^JO)=E1;5;SWC **4[C-.%##'9#SV'0MC1W:.M2[DV% MIP-JT,"^ IO\[3R"4?@_K^ SH%Y-W%^P_AW?X 6_#99,2TU,L\D>UCRRCS2 M06P9]_H*+)L% MLM%MM=MFR]T"^2Y#U'6XQL. ^EX2B?07%-#0\[U0^CS..&#L2< Q_BOPPH): M%8YM$-E,D\F"''7G0@6SW,^C8YLVZG5H8(,SF8PB'H:LLNVK)I_%\:$%C#!% M!"*RUEC\ MJ>E73]TKY7J^ C>C<2>?&302AYHI09I<2F0$O6WW&ZE !HB:?,G+B!&ET9=' M+5;JH[/K#1?^^HTZ.4,,2< P_R>.(S>D!)$(P6;%): \>E-:\9)M$_MIXK T M\"F*0^HC"!,'Q9'#:,HC1,=V$3^<\1^7.?CRD.<[\/'NCL^>=\7F7FUERQC! M1)%Z*8"V_8>#&S)$MW&>P1=L1Z]&U#A?6GY5*NQNF_7)0.PWC MBC'NGX-L^2AX&M(U@V()\N6XEPB3I8EY(VHV3^ST0;0%FTJ;KZ+T^'*FQ?=] M'::841+)V16 M>O@8G6&]@<,$TY>'#!DR3@\61FF9J<'(EL&VENYK$D MH0[[C0P91;ME>_9K)?F0[^@?R_5^56SN^Z9#[!+>(HTCRJ#OAQ$B8==T0 .E M0G5&&K0<_IG+%S1#KYQZC,ZLFK*#LC3$9IGX=H MF36IM/B:ZEZ$3/^Y%X7N\MU#R8.IKWFU$U'U]Y_FN;ABK+Z."OH!"Q,/^Y@Y M;@"3)'((]6$,84H9PDJ%S*T"L2R.!Y17^E?6V?6$G%[.Q@FJ.JK&O^4;B=6Y M.Z.EH[AD'AH[CJEO7D1LG5]937ZKR?:ZK,1/TI!B'S*/BEQ+OT[ K!ME)"!* MM_$-;&IT7=6Z?&\HGW+:.2*50]5QDIOVSO-S1@$-$3L/C3-E3&GEY9/>'3FM ME5VLVI[W=B45#[/ M:X;BBSLBH[.K)EZS)59Z0V1T@O4V1 P0?7D_1(:+T_LA1EF&F XBA!W;-Q@F5/ R@\T;:P4.WPH2F;4KQ(*&-OU!OZIV[T]"JG@;D>' M)&(>CAF$0>C'W<-3)Y&-4E4>:3O]4T#1J,*K0LI%U;+%AYILC4&%?&:E)4HT M4R?EJ)'(BSR8]4;BHX;=DXN7%NARD*^EY>OG_#Y[*M=%5U@G@G[LN6'BI&[@ MAX%#N4QV#2#F1)(2IOI8RS+6PU'OO\H$790SF]RH2=J8M$A+FTUZ].1-@:;+ M$O?*O-,RI\O!Y%*G#;P<['^UC9'/W,'-QDL:1XX'"0I=CP4D12P,W>[Y,$R5 MSC3*/]6RX-5 M/:.%8B1V\RPPXF:T$G1866KHK?^S*Z$.D/SV(#0P%T.?3GDW\X.BCC"+?!0G$/&+C4YQ5YFE&O5T5^JM]K62_;\W\N-N*6U:XF<^0A2,25/U%(H)?"%!W4 M!1&IA1F])]N>V#1@%.-W39+D%, >/XJ3&UEJK*C "Q;.Z( >6_-0 DWLI8GW M15$-FCN7NVOR8!*%'HZP!RER0PR1ZW=M>#A04P.E)]M6@_;V<4TU4"-)4@VL M\:.H!K+4V%Q;.J8$66S-1 SWLK]5@ /2%6F_;7C?>BB>ZID'QJZ3^A#3 MF*N.@Z*4M]7O")$ JZB!VI,MJT$/1FL=0)$D.36PQX^:&DA38Z<.[C$+9]1 MCZUYJ($F]M?U90(1/21SB0I^E"+<[Q-3Q5^+CZG%?-*U7]K5R+DW8_HQ1][O[,O309%V+=)'Z)/#3".*$1$Y*L(=@5+=&B$<2)QEV6E*N#7;G-N/\]VW/-^0;+M]YMJ''LO]9H82-28T!GT-B5\P9P?V:0&,>G\Q@91K+UNR)\ MXS&L76'EPNB4?3\Z\5]L=^UMGY_R;5&N%E'B>DE"2. @ES(W(D'H=U@)IE*U M2Z=%^&>9?G ].C(./-76#2Q4,LXK<'%;Y$_B_:EG*U?@V$#PZ<_S!@PL<#.[ M-\%L69RQW@C=FCHFZ#^]\3(#=T^^$S,'#BY5_9G (T/73K\6JWRSJCYNTZ+: M;8O;O4#"8ZL4(\]UXL )6.0R%/J$]@DBGJ^4W&6X:>N!2(L+B-?OW.35S$*G MK@.&+6>.P+U:&/!I6R[SO&/]W!!PP#N/94* YG3OKT8/FUSE:Z MWKQQ,SM:+K?[;/VY7*]9N?W&O[!@B>M0&GH.=& 4H-B/6$12&(8!1BRD2H&F MC?9M9_>VD,7B>P<:M*A!!QNTN,%O CEHH:N>6K3A'#E5G=HO:OIJQ25V3DNJ M\WI&=VUZ:1X*;-7"U^7USCTF.)'9DR8,H@%-=$E%TRR?[V7*W M\%(O9@2G7N(%"'K,3W$/ 'G2M=!--VLYB&SA@M5>9&W\N_16EW%V+^Y@3DFL MFJIUG%Y+!8$=8/G36<:YE]X[G-('>AN"IGUQ>8-/D:/3NW:VB)Y\*\Z:8:7U ME]1DZ-S^6'"85;7/5XN8,<+B.,&1V+\+O3 *DSY^)XIW=I#G)),=)FUY5/;# MGT$6U8U2DD--SLS(("NW>7&_(?NMR"![ON&_J];U1.FO6;%Y7U;5@KDT#MTD M]5,OC!&"T(OZ*))#_B_S/)DE-X7'65Y&0]M[ M'GX6FTRQVIL*(>;ZP](1R"J?/G3??GU+ZTEC3ZT/[R6 MAH.U)[J_!A73=G$=P*6VV]6Z*OZ\P-1E*26A@YPTHFGH8R_M'HR20*FK2CS. M\7* Z:*CS.>F)$L#"@"#/DQ%[W8$*P MU*T\"H^SW47+:I>!S\52-^:5842RGYHE0[&??OQR@\#G:S):T$O.C:<*7,RD MLRH ?MU956V5[:S7-XLP("0E01K&_']QA"B#_4 =)BQ5Z:P2C[/<6:]WV?I9 MLY_*D"'73PWSH-9/KV_0^_\WYSIH@HTS*.+J@ NM5VNUD4__6V1A'$, M&:9)$$//C]R$$:=[L),$4O?=*CS.XNFIV"C? :%"B5Q'-&%7AC$U'%B'_+' M(B_!I)_Z\G]5NJO$XRQWU\_[JBIT0U\9-N1ZJF$BU'KJYU^^?+E&'P"C*?V, M;JX_?ABKPW[^Y4R'5>!D'AU6!7"I[7^U#GOS>8$PYO/=Q/%BS#SBXLAW^]@: MLD2JV+K"XRQWV)O]]O=<-P:684.NPQHF0JW#WOSR^7_1T8+@FW/S5 4>YM%) M50"7VCZ7/F#W95GNN&]7[3TQ/F0N#ZVCP$=>&O*IK^/WBU8L1E)U:M2?:KG+ M=FC4K]!29>=\W[5+C%H7'H\3Z7-I%KG1.W;6 1IPCNRE32=T3-_NR4^!Z>(N MAWI<6MQ$CA;,=1$#HH M"7V4I@QW+5/7E9K/FFQO+@.&TDWI1@DW,&A8X'KPL(%;FC_.A&:#0X<%NBT/ M'HK7W&L-'V]>9F^#TS_!$*)JD]02K\PC>O.#1)_>1EG$LX5%VEEZ*[)GI1K^>6A23C7&U647O4ARTNR MG+RQ\F2EA!8D"H4]<=&L(_ _/>;9M&TLHC4D2$!)[+@QI ME."DWVJ/G3B0'$B&-&%YZ*BAB4.#H %7_U' 4Y>N041>'!C&XE!M*)@+?=): M/Q:->NH^@,[+DG[&]-,B;H*KR67;B!&ET?='OD9IOA3W5K[/=_R%V>39OFW( MBUCJ^%SN"4L3UXT=A_4)%5$LE_2,[G*#C:@-/:BR*MKR:/L8OT?^_PV7Y9% M]66_?9_?9+?9DN[>9U^RS2[/-JN_\__\Y]>\PNNLJ#HH<1@SW_%CGZ0AP['C MTT[H(?])JAJG50"V%;H!#GKD@$/G_0?4X '=@?<9J/$W-WAS"WX4)H#:!@UU MLN>IRWH_"R67?&]".>?1/+$5]N M_3G)*6S9>6PDJ_(.($0.C$,.#D>NX_E.PH(N[Q0RY$K=TC4!K/'G0/\C>WSZ MG^ -J<@DI:(VT<#TP+;3U:=A,_+WX.G;?RM7Z\\@9^1R8S//VO7C>%YC#CN, M<M.(A) M9V?I/-NRH+680 M*(_U'B["+&F>=*S6QFX@F^80HVW1IGII3I4TBS>F$I6]D M- WA9'*1'(:^-/-FJ-4Z__M^52R+;/UYS[]TWS:51H&#W2"F*4E<%$+L]Z7O M('%\J82D00U8%M .$VA *2K#,.K.J^AHK*E)J3)A5@K GR+EA(P8X7 >Q=Z' MF5 :?*?DYY)/3_EZG>WR%\V$J4/<*/%3-TQ]")$71UV:/O0)DRI+J_UPV_/+ M#I2>G.AS=GG2:9TNQ>GG5$S)STFM,Z8Y.U5F3F*B>LK6-Z:L@VB9/"X;"+\T M]'I(:^@O&\X%6GTMJOHRP;89XOL^]?P(IRR (6%>@L.V&>H$D53]?>V'6];0 M&A0XH%)7!DW.+FJH?;K4-'0RIJ0UU#YC>AJJSMQE#3UIZVD-'4;+Y!HZ$'YI MZ/60UM#K1W%'5;:^*6^SY;)\OUO]]+G\WUS]GRU6YR=8K4FZ??NK4'3LQ"DGD,TR1BUV2ICVRA% L*;NCX;&LU)T= MH#4$"$NN0&?+%6BL =P"T-@C[K;FWQ ?<)M ;Q2HK5+7K_$\>W%PF*53U<:3 M_T[^E!["9NE7O5%O?/]>'C5-T7MZH!W=>9./S>-;7$[75:0C@#,P/N._=>M? M81#@R"&AS_^#<4!0VMV61D.72E6C-M66Y9'[=9>_>MWGP3N.5:-R@QFB+PZV MHW.L-I#.G%[IL6]TFO7&-6-T7QZN9!@Y/109Y7+R8<:L-:6=-V[(!+%M*DAH MZ% WC%PO\5(&8R]@75.Q&TM=T#6H@2FF<$;B=ED"=296%K@S,%,:E;8A\Q<+ M]!FI\O M4NY=B%W?Q0B%/F.0.5V-4!9Z4&KIS6!SEF6YA02R!I-:,HH)-L^K\D1$JFGT MJW*0SU>@8[4%> 5JB.,FKERF[$P:BT&^YY'48M*@TMJ[J50PDK=7AZVBL-@K M#-<;+@5YM?N<[?(%3>,4$Q0G8>2XC"2!B[K49Q:E,%E\S;>WI6312%.-JO3& M8WSR&:4-V/H4U4-33F\M^NGR !@4+6*PY9"5ZA@:X_YB4#H5Z6H2V+'=3(=K MME^K(NB@@L^3L:U4-W(*UC6CV^/W&&1/3^LB7X%R U:2H[M'H7DX8VAG^HCXRD5UA:@P;[!+EP>LR45*#ED&^YS98F33MS4'*.'_J@Q.M=L4CGQ>NN@&S MV5:IKC=DG575@H^,CN]&*6*Q&U(2.JF'^L$QP;*5"@RW:GE8ZN&!33]%>VP0 M@F(#E@*CKCX.)EQU?!J3ZZ&#TX'X0US?P@77&T F)5YW5!K3 ::&I$&.4!Z. M+C D-1:98GEN Y$QN]XA0U+DX-B#D"2Q MZ^(>BD]DZW_9 V![OM2 $7>"<#3@KMQV,R;P]'HJM2O!+?\I?RJK0G3D8L,_ MV6WWUVS./Z?K?EW]]O= MKKS-V7Z[*:H'\:OZ.KE5MME5"P2#P MB3((8AIAZ&,/N( MS'$=S!+6-RO*P MBA[+/>_5?)97M?B;5YF/FLTH>M>AUI5GZVY3'4_GY+&A@VQC2QT-==: UAQQ MWW)K$*@MNFH]VELEOG&P:[;^U1V3Y^1G4P/U!7]G&R67BQ4=^L]]MFZJK2_W M]9#_'_MLRY5D+=*1JEVV7@O@]7=W#_Q1Y?91R 7)J@?Q]*QI"=R(\)IKARCG M+72H_@Z'5>Q^,A\J[O,48_I.\QQ M?^FQUZ#+N]:$!:-!F$ .DJ(H1BYS8YIV( F)W"&9/Y:AC983M#Q2HW_V:E0< M3!B6=6+;@WJ90C-RGJ$<(NY)Z='E:!!KQA/^EUO3YNWL8Z"!OLNWL$OXIV;$A_B'7P4[S13]X]W M-%L^G#*QMOW(SD6 B1OY@<]\"F'H!X[G='>(LB3P-$./N5DQ_H+)JX42,5/* MN37VPIBY4:ZY!#,? R98LF&GIO#XNR6;FQ+@X_D[/IZ_7X'V;?S(!UOQQIT> M:YMQ^/J_X'LW;&EH/H9,N)0TR_=0X/^"T2#%LDQ&0+:]J%ZW--7.)Y:>1@'#.,G+B[BHJ%T$GU C9_;<&K8NC?'0QLL#CU/0\K'IWQ3"4\\OSA9&G@L94%$D!?@,!37 MM?I=X4R&4QB;.$NCW;CE(>T8EYW: _JTJXYB$S ^=!C[[J3%"W_8J$.@[PXS MAV%&<8NU@S Z[AEX!N8MPC3.OPSF?F[#F6GS),^]&.)Q\ '1G+_'_"6_S]&Z M]DF^6O@>A@GT?.I@Q%R'19 WW2)(0TR,G O5:-?R,-879>X B2R,:G];%:LB MXUWUW5.#^0=#IPIUF!\VG-DFW?A(=@ ,>L03LF_H**=E+]@[P:GBC:&G-K\G M2>>PY@"JYSU.#;),]FCF8/8L3+>:U4VQ"IIVA_&O-[NR/BNT8"Q@/H*!DZ8I M=F.'X+"[.89%+M;<$+:+R?9.;UO18'EJDK9[R'8@V^;6RQL8=Z3Q>=UH/AQI MNM?N@35[9KU)HAQXV1RLFZECK;GU2>X]C,7-.(%^<]M%NS M6G]F:I!U"R'!RYH1?N02EJ0NQ:D;!0SY$>[GSRG3K8-N&(3M3<;O*QN='O_' M'_85G65\G+?GIY$&=AL5CH;[R=JP;<]?(X_3XU0[NL2@F5%8SRE_NF%7TTS] M<78(KX-7@E^T[3'*1W*?N(A!@E(J_MNU[?(/C:P!*[7XWV3(5'3#P 5A:QXP MOQ1LH["?&M>&EG^M<6YOX7><0GU#*_-I$3OO04G3)MD%W@&,:1\)*M;B7/RG M=<:5L[B[JW9EG>^:_WV_NA=HVF)/Y5U3ZJF9>HH*/?RO+/DGFWK6^?%)/.SC M)E\$* E8&/N,13[_7XP=V"< .6FDN5LY$5C+@UR;;R_V-6LSP/]I[;@ZKK&U MK&UI1[JGVI"C8>X*E+4YP!UX6&/T%T%UK/P3O -#A]GN (:P49S[.E@IW-_8 M"?Y^ZB5IC.U6'YMWY5/WKC0+CU>@,1IPJ_]L[\K HSQS?F=,']Z9[MW1/:]C MV#LJ)W2F>C'F%N9,3<>E4SC3^DGCW$V']'/^SWVQS07&GXM-\;A_["XB(,5] MMA6P*W'#:;Y:.%X:81[;131*8!"',8[Q(>"+=$_A6$!B>^[?00;; V8N< WJ MHVMKECUP4-7(M0^&V'"7:GPSM:>&!B\'MWT^Y;;#72L'*\"7^;E-^W3/Q.XS M=M;'O!O5S_ZHU30M89EAB,7U\9?KU9%5^+U3Y;H_K0 M4M5< K1P8!I$+/"B" <01U[DPRAQ8>HZ+HO"$$N.N++-D3 A&),H1=0-/3>& M7D@B2,0E>!3%T/9JPP$6:'"!WQI@_Y^T_AHC]N+8. 6G:@-@B[ ^^MA@!-\Q M7$U(L?0X-@75>H.5(2E)P>S+;)UFG_-U^5373JV!1 Y-("\O[EA$@2$N2%.G*:[>8Z? M>+*IS*K-,A9':>#S'NZ'81(Z291&-'6Q0Y*4$11:'C)JN$#@!1W@NO,)R*#& M#(Y!JZN=<3=<'%BF](#: //G(U]ZR)G2"7I#3^.,;R^:%@9L0)^EZ7NA# MV8G*]P^FS,=A2GCLB'$(H8L0=K"7.FD0)]"W?B&( 1:1.KZI<'3Q>'!+D5J M \#H[$CKMUV6]!1:C:W+.OR=C:>55I^*R;5T /32P*L@K8=IMLL_WK5JO*"Q MZR'/=_A372>!40PCKWV+718$5%(+7SXT\1#'##WLH22,,$(TP ZBS,.^EP:I M;UD'!1CICJU(QT7)L\>$FMP)'&)=N45BBP]ID;/'BY[ R?)S6=I>6'9:UO2, MGUS2-&&7 YTN)V7[ZL?[+'MZO63>KG3<9+_G&]S<4(.VM\5N*TC\N/TY7Q7B M3PLG\4(4D81Y$0Y")T@B2KLWF[I1*"-\ R% &*6.D\8!]EC(Y1SY29 R1D(O MA:F/(LLRJ:0,MMD^KZLS(GKHOFZWKEJ#[F_PXI_WP,6EH!UT65EJ,==X[[+J MM@;=LL;!N_%?\O6NZCX1$A;_Z+@_MB(VC-X3DC>2OZ85R+&,+$?M ]HY.J?F M].Z"!#C"#G6P"W$2N,A-G;[CXRB"FFDXIQOSB,N0C]W$B\(0D00R%_F^YU$> M,&,GL)YIPU']J+!Z98G1BR'J^&0.$\VWE@6U<[1UF=5.9K'/L)E\%76FU9-1 M3G(AEV\RC,;)PVG#YKR=-6*")XW$D%'E(0XC AC2<1-=5.7V-[MZ[;7Q;[& M0[.]OA;=;7G4W8H6+]B*V6A7@T_4(.-_!(_\FP]O%^13WW@_PY;GL3WAQGLC/B--\67S-Q19:X'&%;CPM5C6=U+Y#QB/%KL2OR*BVJ)7\G M]]O\)O]CASD_OR_\($8^PB3B2**4RX/K$DJ"-(JP1U$0JU/"EMRO,3)Z','UF"CV* ^DGB\M@+AB0*XRB@Q'&(FT1QZJDH^LC0;(=HK37B] NW!QS @I<6U<+3 MVB1.\;WX8F>6VN PMI/EAHL9^U=M #'K6CZL9+?\89,-+F;]@%F,< M-)7QY2PZH5*V;YHOBY4HE,BRK^7VXUU_4J5-6PBHYR?,H1Z,200=+V L;L)7 MZL,DE,TKD&G*=QWL\B75B[I8(8OK@./3:Z:@L^65Z6\W#'YU<_%[7DN.I[+(YX'IM]>H.#ME%M3 MW$V^XF34F-+*^Z5VU.-S_LB;X>/-QTUS?6=WL"2*^%"#(&\14\])*")AUW=" M0I#*N8ZWVHA]A'$4IHD7)2%+"0R<,"4.88ABB!W;^CL*BNZ[,@4.U\Q1A$#CE,<2"T[ @=>FSB#9/?%NS!),U"J8=;49I] M=713,NH[)'GK5;G^*JJVU$-$>;=[R$5UUFSSO, !I"E,8Q+X'F(0N9[7Q3I! MF#+9DQ#*[:9."'V(/1(';NC2,/&P&Z'8#:(X22-FNQSJAT/-D[KOK [1SUT? M_?RLFUU@@';5%(YQ&1^8S=& !1W:%S$G1PQ:R!/2KYOG,:X;#*5\#'6'<@;( M19:DDD',<3WYH&//LC=31$RS9VQP.A0E6S WCEV"J)M AOPT:3)"B.Q(>!Y^ 4,QAP#M(0ALBW?8I/9G!ZNC@UM\^^H3'*$O$6 MQZ@#X@G9-SQ$6?+""$.4A#=,C5"'IH:,4!I4_TE&*!W+5$6M=_=2]>_5,#+''2E'=MDGA\7(U"$H2$ M=ET\H(G4 :3100<0.3@.(I(2+XQ]"'U*8HR8CYNFZ28DSDQ M=0[7PG48"E@[(70"YCL."K$3.8'4'N4X2&P'4V?3XKA>-0:\E137 MYL1)[M:-Y+OSP=+\W*86 =GVF)74Q4%DG\E4',>)\TA,',G6O-MFQ9VX_ UK<] MGE>.WP1D12$W[ @YX9[.!VI";91^*ZJLQ.09%;;CD7FHKB7;RC'>:355O>'? M_GB'5LWE=VUZBD=CAJ"3^(G8@O"\P,.P:XIXOM*Y(:T&+&NDP"3FY!TJ\%M: MBD0=12'4XTY.[ZS3IB9KZHQ9T:Y3K)R1J$$DSD.)AIE0&GRI%*.U7LJ^[++- M*MNNJE^>5MDNYY[E86';MLN"$'D12X/4]8/(Q7$8=6U[E$B=%3';HNWH[! * M]"A! Q,(G/R=5TR&-4RX9#0V.M>*49@)FNU$7S+,G8NZC#(_#XTS;-/K*,L" M8[;7*]\7F_QZES]6"R['7NCR8"\(*<0(Q3XC'2[LJQ6KM(]F[NN6PA)0FS+2 MXJ6"(^TN8-KQXRA7UYNO>;L<@#:KYC?U[;QU$1+VZX?K!4U"!MT@A20@E/E>A!AKVW=1 MBJ4FYN9;M:SZ1PB%-'"?E9NJ7!=B#%^!:G];%:LBVXIR0**B0UZ; *K>!NGT M#=/.N)B_,Z$?U)2[@0,:I.#8(>(BI?:W![17@/WZXX?KR8B73GR9T %ZF2OM MW?+;_(E_J7: R"M99MOMLQ@KL^;7Y:;^F/^>V_!O%;C-^$.6.:@>\GPGEG&* MNBMU]HI>M2P?'_E?JW;E\G?QC6S3=:3'QNG-U_/\"GQ[*)8/H*C IMR)[Q6; M5;%LRE/N1;#D$\HODE9SA;+@HK\H[_HAT!\L5SLLTS6!75;EO<[IL:W._J MZ_'RS:KZH7Y,66/:\3$ <*%_*K?9]AD4CT_P7.]7^3'!M6Y]ITNWZ3_?&^R&Z+==WL MAWRW@''HB*/2KI=@[+F^"REFOLN<.':"P'<67_/M;2E? 7)8:RI:>@Q,6DH[ M@*+#1ZS+&/6?%P6$8O3F+<< MN4X:XM#W$\)$PWZ"?$H@5%,O PU:%[ .&P]'VKBG3ERN8X=]Q=%7BG)F@F4Y M11N97C51Z\"!GN!W1_A "U"Z.K<97;O,V!EI,TCW/-3-I$&EM5=3M_9KFM_N MCDK2'A6=C3V*H!\B0MPX\)(8.UZ @B1-L:CPI!BA&6C0NL:]+S?W/][DVT<@ M,.K66=4G5$[.1F923%A9+%CV;(-'P_MQ[RU)&:NYR"44.0G$61=^Y'K*]U$8*Y5 MR\O5PC'I'J"(8DM1,/Z:YQD)X@4FI731 ME#?F)H_&['I3))FZ0P]3S']PEUG-1K M:AW&HO0GU)3*\VW&#@TMGE\O&IW#0Y Z+$ M^PY\RK=%N2J6H 4-!&K]HOR#^%:5R?&HUA=)P?$QM7,2Q[/\24FC&0_,31@- M676F0+TYUF1NG,O6>7EWL\U6>9NA47W.EWGQ5;1[ZH*6R"/$PW'JHQ"E#DX3 MFJ"ZHX8DAC1)9*^=4VV7)8P%?DB\P*%AP!R48,@PQ"R-4_Z)[:.] F^=J-^" M!0>TTMOQYKF^F DQ*;](7&]HB)- MI_?3K9$]^8ZZ/(9OP6L.S1)V)K,T0/(]XVI MI8U74$VG/FW+ MU7ZY^T>VW6:;W?,I@71YUPHI#]9%:] E:>2X 2(1\5V"'#=5$2L#S5E6K!8A MZ""J294).N7T:F0FU43K-8GSN)#U,F5GY,L@W_/0,),&E=;>3=WET5<0NG2D MYU<+$DD0N+'C)"R,D>*A\G:?K\"KCCM@ M8\F4 U073B?@7G\%]3N=[.'.:"E5CE&I-57#SIF'D-HS[\U55BL\RHILLPO= MWSG:UXY\XTKL.,700T$2!6'LLB1*?-]I5J'2@!"L5')+L>DH0B2F)"2I1T/F M>3!R0QPYQ!&Y62$CUG>DCO"IZ:AICN54=$)ZU33T"&AS7?,QU'D$FVI2D"5/:OC?8 MK&6]?'6B]Y>7)WJ_')WH51-3D\3+">E$G*N)Z-NG=X6D_KTL-COP*_^Y7F^< MA:;*TWI&3RWX9AY::L.PTOI[K3O!_Y+?B[8_YT_E5JCY]>:NW#[6>X3XN?WE M48"$L!=ZR&$Q\4),?(83%,#099'KQ3YFNBGR9E&H]'6MO/D6$4BS7:8[L3=, MO.K\?CK&]:?Y'>T]:'"$^@KB^KV^ M-P"FF(_R@9^$840=GR*(G:Y))T9*MUX-:F@\[3B F^2&C7,L2?68 >3.K?L, M,>7-OC28'^D=T*QZ8.ORV]_RU3V?OD2*#U&IE ;K?O@]&G451P+#!K0G$FN MAGN+'"7=4>1SKLJC:L9%[='B17K>4&Y6;5/YJHVHF..X./ BWRZ90[OHN(^J_5_UDX7CI2NL>."TVY?3'-I%JTF.&0SMSK^^) M.C?I&D#K/!1HD 6OIUF#V5!?-7_?7_"#4Y>BB$9\%L<"ZK$0^UU\Q:,KJG3S MK<[S1]Q?>Z][%YH6;ZH;;78HT]]LDV'+\F9"3XG4'H(Z@?/0DD$6O+ECH,O& M)2UI"J\?-<1')1XO9>OFHIZ%'SL1<>(PP1BZ"64(IV'76N1X6$9/AK9A/Y:I MT;27X,AIR6#>SNO)F)3I:LH5Z)E#YYD[HRM5OOSIOOSZE\9@H2I^^V>A)_Z1 MGER@Y(2FF")Q6ETQ9D5I]M72C54^YV(J)M:>LYVX,^C9720T)'$0^2Q,((X@ M=2@,NB8=&BJMT@QJR++2_)S]43SN'\$ZW]SO'NH[OXK''#SPL+^Y^B(#2[%S M>2=V+NM/=0,;'9)5(QS+_.K+4@\,=,BFBGB^IT@J]!G [-QBH"&FO!D,#>9' M5K6ZYW^\8^4VYW,ZLM]N\\WR^8"E$Z(DZ&9W$#N.5*5. MLRU:U[$&I%"PNP8F6+8XP>H %/SX6L\4ST,:XE].V<:G7DWBCEEO$8(.(CC" M.*[82;%V1O7,LCX/^3-L4VGS/543Q(_BFE%1OWR;/^2;JDYE$_>HO4)RL\TV M5;9L4\[KG];U.OQ?N6Z_+ZL*;8M*K-!S0S;W3?7S#_GNX]U-]L MQ?VYC=P*K=CDN^.K7,>5AQ'H/R,NM- M8]#U)K^[RY?B^Y_$6,>XYVGU)G.*YX?V7FR.NJ*0L35!] MJQ'R&?*2A 1U]B-S(4J2(!Z:$#\=!O(4,1#\!^3%HL&M0 MZT[ Y\"F\HQ^#J!'V0TY,O0*U&_%.V'L#^!@KEB.:0R^ DYD] M??$:O3 Z0F8&J-B_CZ L+PAP<4R?EP""*75$--NGBB#10R^\9&]L8H^R[=:VG7"B/ MUX,VY0ZL7J2\/+0I+\4!O]J0.[ICY0;5.?M4;=@\'AZY.\^L/+VXCE4FNVGD MN:AAGYP9\Z;R_CQ&MPL&04">)$^:X,/5(Y =1 MG^_A1TJ["T/;LIV)(5:J'I_XW%XH3=Y>8*XV'@RF4T[?QV123:^/U@)?2?=D M>P07R#HCI*9HGH;W4.UB!GT2! E 0Y(C'&<(+?;N44NPEBB>OJ MW9$S%%7D^CA GH>8DX:AXZ(T@@GV@M"GR'-3VQ4<7Y1W%3!_O!4XP;$QX-B: MNLKKT1=;BT!MDEY9LQ%=+#?2S-.[:H/-R(ZU7<5WF!_.##CC^WH>8\X$=K]= M^W=4YF5'GJ8!_E?JT@28.'[H,]^-2,00CI)47*W12(N78*4E_9=/C@+/#4CD M.6% 0AKR$9-@QM'[S VB*+6]K-+T;X%&JPJ)(DMR FR/(#41E>?&BOZ]H.&, MANG1-0\=TL1>FGAA%"-1;94ZH-NL/O$7[$/VF+4N;1"B5;=D M&K])1IIS=YF:7JIYRT[,:('1<^'CE Z@@AR4)ZZ2%$*)TT>1;;81(5)"%%"/$ V88)YX+ P=B M/^26AK%K6=6/8#5SSDJS'(PVAW+R/ 9]:@JKPYR=2\A/4W-&*H>2.0^U&VS% MZSO&C;!R27.>'K]KZ)=-L:MNOGS^G*^;"NXEV5>[\C'??LKS[5^WY?ZIA1+P M\%DLI_D1]?S4):Z?QGVLP_\@(TB# !!/K"A''D2)F-,S&(6$>9@%7(8Q1+8/ M9G_7YT -_0IP\*!##VY*T.$'P@!06Z"H:W;]=%[T9N.B@8KX9_7.JES6>[EU MQ#)_+[V .Q-OO1KIGA[%Z)4X?CMV#>'NQ, VBBNF'?7&,;$<\=4>-E[6A]". M?L.R)7=+-V8S3!+71U'D4N0E 791X'5=/'5BJ1U&O98=R+PDCAB/=)W0#7CC M:>R3@+JQ'WJI9WL-^7:,&Q[]N<1M2WH'^T!L0QW.%H9%PYEX8-O"-YPW# M(]X KVB.I4AC@S% ^SY'-D&T7AC23#!K;OWAK9>Q]7UV0Q<@/20J=)(Z# MD,2>0V#7E1,8*65C&H#C84+CR$M8DJ0AI!XB+A>4%+$X=/T@L'V422:MXD)6 MQ7O=*J5C.-/0%L:X?E3,DAG'A=/L=%PD?LB^ACFOSF-=;TR#5?G,.9S.88Z*8I" M5ZDN]6B@(0P]&B;\OTB4V76A'T&?,$JH%[D!A99'GP][$2OTZ7T5J.%Q?7I7 M;$!5?_3#2&.*<7=;'GFF]/3(X],5:/?DCT_?-C./';<7M 9?-6]/)>I:-$;_ M2<8R15?:&/%LO4U_\G'1&BVF1D^[?IO;&/N/O+A_$&>7O^;;[#ZO?YEF.S[S M++:_9NM]OO"B,/3<.'"#*$08>= )N^1Y'*2^VOF(V5B5>CX)6>QB'(?\1OUQ7ZT_2UAP!3I>P-DW^K]F^'#QG9A!?&'NO?WO%8 8 MY&VB",6TYZ4/RJSK=R1?G3:4_B'^F"^(X].0>L2)F1LQBL*CE&E&XDCI!(U< MDR%D24*$E6$:^C'_,799A*/4\5,G"6W?1_5"FO,&DRB)#JI=N?P=9,+'BD?R M37$M-]9.0+/:0-@#?/N,8PMRY),[4L2=.])CEOEY2+EIHUX? K+!F:P(-M4- MO^QX^[5^WW+1SI:[11#ZB+G$0SZ/=E/F$YQ&S'<<%".'8B@;]>H^WE[7:Q"! M'A+XK0,U\C[(&]2$]693GCH,0AD'L0(<0ZA"'.7[0(>$@R8('/K>E; QA M X%*=SL&*]WK6M!B1M;"$W6J"QY7[+(_5"]0L>(#.3V;FGPUK6O1-B6<.[S@ M&P?5PLU:#VCDS:=- \-M6IA.=XKKZ:]M%8,M%E]R=9Y M=2.$8^%A'*"0P"" XM2^!U-&NY88851E=J;S?,M3,7HDDJ+:X=.V7.V7JN6$ MM8B3$T3;G*D)7DN7*&-?XP$W9T<7*UIV@I$S6C6$OWEHT2 +2G-OD]$XKJGI M_DK5/!\C-V4L)$%$D8O#E*0=$B_VV&)7[K*UD2A.JWTE+>JARF=NY#NP;>.X M684'I\C2#P\&43^/+FG50K7PP ";LEV:E-7NX]U?RW)5?2G7JX7K8B] -*;8 M\S"+(X^YO7 X81"J3;M4GVY]2B4 B32J2DBE6CR@S)1<+&"3(K4XH..FQ@($ MF'$%ZQ439\1(E[-Y"(TV^M+,FZ-X7:WF,KJ&(60+'HGCEB HY$CM70!6%/-65Y3Z&%>@>P%T'K>O&VA@J7 M*GW TAC5YZ5E(I;5%&?>!$L?6YV":+VSJC"*E^OQ2IW!NZ*[>._5=U:6NV4*M]^+99Y=27N=/K&ORG^WWM*?&/%YSGK M\JG>,FR>+3[-^#?+.O_L/M_D6]YN_>D185_S+H6B^@FDQ3;G+790NE^ =R*[ M(O\C>WQ:YU=@NX*?,M$KLWN^:I]*)\F[.I+8'\ XCQN_[=W#QG'E&U$ MY?U5W<+Z&0CF&L,YO'J24$\6GO)E<5RLWA^6(?@FO9)M\UUCYQBH47'[+MO6#N\WE?;/,GX2W^\^[%N]#\ MMM@L19%X_A>;JP@X5=ER*>[N$S\]U5E(PH)3#@>;_%MO!9?;Y<.F7)?WA0#U MU\L^;S>\.B357CR]$CQEVZ*]RKKQ9V7_ZJ;_'C'>RI7W^)VG8M%'=YH@&G, M4.JQ-$A=S%#HP+1O-'"(4HK_M+$_G\MW,$#R/^9PI8U[GMYGD2%:Q/O+!--O5=QV*]"!Q%\P" MD]#%.*!11!E):! D:=]2P/]16?/1>;[EM9\>DH@Y.*9QN] )0L[TFR'TS:.S M#+*@-/ MR?4.[6:DN@ALNL@Q(H7TSP99%Z!?\?A><:54GT.Y0=LN>9I)LRUK;?;LNQ;5 M#U?@PQGZ+.7-GJ;G;.+L0$;G(3G#S?@N==8(+Q(KL?RAS6&?8IGF=\4F7V$^ M=[XK=E7;JMA&WO)I<'G7?M!O'']IEF;$]$:DQ9<;/C5>N Y.TR"&'@\1$H]$ ME/^I7RKVDU!RQ79L6)9G)Y\XPFYYH%F5RA^?UN5SGH/;QB[%1\Z^P1LZ2#ZO9&@=8J4&]Y]W;-U\/2R\]S]K3> M,C6?".TW=5Y"=ZCNW?;(N^V'/]0KI3PJ:1>*@?@(MF'9YDC_K=L]_JH!8WUT7CT6S:GXE5CB:H5\\ M^:H&N:P/^6_SW7Z[^:%>9:Q34]=B657,Z:Y ]FIZ_\0-V;[$^*Y9Y?[A^R^_ M$RN8S7.__V6]<%G4/[VK&_L!E+?KXK[^PA5O8K=;-^=Z7CQFN=_NLF+]^A>U M4BYS\;L-X'8^%INFI9:K06NCAE_@TVNH4_62R==:)S.\G%RA=$[XB3EEEZ-7 M;/8<0COI+#<5SL7^0/.].N?VYV)3;NLCW$W?1YO5RZ<\YE1UC4KM_H'(V: M$VE*1T3G =GF#+J9.#>WI/<'LAI3P<'6[A5HZYPT)H C&ZZZ.7C-!)]_;=ELWG;43+%6=91?'AVFC^_-VDN*P0$-Z\*F.(Z3\-":KU9^6K<-VRL/V_)K4:\]B,G+T/%+@T*5L<8N>UKC H=T MF/*WJ-ZNF&91P[_CYJ+>ZK,Y)VT<8,5)'1O*BL2:JI34<4EL?O,EYW/@.IF( M_?KA>D%=EV'L4S=PPQB["4S#?GO)\6*WV^^YD5I'M0I%8T_H1N.D;1-P%0>\ M;6)@AU64-116_O"79DE!>M_(NJLN+II.[QX#,;. _G98##C\[K<' ZX ^_7' M#]TS*K.R^1_X'B;U-LGL:Y7;D229ET?M X< MQ)?:=$RQUL=_$NN@;3CQ;EV_!R+KJL[I%$SD_.,NIW(O)D)5N2Y6=Q>;%X&T<)HMR:[.EI M7>2KG\#!MFQ=E?WRJ4A4W=R+F3NX$\4DO];E4<6B;O/<@XP,65$<\EZ<7CX< MY4V;?*UP'"O+VTO%U'&_E*X9Z#,[&R!E'S"(]U@+^^*UC7=MF7F_O^T.70;K[ M[':=WY0OE\>ZA8*% Q&.41RX$7,=RD&X@=_A\),X49F2FV_=\F3]N*N [ BP M&!(W+]<3N^T_Q7F\!8_(S?"G=89Z!L#+&!>]5*3TC@_;<,P^UM&A? M.=:+/D![%YB%S'?%C9D!)CY,/3^&71L)24.5V$+MR2.&%]]IYJ>?):>8FJ1I M2)]1ODS+VJ=L>RY'R;Z*R2J4-(LS5!]Y[.>419$!Z5)^;5?ZE&_KJL>'JJV$ M.5Y"&&-Q0&#LD80X77-A@F.E>GZZC5A/TVSO1 &K;)?]NV(M/VWFY%1D%-+4 M!*5/CQ#$-7<13U6T^2UVS@C*8$+GH2W#S7A=Z\\,+[J*@[.J6"X\-X(8,YH& M"80QGYSZ3K_8$D)?Z>2J7@N6M:8&<8A<^NN8C%S2I,FIGA"9IW.H"EV!&M.T M"E1#4) ?-1KGJ3V*-EP0'AU&=%4G+=;[7;Y:!##"@9\ZKD_#Q FIXX7] 1LG MH4J7RNBV85EY6AAC:8\TLWKJ8X/4X?K3HII6@5H0"AJD2N8\54C9B@LZI,?* M)26J=S&WSXM?Z<*-:.B%K@YTAL[M.B6J[+:K_-;_(_=IC#_WWA1Y&','0@)!Z)(T*1V]Y% M[OL.I4KK)#+MT3B*D@BE*72"D,8>##SL8A]Q0?(3%ZO5ME#O["U$T&-4O$W6 M!*-R@<21=''<;9L_B)/J7_-NG;DI:X?^**I%&!#>]=(XB%V4^MB'O@NCU$FA1PD+ MU"YT,=*@965K;B]^ ;+;/>E@@M\$4,GPQBS9 8CLEDR1H.R-[ M1EF?A^Z9->EUE27S?)E2OK1\S(K-(@BBV,4I0H'C):X78.B3MO$4^J%4'6K# M3(GH252P 35 !Q6Y_W,HH:I1BEJHQ=E0-6R6 M<1;,8Y!"YH8I"QQ,/$J]OE$GB (3*BC9U'3JUV;.J"UMF2)XF.99X-:8ULG2 M.JK2-6 T%$Z1Z7DKFZHQDHJFQ9'$Z7+^OZW,OE M_G%?WSKP%J3/Y7K-RNVW;+M:>-1S_#A)$TR]%!,^[W9IAPN'6.IL^'AH+.MA M:P7HS+@"O2'@R!)PIH/_)LP!K3V2LCFB-\\KZSP=J2:^__5]*'V,8Q)YT9)Z\O4)D7.J6Q-.4*_[4&=;VI=MLZ^*PZ3)_S MY3JKJN*NR%<"W[&AY/IZLRO;RO1->/ U_]04#1$EZD,4Q"YQ$G%4P,<0NACW M<%,O)@H%C";'*J6K@RL<'?**I\E]=7Y.W*B"/>2UJ MN-AS0C_ R/L:_Q< MWT3LGUG6^/^GI]8]/@_-FQDGDTQ/U3PF?=1BQV$+U?YXQXI-MED6V?I3V5PP MTQ](QY"'B<1!(2&>ZP>1$\<.!YAD?1YR8-:DU\<#S/,E':+4%P+WC81)G% :T3 *F#A.A2B,ND9P MS)3RP!0?;3G/ 7WY0F^^*&Y7*)(CN:]@CQ?%#8 :R&0B\Y*'<^&)'F'S$ Y= M\*\'_"$RW MHECB@B0N=%/BNG'BNRY&7D+BKDGB8:2V'CRH*>OKNC?;;)6#;8^M N_X?RJ0 MK?GLD(>D>;U \O]ZH5CZ%0EB=>\]_!PKUI(91KQT!L[ MR+'8CE^E\QQ+YQ>-AI,[#WDS8\KW2S2F^%$ZY'-HKSIJT$TQ3$,:$C> 29! M+R9.UV 8NNK''/6:&>5PSY&(:9SAT>1/3I%&HDY-CQK6CE!-J49O,W3IL,XP M6N>A1"8,.75(QP0W\EH2;H9A22%RP,MDZ5WAJQ?1LL>Q52D37(0 M5^_=9FLQIP?50\Z%6%S>)WZS/GK_ZLO^&L9W);C-@;CHCV-8B?F^>,1CMMG? M\:Z_W]8M;%;BAL'5?EEO7/(_+O-JX,5[WW-Z0J6'LC_Y@;!AZ$LS[Z!FA/V1;:N%B%F(6(.]&"*J),&8>+BKJT8>DI[AWHMC#.[S+[Q=[^%I!GJ MJ?&F&.M9HTP[V..(0 _I"OQU6U8C)[J?)$%&E3 MU!=[C&D+3,];C6E:A7E!CXS$Z/$Y,XW1-.(MD1G"BEC#(T9#UJ MND4HR<4G::9FI@U*T,\L-BG:K[1KUN17=0OC(0I)F$24!@Q#QB+BLWY[+G2B M5&WC7Z,!ZTM-S5QFV< !60U.8[-,D3:%33)[?.ELCC5HIMP2>\''I:TP/?+F M(1M###BU]36$"[4LZJX-'J?$(?(CDB G=6(W37A+;1M)@)E*+*'VY%&"B2&B MH4B4G%[8XTA-*B85"5E]T"-K'M*@B?UD*K4> [*"\&E;/N7;W?,G_H+LT&8E M\AJ?Q )^/3-=,#=*4D@#[*2\31Q0#].NT2B(E7;#!S9E>46C0W<%G@2^>I\@ M[Q#6N;[+LE*8VM4RHX&RK(GO\ZKZ=Y =E5];'9FC75'/LJ,D8[$Y^D@QC#MRS+$- M5Z"WHM;<8SNX%K]4Y:N7LCQ9/8%!3C@71H[MYWEH_/AFOWWP?TS>!\>]]?(= M#D0I^, GO@<)9A '?M=D2I&O,B\>U- HT^2G\Y&O\CK\,&H'QKRF634:\8Z^ M=G^.)IUH5X7=>>B@&5-D(UUU?F3U2NPO?BO6ZP5-O!!B)Z%I[# WWZ[Q9XN+= MAOZQ7.]7Q>:^;YHE?+PG%$$:1P3#R(D@/C2-%6L<&FERI,VNHL?:+EV?'X0M M[?I>YNOL;K!!NN?1JT1'A M47=,$M(W&,90::P9T(SET:=#QOM=74=^E_VA>AYS"(=R >](]*F%NSUS;05^ M#JO?@!X]UGV;H3,Z98#6>:B3"4.^JU]JB!N-_)8/W.IN(]P-N. %V"/802[V M/)3V&^%^%"G6MM!K8Z2!?V!VBPII!-KR=[Z+-B%K*RR*.? 93UQ/ER+P$DS#R^XO5P5],F$%46;9?OQ^R*[+=;% MKL@/U05CC[J>$_C890EU$I<&07^8.W%]J0M2ASS?]O[K-<+7[Z]OKJEB!]?B M2JZWVZ9)K>L?H9FL2L,)1L[HPA#^YB$2@RPHS;U-BL6\'\KM[B;?/N)RNRV_ MB2N,%H[KH# @00Q#Z,8>@2[N5S>]./94Y$/G^9;EHX;T(_^+C^"V!S5R?>[O M63G3-X9P.(^^,Q*5)Z+"*RX9!YZ:,FV MUU&$1095Z_-^RIY%];JN,0:QQR!)(H82&L1)Y(5>UQC!C.A5YE5LQ/KR95\H M]JD!IE=A5Y4ZR>4)^YPI+E=T9+6()JZF^Y*7\YF40XB*-VKF#.%&0 MF.T^7QW-F=KV^JE3E#"2Q''B0ICP_P=![/0K+QYSF6(2^\#6+(=C+4"P/B!4 MK&AI@%!I#1J12V4YJFD\ MV)9E@;H1>7!7(/]# M^'] $,WSD"UCUKQ>NS?* MDJQXT<>G=?FDR0*B<>(W+I)I\==A^W#;@3LX4QY6OBW2=$3!S5,]#P@S: M4]IZ*15/)!1?BU6^6;U>58N\F)"081($,& I\].CB"_QE+)]=-NP''/UL/16 MTK69DU.I,4A3TZ8#7]/&4V\P\[V.V#-.(JGD ^*G:@A M5QU)\M%Y>"]!"/MA& 0,.R&#U GZ+-(@9HJ5+\9&-_.MO=&=)2>X<_:27H0H MBF$V1M7JW"R:O;2K_L5+RT!KVH1E/@R[XHS23^7T>0P)DUG_NJKGI%Z0NFF^ MG_MW($^WC",60@BC!/LP]1(W80GI"\4%OJ=P^[RA%D==)JSEI*QU1GD:;Y3F M\Y(_%;]J,GZ\D A0+^ OYO\2"FV/Y!&/XKC12"K MQ&%C<9G];<:_N,Q!]9#G.[#*=GGWF_WF*2M6H-H_=I_\OBF_-8-N7NV*QSIW MIWE@GUX =B6H.+;J[AEDZS58<8;X=Y?UW[HKMWEQOSE*_03E(8@&JSV'DS^7 MHK-MBDWY;P_%\B'_*HJ;5O6A:5'M;-/!J4]2 M'U7R6*ZSJBKN"H&W:GKR5=U<=L>G>M^UMBFWCWR^]ZK1GV2CA:='$0$DCM^. M_PJORHDQW<:+-NTX;<6BTEZWU%[G7CC$29$;,"^-?!B&:>0>6O"=F&@N<%]\ M[B@KVR96M"\SI+R4;90<[37LR9:NY=:LI4F:1T2OA?SM56I%ZV5[/BD?'XN= M&)R%\)!R(\:.?+,4+4:>'Z+423W'BU.'$2>!4==BA-6J[ ]IQ_)"] LP:JHP MB#TYE1B+.#75.$+5+#=+<6A%1\X0=$973- Z#YTQ8DEI_J53/'*V*Y>_/Y1K M3E8E;A+9/?.0J"G]_JFI-(1VNVUQN]^)B/VF%"$1A\6)X@^]O][P?L]C]O[( MKN.G'HT#EM H"<($8DS"0ZJD$RB=4!L7FF6U^W+SD?ROOWU\G]+/7_['_Y-X M;OP_P;N4LFMR??,#H/_QR_7-?RH>;1O9=7*Z.6.OJ4GML2'_!AI3KD!O#&BM M B[W4IQ@Z:=CGKR)$H=I>H_+CK:\/-XA )2!=@4T)GK(M^"JP@7?> ME>O *]^-KGS?!=5#QI\#BJK:UW>" +$X5$=ZHG?_H!XEJ_$L'QI;(U@]'N;, M?FF8K=%PC:[9&S\:/N;D0@BL1=\\E$X?_HE@=P /TFGLJU4AA"];?\J*U?6F M3C"*:NI2XCN=&I#])Z,)(\6"R@0:M*](!(Q +]S]RI5DV,!73 MW V0*R'^MHVL1O+,4]V$[P,H>=4TY)K9B*AMJQ[^_IV"RSJ+XWB7&0EW&SS MK-IOGUMA3QP*ZPW\E* (A7$0P*YMC%"DLFUKIL51-G2K%ZMC>0T6W-9HP:Z% MVWQIZ**F%NFZ:Y6V^1Z^!-F1W&&<(K"4XDUII7 ([_/01L,V75S7&\Z8K Z^ M:*.9J3/'=]PT\CP410XA/F^RKX@1QDFL-F'6:,#Z!/E]7E7__G_;>[OFQG$E M3?A^?P4O-F*[(]P])$&0X%YL!#Y[ZT1UN=ZJZCEQHB\4*HFV-4<6/:))"_=S>O9!Q3DUKP M$X3)%8+A51AF=7X.PO0JS-$53/-]%N]%^NY*?D[U4"QVTHNMGPR3>396T&-! MS_";4=YS6FM3>L.RVVL\SE!9#_"FP5M]%"B=3:2^D=D,(RH(A5D*(R'#OS + MP?X>>AR+I%\8=O'C!XFY/O[^[EG)73!D/;J,HI? Y"J)=' MMA_G(S1!?8624<"D#>DT6*:/ A=#(4,L=%GF]]6FW-8GJ,VIZ(RD"/!$I E* M!,F22,99>S*3/R9F48_QQWN/>5Y4+JQ:P0R38N:PZ=&*5[P\D,H;=2##LLQ+ MT,YPC#6^TV 8>_%+1_-LC,*[6<1500;)!8)9GF:4YX?GC@$1<;^XQXM(@^>G M=..D"9=?>2^[TK;:-%;[T$I[*;,RQ-SFK?+-\D2X!%-&N8BR&&61YT\AN,-]L#^_OAEU2S\ YLW[L0)S&8K&4O70QC0S;/,UE>+%8/=1WS3\7 MB\=MO1+9JFJF2;&4B_*/S?+P/6]GDA**K=;J1[.XKD(2$0_S* H%!YSB;OGD M$.8F=4!N)(IHC( #*2A@ !(T!B.0BAP#F*(F%$)L4U3O**J@B,1:P?V>"ST MVRNR/NWYY6M]./0P;QH(S;_/MTO3IE##F%8OSIB>5UKK3X/B!=7[9WVD$Q#6Z.CUS6?C;?+5N-JQ' MI:MM<$?FU6HA9=R+ F$B/1G)$ E)B!C :=SR#(ZAT-I$]A) )!'-57P9QW+[ M+$?ETL$F<<;EKAJ#Q*R>U'QC^2Q(NRFWP5?5)7USVTGI?GR/QZKMI>!6D#.PZ\^39BL 3_A=0>QW^AMF@90L1QP/9AM MR_Y>K&[OE!.7&_[Y;?'A\?YKL;V^^5P7@ET_[JJ=G-%R^M;2S#)&,PP1':1X+EL$DY@ARR%B*"%5Y%.:["4(G["_S1MJN M4N[@/Z7/#'Y:;=I_,*R1 8P\YB=G$$K:-!(JLH;&UF#(V&O&G\Y M[*['",DSNQL_%IG&+L:3;N40<]J,4B6_-]UO]Q?IZM&?'ZS5/R/*]W]L7#_> M;N6DK_^NFN59AI(PI"AGL=PH90G!72X$AU&*3'C6@3@AI )0%A')/%!NV@C@ M% D@" $BCS*S-V;,R??C^K$*%EU/H=WZJ6XS4(=1#\7V1O6QK)M[UO7-CYN5 M#,M^^OCY#QFO61/R$#;48^F)F<^,NH^$W^]M&LI^67141SGJ9AV_N2D6NSVY MM_%QJU9PK->P'-_?#F>(?T C3\,;#*EP.=J"[.>"\>/DEC. M W)[6_0*R0@?)3#"$,TS0/SWG:9!AE[TTXO.'>$HG;K"1E'+MMHXW"> MP?]297#%4DATU*WMQR97>'W3G69\++:UA+CNO3Y#>8;B7 9T*%*[ABCF>+\' MYS0T+*EW(Q/C-,\ABJ4,'(:$HP2%>03"!'+IER#T7O]QK$8;CC<)37LB'LA: M>O0\/3.9D?8S^QP4"#H- L4-P9$.BL[W!\M2C8;;KX)&DX%[7;@ _PS'#VO< M:3#_P#J_[)8Q N*Z7H(\5JM-4552@J^K3?-VQ[Z[)&$RR,]I1%DB*84P2B@3 M-(ORF(4T1;K17J\Q_+%$)U9P+-=H76#/@71F-3O!=AJ+U(TJI8>Y9WAQ:'%7 M+!_7Q?5--SA>_.?CJJH[D%7DZ>B[+VH7/N,J]B.AB' J:(02G&/:B2%PRHUZ MW'/.LY-7>>#]@CP6^2KX^G3\@^#/6NZW5^= -M&COE'-84:'[BWAY[J6 M(:)GN-.;<:;!I_[4>WG9RB^.IJ',T7#XKU4U0R&)$,)R+R0@C!FA*!'=:(GA M"^*V8WAFT5/K548R4C)#GK3&T"P2] F?91!H@)S7^.\%-!JAGRV8TV"IWEJ\ M$?#U0Z4/YZ@OMT7!ROOY:C.+<,81"B$7":("(H'2?8P9YAGIRSYFHXW 0U=! M)V/P9R.E TXRQ-B>G?S!VY^G3) =C+.> 6;(7G9@3Y?'+/718+0^2&G<.I!A MVGPQ7Q?;.2VKW7R[72V*355\_A7_BC?+WXO-.&CTU.7CMG^8:6#&]/\] XYF@/;] MBQ]C)MC=SQA_1ER^CN$-_]/7-<8W]^C7.28 03FAY==[W_9>_N#=KKBO9@)P MGD&"2,)B#.(D8BCNAE0M#'MNV?0'&B5KI,0+:OGZ[],,,+7>HOF!TT4620?) MH?9E>Y3,MF3FX$YV-V:ARN6-F"T^/7CJ8R'GH PA;B5S_GNY.V+,JMT6+F<9 M(Q%D,(]5VYT\B6*,P)XT"88]&G.9$]RM66YHR%UDIPXR MJS/%1NI]T%EUR:N!BV7ML#5C39?&FBR?.E7R,M.ZQ[1'B10M-]5*0EY_\V4[ MWU0WQ59*$,T$AB!)4HIP!E,B(]84H$Z$',9&[ZL['=@SWZH> MT3',&#"O_M M"-<-R&8T.SB^EN1Z)*=ZM?)(TN!(U-'+UM[$T*R,K;\IID6=;E6[7.;F"K]^ M--G>97TF3->@\FD6IA#F,$=I*N(HY0F%R3YH)B@SZK/@8WS/I'F03UW[/0CH M@CI[ M^'08?#W!&1=D9X)O%5L)=Y"I1Z%E1C9G5CHBD3K",-M7C6)9H]Z/;S MKG@XBIB[ON=-E/QN?VB\[X3^^?%K5?SGH[KU>RK.GJ60A9%(8!JI+JEY#DF6 MMX)'G).T)SL/+:YG,K_^OI%_=+=Z4,T:6IEZ$_G@)K7F_2E;TX6;4/H]3V^T MS\KL,TVKS;X>YRK8ZQD<%'TK.S*Z>W%L.S-O--;$F:SS&@V0R[YN7%MIWWP^ M]"W\4N+ELAYUOOXX7RW?;>C\8;6;K^MGJV<@BP $@(8YCB%C5+KJKB@T0G', M9YOB5CUR_47?T;D;7(OA\H;A7LFIS7:L6*A7(>OF-/.]N,&#E/<7R6B+1F+# MR\SN#*#GCP8&W>Y2\E$W38GU0RM,@Z,] MZ/7RAK GY Q:N97WQ9?Y7VQ5+=9E];@M]IC&HQ$PXQ/K40;BE*O@2#3+F[0]H-2DF4%0M*,: M0P ]-2]Y Y]S[-,;TXDP4'\]7O4=<8.,*1.)>>X9J%Z/6Z?9G]\GH$DI# ,,RZ2),0Q33C:DYC(]8KC##[.,X?\ ML5FI-MIUY%@9TH<)*.>IPA,>9K3PQX=W7[AZXQY_X6\_0'B&"*IB\>MM^>W? M6FT:'FB_>4D!!XU/+'<+.,9=VC8"E]:FM\G[OM_?"$OR2% .8QCF@@C$21S1 M;I0$(MU6%U:?/6C^][WIC5%KQ$P2P7[ ZI,,'@XGFZRP'[Q<9(9U<#-*#^]5 MO9@B-@=E2FEB"^E/IHIM4=#J-/07?=Q5>+/\6_FUPHO=]8UR8/7@#^MB5^!% M3=RKS>W';?EM5=4'XWO9^%\/JL\ *3;%S6HW$R 1C)*8HD@(B,,LS,-./)0C MK8S0X$)YYNHC"8.BD/]XUK5MZK4R^IVLW\AX[+@&((<@Y"D&:=I$@&, MXD/ (O3N8T](7,^QPI'LZHTY)?SA7?>'(S[:22):W,VWNE=<)@2ATRAC,L8> M(OXXGAVMMOM7D\:-3OQ.&!]QRV0FSI 1C><)Y#3>Z6.@WI'0(+/C1XJ1A@'$ M*GH:T%9NXRIZIU[Z?;>1?_))2J\A+8LACT$J5!_]/,%A'D&XKY>.0>X^F'(O MH^<(ZE/QRWTQ5U7F]3O>QS&3OWC)@R5=!DGC&G&(R*C14/YK[;&4DN/&0QXF MA(\@:-R),63DXV6".(UWC&W1.\CQ9_T?*;+QB()5../;*KK%=OSFIEBH%U/W MPRIQFF8KCU+.ZX>VT4HU"V/&!4CC7"0PCDD:L\-Q/L8),'NCVN' )FQD]1#U M7M8Z(2/%,NPXXA)DO1J]D= U"P(.L![QLI(S^%2HQ;]:K^;/FG@,6\VGC^&9 M"C\/AIA&U9\/Q4KOD]B,'.N[X*^9&. HHX(QD 4$9")HPL8F,6Q13L+RY&T MUF;OWA5J67YM)&J>=%_+CUH'VJDFR7(J2OQ',=]6Y.GW^7^4V[_) MM58M5XMZCPCR*&<9BN-(0$I1 ACEW8 1%EI-Z!T,XSGAH\2KEXX24'LOWQN[ MB_F9(6$S9)MCQ*J / 6U=,&Q>,,!J9W7&!)0N]1$+V O)Q,N ' Z'^ *M=&W M],X4*9W/*+/8\= 'Y?J&RNV_]!'U-/M4U&<8ZOVFZO/=?%N0>54L/\Z?FK9$ MQ5\[(J'XYXRD&,@5F+@FW@](3\3"@]ES&G$S(-I6XZS9,PX M_9/:ZDJO(0685W@3(C!./L*'GL/'":\]1.$-3EG!-@W5LA2^=3!G3;@5WQ?)Q M+7GJG=Q(;&Y77]<%KJJB/@;ZK2R7WU?K==T$ZL!..,\ RF5LP3&+< XS'*5- M7$$X "PR.TFQD0#&#*"088YDH!MF@+"648$GHQEQZ#C6TG,YH[ M-M KF]26VINMZ2D7C!;L60![ACE]FFD:].I5PU?=''RC:4[4^V'W(ZKQPIRQ M$+$0TB1-J*H4;%*1)I1IG<5 *80DXP BG@,D0%)(((14;I*ROB M_;W\5C2[L]5FOX1M.=0"25.N] NA/2=.D/U>0:7%FCR)FOU1<>< MG<1*M7!YO_I6+%]2Y@N>C.(P3A, 0A!RD:0ARB/4K;4P#HWVGS;C9T(R-8@ &WZO2JJO@4UT"*%?H M'U5Q\[@.E"9-P/+W8G5[)W<#OV#)G.JYW$^%:F.F_GC_NS?UG\K/VNY6_U4O M[%?!CRU9.C2L*8F.8U-[IVQ>: MQMV9FQ;0/,U5[I$S#!.6T3Q,<,R$R%,D0LJHT9/%AA_M_7RFE<:L$;LM3IKD MYP\B0U[31L=O%^:WFK7W!&PB#&,I_%L-EVTPT.4%6M[?JS>^)/.TO0V1W.AB ME.>(BH1G(HTCF'?CI# ,3:C!_-,]LT,C4- ^BFP1@]Y"]=32+3]_9./EC5CLF2*,PA%R%6[<( CSC%W9AY;%8O MTF\DSWSRXD6W7PXONEFR2T]<]9AF.$C-6*R#L#U!D^<@/P-+C)D2ZO M7K]SAY!^Q<1NOMH4R^ZN?CL8QY#+\1#'#$: ))P T T6T\QH+V0YA&>6ZJ0) M/A6KS;>B4N4"3D7CI-#!G*S!Z M(3D-)NJKQ*N*# >8Z'+/EVW=(>+I.#(+>1(C(G"(.:4"QBFE9!^9Y:E6:XT^ MG^]]KU7M5/[T4_$@?^.NKL;LL_&R@E"/:'RC9\8RG32C;K].0'*&7_H . UR MZ:5!Z6XZF='*!ZE4OW7:OLG>O5.0)(0P S'F$DS07*0'(D"CH'TADN?KT?M]5G@.:8413D86IX" /62BZ@;+<;-=E\?'#G4*]-WT!H@]HAL=1?O"R M/I+2@;A0JJ"E8T__NNR7'?E6L) M5L7_\W&U>_HD&4V4V^_S[7(68BPW:UBR61KB7#7@0&C/8Y B$WIQ/;9G[NG$ M#7[J!/Y997N.9?Y?02-U\*>2.V@%-^0GYR;1(Z\QK6'&;!X,X87]#!$]0XV^ M;#,-WO2F73G,##>-V5Z.*>5:/R[5XP&J(+'4L3/*4 MXI2Q. ]AE*0[EYBGM<0'DV5AK45M/@B:&5?A63C8"Y+JM\W)8WJ]W[LJIF,AB$ M.*)()"+.\BAE L-N ,Y19!*B&7RL[V14L=L_GS'L8CY@<&9!6@ UC45E(WC9 M>Y)8M.A3'0*VQ5VQJ?;- M60 M$;/K74Z&-%D25O>\FF9SBV,Q#V_,_+26LA;5SU?!IJ@/C%9- \Z=>H9PA%YT M%] \L[B<&F,:R\ZM2J>ZUKG%RRBZ?5=5C\62U/ M6Q5D-H+>CG78S-2'0O5; L%FN)^#+XZ7]&OX9)?2U4?94%#S): MJI0UU(M\=9W>3J[.(I!:[.ZJ0/ZU_*O?)=1W 8BNZF*-69K3<> MNGSU^VI3;NM<2I,?Z9*S0FK(5E634%'MW]]*J/S?)B,SRR,9M-(LQ"%%B- < M)' ?S\K8%IIQW&!B>>?%?:/&71ELGM>AK+J*'C,R&\YD>@0X+5NY+!"Z"CI= MFI[\S[11!GVKL*C5:%C2=66',T0]N*FG0>[#JUV.O,0,;]LVKT;*R*QY3N3Z MYD/Q_?A1[M5FL7I8%^\V35A^?8.7Y4,=A4>8BPP0#@3E41)22M"^,"L2,3&Z MENM/#-\UY7O)@Z(6O8DC*_&]E:3<1\_C!7O)54E$(WO=[*:5?N"[QM8HG_$! YAN&JP_A*(O MKSD/A:U]M42=W)Z!- 2 9Q22')%< (3%OAJ.,4HLGF>R'567RCF8H82"SSNJQ. ^WU*?_@OTNR')EIJ@O> MK])^2K+,,->EDZX% "WOOZXV]9G/X<6+HT;(H=P31PC1F'"4 1ZGE"68D2A/ M9!Q%C&X3.AK2\V83+Z2IJKI-A>&^T16D>@'."&B:Q3O[)A-'$@9'S_F,]S2/ M'G1GV-0Q]M-@2]=*E5[GJV$*KFDT\UYE!:^_KE>WS:.]BG$?M]MBLYLE(&J&MW+7*$(4&V7:+H[&Y6>G)$]C% .8T(S(KQD 21[& E#N M^RG+KK_2ND[>EP<1KX)%U\SXFRH.,$R<]4=9,S\V*,"&:; 6VUJXX/H8VX-\ M R>Z+L%U+I_E#.IIL)Q#?5YFIQPCI?$P[Y=2#LB*KSO^5QM8?KZ3D>678GM/ MRNVV_*Y*;?%F^89H,Y@SB'/(2)(1(03/61YWRY$EJ>:C$PX$ 03D@J<08$&A M2 3.,X33'&5ISC/(C7I>6A4Y*MF#HA,^J)3TOTAFO0^^[N6OBVT6;JES"".> MY]2)6<^,;&O)@]IX>]F#6OA 21\]JNR^E]E6!U.T''S)&#;5W1]@?>[.J_]X4!-=SKL_#[$^-]U(&C9BJXC7Y)U G,?MKPZB!W9N?B%OEI[%XA)@J:S?B>^=M75/Y M8FX/5AJ(NR\9:"+LW8CIE+\-;?:C,KBIFKTYW I7_9/1]4*-6RS_V$BH/Q7? MBLUC\=OC:JG2;N\VC3"DN"FWQ9?R8;5(P[1[KR,7B&.4LRA'$4$\HQBT A%* ML=F;8?[$\'Z6VDD>/"K1@U;VH!->E;JW//&UEC^H%0BD!K:/D7FTF>X!["3, M97HRZ]-2GDYN;7$^>Z3KW7C3X/8A%'UU"#P0MI?XO<[D;)]F[]B,0"@X#FDH M: [3).5Y!OX)2+* 8EQIL!"ZMS6ZV5!F?Y2E+!8=I M'@) N6"19(#N@X5FN:W!QWE>JK\5V_OYYLERH>K H;=0'2-AME!_XY]^QQ_^ M,=0R9?S,,C4 8AK+U$3@TMKH9LOT;Q]G*>(QHSB-$6 13E%&HVXK1L(PR4R6 MJ<;'>5ZF?YL_S#>6BU0'#+U%ZA@'LT7Z-_P1?QAJB?[MXYDE:@##-):HB<"E MM7HLLAZO3*IU7U3_)$BLWB[GZ^_6>=$8> )Q#'.)5CI! +CG*\=^ H M-*OV[CN8[P3%L7R!$C#8RV=U"M@?7F#JZ=WT\UB=2P>X@GDB MFWYGZKQZ9-TI3O9;%0NLSH; MZX^O+9MYA-8EFXURH'4)+2,^LP1ZJGQFJ\Y%/NN%D\9UE38;NK\%C54'^*I8 M?IG_U>9 (\+"B ,$DAR%$0O#$.UW;$P K8V5DX$\\U@KX%6P%S'H9 RDD(:; M,3?0GJ>QP5$UH[ I JI]E6-88.TN:_0&^/)]BHLPG"!]I^B-?B?"H2JEA]EE M2O3[:Q:OATQ#&)$<,I2AF*9)S'&VCY7E_V$SHN\QT%!$?[B>YH27^D"K2_0# MH6I)]!,"U)3H!P*V)]'; JQ-]&_#<);H': W%:)WH&3X]LZQ?Y 75. M)$EI%LK14(8)%YA@ /-N1 2PT;6U/N,,GY=0HKE*K^K#:9U9]8)D[S2$#HA# MY5,[A,Q2J<:X3C7K8*')Y02J)3K6S*3&:[,;6"0HP2(3' D2H12 M+O&1C"E M6E51+L89BYG<)$M- +7D)D]8.N*F:61'#QB9L),%LA-E)QM-+K&3-3JZ[/1; M4=YNYP]WJ\6KL;MX#0@&4L1I!(6@""8\["YN$9J!W(2C^H_FO5JL$S XL=KL M*N4=0*S'6L.B:\9=/8'UPF 7\3K#8^ZPG@:;.=2G]#4K35\\J7;EO7KE]?2H ME N8$P@$2"!/682B+.Y&32-HQ&M]Q_(=?[7BN>.TWN!JQF$#XFH8B_6!U--+ M(F>Q.A>3.4)Y&DSF3)M7#W^X1$F_X_Y\5Z@$:M>Z]G-Q6S]65^]8,TQ%S"$C M&0&YXDJ>IX0\/2EP!I0SC.0& MS&GPD2-=7O7U=X>0-AW"HH9X M" !<4)B$0N[G0I3+((CL!^*(FY""Q<I2N)YAV 6CW M^=>;HDO1Y'%"441"@4481VF&XL,!?X2T"H&L/G@H5I$2F1\\ MSA>[OZ]V=]WPIPKT9R#.)1"$I_03R-<\:IA.=Q$-EO2_*_%JBKP9OEYOBXJ.4Y1S5)( M ">"9YSS,$HYR"CM1I*#(KU'M?J,8+(HK5[+:H2J@IT29]AU>0*/,^NN#WK3 M6%>]-"C=S26GKN[4%859%J$XPCQB)$2<)5'&:==4C:(X 6;KQH<$WM?59-W= M*;CLW5TO\*>Q++UJ:.;N'*!I74__L=BJ'\QOBVC&2)R%:0Z5.V4 YW%,NU(R M"A@Q"E5[#>1[Q_^LZFBKJHX>]M+U+*U6U?!Q\LP#E-. M?P31N=HM%\A.@\['^UX?+[=J$?\Y$B?[^;'[XKG44X))2E"A(0$ M0KG%Y_7#FVF,,\",2B;>'H5 PD.8YAPE$0RCG$1Q$N$0TUCDZE:39VKJ!%,K M*:A%,^.C'O#ID=$PR)DQT6O0@C^57$$MV, G'F\"=&Z3TQO4:9"0 SU>;G@< M(:-+/]>[.U6D>O^P+>Z*3;7ZIKINR!A-E-MB=;NA]3O@BZ?Z:8]U38N_S5>; M]V5581E'2$G9XU;^MWD01(5Q4K DB3'ADAZS4(0(Y1D':<0R@# F\6Q3W*IF M\U_TR6MP&;56;MZLW%?J:*_B1HDF(Q'(B&+1ZA'L#HH$\^5_R*"YKJ(R(\;A M#:O'I],TIA4-UZH$SW0)6J/^I 3^^2IHM0HZM8(CO0*E6/N;0:M5:N;]GTJO&=-E8+ MU_3=1_4G\A\VR_IS/I;5;EOL5MNF*KK8%#>KW4>YNE6.<:;RB"G.$D$X2"B# M%"9IJT N?Y Y]&$C2#^.=YO?E]O=ZK\:YBMO@DVQ"]:ERO]8Y?VKT_#E0FEX%3(JZ M*99!*W2@I+X*7B(0'" (%,4&"H0)N4WW5K-PJ"-.G6F[VC&!T73"H]NNKWO^ M8[,MYNO5?Q7++FJXWC 9*GRK'XY\*X2 -(QX @&$>9:B*&<<[65,$6(./; ? M <=QLC\IC_KSO]VJC<6V6)2W&Z57PXPW\]4V^#9?/Q;*_2X/&@;S1?V\A?I% MZ8;G57!7+&_/'.=-P?[]G.F(-O>UTSRH]&Q?*2?%D6*3WV9:&<;")?J= -/V M>IYUUW1L0UA@F*WE,[EK(9.<0I%2@.07(HIP@G$G9 ZHT5,] XOF^;3GI;]2 M[NK??E+NZN=FHW=3;+>2P79E4'1G'&,Z+U\38(BMH%?;.W=?6AN[%]YL0G[+ MSB3>]G+6MI^VY_*MO-,]64\;:+=96$C">UP7US!:SG,#0J"&#I0PLA"@GH8AP%L(T87F$ MOVXQD+6N==VRE#?C'SX;=''P90\]A3,$.9IZADUCA M_[JJX>J$3?ZL90]&*W>PQ/@,U?NVVC0XW;N6+UM:#(*J+DNKY)NZS-J\NB?2 M!&5AE@+YV5P 0 $76C++Z8,]\JF0)E#!6'2_,(-(C1&_HF+&< M-C!>&.L8A#,T9(75-+C%3O32P5RQ8X'V#KL(>0RE=\]3(ET^S7"H_C\09ZG<$X32HWY4RI9=I9MIUHMIM5XM=L?R\*Q?__&.SVE6?/O_1 MCIFD*6>8XA0""@2&\AO8C2G]$#5KI=1G),_$?Q NJ*4+:O&"GZ2 U<^6CX[T MA%8OI3 V:N6\9>O2LC@6,K@ M(*;1B8@SB"]&KX.C:W@Z/%5@M0/8P0&VBV = 'TYA-7!XG0,ZQ3%T8-8M]J4 M?N::*V?09LU)E.891!ABF"8H5WGS?'^>%@NM:B-G@XWN#@Q/Q=RAW- #8 MM4<8#5M7/L$#QKZ<@O'QI;E7>/.(TCF04_<+INIH.P8KG#0\PV_;N?SP^:X0 M\]7VWU7M?KLAX8G 22X@!-(;\13D21)U(T4BQIK.P/KS/?-_+5>@! N49$$M MFGFFU1Z^BRP_"')FQ#XZ:-KT/0AX=HS=@+A4(!Y=F.E _+4'2[^E]&EB[@W1 MZ%S<7X/2W8319MR7 \ 8@AQ S.,L V&64X3IOE8%YUKY8XN/]-E[!FB3WU'IQN^% M2H=_D7_9%/."+,)J))83%$N:C3@361*G@ H.H%8CU5X#>";$XZ*C1K*K0,EF MFAOM@>!%@AP&/#.JG !NV@0Z#'YV5&J+XV56?5/KT_S:'Z31F=:!"J7#2=./ M?=O, H9QC&B2A+E 610REG/>#,92GD1Y'_[5'&(T!C9-1O;"T8Z%/4#HBH<' M1:\?%WM T8Z-.]#J?A@#4_.Y;*T+U*9)SZ9*7"!H*TRL*%IMI.OD\%VYEIA] M*G:/VZ[>C8DD@QC@B$CW0#)(0(+E\"".,"/225B3=I]!QZ#Q.MMP)'#02&R^ MNW:,OP79#P6] _J?*NH]G,10Z#L,XJVM8.,_SN"CZU%<0#Q!'^-$K7->QQUN M-GZHZS#^H7C<;>?K^F#R<;/$F\WC?-TTUBF6UP^%>I9G<]OTX/EM6W[?W7V: M[XK#8V*+_WQ<-:VBJU9V01'&<191*33/6!I2'$K9DR3/$*:9U@-?TY)X! _8 M*?M+JVW0J1LT^@:=PL%>XZZ[5Z-SH)2^"O9J!\=Z.V#T$>>/N1/^,:9.?P_^ MW[/F[5EC'T3\&+/'700R]BRRB&.\F4@S"!I_BDPO@IH )F?"KPE(9QV['?T MJSZNU>[S0[%0;1%_+^;5HUSNUS?URS'U;RG96M$P0"A"22KBD.4B0QG&J1*- MLYQP"H%M:.9-H!$BK^.?MQH%$> ML;82"*0$$:-.Q(-+YSDLX-5N=:]>APEDU'S'NH7L^[G?ZWN'^^#]>I>_NRGE?R$6L6?#3L;#V_V\Y'"CV%Q ML[#AS1LW1^H$7Y^"X]]K50IJG:Z"1BO53KG1*S@H-G"?9-=V.>&>QI\#T^@J M,*+^+[LNCVR)H;W8M_EJK?I'BW);E_G/0"@EY"*%C((8)@1&87>_%D1AFH[A MS(R%].S36F::=W+5E2JW]=V5QI/M[HK:>XWOKLSM.ZS7\FK:"3BO9U.DUO#' M]&(O[32 ,[.>&O]:/LT>!D^NK:==-)*T)SJ977_?2)Z^6SV\5]N &$$MWY!H:NH0@1%G*:"IC1,$EHFN[E#2FCLV_%]FNIN[T:3TX33CA6 M29L2U..J^]>?GZW5A90WV!;K.J6X*VO_UBC8KNPZIVCX?.:(%M?;;OT8IC9S MJGN'VBH5O+4!NPKVFC4;K>KJ93\?.2>D9L%3L0L.N@V[T_)FHC-;K?&GQ33V M6A/ H9S:@ATHGUC_YU/15.YTZC;O74>S& O*$ XCB".80DQ#'G:R)B%.!DDF M]I+0\_ZNEDVZLU:XH&JI\*$6;Z"483\3>LX7#F:]P9.%C>WWJNW=X,?SMI]6 MFO"<>7SD")U,AVDXK9$Q<)4==&@1C=3@[W*7?_]X_ZG8R1UA+<-M,8M9""*1 MPI1"(0>B C*T'X4D6F[&]K,].XA6IN @5""ETDXUV<%U,5?G'2DS,AX%).T4 MG'>P[+)NAJ!=SH*=TO-TXJL7(J/GNOI)7[J9%P-%]US2^N[IW:;:;>LI5EWO M[HKME[OYYOJAKM/_]WK_\F[3$/Z,)BE)!4MQ'LX)" B3LP27),1 MVWN^Z_-1ZBIH4QW+QZU*:#=;@1$J"9S;WO-.84RC#[YY:)0-CK0-:G75J> F M:!6^"AJ5U0')#[6K,#2ECXV&K]GT@^\]O,'B:COBUVY3<[AURG#?F7+&421W M591%"2$TXE$J>-PIP\-8JU'9Q%7PO-\ZZJJJ"B[Z'BQ-%,2)N6*/4^!'<;CMNCJ^>1'OKQ<5Y$"+^Y6Q;=B M.8,")#F*$Q9F:0PX"$&V3[:&/,MZO5'U@^CHOQYS?TW6Y(SN1X?5]N&M'T0] MWQ$%.1]1D"ZB(*\C"ADK- #5EZ_OBFZ MJE8!*8(.K_]'YG3/!\]^$#7]GR1HS?&O9^;X5< >M\V?R$W7[N0DKZO=]W-; M_4Z+0/TQ\L]JQ&[>FM[.'WB;AO5/GZ],66+M^3KZ.<^_!HJ77M'[T?3Q'ZF_ MEO/OQ>KV;G=]\VZS7-73L;V6,U,]K8D4$J*0QB'E$<2JQ77(HR@16.A>0YJ$ MK -&SO>UJ,'W6M0!@@V7%O48"(]DS.$#VA/^64:OM:XJRMUK6_^FTO<'FR,# M!)8CS16/ >)@<\9GQ*=O%M>1FX<)\0-'8#[0;.23>O+ZK!EPCL9VWU9 MW1?7-_6=[G>;MB?G[_/M/XL=WBP_E)OFZ_9O_Y"JD2?Y5[2YD/FE9%VDUX2) M[;WEZYN/G_^H8\*_K]9KE:V=93EB0C":"A BP"#GV?Z^>!:EPK9SYE3U\1Q9 M'9I./+R*L:KF@NRNW-\)+YKF),_NE4N-_E=[G_R[5*H^]K3OUCA5,UAT[IRJ M*O["NU.9P:/,"M[5.4B%@_*Z-1)7P1Z+H $@D&C4%[';;_?^6D&B'+WZC!:5 MX$L9[''I$IS=W+SNYF:=RU3PU >G_X)ST[X1Z515\A]67IBKUJ3Y]:FFRFZ>[H[GZ>[Y/#W!H6?GJ453U)',?#I,G8ITVI-P]%#V MQT/L3$?7RG;P)N:J MBY)RJI^*ZE&ND]5&_D6K3'DCP]HO\^VM],?[IG]'?UP/^<=FM:MFC&/!.8H! MP2A&60BC#!_41+HW;G],Y7SWA.A4; _())4>)W9N:BV;G<8^J5,%JZ9P8E=K M&&SV.2$51%ED=7Y,R]B>SDU=KQ&.\RX-9ZK/Y/S>:<]GW>S[2'ER#/ Y%3S1YFLH^>.?G#X+IV;_C"*Z(;L4HKG+;.O;VC] M]DU]R_]=53T62U%N^7QQU]Q>.277# LY2V .!_D,IT=S=E_*L=- QDN(M!ZO1L9A94*G,= M0KE&!?55HT30-+MHU BD'H%2I+L1>=I13LV$VG':]$QI%U<=F?39"CQETOT2 MM#/IY=#'":BG0Y5A[35Z:#&PNN5(ZT+;=5_?W%3%3@40N))?5'BS?+^:?UVM M5[M547U1SU[,>)Z"3 !$X@@1D( 4A4)PG(LPHX!17[XKZ:J69\(!)92A"'G.4L";-N8$&([OF'J^'&]P-* MUJ 6UA5M&8#=TR'XP=FY4Q@58D?>P0_4=A[B&-!ZSS*^R]C#8^,VS+&=N.NP M4$C7?=ABI5M3=AB=%=O5-SDQOQ6M'%^KW7:^V,TR)!A * ]I#,.<9#&A^X$C MED*3 C$'P_D^U*ZE,:OP<@&B7KG6P/A9NX:#=!U#_=D)J$U*;NJG+B-VIAC* M(=S3J&QRJ5#I;6J:4=AAN'T_K>N;%S+,T@23C!,1)B(3<0IH2'DW=)@P;D)B M3@;T3&._;416CUJ&QQ5,W)[R6C'?1"O@A9N]0_#TIL. M:F<(SBGHTZ XMRJ5'B>I+%S$^S7@>4QG)4X)@EB Y-L[W@TOB MU;JSZGC( :FNW1IUY2ZTW"R+35-BLZG*]6I9O\9(YNOVC*PTZ+&YV /S5V=*/4F_SH$#-+AJQF":8B% QAD60409)AD7;# M)!$/9SO5A=6*"R]_N!'K[>707GD?U.WE-KS[V+Q*W;1I[LU[0ZS&4WFCWDA/ MW]1'2E_)3L7O<;NB\NIL1P:(DCQ%*81CGG,6A MV)\Q)TF:]2+FWJ/_2)RL% H.&JOT62$Q6/[;QW6QO+5/HO4WH2DS#V.VGJ1\ M=83U57 05'4R:42M+3(6'5_"4(N)G1EB:B3L3K$W^=D-TE#D..GDRE(MW$>D/+TCC;,X]SSO<&/#J?&T=WTM3DI<(MVGX.6HWF9_5BU2'I*0 M$"3#^I3D"4D8W(_.]6ZUN1[3\T'*D4C]ZU^L,+4O@O$-IXM*F&<%>A,JASF! MG6%-3!_TIT&4SK72J([ICYJC4/9P,!-!%D-$,I121CD2A %P2#%GS&&9C/Z@ M_PJE,@80.XE&_:!K'73NQ9GD ?%Y!.W#27,C3(,,W:ME%AS:XF9.A_N1GI]4 MMW4\@#(4S34;X M[Z*:\^M28FBT#$TPG^JJ,]+AXB(S1Z1'U''Q4#D*Y?@98AQ@CI"4(&-LO[H! MBKHS7>L@I+<$%N>Z/WR9C4/[60EK.ONR&U_F:O/BU(V7,NCH.;%1=_S$U>YKZCX%,Z)#PJM.=/;H^HEIJ0 ^0\ZK#Y2_'7CDAH_OE^WPH80R)BD ".H8RA04;")-Y3 M+H^-.O(.*MB4,R"U3H%2*JBULNAC/HZQ/:9$AK#S@)D1.Q-/)T?RACEKS>WG8OMMM2B4XU1/9)8;J<,L!CSA/(\BAJ7WS 4.:=8)"-,4S>2G M?2TU$BY#"V;"5\RT2C M;[)'4[P=8OGK4=U7.PVLDAU_R1?'T#36N(;:/((=#M'R)>U?]MWZ)0Q6]'0JL7USNQ MQPX"WT#3*,+K:Y&IAF^]];H8F[E!SIX?%5DO=L52/.X>MT4W_#.I/A7W\]5F MJ9XC%:MJ,5__HYAO9P2&+$P034+((QP!3G'>"2C#1<.;JH.)Y9EA\6:W6JP> MZC+C^7*Y4I+.UT%QDGB#Y>-6]>M0I)QNU5QVTVM6_ DE>M+ MU/YL;0GOUIZJ M&_&O^$4_,Q#VNH[H\^*N6#ZNB^N;W\IR^7VU7C?U&CG+<8A31K,\!@R&.!$8 M)JF(8$SC- 4F7L5V#,\NHA-+,4 GF%W]FS6(>G0]!'YFW&L%G1<&?0.;,W38 M%\UI<%MO+4JW<\R,=;HQ#OG-%#94EL,01%@-!=-V',;BU.A(W_S3/3/-88E8 M'RM9(*9'+G[!,J,5,YR\\,DK.,XPB3UTT^"0'O*7KB:1'6]\*M=K46Z_S[?+ M&<80A!D6A$0B"U%&1$B[D7AJ5@QD\_F#<8<2*FBELF0/(]S,^,,79+8,HH>6 M5PXY@D2#16P G!:/6&GP!I/8HV'*)3.<$I'!,,$X@1&,0D!8UGU\ F@T>ZC/ M6S[OYMN=&8U<_&B3A?!2"NTUT=ZRKZX"5BSJ.J< 1%>!FKSCK N-Q:"-W+16 M@+[8;TQ[0[U-Y_J7[7Q3K>O";;Q9?I03YFY>%7BQ4!\U P0L(8XXBGG&4TZ22"&3#*!/B4P[,?IG?RNT*EBHM@5_YO.__K!7\S M/STV]';^_"HXDKLN^>HD#PZB!T>RC]9DNP?.&KSHTWK3HE*OFK[!OO[1]4C8 MLRR,48) #*C@.1&$\8QUDH 8&_7O]C&^;X*NS^D6;S>2'@YH;XSL%..!F'CR M].N6=K5-],/2K;Z&_6G6$$WCO5\B<,9)F, TSC%,0X33?;@=QP2V>S^^T>RR MJ?W!YCN_3@:+?=_O$I>[;M.'IKOITP5M6DM'7^RW-GUF>FL4=__^N-ZMU*GQ MI^);N?XFUQ3=%LO5CO_UL%*5+J+XNGV<;Y^^?)>+[(FKME]W7[Z77^[*QTI2 M>O/CZTW17HN*28;B') HY!A#0:6<),$)8@S#"$=:D<7P4GF.-VIM?E'E0,&V MTR=8U I=!46K4M#I%,1(K;XX,K]'/K0QST+8<_<+& M6'J78Z\B9Z'"]6)7RH'%:EOM7LDE?]#*)2),$QF@XQ E24P)2O,\P2B*PPR( M!"!'(8(C:281&K2Z!'58'L?N/8D#8OYA;EMEC=;OA?B_K8LBXO MGR]VU6>YA.H[YZJTO'T5Y6-9U==CGE\]GU&6YC%+>)A!(>,,:: $"I"E%% 6 M4VATG#"H8)Z=^Z&3W]S:-7'#VCU:61TQU']S4K\P?'7V"X>I#LT M%#]Z5>OP@O*[S9&8?+[=2.>X[W^BV@]LB[MB4]5_OBCOBQ>"1R'&*9-.,?9@5(H,.SR.>BT]@V3_"]J;GJG8Y?+>=BJ2#N ? MKV^"H\AA=_OC(45X?S0W\QMQHM#7QGI.=+-I;Z*E(['^//;G)M&,;I;1.%%B"92! M".<")]D^F(12 ;T6;^/)9\*&5IW>_K_'^7IU\Z2"K1=!UY-DP8=RV[XHC1>2 M:A_7=:1U+IP*?E):%M7/5W5,)R.QE@^_S/\JK!,,@TT'TRS#%.>!?:KAM#>\ M.HJ]SSB\VO _3RCEX,@V6GF'H>?!U)(/@^O_9@9B'$M8I+M7F]6N>*\>BWTG M(]C-[4H.WS1\:]H8)!11"D0N $DQS".4<8@)$+(>7@R:AY[3 L\QG+>LOM;#!0=JV+5[?OB?]#6"O0Y%OYF_.D4>B\,:H#C&0KU88UI<*@7 MS4K_<]D9BQ[&_S"_+UBI&OK-$(YH&,$HQE$:)Q%#0B3=(HX0-GJUUG1L$<44 MS%+QU-'\,&^ZMJWU#YD[I4TPU'&()A M"N,$T%B@/$481=TJ"*/4[+V1MP8)61CG0F[44X@@3U&>4"[7' L)C5F*?.?] MCN52)T??2WL:L0=2CTX&P=",5I[!U\@T$K^\!281Q'*-4 M@)3)36JOD1M.TW+XJ>PLY_I^WWPA@PAU$6BY12E$(89KDZILO3#*G'PY(T)..>5=F_.N &[=Y) M5#] .SV4&N_% AW<[!*DYK!/8^_@5B7]5*@M7@ZX[[=M654S**F5I3&*I,9Z.2-MM9XZ7+>'CQGX^K;;$\0[A_+]06KUABR1SSV^)()((B0# 3 M(D("TUQ$<4+;14KC,#:JL.XEB"!J^Q$+F(<19# E<8PHCKG( (^SV/=[39U@ MO[22M2_-JOA$9PF/8!@]]IR,3OU7YT@D?='8;C7#[('V&B AA5RQ$6B/8AU,?';7/?L&:O3T5]V; IB%RH?'";I,LYSR,"291CS#.2 M921)8<(P98*R/!6:1TV:H\D073T:JFJ9W8 G!"0H:H( E,$.1[UY+C@!*W;F>Q%;WYDS'M^['+1RXQN M$L/X_H>VAK9/&MTJ=A[*EW4N^RP;P$Y[,*_0C^[/_&I7#C.!]7Q=_;S4]FGV M[OT,"KG-2A+(,!: 0D1#CMN%R7!,M-XT/?HX3F FLDS(N!/ F @<)8CF'.49 MQ#Q/?+>;?U=MYU)/,TXS0>.\T_ $A)D?>/?Y$^;O;1(U5;'X];;\]F^M&DV> MIOWF98KFH.H)KK# 8=SE;R-P:6US[8!4]0]1E4:**S:+I_TQTX='-;VO;YII M7KW;["/F.DJ>Q3%B@,8Y)V$&">=2HKB;Q@(SK8OJ/8:G.,PAR)-,B!12$.,P MY2+&]7X4I]Z3&X?3N$TMJ&H^<=^(JEI./>SWB@LEK7; MU]4(!Y&OCHY(&ZE5S\-6;M4+\;"!I],PBG8\.@7CV(6DWHQT.2:U!.UT6.K; M J-'IMX5+ >;S6;'L"=::GTH=T?=M$C.HPB+%". ,YZ&(0'MB1X.(P:THE?M MP?(HRP! &&..)T!/HUC3'?JE)XFIF%%W7RUK1].J0Y]!:OVE>+/ M=T6Q>Z\ E\ZUT#)22=AT#QYP">J3]@UC?C.X'-;R?*D1O9CE7 MNSC^7)B&)YH"$"_K)"<@DEE'BG:88HFK=N1#4]TVX4TS$.6,P@R+#""8"4#B M/8?EE!@UI] 93V .,.4YPP2*),8(@TRPA @L]R^Q[ZY@!Q&#>;5OF7Z0TK9E MA0ND];S%T"";T7Y_?/UTM;@,VAE2=@GY--C5J48OVUXX1TN7[TYQ<=V,,8I3 MN;6(LQPQKM@U!;S=7<A0V"(1FO&6'GA>N>@N=,P35&]!IL%)_-4K'$ZT__[3M"7,! M>$02Y?$A"1D089)U*P>)T*@1ZYEA(&,)C\($XCB"ZG0]IB0F."(,\@9P\.P2"-=<"2>9:M*>S#/,\N@.%H1S 0@-&OE M.0B4=G6,/2#5;-CYEO*GZQ'=X#5ZU:$C-4K'\\@BS'L]&,TYR?*<^ !J$ M?GZQLZ'G/ASB, C4X1M'2$XH'.RAQ*F8L"\F^D4-^]J+?4'&^WT;S"0$"020 MI9+C\@0E+*;)WAMGV"BK=7ZDG$0B C3+0 YA @0"J8P$:$Z2,(X8]EVE_*RF MZE!LU:/S;D]@]8AH.$S-^*@7G)Y*%LX@=;98P07"T^ I1[J\*E!PAY Y:^V' M/'[KO-Y0ST0NN9%&:8@1)CR62RM.NS46R3VV66M/O2%!FF6Y).=1S6?[1FEQW4DUU7>YALU^;YLC_$.O30BVS-6J+FW9SV/6Z M_*Y.RT6Y9>7CU]W-XQHOZCX U:=B44@QOJZ+]BAKQD(( 8X3P%BJZ@H9P,UE MC"R2[E3O"2O+D7.:Y2@/(8]BF$6"X!2@'(HT CCB*/&\$S@()$/7>2>YX05% MQUCK;0;&@]EL<["7,[@IMT$G:=")&AQDO>J.RP?NWVH"Y!FB]&.0:;"E)]U> MMF3UB*#!;>[[Q93$7.2Y*K5JT@)HIC1=LV2,(^,4K&G M1Q" J,<_..>0P@A+1Y )#"!$(,8(XL@S#S9"!962ZBK8E,'#O U8@I]6FV!9 MKM?S;14\%-N@NIMOBY^-KW#;H*K'A/X!-6.\%LO/#98?RD#*U&1$!K^9_1J7 M,P36#\=I$%5/'5Y?O.Z-B 7Q?%8KK'I758_%8!F;, SS.,HEH9( 9G332?.<<(8EFA.( MG"&9/OA-@V!Z:5"ZFTV&J:C[2$I! M'*8L9#D *4Q%,ML4.\W,4[^!M-9*WJR53B;MY7+TA,V\?<+F85O\LIO_%A6'$LS".$QH#AK*T%2K+,NKJ1687HG@.$0[=)D\MTZO@ MJ9";^W(COY++^O%>-6S8E,%\N5RIWYNO@]UVOJGF]9,055 N%H_;8' ^P_$#V7$:/F H9?7?S'6/L1\?\@])A%^^E[,(QD+Y,![Q%- X MQ !$G2PIHEIMO?U*, 6/L?M>_K@>0]O4/AR%#RL/X1^4W-(_E%/V"BVVSIR! MJ:U^1!]@K&,OZK=#U"/CR\E:S#)$:<0 3#'*LSB.4$)!)TW"A5D[5T\R3(+U ME:0_.._K&=P;\SNW]7#G8"6"%/P 3?RKW]L%Z!G;5\>P+FA!W, 2O*I M\[^2T2G]&YGK1V5_,R5[D[\%IAZY7_[NC'*>9^ M'1$FP?U2T!^<^[6L[8W[71MZ..Z7?S-Y[I>_ZY;[3].X.W;6E(XTUM _>#3H\S!D#,CQ@-HP4&P M$=\D.P?3&89S@NXT>,R-*J6'V6=ZW?CK[O 0O/>"U:U]RF)",-AG*64)_5+ M9^IFL1PI-JJ(/_7YC.<,@JDLGO/RPI./6KRC:09(SD"T=.E[%=(G2&E/KA.@XMZ M:?#J5G5?-.R8IW[X &8YQRRB<4XS*A*<\.X1HCBE.#)ZA^#4QP-!(".IW,X+ MR%*.YOGW\-&KGJ M-]$MFE5;@7:>8P9 RXQ9_O@\!DC:?;Q]@V77O?O5W.K1K/N$AB>8M"<4HS?F M[B5\Z60Z:',E?]R6]0 ?YT]J1]FUX 5LH3%N>(HU0&,)PA!DA.PHPFJE,F\'Y>*:6R90!;O"XRY0!0F9'E$4JM2$$C MDW>LM ES ,SL./,U=CU(\[26IWFS)R*C4V=?^4M75/8T MD_;#970B[2E^Z6A^F&4-C_FZ?ANB_;H;->=UP[Q$)&E$F! \XOM93\/$Z!#B MTEA1#AFA(4M2!F&4 XRI""/,4_D-2Q#Q3++-.R=V3\+TAE$O=3@D@F:T^RSR MN@H:+#OI1GHPY@):9Q**KG">1E[1F3:EG]EHQECJ?%T=KZODYA?YE_612DI0 M1JDZA>6()C1)Q&%]120/36CJY #J&4^11T3^ET-"8AFW,@9R)./:3'H[WZ\C M/R\JN J47%9'IG;HZ;&3=^#,*,D&,R\\= J7,^33"\9I,$X_%4J'TZH?M[3' M):HU61BKUR*I#/_#&&2P>U IDY$7Z,,N[1 \2N,$Q)P!SF!$02XBP##)$HIS MX/\^\>FU8G5\:HNA'<=X@,\%RXQRKVWJ[OL\WI!&-N5PQ6#KA%$60JS;0[2%7C&+-?-;%<=*< MRC M$PCE! (>RGT*13S&2"[3#&/?K["W\@6=@,&1A.:IF_ZH7DQX#0JH&1=- M#4OMC-B@F-HEQ_IA>SE/=@F"TRDS9\"-GCUSITGI?EKUJ<1[OW^ND(9AFH8B M8E&"<(X92_899)3 3-@7XAW&@"DC H4YI""& @$<4Y)B=VMQMOS.%A63O>N7-G#% MFR6=/ZQV\_7[8EX51\3W;K-8/RY7F]OV7:/?Y[O';?T2M-Q2"QQ*>1#E$](409K*76ZI/E![F]9+F%CBD88D2E5O3RC\W. O9R M6^[J@OEF&;0Z!+42Q][_*MCKT3TI%APT,=\\^S6B_C9[,O;KLR'W8CION_<^ MD%_8YP]BS6GP^'#JGL@=#(BS6\_0/71'!4,)RB". 8(<@8PE77$M8ISG9B_I MFHT-I:8@3D "(@*S,,_#/(ZB' .4)5(0HQL05E7=[XNJ"A8M$SRHE@A-YY/U MGE264I$I$L/E%R/]F.)'6O+&NEFM;SL$W2[FF;I6'1.,9X&*G79D4H_Y=F"(E<\#0!*4J!R,TN8-LMWV>^?XK+M/?ZU ;Y1UJ8 M^DI9K4A#S.SR/.\V[3?%=\WJG>7!\+.4LWN_EM,8L$2D3"L*2")(NE M=\T ZY8CCIDP?9Y>>V!"$ AE3!&2#$$849)1(2@7!/"< FYT_&ZU)#OI@JV4 MK$\*J!^^-EFAP8#ME2A2>Y@68B7H5="(&AQD'3-[= Y#[822$T-,@P]]*'8V M[>00N_Z\R.1&9W,K!5B5RQD%]=4JE0I+TDQ^D8GN.C6*:)*ZXL3G@Z8YPB*/ M(I%0&'. "2!1I@#()6? @?GP*IC+#SFW1+T"W)<4O2'KDA"#1LJ@$7,J7'@, MG14/6F$_=0ZT4TJ;_WI@9L=];6KGB:G!BVJQ73W41^$,81CF">#R_R @. _I M_A!+..YX] M[^57_^=_=#^1__DJ-]?_YW_\_U!+ P04 " !V/YI,I9EL(\ZN #BA @ M$P '!M+3(P,3@P,S,Q7W!R92YX;6SLO5N;&S>2)GR_O\*?]]HVSH=YIGY4/16:5N&8QJWF0K?GU'\"JS#JQR$PB3T7-[':W+25 X(T7 M@8A (/#O__O/Z\4/7_/5>EXL__(C_!G\^$.^G!:S^?+J+S_^_>-/ZJ-Y\^;' M__V__L>__W\__?1_](>W/]ABNKW.EYL?S"J?;/+9#W_,-U]^^.; MW6]_V6QN_NV77_[XXX^?__R\6OQ[_LP= M_^3^_ MO?VXF^=/\^5Z,UE.\Q__U__XX8=;.%;%(O^07_X0__?O']X\ZN3F>O[SM+C^ M)?[=+VH:(-\N(MH7FR_YRA37-ZO\2[YSZ_++*+__RX\UU M0 $*@&\Q^)\-.MA\N\G_\N-Z?GVS"&#\TLUHXQ\5RT"B]<7EP<_=9+4,5%S? M-GN7;RXN/TW^M/EF,E^DS[G=8?2"W*?)YT4+TG[<31LC_]=VOI['E7QT<,^_ M;/?WWTU6JZ!3ON8U:7*\9?KX]&3Z^]6JV"YG:CG3D_4\,.[]*E\'[NW4W^$Q MUFW=_3AK0=JPDS9&O8BJ]>.7/*[,RW6^V835>FR0A]IT-:::^-5HVM4(ZRB8 M.BU;&%^^S"_GF_?AMXZ-9\^7[?[^PYTBJ/_W^6H>;*3IW2>F6&_J23:ERW9G MU$Q+UFG9[OAJ\?#%[]/'8HKE+.R8^2S\P[I8S&=Q.WU(_"-CJ]^^C[&^GZP" MT[[DF_ETLD@=^-[..IK%Q[!EY->WJ\1,UE_\HOCC%.0/]M/GV%,E4;_3/F:U MSTA.G=2A/H>:4ZM2J_T#//FV+Z^Y=B,E\XX(IO_F6 M.)6C_0XYMS9YV.Q'6IEU-!/SY71^;&/?^VG+(_AK/EELOI@PUVAK?UM\ 2OZKLZ*3VV/)^WD\_YXD.^<_O#QI"OFT_@6!'7R_DF M/V6R'?YZRSCM@C@IQ#S<0_S_R57#&-W'IOP_*_--J M/EG8_&N^*&YVVV?S>33L,7T^Y4%-^$$7QK'Y]F9Y6:RN:\0;Z[1,'U]E^N:K MCU_"IGEX3"]]W?XXS&0QC='S,-F+RQB^G 8<['RQ#?1S-_4DG]9G^W.JHQP. MMTD?DY_,5_^8++;Y;_EDO5W=FJ&'AW2P24!,M@M;U;N9_C4JE6^R9:W/-@5M?7>$.,I"/\F@46&W71T8CK M+(X:#5L8W1Z1'AG6@1;=C*>,.06:OYM/-Q;)V["!:V2^>O-8CTVC'VXTL'N@%7ZSR^=72_3G],@DK/VJ U61: MTTYII^]NYMA0G33HH9OQ_N=VLIA??@L<>,RP;Q_RFV(5J/1FV335X,TR_&+8 MCO^LZ>8./JQND*VEIH^V2Q_;KT4Q^V.^6)3K_\UR$Y;%//R("MAL(CB'!]F@ M@UY&>^P3_>UC?A6AK,6^#G^P%S1^*[[N-/V;9?EQ6],^VG,O\VNF4!,Z[&4V M>_^\K9G5Z;R767Z(^^[%Y=_7^>5V\39 '8V/?X9-^4M0UNIKL.^OPF]=3^91 M1S_XZN)270?M/O^OJ *[0JF/P?6"'MN>#UO]]5J$Z=(J MB!'WSX%4RWQ]=!3/OVSW]\TJG\TW?C*=+W;N0TUP:G?0[FC?%LNK3_GJ.@8( M&H_T0.-V1]EL:ZK3LMWQU5$0+W_?QEA*[W7]9OGWL- >.*@/CJ:.#;!1)[V- M^F&*40P\EU[VG9]2DQ(=_%1O"#2E?U*GOVJS%^R+_FRVT>,SBN MEO/:0?P3.^MJ%G467IV6Z>-[ORIFV^GFGU$5+8\E:+WP<>NCN/?&G_S%Q>?% MW1%SO266WF_K;SK_$G#@_J M6*ONQE5+GC4;MS#*VRC=;0CYZ(V;E[YN?QSU4#KM0L7AR7\>(X9+O1[NNMY9&^RS?M#O9I MARV/]_:2FENV#/'^;CL9>[!Q5RUC_E+'+8__4[Y:Y^V._'F7;8^YV$P6+8_Y M69?MC?D$8FR>#[,F"VX>W(A^&_[@[OO8;RN5(&Y_./]SDR]G^6Q7=J+\Z44Q MW3?'W?PN)^O/NTENUS]=328W 2#(?\D7FW7Y)U&G\Y\ O"NP\3_O_C@[.+;; M8X$XPK)Z@OJ\WJ61E.-=1-3^\F,86Y;88\8LT00KJS5E5%BJ/.*:"^B4IT(J M\!BB12Q!4JSNA-,M1GMF\*[8Y)^"F'3XQ=\/@'&L:28AYQ@+I;AFU"*@-+$: M0NH,D40A7F?6#TFI5M,?BM4L7_WE1_CC#^%O+O/5ZFX_/%!)9N5%T"G^8;*D-?MFK#KI7%%U4/_DN MU0V!U'J/K EDHIACX;DWS&""D6 8RN'43?#]%Y/U>GXYOZVR=+'=')%U>7S[ M()JQ!ZFD?C/+"'.<$R20H 93R9V%C&E. 4%2J/]65(U850PGFWLMUBV/J_3; MVPNJ]YI+_3E?'^#IP789M1QZ[;RW E"AB4 0&V0"TH@'&&JMV]?#PYYX470G M@;[8]F2HMHBY2P=8MO?[#$B*I0UV!8>((H"U-@YHQZ$67&-S9NQJ2-ZYD?!SK(/&0**D)#"AZ@'@ @L5R#NW8:]X$RSJ0]YM5S^902F0HU02X2'UV,M@I6,7-B!'N<"*G->./XQC/!+A M]1?!N2\V=JLXPB06VUAFZ7U,=0D ;#:K^>?M)J+ZJ7A7Q"S@31!C&,K5FV6@ M0;X^%+QMYP:VDVF= MD]W$GC.,B&*>0$>]#VYB6'46>*$L"UN0T*H69J]'9W7.K*X*9'']>;Z\38FOH5,.-L(U=$/]3K(*)#002$,TDYP[! S-B"@@TON(*FG.E^/&FB' M#$4/2/>YI ]G2+_R):XMY%R:X/<39X2V1AOK#8<266"80&.P#W^$XP[\O'WC/X(_D1 M+[3(!-!!O2D4D^(HLMH(XLOYA9F?689.=^)_87M)@WM(.L5_7.7YT92(HVTS MJ+@3 E#GB3">"B]8M5:!Y"FQ\A%2+%GR-9B4@N]Q3CV]RW-SG87%,)E.%OEJ M$NO=!\MC/HV%$S_^K'Y6R]EOL8AZL9C\7S.YOIDLYY/XY^^WJ^F7R3HLM?V1 MFQ?%IJJ402!\.:0*0$KM:>5BFI/Z]#,9Y E./L:Q_YOGGYP/MZ M5&%\EU1W*U-8@XUUNLF\HI@09H3BE.FP!3 L2B0D16=V&-TI!SO >UCF[:MR M_W8^^1Q+ZGUK3,"#O66 42JI%(QY!)DCAI(*?"UX2GAUA!EF/?*P3=@'I./' M37[S *WR]/I6L;^I3.SJ/#L6-LO_M0TSW[LU-&-ORS^>,6H!](2R@#,"4E+- MY1WJT#G-SBN3K2^R#RNEWG(NJR22]:="S6:[44\6[R?SV9NEF=S,-Y/%[OST M4/I W3XRS"&F&!L@%:+6FJ OR@@*% BEA+]I;:8>J]3P*@C;%>9=GW\=>VY^ ML#.PB]759#G_K\K>NBUI&3FVG#T5"':7]DY)#Z*A9T_R$?8D M%#SXY=UC.F%S* .!9?7__:D!-1IF+DR!>RPT@D)C@EE@S=T<#+;FS'*:4H18 M=(AK7T&H^UM)]^KCPWS]^Y&$N$/-,AOB(0VT+ON@,X_[95#Y^^BG\_M$LN$/-,L^<48P;HHR!6 2;$]ARI@'16D4J M7X\^:D?H+S(I&=^^F/3"6[I'BQ <;)<1Z8UQR&@-(&3:P+ >J[D*D)(Y-&HN MI8C]J;G9(L G95,>5KEO#R27U6^<,4QT<*(YT\)19V4P!7@Y#Z_UF213=+2! M=89S7\KGH4-2+J&[>31Q"UYJG''A+19" H,HD)HC;:I90\O.)%VL"QH4'6/= MOZ'TX/WX)W.H93"]W#QC1&GNM ?$V7O7*M1;P' M8EN] ,+MIUFP0SWP5BA/N!%4<^59.2,"78J;USQM\-G;&:^704V1'8@K[XJ[ M,/#N[H"O[3K?G?D0Q9,SD@:]_8N!D3P\Q<@DT MT%J$?81I232QM)J_0RD'E"/R-0:*GJ0#/A)]V"KL_1.O&NEC-[U^].Y0!V%9&ZN XLY:Q0S61-V' MW4T X#ST7/^D:Q'TX2@WS^M%5QY\GUF(D8EYH 8S U&\EV(JZ"1,<3E>28BE M6T(UQWA E=5*P*5V;QD$ 0TNK,/*"1'PX+8Z;C98I)R\GQIT.3/VM2V#(0,O M'^977S;19Y\N)O/K$X(NSSO(E$%Q^DH3R0@A5#@"*F/")#'P=05D6 D])Z;)ES5/-@"9>!!N%2>/M*(B]#^!YMRF287/J!2^6G MIM);A3"UCD*./&6""Z,#YEHI"()%S@AMT7 M0XF)0,XIQ?G9YF2TR*>VP.U\!WCP6.)@&C\^\Y OU^5UU0_Y9K[:74R]OXU6 M8RMHT$O&&-,HK&[(@*/>* T-=#H(7#&O#:Z5X=8-%N_C8Q>[">PJ@;POPHBK MF=Q)J^%%RE.[S R## -NE6><*BJUT8*$5>#CN;NT9[:O=,*?8A!1]*DU[A^B MOKA\EV_>!XNXF,VG=Y_$6K5#W\WL7[UP I S"B,O.7;*8\,QD11Z1A1"H-8& MV@T6]S5A][R6>S^3%Z^"GM1/YH'QC#K@6-C@I%7.&EOBH?6YE7_NA"DO/JC0 M/OY]&;+WP,11QQM&1^Z.[F^0,6LG'TI2:9\!H ZP@'84GB6)E5ZG*&!/9[!;F/YRG3Q'R4-2>A MVA=O[JRQVY7S:#$=O2UZK&EF--<8 $HE!M(+#ATN%;MF3)[)3:WV!+_?4&X+ MW_X.!IZJY'N-_+;&ZP6UVF M3W7_;LG6-MK#J;F'@[^X_#7FAL3GS(\DY-;N)3-&*^@X84!+RQP41) 2!VMX M/^DP"\-#T'#CE866\?"/ MK$*'@Z0SQ!%:>\,QLA7XAR/G_I/#1G3R^E!8I!4^+'$#'G%1#KA%E']4GW[*EI&Q=%?GVS*+X]710O'F'7:)5QS[&V MR!,> !$ X9CW?#=R;E2M5X)>,Q^:"K#H"MK>4B'V*==HRK_,H[I-,TFL#;ZF M)%0ZK,)4B:#EC"4A*1[8"$, K9&I(WR'\_%K[.2/[TI4#FO;IOT+/Y,IJCW" M\:$;&DP&S#4@J%J;#J4D[8R0J4?R1!VQ#D)H55!.TBO@.$E+I0QT><^WN6# M*L.2JAB)_(93[;O''.:?MY$C:_W-[0R@@U9#[3XRX6V,EENH!-$"6 $-+#%P M6*8XP.>BE-MB<-?"&3[#Q&\W8>LJA_]H5A_R:*;-XC.6/FQRD\7_S2?-&'SJ MCV2: @N(, 10!Q7$+O@!)8I!>"GW8YK75_I>*=Z3]/H\[!BXDD/_1QS00H ( M9EH:1:$GFL=<(V>,H=( 42O-J^N+=\%&>.C$U;ZY7[.'C ,7[ZJ'^3)$#9:2 M(>B\=YX*(P$[L]<[.F''BY?MVD2^:T40--@@[Y[4/%E.,50O3S] MX#7JH/KG-?/OZC3/M-2:F6 F&X,@)@QP;CURB-$8(]&U0MH=I1[6?1#J2>%H M*KAPCCG*B"<""^4D*V>DN3^S6[3M"OEI3F$*LGU9L;$ 6E!I\7_$\8Q4MY4\M\GDYCA;)@S$[S,/*P@X5=S6Q7J_U1J3K-,B.@A-9 R 6&4"LD#"]G:I#N MM;)Z'W&FEFC4(J:]59^*;MK]>->UN/-RHV"3:6FIHP82*8B0B!M0SI)2V,_% MC->F?EK#LR_6O%E^#8,K5M_"2&L8/OL^SYS1E#NJ"/ $>H0@5=5>+QU-B0.. M\$Y%2TQI P-VK:&9D)[/9.<"K#-!17E-C*\EMXS@WWEC5' 4OR4QM>(7I&'FXQD M;U&1FM1X/)C=BT^'LF$/-LR"\2VL=+'R09BL)@YI5\Z6$9[BV/#Q M&2 M$:953'L,LVZOM_'=AYG-@V"F\\GMHSHWB_SNL/+A#=X7YW@X)-O*3V1, M4JZPM=@PC UW$E1J63O4XZ,Q=FR ATWJ0\TRHPFUGA!L,)+Q.05- M<#E3ZU1*<4UYMMMEBXCVQ9WH&OXQ7QQZXJC\)',"4:F!<)8##PD4FI)R!AXP MEA+J V>K?$Z$KS__>S-97LT_+^X>OPY4K1*=:Y"C3O/,BZ NC0N.*6=&2P:8 MU/ [ MJ;Q93HOK_-/DSXKWA[.[7VB461HKFLB@794)IAHWPE1K@W*9M&.-,(K'V)?L\+HP=XL.\] M4HX<1(!@#;UP0$!'2'7F(B ^LP)YG6;UIL/;%VT^?BE6FT_YZEH7JU7Q1["\ M#ZF//5]G 9\B"%<4@DY,A+JRN]#O-XKIZ\G;3=)LD]O::=.' MV=LFCUJ!M$?"K+9!$/?SOQMOG0M.Q]IF3'@C.!=02A'^EQ .*JL/>9AB,H\P MZ;=E$K6*;<]\^FVR^CV/+RGO+EK64D,O-LLHDPR%50- S#S!A!M4Y1B$*9_9 M8UPM2GX_I]H N3=+>[+(=_'*/Z?S=0P[U=[8CK3,C$)62FD]$XQJS35%ESNTF'^=S_+EK+XA_D*+C"%N#/7:$"*)MQ[;!WI9H!0N MC="$ZHY)[>#;[^G%2V 5"6V9A4P1"'R5^0:@2_'N1DFF#OR[9%0'."FI M$;%\OAZD\ H1B0%1C@-,L'?5(7'0O"F9TR-,M6\U+)D*YKCBW\N.OWV??G_=RO"G+S\#\'!Z==**6OZE# FE M-*:4$*^#YRM=+)A9JG[N4Y1?XQS\U\;5865Q8B&.RCXLAUV7@0U:9YIY*J4, M1B>6%@DHO*A*77F"D](1&F?QOQ9:=0?P $9]/6L^ P98!8E'EF%)J67P?AX8 MI+TTU/PLYK7:\0UA[(L.IKB^GE#1IAJW6EV7'LP]W9VMRFFOW\I%D%1\O5@90 M-K?%N7=U>(NH+F.Y[F(1AG+U9AD$EJ_KY"&T^T,9P!8Y3L+J9H)0$>1EZ'U$ M&/1;2>1UDW90R?2I-HOE;JI':[H^^32S$@1WB"'/D<5.2V!I%296RO7Z4EL? M=M=0A-BC3!/DT%NX?C;;K<.P(B?SX&+?!6P>C/Y0W/YHXP"?5D@RYBQT!@($ MV7VU22A9K\GKWQ'[6I=,7WS\$!_=7N8S-UDM8^+UHQH*E_/I_- N?;QQQ@P4 M&BJ+F+6<&R>EK5:A$S2EP, H\R9&PL?6)3- D9:=[QU?DUCE7V*8YVM^ZYN_ M+=8Q#GEQ&9STPX><37K*J(94AU5)*%0TN/;>J*IHC<(HI9[8*&W$4?"T6R$- MYQ;I_+)8Y9]6^62]77T[MJ_7:I\! 9S)YC_"NXD@( MVH5H^J+EHS$>\V.>?YQY@ &T#"'%&# &A_E5>524BUX/^+^CO3M9$L.IO48Z M+E/"^( )9\$Q"XH<<("K@T2$DI[/:7[J__TJM(9RZ(M=O\V7Q6J'TNW,#W#K MZ:>99@([XAD1Q&M.8%#,U7H)?YQR$V"4Q_\CX5:B'%Y7%+OSZ'4&741=2R]B MS97HHMT76,#:IQSACK XWT@X/(CLABB.L9PUVK^/-])3V8P6L+YGUU#O6K[?8?HEW\RGD\7CP9W9(Y?$$NLQ1MIC0;&5 MDKOPSRK\GZ$,N%HZNZ/(VF)1_!%%XHN5+;:?-Y?;Q?/GSFI<'FC23V:EX5+( M^! SHAQZK1@6DGH&PQ)PXGM\(K,V19[&RCH$?H"#U7=%T H-3E?OO\\\U@H[ MXYRC)@8"=ZEYF%*!D1)4I6PU([SHVRFIV@!X /)\_!*@6[]9K[?YK!Y]'K;( MD.'*,@RA(RI>*E54(BC#$M&2AA\_LS<.^R)0 L2#A$1OQULW)GK[=<:IX,3R MH%@EHC@8=TI (HTFP= G(NF]B%$>$W5(G71X![%L*TS6%Y?QO6$?MN51O-Q> M#::9,?NL6>89Y58[!53TH947./R3(!8)JX,?72M\ULULX[NJ8;CO5T6\^CW3 MW_Z^CA=5+F[RU21F3ZKI9OZU;O''YIUEE#,@+ -6*H0DA8X3?(>,P5XD51H> M]>I/($G1,^J]W3A:%9?SS=NCKP_=?91A9#15@AL$;+"DO&8,EK-@'/7*G3Z" MTET*^OF+'*>AW%_:W__;WI5J_U0$9ZT(.^GN;?'['(=/17N:K8N?RY3Q"%H6 MP%4< 2U<<"-+9*E+JM4_0J^K1_:.0%K]W?B]?Y?IR7-,!^A\H%4&(.((6R0- MH!1+2(VDY3PE3\J*&>&./"Q5GET4;DLL@UTX=W_>1/O^[F+H00H>;)E)J[RF M4'JVNP'&?;P5>#??8 Z=68W>D=&P3='T1<4PVNC^YC:__=\'V-PEC]?8Y^MW MDC$M'0X&4'3,#?&&*L1*%(SPO29B?V<$[4Q*PW'U_KSA\)OO!]IEQAFEH5$8 M.HN!M<&5K+8(#M,>8JG-2'G+R&5^M2M&V"4GNZ#!4::=#OAPY"H?+S]\2?E@ MNTQ0Y+0R$D+!+?5>456Y@832E%MX]??CQ)VXQH)80C MTCL?M@.O9-P?[N:,)$NI,C3*RTV#D"P-]%-+M#P?Q).JD&5QD++XY$LO3J5T MET%HPFR5&5%V5@/_?6ST.+]2B'097;DQ*4)ZJY_;UD%GJ *0N& MA"!*\/BR<8F#)=ZF*+Q1E@<=2N&U G_/E==B_9)=7NR1DI#[/L^(",N+:$L! M 5AB#UD5+K+*T'Y>%>E1T8W*/VU!(@-&3:*V?KHJ#Q>/K-]))J6S5'-$!$)& M2F ,U24*VM.4L%Y]A?>]\K(S.?7%UOIG2*UD*63&.NL=E]1I;QCEDE-0HF"A M3CFA:Q[CZSP%O\<3NLYD,# 3;U\0;REOYD!GF<<82Z2X RY>OS%,*5:M3RA3 M]O<1'H_TF3?3'NJ]V8N3;W<;C)K^:SM?Y6%*82%MOL6ZK)N[E^QOKH\4X:W= M22:"5>X9XP)!$_# 2EA2HB ,ZN=AUA[W\"Z)\M1R[$H*@W&QO,#W9OEQ^WD] MG\TGJ]NH@+J\G"_F07@'?9L3NLL8(1@2#X0S/GAV3F&!*Z_.Z!2G>I2AZB'Y MV;X\^F:J+U8!N6F>S]8^0/O7?':5[X&N!DEK]I1Y&PP9Q0D#A @?#7EC[O!P MP27LY^'8\^9G-Z(8F)H[9ZT5:K[44P:TTP))!3"DBGICF2F#%(XSFT+-48:- MAJ=F2Z(8G]_3BK^38:D=@$0 J,-6@3D*/M\="EY)W.O[68-YX%W0L3,9#,S$ MNUM5[7C@!SK+B)&.Q+=:.*708L&-+[<.+SD[L_RO/CWP]E#O\>9*I= _Y#=W MFO[B(U''VU6F>8O=0D8P0:8RS"TAL?UA6T M4I5DGSRXML4]=E0SW$-OA?9R]+ &Z*^=Q5[2NYK9XN).,8&L0T=AY!V(Z"2+4 ME2A0J/NM+WBNVV.K,AB2B;Y8[4*5>P!K2,<#/666$$P(LX9AZ[ CC*)J97*8 M= &@^1/HY\[)]@0QOIA?*[&^+/A*C!&*>7"2L$? >5Y9L=0E/>4YPH+J/=*Q M,QGTQ41W>9E/-Q>7[L_IE\GR*O\0;*:+99Q3_$_,TO@Z6>2[0I(!JODT6%3Q M+]1R]O@/'GQY@+(=_%JF"5,$2PB,8AAA!KC#):Z$Z_-]PK&]^/7P8NFM4N3M ML)\,]GV^FA>SIUG%-0+>IW2706*(]TCBJ%N()L$#]"4R,>_TO.S53@C; ^Y] M,O+D5;9_QE5=^H?K^7:-'^%R?P/)'&4",>*!E#!X"]X 7X5RM7$I%O(('Q?O MEK![5L=H)?DJUE57RR2S'"H/O-5,,R,$5QKP$BM/0$J1V,:A_)N=I(-^7FW^ MF_NGB.?[IK)&%$MKI=#.LYBK(V1IX$'I3*\U#FZI[);=1GM?$9&;">>>R$-7 M2Q[=>R"ME4YV,CC_P#(A":7 <,\<)5)@3#QAU-6J+-_58>)#%AT\0GSX8>:- MU%Q[RI%0VB$0C ?9Z0$= J)E)3&$29&M"/<9P>$"8@.OVH?OLE;/B@]AD5[ M>RLI(]%R#5I?<>1GDQ+VWM\K6P\ (-]S2;ER)VB#-,%,( MD+!_<$"=@^5,C$"].F7]/(_8D:0/E*%N!'%?)F:=-[9/CI*E=YXQY1S&6 ,@ M)((:044KU(+:/;,2TWW1LG?!G%1TR^P"#O/E=%=Y:?HM_/!RO=B)<5)5I3A MPZ9=9)H+Y,+$*+7$!VLY(*JJ.5F64B)PA(9-GR0H>I'(T$K3%ZM\?K4T=U/[ M%*<69G%;#/O3_41_G! MADA:5 F6AR5Z+O9 =X2LJ7&'$]K0B\7FE_-E/KNKR1W+ ZSO:PUU9GJT\*N9 MQAR&_19ZJ"F$BB!RO^MR(E,N!HS0)AE@FQB?$(=>+!'L#_ET,5FOYY?SZ2UM MJBG'G"AU8=[3Q?SR6\SR6N\*,W3G M*;?PJQD,6M=Q(SDE!@H=3P5TI7UYTMNX([SG.\KMJF\A#KU8_KX,HU_,_RN? ME7;KQ?(!"NWZ/:?_6(;CXZ*68P,PUSI ;!DJ497>IQ3S?%6;3H_\K+EF>A/J MT$NEWN[Z:/*=6V][?RV#7@AMI9,2 A IJQ,E?;0(%_KM*/EJF2?_GO-#"+< M,2R:Q%5P/W.AN"0!<$*YP$AR#F450Q>3[B",VC!>EHCU?-3E MB*L$R??QK<,@_LUMR?18GO]3\:X('R\W04"+766#VUJ#AU*SVOVES#",A&5$ M64%@RG9M>.^"C04RSN4SBMA=W>LSK14T&%EJ#9">F*!=+3$*[@P_92G M[HW-O;.L798WE-8(V'T:*]=I@82PTE[$X*,OQ!/S<0O[YFM5P"\?S71!^B&IKV)QS%]':@MT.32$,],UB$?_ Q M2TBI$DV)38H!=08!LV%V@40A#>[_#7X1\!;L:D@UO+D76F1!SZAX[JDPUE#?*8\_/\C MN^D)O66<4$D)!_%)50=,L.G'R6*GL0Y6+=SS=8:T)HH:24C8PZU!TGI7SBL62#ZO3/JVF92.:']ERP]R M/DRD1:VUK[<,8:V@]9Z:X"TIJ*DUML0%<912LV"$Y^ ]ZZP6$._O7&0=K,!? MBV*V_EC<0[CW+.31EQF$&A'EN-,(:<\9\K!:68"2E L*C4WFU[COI>'9%S]^ M705;_?;6_@%N//@J0U8PI"""H4=K5=B8E;B;!P2;7<^7\SCXN[N6'X($0I=?(DWWF3'U&V=6*BHAUMIR&PXDT>J1^S3,KXT:'8X/.O,VTH#*Z M8\QY(QPAPE;S(N'_$D@CSG]72D>T+Z;!^K^O(DANG?YX:#7_B89@XH' ME*CQ2!A*G>."ES/4TJ0H&CG&1WS:9DU+P)YDV(2?N3TKF4\?WR%>WXTCNG"K M]6117-[]0>6T?FA MR]GC7F*QU,VWW_+-EWC%);X5O3N^.'I(T,LH,NPD-4YC;X.:4$PCCTPI!^=( MTH74$59';U\#CU54_2Z9,+.[97^G%H[2^UF+C%'E$2*.6N4YU9P+>C\_S$ * M%;^#X'P[L)YD"]3B;^#Y[=]\S*?;U>ZE(O^/=V_V;_PI/68.0J\U=I! RC44 MTM+*< :()]42&V^638N;?8_H]Z6FFM:G)(D:5 8D[8LC MO*7;MC(Z&$EW*RTSY M:O?X;8W,LI>:9,1X@(3QWG-B)$=&&%#.D J=DH8/OX-P?DNX#L4[SN?5TL/VZ*Z>]V'E\D7L[N M1QXSSU<'.52G>68(M!YRRI'T5@=]C76%)% ZA5 CK"/9.J$ZP'CPE/_=;+X4 MBR#$=3R'F,XWMT&(P>X /+CJ\7!PMZ-J=K_[Y?:9P1K:^/PE!)I(RSBBPGHO MF?# AC\;[GY -?Y/T0&K,]'=AYECTAILG5646&XD( J5,S+6I.0+C-#$:%G* M18O0]K5C5(.\G71U%+A6?\X/.;\'VV40>2MCO0O$$= ^OGIHRKD*R,ZL=,VI M@GZ)+RU VIN=^GBHMKB>S)>'K-1]WV=8$X")IL1@I[FG&@A6K3!P;D7?6Y+S M4T.U!60',%-_RZ\_YZMZ-NGMMYD05JK@K 7CBSCN&0I^6CDG1D'2B>3XV)(H MUY>MSY/0["V)=C:;[Y[>6;R?S&=OEF9R,]],%D?9= M4>5<);+GY@NWRIPVD>WOOMEF$I.B2B?N*'WV-\B0T%X!Y8SQ%#%C=+5Q MRZ17*D=X6-TN>]+Q[.TP>N_)^5'"'&J684FTMA@KYZ B3'IF>>5B 'QF%]/: M94Z+P/8>XGD;]N$WX1]KQ76JCS.'#5?",,\!\P[+@(\O9\5EDO4S0JNY[6#. MJ3CVF"G\Z'V'-\OGH= /@>V^6/TQ61TZ/6K84P:4"I:>"FN& 26MP$94<55! MS9F]NI1"B.CKFEM_0:.<',D D,XI9BR2@D#!';647&-GODZ8E!Q#16).;PY*G"AKAB4=-S*4:TXY!@"++&!P)*PV=S-W#N>$FEH',#JJ6A-+^3J /Q> MM]\WZ_4VGSVLL?J/R6*;E^EQ^:X\9IC83NC'MMI&G67 (@6!9MJ)H+ =0%+; M:C$:D;*MCK6.4G];:I>BZ(N@57;4@S.K Q3<]WD&??"_ 790$DD@-IJ#ZG#+ M4IVB]^K'R/HM9= +R5H NR\:/;W86T(3[]#96%LH6I?Q2O!+UN5?;\$[0+VV M?B*3,&P'A@,%@ARTD9C0:J<(NT9*'D3]P-P9TG4@ ?663G%[$A*?V[F\S*?! M['B7_Z&FTV(;+[Y?O0^[P'1^LPCPWNX%%Y=J5MPN%@\ MR6A1A4&A1RE:=YQ76WHA<6\"&2X M#.G&T5T=BTRS #&CANJI=#28Z%\%4BS M-ND@M7Z5JP%NE@\4HSD%]/^.*CX.63EA$>=>(:RXU$!3IJO\!Y#VC%[](EN/ MHHIN>1Z;_2 "&N\5C-&]O-?A?0PNE7+:>R0$H01:[:73P!",/"+&UHHIO.*+ M691CHC#@EC"*L5;!E4 ]J(AH!^;!"LR' M>WPE C>O2M$\&E/PM*:+8KVM=7&^43\9*$" \@8QKB6OM MI@/B\2D(2"\.Q[>:=90QI@QWAAJ+'/4(209IV$A-L-F$H?[,[HIWQ)8]2J$S M$?2J'OZ:3Q:;+R9@&^L_?LBGQ==\]>WM?#._VO5J8]+NXGO3(H#&4FQ(>V>, MHA(9$90Y81X2IJP:\KFG>)[T:/3'KG7N;Y YX[#'%B$!M$.$<$SQW0RU#FOA M>]8*M:5?= !U,_=XG4]_OBJ^_C++YY%#)/Y#I YY0)WP1]G;_&JR<&%HP2+: M?YUSSU<99=P;@S"6P5I"V!/J2#ER"%U2H;[QD215?$5;0'9#@=OAO'@O\^DG M&:;QW7H+D,7,6RCC3E6.F?ASN5R7)*VB%>B.BWM/2<^/V\_K^6P^67TK'PG^ M6['*)\O?)LOM95!B09^M7K[EU*R#C#J.&$+(,.(M]0([3,OY" '.1 ^<+L:B M!U3["IL^TX+ZV[M)'/?%Y?T?O[2)-.\D,QPAI;SB$/E8+H506:E7YWW*.VPC MS'5K:8_I'.=AV'8W^*.U PZTRCQ@RA&C'1<.>@2(8::<)^ TJ9S>*^!3"P0X MR+$4L$_:Z/8[J&JZ.Z4_M,'5:)@)HS &! B%.9'.J##LVM>MQ/:T3:8QA]HIK8EV0,77,36O-+2&*1Z-. M?O5TM,NW]YRIN[/\Z,VD.0^[_,*$$@Z%?F$&">R^ FB"H6,(>PNU5CD=<9/;'BOKN^_S MS LI&(0,.RN)DI!Z+RO+6SB50(X15IIJ.UB?CNA07#D>D=_;( O^$R5$"*%%A@@-1K:$/&R. M$"M /5.5-TY,BL7Q"AC35,A/*URT FK_2L9,UL<"\,\_SEC<2[7FCH?5I2QD M$I;;K.$HJ5;X"(O7=;89G8CG,"RI%75_J4DFI0#<:FDA%PH8R"PL;7&C.3^S MZO(I(C[(EI,1/>D ^-.77&V"');YMU_S9;Z:+"XNWTZNBO4N5G/H!+A.RTP1 MZ03A7%HI@K%.H$6ZG &T!)\S)TX19-$EO*T1Y&^397$2/YXTS(1 4CAKD>'> M6YN/&&I7@\(XR =$V/-'1;8\>O1?CUD^CQM&5F.-=*.*\,E-I)B)DK M334#-$Q)C1QAN*1K?B3"VQI!+KZ=ICT>M\L@4DA*8HDFW%JL!'>EW6T,33JP M'>.Q6\?D2 *W/6I<;9>G<>-QPXPPH1D@CEBAI.'0AA^N=!^#*8;'&&-I79,C M"=W!DJO?UBC$_7*C#!OHM"<, 18,+29B?<%J#0"3XM",L+Y.U\G3I^)ZDFZ) MRV"M5\7VZLM&7865L-[$4GR3Y;?]*N7E[X.-;8Q@%,, @A+:"JBJ3=(8UFL6 M:Q\%%-L07-$^L"?1X$E.KIU<3Z[R]7%VWI.^PER M2D^9#,8W(]Q#)YAF1%-41:>-],J<7H O'5*^6W,^6Z'5"_WE2GO M*3!:F[#S>H1QL,>J.)/R."7?;(Q>46^T:@WR@>[W/)K,KA!M;;MG3]M,JFP1*FW!T;HW_5'LVZ@KAU??5N&ZWYB\OW03Z1[,VUU-,> M,J<55$9)YQQ7W@HF7,#*Q0)?3#*04@]EC'Y7;[HI$>A>JY[L(/^0[QZ-V]E_ MWV>9$RVDT5!;CQBA DH5DYP4AU0*"F9-F4)_K=789['F@ WHF*%,)B0*<^N!">D\@4OA,2B6T M1873K[,WP_GU7F$Z58 M= ;O2=1XOUW=%*ORI85R#(O)>GU[I_X0/^JUS;PQ!C'FG&"2(L4$%-8(:+CQ MQO*DJF^C#_M >I+Y-5 ML?P0>;_ZQ\_OPYSG-[\5J]5\_78S^SDXE;\NBL^KR7*V^_=#.](I/07(G-9A ME1FO"65A8[4$,,L!"S.W+DG+C)XSIPBZZ!/NUU>=QW.GA0&":\:IP4A9@[". MJ:B:2P*_C^H\IVY:[8#Z.JOS4$J)M%0S A4-,&F.A/(66 0-\O3,DL*3)5V[ M.D\S7%]7=1[+A%'$6X0)HP(RB134WC ;P=/\W IEI,NX5G6>9JB^SNH\%@'M MJ71$0$TUAD)B91"$Q%-!;%+^UFLXQD[%,+7>DU 0H>]U0!P*JA#5 #DM0D>/[!:.)*B&UY#RE/+A]*GXCKX M-0$!& IJS1J/J"-$^@A"L-:18!:A7H-K U\3J"VX>M<$&@';1HZD6V_FU_'X MJ4RZN_66UF^6U2'5[F"J5KIDWK.24?2KY=_V0SJUW>88Z%12ANF=M6Q!%; \4L8( [$13R M>5$I5<@U#W.:@?HZ#W,PML&G9TISHJCA,/AV3AI*)/ !R"0W>83$299T[<.< M9KB^KL,'\>J\(2 $A,(0 *@@%7 E)PF(2 M&E+GG>!G=L>I"P(TN"+0#.S$*P(?KXO?HQN]G)5OK=6^)G"@:::T1PI B(RC M% "NO1"(!I2P,4'1GS5A3I3FOJL"[4%\$DV>_?Q])OKAAW^/MLL\@"ALS,9P M1:D%2!B.(!,,"X69EREW24:_0R43I'5\3V)'I\]F(D0AUP93QQR%&$MA C88 M4(6QT2JE*.;H\RJ3^=$^P*>=*#2_9'3XWHNF@;N$:$6=HP0KJ8DFC# GM78\ M*?]M]%E,R:1H$]IQW4LTGD.KD<24AYW00B4!(@8@ Y'BP*14F!K]V7.+QD8[ M\)YX+_'S8CXU82"+&OO'2U]G0CJN'4#<,$HE@=()S*QD1$CI/4@)PXV^7'\R M$5I"];4FL& D4+S<+;T-.I!!Y9R!C $-L() I*0NC-[@:#]DP:$LE M> M -9:14E8JQAG5F"CK,?2 49_5J.XP[3T 8XQFG"(590BZTL<95,]3BN\X3 MJ"W]>GD"S: ^UT,81*EGSBI(;#"4*?=,R#L4-'1)U=='2+A4*IQ^"-,,Y]=[ M"&.,((XAK0*D0(!@?4M8S5/:LRZ_TPX!&AS"- /[)+/UB=UQR./=^VFF'":( M(QN,,RR\HES*H<9I0=:U[X(V0[;[ MBX&?_KJ'(/=_F0F&B-6:(^*(XUI:XNX5)8-G=L#?@MR*1 B[%_G?/AP0^=\^ M9-!K#B$G''EOO*'*B]))U(8GV9\CW#?:%WEC"'MS51(+]SD.O,$T6$H..2$4 M\:[2AMXGO6_Z>D+G)SNZJ7@.PY*TPGV[.I@(8,BAD"@X;)14'INRZ-Q*#B>( MN&[AOF:(GN2O?OJ2VSS,>!=5+"X_WN33^63Q9ODU7Y>#6A>7P:WZ-::;+&^_ M^O1E,E],EK,C3QFF=IP9*;67B$)(35A_T0VL/$ 2=.TY,^H4&A0#HG\J^SX6 MV\V7OQ6K?++4Q60UN[A4V]E\HY:S-\MU&/:Q*$JC+C)KM#?0,$D(DYB&%7MO MG@&25.UZA.9.RXSJ#.?^=[OH!6[7M:VB^\\SP"2'F%,EK 9&40,8*F?&F$IY M!FCTZ6HMVD4G(SH45QK810\;9!0'SR(F;TO)$%#",<.JJ$)8(N>ZAYTBX"-L M.0G1OOAR5[J@1NC_2(L,08T@]XA+9#44.KB3N/(GO3JS*$RJD(LN0'VM^6Y M8Q/?W5,,(XZ]I)C?KS1D4TX!1I\TV_[I]*FX#G4:?5=7Q08I+6>3_:\>UFZ; M62VI$\%L$X1":AUT6E0^@YB41=H]UK$N_SVPO?:1XO1QHY)K0,&P:V3$F"D20":,6E MX[6R7,>=QXN%(8B[X!A:0AT*VY\)Y$<4D?B>":Q5T>SU&!L=2;]>'F\SJ,\U MCY=1"PQ7" ,;/,WXA VC/JA :J4@4IY9<:=4*IR>Q]L,YU>;R-P![R\BHQ*A:.D8P13[DF$EH9_A=[[0QR M.,4?&CTM3I19C=GDOI@TM'@9?*!FY"(+F)UW]1BC7T M&KSHM,VI'5 ')$U"R4J$;%A=4FH,.04TOB&+L*&&4J^0A6<6LTN6=.V2EJIUU8(@RF'A&)F@#SS.%WB-M42K*_SSHG30(1EY1W3L?P(49I++]T. M/P9@2BW3,2J==%G7OG/2#-GN+R"H0Q<0U(<,>!V&"!!E'%-MB3#!5U3!CK<& M06W/+-NA!;D5B1!V+_)_N ,B_X?+&'-(X;##$AYI;@4FSC%"K"&QB,B9'1*V M+_+&$+[6=!;/M?9.88QTO &N!?>.Q&?V/%=(V)0@[>O)M6PM2'LJKD.7;V+6 M6Z.QDBK,6A@;:Q>%,0G=N#R3;4%5ZM\4S-@>SWY?5H,]WNOY.21 M]_'Q0:\,UE9['J]@8"ZPY.&_;*VJ$.,^ 99,>10F%PAHM+:<04C+&>*S"UUU M)/UZ)\#-H'Y]X7.L =0 &"V(#R:6]?A^?I+*,XMHI0JY9OB\&:BO,WPNF;92 M'S8(\[$B9"H)(FS,@&2ZK2 MS0B>V1W5%F1<*WS>#-77&3ZGB&F&@EX.WK_&DMK@0MW-43 ,SOU9W,1MJB58 M7VGXG!DLH;!6,DZ ]( $S^UNCE* %$*48< M,?$F]^UXL4??3_B\KMR>A\^;0=B]R/4AD>L/F7;06V% 5,<#0:NMC1M]9L\B=2#RIA#V(/)#BMU\R,(> MQ VPGB!)G-)>@7C=ZW:\QN@SN[W=@H_P<:/V1=X8PNY%_OY0D=7W?\T$Y5QZ[03A$F$6'!8#RO$" M05)*4/'O0>2-(>Q>Y!_^?D#D'_Z>(8HHB97&.99AM H);2IS,_PG0>3B>Q!Y M8PB[%_FG0WOYIP^9TCJ8& (@KCTR4#,,JXTHOB6=('+Y/8B\,80G9:E\G!:; M8X4L'W^38>EAV&08P0K%J+0!N#(J/5=)[S. [ZZ34_;U71: MYVJ]+J;SG7 FLWQ]>7!;J=L\"\L)0B2,=4XI923DKHI<*0_/Y YQ)](M.H>[ MM]3JQ'+^))C-.J9T$,BQ I@86\TJ:.PS"R>V?-B??#-&3-B7UQV0UNPEH[=1=^(=O^61U:!LZT" 3 MSG$CB#$<04EC!2)1A5DXX&=V22]=;$4'J)YV^2*?SA?SR=M\4VQ7RWRR/<2 M%S[.$/,V.&1QVE9 R 'P5<2%\:0(Q@B/F=N4?CN(GB;Y(A@V\\5_;O//^;28 MKS]N5V_SL/E-IF[S=O)QLMSDP?_^C_!?__=KL*^"776PKLW)W64HWD_! '-L M+/6: ^Q*ELOP;^=V-[Q-]O2$>3N:9=]H)X='N[N1U$@CI?U()A60G 9,-(, M82 \*0.)TJ<5%QRC[=NE)NM5$J=90+/)]4%V/?@@TUPY1:REA KHPZ9L734> MPD5*'N4(3]Q;M7!.1O&T8,OVOR;+9?X?D^GOX<.#<94]7V;46B* YK;^-R- MXL;@

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end